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The United Kingdom Focal Point on Drugs 
 
The United Kingdom (UK) Focal Point on Drugs is based at the Department of Health 
and the North West Public Health Observatory at the Centre for Public Health, 
Liverpool John Moores University.  Along with equivalent organisations in other 
European Union (EU) Member States, the Focal Point provides detailed information 
to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) on the 
drug situation in England, Northern Ireland, Scotland and Wales.   
 
The Focal Point works closely with the Home Office, other Government Departments 
and the devolved administrations.  In addition to this annual report, it collates an 
extensive range of data in the form of standard tables and responses to structured 
questionnaires, which are submitted regularly to the EMCDDA.  It also contributes to 
other elements of the EMCDDA’s work such as the development of its five key 
epidemiological indicators, the Exchange on Drug Demand Reduction Action 
(EDDRA) and the implementation of the Council Decision on New Psychoactive 
Substances. 
 
The United Kingdom Focal Point website can be found at www.ukfocalpoint.org.uk 
and is currently under development. 
 
The EMCDDA's website is www.emcdda.europa.eu 
 
The Head of the United Kingdom Focal Point on Drugs is Alan Lodwick at the 
Department of Health (alan.lodwick@dh.gsi.gov.uk).  
 
 
The structure and content of this report 
 
The structure and content of this annual report are pre-determined by the EMCDDA 
to facilitate comparison with similar reports produced by the other European Focal 
Points.  Ten chapters cover the same subjects each year, and three further chapters, 
giving in-depth information on selected issues, change from year to year.  
 
Each of the first ten chapters begins with an Overview.  This sets the context for the 
remainder of the chapter, describing the main features of the topic under 
consideration within the United Kingdom.  This may include information about the 
main legislative and organisational frameworks, sources of data and definitions used, 
the broad picture shown by the data and recent trends. 
 
The remainder of each chapter is concerned with New Developments and Trends 
that have not already been reported in previous reports. Generally, this includes 
developments that have occurred in the second half of 2005 or the first half of 2006. 
Relevant data that have become available during this period will also be discussed 
although these will often refer to earlier time periods. 
 
This report, and the reports from the other European countries, will be used in the 
compilation of the EMCDDA’s annual report of the drug situation in the European 
Union and Norway to be published in 2007. 
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The United Kingdom and its constituent countries 
 
 
The United Kingdom population was estimated to be 60.2 million in the middle of 
2005 (ONS et al. 2006): 83.8 per cent (50.4 million) live in England, 8.5 per cent (5.1 
million) in Scotland, 4.9 per cent (3.0 million) in Wales and 2.9 per cent (1.7 million) 
in Northern Ireland.   
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SUMMARY 
Main findings 
1. National policies and trends 
Classification of the following drugs has been considered and the following decision 
reached: 
• methylamphetamine to be reclassified from Class B to Class A; 
• ketamine was classified as a Class C drug; 
• cannabis remains Class C; and  
• khat is not to be classified. 
 
A new Northern Ireland Drug and Alcohol Strategy was published in 2006. 
 
There has been a strengthening of the law to tackle drugs and crime.   
• Drug testing is being introduced in Scotland.  
• In England and Wales further implementation of provisions of the Drugs Act 2005 
has led to: 
 drug testing on arrest; 
 Required Assessment for suspected drug users arrested by police; 
 Restriction on Bail for drug misusers,  
 a new probation order, the Drug Rehabilitation Requirement, for those 
sentenced to a community sentence; and  
 a new presumption of intent to supply. 
 
Importantly, failure to attend and remain for the duration of a required assessment 
can result in a fine and/or custody.   
2. Drug use in the population 
Latest survey data for England and Wales are for 2005/06.  These show that the fall 
in recent and current prevalence of drug use amongst adults aged 16 to 59, first seen 
in 2004/05, has continued.  Cannabis use has continued to decline, whereas the 
previous fall in cocaine use has been reversed.  Similar trends can be seen for young 
adults.  
 
Data for Scotland are for 2004 and show the same downward trend in drug use 
identified in England and Wales in 2004/05. 
 
Amongst school children in England drug use has remained broadly level since 2001 
with a suggestion of a recent dip. 
 
3. Prevention  
The ACMD suggests that there should be a reassessment of the role of schools in 
drug prevention, informing of hazards associated with drug use. 
 
The Inspectorate of Schools in England has criticised schools for not placing enough 
emphasis on the negative social consequences of substance use. 
 
Drug testing is being piloted in several schools in Kent, but the idea has been 
rejected by the Scottish Executive. 
 
There is continued emphasis on vulnerable young people.  In England, the Home 
Office and the Department for Education and Skills are working towards ensuring that 
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any professional group working with young people are able to identify drug misuse 
and a Common Assessment Framework was introduced in 2006.  
 
4. Problem drug use   
Problem prevalence estimates have been produced for Northern Ireland suggesting 
prevalence of 1,395 (1.28 of per thousand population problem drug users (95% CI = 
1.21 to 1.75).  A wider estimate for problem opiate and / or problem cocaine use was 
also obtained, with 3,303 problem opiate or problem cocaine users, a rate of 3.03 per 
thousand population (95% CI = 2.84 to 3.95). 
 
5. Treatment 
Recent initiatives to improve the evidence base include: 
• surveys of inpatient services in England;  
• a review of the evidence on treatment effectiveness; and  
• a further round of research funded by Government under the Drug Misuse 
Research Initiative. 
 
There have been several initiatives to strengthen the treatment system, including: 
• an Updated Models of Care;  
• new guidance on needs assessment; 
• the National Institute for Health and Clinical Excellence to produce clinical 
guidance for:  
 psychosocial management; 
 methadone and buprenorphine treatment; 
 opiate detoxification;  
• consultation on residential rehabilitation;  
• Clinical Guidelines on drug misuse to be updated; 
• Healthcare Commission improvement reviews into substance misuse services; 
• the Healthcare Commission are to undertake a technology appraisal of 
naltrexone as a treatment for relapse prevention in drug misusers; and  
• encouraging the management of drug users in primary care. 
 
There have been several initiatives to improve capacity and skills, including: 
workforce planning; nurses prescribing; and increasing the role of pharmacists. 
 
Two major reports have suggested that while treatment works it is not a simple 
process; these refer to: 
• Treatment Journeys; and  
• Addiction Careers. 
 
Scotland has undertaken work to look at how to provide effective treatment in rural 
areas; this has suggested better use be made of the internet.  
 
Improving treatment for young people prioritised. 
 
6. Health correlates and consequences 
There was an increase in the number of drug related deaths in 2004 though this 
followed a large fall in 2003.  Opiates/opioids, alone or in combination with other 
drugs, continued to account for the majority of fatalities; there were increases in the 
number of cases involving amphetamines, cannabis and cocaine; and GHB was 
found in 3 cases. 
 
The prevalence of HIV among injecting drug users (IDUs) has continued to increase.  
The rise in prevalence probably reflects increased levels of transmission.  The 
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prevalence of HIV in those who began injecting in the last three years is a measure 
of recent transmission. 
 
Data indicate that overall more than four in ten IDUs have been exposed to hepatitis 
C infection in the United Kingdom.  There is also evidence that suggests that the 
prevalence has increased, for example, among current IDUs. 
 
The prevalence of hepatitis B remains stable. 
 
The outbreaks of hepatitis A seen among IDUs and the homeless in parts of the 
United Kingdom appear to have waned. 
 
7. Responses to health correlates and consequences 
In Scotland there is a new strategy and action plan to reduce drug related deaths.  A 
pilot has begun for heroin users to be issued with naloxone. 
  
In England, D(A)ATs are to have their performance measured in meeting hepatitis B 
prevention targets.  There is to be a review of hepatitis testing and vaccination 
against hepatitis B of all clients in drug treatment.  
 
Results from a syringe exchange audit in Scotland and England found that: 
• pharmacists were limited in providing interventions necessary to reduce drug-
related harm and blood-borne viruses, suggesting that pharmacy schemes should 
be complementary to agency based services rather than seen as an alternative 
facility;  
• not all agency based services provide comprehensive harm reduction and 
hepatitis prevention measures;  
• many did not address hepatitis B vaccination and testing; 
• did not offer immunisation on site: and 
• did not address hygiene and safer injecting techniques. 
 
There have been changes to the way mental disorder is defined to make it clear that 
people who are dependent on alcohol and drugs are not excluded from the scope of 
the Mental Health Act if they also suffer from another mental disorder.  
 
Considerable work has been undertaken in Scotland to address the needs of children 
of drug using parents, with a strategy published. 
 
8. Social correlates and consequences 
There was an increase in the number of persons found guilty, given a fiscal fine or 
dealt with by compounding for drug offences in the United Kingdom in 2004, with a 
rise in offences concerning amphetamines, cocaine, crack, ecstasy and heroin, but a 
fall in those concerning cannabis and LSD.  The fall in offences concerning cannabis 
is probably associated with changes in its classification in 2003. 
 
Positive results for mandatory drug testing of the prison population fell in 2005/06 in 
England and Wales, but increased in Scotland. 
 
A survey of prisoners in Scotland found that:  
• half of prisoners reported using drugs at some point in the past; and 
• 34 per cent reported drug use in the month immediately prior to survey 
completion.   
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9. Responses to social correlates and consequences 
A consultation has been undertaken concerning the Supporting People initiative 
which seeks to find appropriate accommodation for former, or recovering, drug users; 
results of this have not yet been published.  In England and Wales, a Comprehensive 
Rent Deposit Model, funded by the Drug Interventions Programme, aims to help drug 
misusing offenders leaving prison find accommodation. 
 
In England, education, training and employment are to be integrated into treatment 
plans.  A report has been published on best practice in helping drug users to find 
employment. 
 
In England and Wales, an Integrated Drug Treatment System will enhance the 
treatment of prisoners.  In Scotland, a new Throughcare Addiction Service, which 
aims to help prisoners who have been drug users to access services appropriate to 
their needs on release from custody, replaces the Transitional Care Initiative.  
 
In England and Wales, the requirement for drug users to engage in treatment has 
been strengthened through the ‘Tough Choices’ programme, which, in addition to 
changes to better identify drug users though the criminal justice system, and the 
required assessment and treatment referred to in section 1 of this summary, also 
includes the introduction of Conditional Cautioning nationally; and stronger links the 
programme targeting Prolific and Other Priority Offenders.  
 
Scotland is to introduce testing on arrest.  
 
Drug courts are being piloted in England.  In Scotland, previously piloted drug courts 
will run for a further 3 years in Glasgow and Fife, based on evidence of reduced 
offending. 
 
Northern Ireland is to introduce Drug Treatment and Testing Orders.  
 
Scotland is to introduce arrest referral following evaluation of pilot schemes. 
 
There are two new criminal justice interventions for young people being piloted in 
England and Wales; drug testing for 14 to 17 year olds and two community 
sentences for 10 to 17 year olds who have, or are at risk of developing, substance 
misuse problems.  
 
10. Drug Markets  
Seizures data for all of the United Kingdom are not yet available but, in England and 
Wales, seizures fell by two per cent in 2004.  Cannabis remains the most seized 
drug.     Seizures of heroin and cocaine rose.  
 
The price of heroin, ecstasy and cocaine has fallen since 2004, while the price of 
cannabis, crack cocaine and LSD has remained stable; the price of amphetamines 
increased by more than ten per cent in 2005, having fallen in recent years. 
 
The average purity of most drugs decreased.  Heroin seized by HM Revenue and 
Customs was purer than that seized by the police.  The purity of heroin seized 
increased considerably between 2003 and 2004. 
Most relevant developments and trends 
In terms of epidemiological indicators the most relevant trends are: 
The fall in prevalence of drug use in the general population, including prevalence of 
cocaine.  However cocaine use has continued to increase amongst young people in 
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England and Wales.  A rise in cocaine use amongst school children in England 
should be treated with caution. 
 
Also relevant is the increase in drug related deaths, though again the trend is 
downward.  There has been a small increase in HIV and in hepatitis C. 
 
It is difficult to pick out the most relevant issues in terms of response, given the large 
number of initiatives in the United Kingdom.  However, perhaps most important are 
those that relate to treatment: both treatment per se with initiatives to improve the 
evidence base; to strengthen the treatment system with measures to improve 
capacity and staff skills; as well as initiatives to provide for vulnerable young people.  
Of major significance has been a strengthening of initiatives to identify drug users in 
the criminal justice system.  In Scotland, and in England and Wales, arrestees can be 
tested for drugs on arrest, rather than only once charged.  Also, the new sentencing 
order, the Drug Rehabilitation Requirement; the latter, with Required Assessment 
and Restriction on Bail make assessment a requirement for those identified as using 
Class A drugs; failure to comply may result in a fine and/or custody.  There is also a 
new presumption of intent to supply, targeting dealers.  In Scotland and Northern 
Ireland arrest referral and Drug Treatment and Testing Orders will enhance referral 
into treatment from the criminal justice system. 
Consistency between indicators 
Opiates continue to be the main drug for most treatment presentations in the United 
Kingdom. Seizures of heroin rose slightly in 2004, and the number of persons found 
guilty or cautioned for drug offences involving heroin rose.  In the United Kingdom 
there has also been an increase in the number of deaths where heroin or morphine 
was mentioned. 
 
The latest survey data in the United Kingdom show an increase in cocaine use within 
the general population.  Treatment demand in the United Kingdom for cocaine has 
increased since 2003/04 and there has been an increase in the number of deaths 
where cocaine was mentioned.  The number of persons found guilty or cautioned for 
drug offences involving cocaine and crack rose in 2004.  Further, there has been 
concern over an apparent increase in risk behaviour with respect to infectious 
disease transmission by injecting of crack cocaine. 
 
Use of amphetamines, having fallen considerably in previous years, continued to fall 
in 2005/06.  The number of persons found guilty or cautioned for drug offences 
involving amphetamines had risen in 2004. 
 
The number of persons found guilty or cautioned for ecstasy offences in the United 
Kingdom in 2004 rose slightly and there was an increase in the number deaths 
associated with ecstasy. 
 
Cannabis use has continued to fall in the adult population and the decline in use 
amongst school children appears to be continuing.  Treatment demand for cannabis 
rose. The number of persons found guilty or cautioned for cannabis offences in the 
United Kingdom fell in 2004; this is probably associated with the change in the 
classification of cannabis from Class B to Class C in 2003. 
 
Lifetime use of magic mushrooms showed a rise amongst adults in 2005/06, but 
current use declined significantly.  This is probably associated with changes in the 
law on magic mushrooms which mean that they are classified, regardless of whether 
or not they have been processed. 
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PART A: NEW DEVELOPMENTS AND TRENDS 
1. National policies and trends 
1.1 Overview  
The Misuse of Drugs Act 1971 divides controlled drugs into three classes (A, B and 
C) depending on their potential for harm.  Drugs are placed in these three classes to 
reflect their relative harms, and maximum criminal penalties for possession, supply 
and production are set accordingly.  In January 2004, cannabis was reclassified from 
Class B to Class C; in January 2006 ketamine was brought under the control of the 
1971 Act as a Class C drug and in June 2006 Government announced its decision to 
reclassify methylamphetamine from Class B to Class A.  There has been a 
consultation on the threshold for possession for personal use of controlled drugs.  
The Drugs Act 2005 amended sections of the Misuse of Drugs Act 1971 and the 
Police and Criminal Evidence Act 1984, strengthening police powers in relation to 
drug use.   
A United Kingdom Drug Strategy was launched in 1998 (UKADCU 1998) setting four 
principal aims: preventing drug use amongst young people; safeguarding 
communities; providing treatment and reducing availability, to be achieved through 
education, prevention programmes, expanded treatment, legal sanctions and the 
expansion of legal measures.  The Strategy was updated in 2002 with an increased 
emphasis on Class A drugs and problem drug users (DSD 2002).  Government 
targets for the Strategy are detailed in the Public Service Agreements, placing 
responsibility on a number of Government departments to meet the targets set.  Each 
of the devolved administrations1 (Northern Ireland, Scotland and Wales) has its own 
strategy, reflecting the aims of the United Kingdom Strategy, but tailored to their 
individual circumstances (NIO 1999; Scottish Office 1999; National Assembly for 
Wales 2000).  Northern Ireland launched a new combined drugs and alcohol strategy 
in 2006 (DHSSPSNI 2006a) and in Wales consultation is beginning to renew the 
Welsh strategy. 
 
Delivering the Drug Strategy is a cross-government initiative.  Since 2002, this has 
been led by the Drug Strategy Directorate (DSD) in the Home Office; in 2006 this 
was merged with the Crime Reduction Directorate in the Home Office to create the 
wider Crime and Drug Strategy Directorate (CDSD).  In all four administrations 
delivery is through local multi-agency partnerships.2  
 
A Drug Harm Index measures the impact of the Drug Strategy on reducing the harms 
associated with illegal drugs.  Latest evidence shows that the index has fallen by 
27.9 points (24%) between 2002 and 2004, a reduction from the baseline value 115.8 
points, at the introduction of the Updated Drug Strategy in 2002, to 87.9 points in 
2004. 
                                                 
1 Devolution is the delegation of power from the UK Parliament to the Scottish Parliament and 
Welsh and Northern Irish Assemblies in specific policy areas. 
2 In England known as Drug Action Teams, or if they also take responsibly for alcohol, Drug 
and Alcohol Action Teams (referred to collectively here as D(A)ATs), in Northern Ireland, 
Alcohol and Drugs Co-ordination Teams (ADCTs), In Scotland Alcohol and Drug Action 
Teams (ADATs) and in Wales, Substance Misuse Action Teams (SMATs). 
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1.2 Legal Framework 
1.2.1 Laws, regulations, directives or guidelines 
Review of the drug classification systems  
In January 2006, the then Home Secretary announced a review of the drug 
classification system (Home Office 2006a).  However, in October 2006 the 
Government announced, in its response to a House of Commons Science and 
Technology Committee report on reclassification, that it would not be proceeding with 
a review (see 1.5.3). 
Thresholds for the possession of controlled drugs 
The Home Office has undertaken a consultation, seeking the views of the police, 
courts and drugs agencies on the setting of particular thresholds for the possession 
of controlled drugs (Home Office 2005a).  The Home Secretary has subsequently 
announced that he does not intend to proceed with the provision establishing these 
thresholds (Home Office 2006b).  
 
During the reporting period, consideration has been given to the classification of a 
number of drugs under the Misuse of Drugs Act 1971. 
Ketamine 
Ketamine was brought under the control of the Misuse of Drugs Act 1971 as a Class 
C drug on January 1st 2006 having been previously unclassified.3  
Cannabis  
Following a report by the Advisory Council on the Misuse of Drugs (ACMD)4, (2005a) 
cannabis remains a Class C drug (Home Office 2006c).  ACMD’s latest report stated 
that: 
“After a detailed scrutiny of the evidence, the Council does not advise the 
reclassification of cannabis products to Class B; it recommends they remain within 
Class C.  While cannabis can, unquestionably, produce harms, these are not of 
the same order as those of substances within Class B.  Nevertheless, the Council 
wishes to emphasise that cannabis is harmful.  We therefore recommend that: a) 
further efforts are made to discourage consumption through the development and 
delivery of a sustained education and information strategy; b) the availability of 
appropriate treatment services, for those individuals who are experiencing 
difficulties arising from the use of cannabis, is reviewed by the Health 
Departments; and c) research into the relationship between cannabis use and 
mental health problems continues to be supported by public and private funds.” 
(ACMD 2005a: Foreword). 
 
The report did however suggest that:  
“the weight of evidence ….suggests an association between cannabis use and the 
development of psychotic symptoms which is consistent between studies and 
which remains after adjustment for confounding factors. While bias and residual 
confounding factors cannot be entirely excluded, these are unlikely fully to explain 
the findings”, also that, “the current evidence suggests, at worst, that using 
cannabis increases the lifetime risk of developing schizophrenia by 1%.” (p.11). 
 
                                                 
3 See: 
http://www.publications.parliament.uk/pa/cm200506/cmstand/deleg1/st051031/51031s01.htm 
4 The ACMD is an independent body comprising experts from a range of backgrounds in the 
drugs field. 
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It also noted that the extent to which the potency of cannabis products, as used by 
consumers, has increased over the past few years is unclear.  However, based on 
current evidence it is suggested that the potency of most cannabis products appears 
to be unchanged, though the potency of sinsemilla5 may have doubled over the past 
10 years. 
Khat 
Three reports on khat use were published in 2005.  Two were research reports 
(Turning Point 2005 and Patel et al. 20056) looking at use amongst Somali, Ethiopian 
and Yemeni communities in the United Kingdom and suggesting there were 
problems with use.  ACMD was also asked by Government to carry out a review of 
the scientific evidence about the impact of khat use, risks and current treatment 
options (ACMD 2005b).  On the basis of the evidence, the Council recommends that,  
“Khat is not controlled under the Misuse of Drugs Act 1971.  Use of the substance 
is very limited to specific communities within the United Kingdom, and has not, 
nor does it appear likely to, spread to the wider community.  However, that is not 
to say that use of khat is without detrimental effects and its use should be 
discouraged.” (p.1). 
 
In keeping with this the ACMD made a number of other recommendations relating to 
educating and informing users and potential users of the harms associated with khat 
use, ensuring effective advice and treatment is available and restricting supply to 
children.  In particular, it felt that this education should be focused through local 
communities, including peer education models, and through primary care services 
and not exclusively through addiction services.  It also recommended that education 
activity should reach females.  The ACMD suggested that users, when seeking 
advice and help, should not automatically be encouraged to attend addiction 
services.  
 
On the basis of the report the Government has not classified khat under the Misuse 
of Drugs Act 1971 (Home Office 2006a). 
Methylamphetamine 
In 2004 the Government asked the ACMD to review the scientific evidence of the 
harmful effects of methylamphetamine and the nature of the threat posed to the 
United Kingdom.  The ACMD’s report concluded that methylamphetamine had the 
potential to be very harmful to both individuals and society (ACMD 2005a).  However, 
at that time it recommended that methylamphetamine should not be reclassified to 
Class A as there was little evidence that there was significant use of it in the United 
Kingdom and that reclassification might draw unwanted attention to its properties.  
When making this recommendation, the ACMD also made a series of 
recommendations relating to an “early warning system”.   Furthermore, they 
undertook to review their position within 12 months.  
The ACMD reconsidered its position in 2006.  Having received evidence that 
indicated that use was starting to become more widespread and that the police had 
become aware of the existence of a small number of domestic illicit laboratories 
                                                 
5 Sinsemilla, a higher potency preparation, which is both imported and home-grown, 
comprises the flowering tops from unfertilised, female cannabis sativa plants and is most 
commonly produced by intensive indoor cultivation methods. Skunk is a form of sinsemilla.  
6 ACMD notes that neither of these studies used random sampling techniques.  Khat chewers 
were more likely to be sampled and thus the extent that these findings can be generalised to 
the communities studied is limited. It is apparent that khat use is widespread in the 
communities mentioned but almost unknown outside of these ethnic groups. 
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making it in the United Kingdom, it revised its advice and recommended 
reclassification as a Class A drug.  Following this, it was announced in June 2006 
that methylamphetamine was to be become a Class A drug (Home Office 2006d).  
The parliamentary process required to effect the law change is underway and it is 
likely that methylamphetamine will be reclassified in the early part of 2007.  
Date rape drugs: GHB and Rohypnol 
In January 2006 the ACMD was asked to consider the classification of so-called date 
rape drugs, including GHB and flunitrazepam (marketed in the United Kingdom as 
“Rohypnol”) (Home Office 2006a).7  Findings have not yet been published. 
The management of controlled drugs  
The Home Office published a consultation paper setting out its proposals to amend 
the Misuse of Drugs Regulations (2001), in order to implement elements of an action 
programme published in Safer Management of Controlled Drugs (HM Government 
2004), the Government’s Response to the Fourth Report of The Shipman Inquiry.  
The purpose of the proposed changes is to strengthen the system for managing 
controlled drugs in order to minimise the risk of their inappropriate use.  The changes 
will be introduced over a period of time, the first two sets of changes being 
implemented in July 2006 (Home Office 2006a).  The Health Act 2006 also 
strengthened the governance arrangements around controlled drugs in the health 
and social care setting.  Regulations under the Act will become available in the near 
future. 
 
Guidelines have been issued about the safe management of controlled drugs in the 
primary care setting (DH 2006a). 
Drug testing on arrest in Scotland  
The Police, Public Order and Criminal Justice (Scotland) Act (2006) provides for drug 
testing and referral on arrest, bringing Scotland in line with England and Wales (see 
section 1.2.2).  Provisions will commence in 2007 and will be piloted in the first 
instance. 
Research  
Following on from previous research on the policing of cannabis (May et al. 2002), 
the Joseph Rowntree Foundation has commissioned research following the 
reclassification of cannabis from Class B to Class C.8  The research is due to be 
completed in the early part of 2007.  
1.2.2 Laws implementation 
Implementation of provisions of the Drugs Act 2005 
As part of action to reduce drug related crime, from 1st December 2005 the police 
have been allowed to test for drugs on arrest.  This implements the provisions of the 
Drugs Act 2005 (see Chapter 9.3.2) (Home Office 2005b). 
 
Under the provisions of the Drugs Act 2005, courts are expected to treat as an 
aggravating factor, when considering the seriousness of an offence, dealing on, or in 
the vicinity of, school premises, or use of children as couriers in drug transactions.  
This provision commenced on 1st January 2006 (see Chapter 9.3.2) (Home Office 
2005c). 
                                                 
7 For more information see:  
http://press.homeoffice.gov.uk/press-releases/home-sec-resp-to-ACMDs?version=1  
8 For more information see: http://www.jrf.org.uk  
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From the same date, police have also been given powers to require x-rays from 
suspects they believe may have swallowed cocaine or heroin, or intimate searches of 
those believed to have secreted drugs in a bodily orifice to avoid detection.  A court 
may draw such inferences as it considers appropriate from an unreasonable refusal 
to consent to such procedures.  In addition, suspected drug "mules" can be 
remanded by a magistrate into police custody for up to 192 hours, to allow extra time 
for drugs to pass through their systems (Home Office 2005c). 
 
Provisions in the Criminal Justice Act 2003 were brought into force on the 4th April 
2005 introducing the new community order that replaces the Drug Testing and 
Treatment Order (DTTO), and other community orders, for adults.  The new order, 
with individual requirements selected by the court, is expected to allow provision to 
be tailored to the seriousness of the offence and offence-related needs of the 
individual as it will consist of a “menu” of requirements including the Drug 
Rehabilitation Requirement for different types and levels of drug treatment (see 
Chapter 9.3.2).  
Implementation of the law on cannabis  
In order to reinforce the law on cannabis and the harms associated with its use, a 
widespread education campaign on the harms of cannabis (and all illegal drugs) 
began in 2006.  In partnership with the Department for Education and Skills (DfES), 
the Home Office has produced Understanding Drugs, a comprehensive teacher and 
pupil information pack which is now available online.9  The FRANK campaign has 
updated its cannabis information resources with new TV and radio adverts and 
information leaflets coming on stream.  In addition, the Department of Health will be 
issuing a toolkit for Mental Health practitioners on the links between cannabis and 
mental health.  
 
The police are to focus on strong action to reduce the supply of cannabis.  The 
Association of Chief Police Officers of England, Wales and Northern Ireland (ACPO) 
has conducted a consolidated campaign of action to address the production of 
cannabis.  At the same time, it is to revise and strengthen its guidelines for dealing 
with policing cannabis (Home Office 2006b). 
1.3 Institutional framework, strategies and policies 
1.3.1 Co-ordination arrangements 
See section below for Northern Ireland. 
1.3.2 National plan and/or strategies 
Strengthening of policy to treat drug users who commit crime 
The Drug Interventions Programme (DIP) has been strengthened by the introduction 
of measures contained in the Drugs Act 2005 mentioned in the previous section; 
Testing on Arrest, rather than on charge; and Required Initial Assessments for those 
testing positive.  These provisions were implemented across three selected police 
force areas from 1st December 2005 and were then expanded to all other DIP 
                                                 
9 See: 
http://publications.teachernet.gov.uk/default.aspx?PageFunction=productdetails&PageMode=
spectrum&ProductId=DFES-04214-2006 
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intensive areas10 from the end of March 2006.  By March 2006 Restriction on Bail 
provisions were extended to all Local Justice Areas across England (See 1.2.1 with 
respect to drug testing on arrest in Scotland).  The Home Office review of the criminal 
justice system, Rebalancing the Criminal Justice System in favour of the Law-Abiding 
Majority, announced that the required follow-up assessment would be introduced 
(Home Office 2006e).  The new Drug Rehabilitation Requirement, a community 
based sentence, also further strengthens drug policy to treat drug users involved in 
crime.  
New Drug strategy for Northern Ireland  
A new Drug Strategy for Northern Ireland was published in May 2006, New Strategic 
Direction for Alcohol and Drugs 2006-2011 (DHSSPSNI 2006a), combining both 
drugs and alcohol in one strategic framework.  The overall aim is to reduce the level 
of alcohol and drug related harm in Northern Ireland.  Long term aims are to: 
• provide accessible and effective treatment and support for people who are 
consuming alcohol and/or using drugs in a potentially hazardous, harmful or 
dependent way; 
• reduce the level, breadth and depth of alcohol and drug-related harm to users, 
their families and/or their carers and the wider community;  
• increase awareness on all aspects of alcohol and drug-related harm in all settings 
and for all age groups;  
• integrate those policies which contribute to the reduction of alcohol and drug-
related harm into all Government Department strategies; 
• develop a competent, skilled workforce across all sectors that can respond to the 
complexities of alcohol and drug use and misuse; 
• promote opportunities for those under the age of 18 years to develop appropriate 
skills, attitudes and behaviours to enable them to resist societal pressures to 
drink alcohol and/or use illicit drugs , with particular emphasis on those identified 
as potentially vulnerable; and 
• reduce the availability of illicit drugs in Northern Ireland.  
 
Five supporting pillars have been identified which are to provide the conceptual and 
practice base.  These are: prevention and early intervention; treatment and support; 
law and criminal justice; harm reduction; monitoring, evaluation and research.  A 
number of key performance indicators have been set to measure achievement; these 
will form the basis of an annual report.  
 
In common with all strategic and local practice throughout the United Kingdom, 
integration and co-ordination between policy development and providers is seen as 
key to effective provision for substance misusers.  
 
Local Drugs and Alcohol Co-ordination Teams will continue, although they will be 
redesignated as local Alcohol and Drugs Co-ordination Teams (ADCTs).  
 
In order to ensure effective and co-ordinated implementation the following structure, 
a new Strategic Direction for Alcohol and Drugs Steering Group (NSDSG) will 
maintain an overview of the NSD.  Reporting to the NSDSG will be four advisory 
groups who will address the following areas: 
• Children, Young People and Families. 
• Treatment and Support. 
                                                 
10 intensive areas are those with the highest levels of acquisitive crime. Approximately 70 
Drug Action Team areas in England have been classified as intensive areas. 
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• Law and Criminal Justice. 
• ‘Binge Drinking’. 
1.3.3 Implementation of policies and strategies 
Northern Ireland drug strategy  
See above (1.3.2) for new implementation arrangements in Northern Ireland  
Local Area Agreements 
In England, Local Area Agreements (LAAs) are a new contract between central and 
local government to deliver the priorities of local people.11  The key aim is to improve 
the effectiveness and efficiency of the way Government works with local authorities 
and their delivery partners, to improve public services, allowing greater flexibility for 
local solutions to meet local circumstances.  LAAs simplify central funding and 
reporting requirements.  An LAA is a three year agreement, based on local 
Sustainable Community Strategies12, that sets out the priorities for a local area. The 
agreement is made between Central Government, represented by the Government 
Office and a local area, represented by the lead local authority and other key 
partners through Local Strategic Partnerships (LSPs).13  One of the mandatory 
outcomes is to reduce the harm caused by drug misuse; as a minimum requirement 
this is to be measured by public perceptions of local drug dealing and drug use.  
LAAs were signed with 20 first wave areas in March 2005 and a second wave of local 
authority areas signed them in 2006.  The intention is that all 150 lead local 
authorities in England will be party to an LAA from April 2007 (ODPM 2006). 
Local Delivery Plans 
Local Delivery Plans (LDPs) provide the main mechanism for the Department of 
Health (DH) to ensure national priorities are met.  At the local level Primary Care 
Trusts (PCTs) agree LDPs with all key stakeholders within the National Health 
Service (NHS), across local government and with other agencies.  These LDPs are 
agreed by higher level Strategic Health Authorities (SHAs).  At this level it is 
expected that plans submitted to, and ultimately signed off by, the Department of 
Health must, as a minimum, meet national target levels.  The key measures for drug 
misuse within this are defined as: 
• an increase in the participation of problem drug users in drug treatment 
programmes by 100 per cent by 2008 (from a 1998 baseline); and  
• increase year on year of the proportion of users successfully sustaining or 
completing treatment programmes. 
 
Additonal targets have since been set regarding performance indicators for 
assessment in 2005/2006 and include: an increase in the percentage of users 
sustained in treatment for 12 weeks in community services (Healthcare Commission 
2006). 
 
Local D(A)ATs and PCTs have been encouraged to set local "stretch targets" for 
those in treatment that reflect both current performance against their LDPs and 
improvements on these (DH internal communication 2006). 
                                                 
11 For more information see: http://www.communities.gov.uk/index.asp?id=1161632  
12 For more information see: http://www.communities.gov.uk/index.asp?id=1139881  
13 For more information see: http://www.communities.gov.uk/index.asp?id=1133894  
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The Drug Interventions Programme: Tough Choices Project 
In England and Wales, the Tough Choices Project, initiated in December 2005 as 
part of the Drug Interventions Programme expanded the programme to include three 
new elements; Testing on Arrest, Required Assessment and Restriction on Bail, in 
order to increase the number of drug misusing offenders being directed into 
treatment via the criminal justice system (DSD 2005a).  Importantly, assessment and 
treatment became a requirement for those identified as using Class A drugs.  Failure 
to comply may result in a custodial sentence (see Chapter 9.3.2).  
Changes in the Drug Strategy Directorate  
In April 2006 the Drug Strategy Directorate merged with the Crime Reduction 
Directorate in the Home Office to create the wider Crime and Drug Strategy 
Directorate at the Home Office (CDSD).  
1.3.4 Impact of policies and strategies 
Drug Harm Index  
In England, the impact of the Drug Strategy is measured predominantly by 
performance against Public Service Agreements (PSAs).  An overarching PSA 
target, which encompasses measures on reducing the availability of drugs, drug-
related crime and other harms caused by drug misuse, is measured by the Drug 
Harm Index (DHI).  The index captures the harms generated by the problematic use 
of any illegal drug by combining national indicators into a single figure which can be 
tracked as an index over time.  The harms include domestic and commercial drug 
related crimes, community perceptions of drug problems, drug nuisance and health 
impacts such as blood-borne viruses, overdoses and drug-related deaths. Current 
performance against the PSAs is shown in Table 1.1. 
 
Table 1.1: Performance against PSAs 
 
Public Service 
Agreement 
Government 
Department 
Responsible
Performance 
To reduce the harm 
caused by illegal drugs, 
including substantially 
increasing the number 
of drug-misusing 
offenders entering 
treatment through the 
Criminal Justice 
System 
Home Office  The Drug Harm Index shows a reduction of 27.9 
points or 24% from the baseline value of 115.8 
points, at the introduction of the Updated Drug 
Strategy in 2002, to a current value of 87.9 
points (Macdonald et al. 2006). The number of 
drug-misusing offenders entering treatment 
through the Criminal Justice System currently 
exceeds 2,800 each month, from a baseline of 
384 in March 2004 (Home Office 2006 – internal 
communication)  
To increase the 
participation of problem 
drug users in drug 
treatment programmes 
by 100% by 2008 and 
increase year-on-year 
the proportion of users 
successfully sustaining 
or completing treatment 
programmes 
Department 
of Health 
(England) 
In 2005/06, 113% more people entered drug 
treatment than in 1998 (181,390 drug users 
were in structured treatment in 2005/06 
compared to 85,000 in 1998). Of those people, 
78% either successfully completed treatment in 
2005/06 or were retained in treatment on 31 
March 2006, compared to 75% in 2004/05 
 
To reduce the use of 
Class A drugs and the 
frequent use of any 
illicit drug among all 
Department 
for Education 
and Skills 
(England)  
In 2005/06, the use of Class A drugs in the last 
year amongstamongst young people aged 16-24 
was stable, compared to both 1998 and 2003/04 
(British Crime Survey 2005/06).  The frequent 
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young people under the 
age of 25, especially by 
the most vulnerable 
young people. 
use of any illicit drug in the last year amongst 
16-24 year olds decreased by 23% in 2005/06, 
compared to 2003/04.  Class A drug amongst 
truants and excludees aged 11-15 was stable in 
2005, compared to 2003 (Department of Health 
Schools Survey).  Frequent drug use in the last 
year amongst truants and excludees aged 11-15 
decreased by 16% between 2003 and 2005 
(Department of Health Schools Survey). 
(NatCen/NFER 2006) (see Chapter 2).  
Scotland  
In Scotland the Drugs Strategy is monitored against a range of national priorities and 
drugs targets set out in Tackling Drugs in Scotland: Action in Partnership (Scottish 
Office 1999), Association of Chief Police Officers in Scotland priorities (ACPOS 
2002), Scottish Prison Service Strategy and the Scottish Drug Enforcement Agency 
(now renamed the Scottish Crime and Drug Enforcement Agency).  
 
Many of the targets have been achieved, including increasing the number of drug 
misusers in contact with treatment and care services by 10 per cent by 2008, and 
reducing repeat offending by increasing the number of drug misusing offenders 
entering treatment from criminal justice diversion and community disposals.  This has 
resulted in 14,332 new clients entering treatment in 2004/05, up 35 per cent from 
2000/01.  
1.4 Budget and public expenditure 
1.4.1 Direct expenditure 
Direct expenditure on tackling drugs in 2005/0614 was €2,17015 (£1,483) million, a 
rise of €203 (£139) million from 2004/05.  The budget was divided into target specific 
areas in the Strategy, as follows: 
• services for young people  €238 (£163) million; 
• reducing the supply of drugs  €556 (£380) million; 
• reducing drug-related crime  €537 (£367) million; 
• drug treatment    €838 (£573) million. 
 
Each of the devolved administrations receives resources for the purpose of 
implementing national policies in areas of policy which have been devolved. This 
includes, with the exception of reducing supply at an international level, the Drug 
Strategy.  Funds are allocated by HM Treasury, under the Barnett formula, which is a 
mechanism that allocates funds to the devolved administrations based on their 
relative proportions of the United Kingdom population and adjusted to take into 
account additional costs generated by, for example, heavy industry or extensive rural 
areas (Home Office - internal communication). 
                                                 
14 UK Government financial years run from the start of April to the end of March. So regarding 
the financial year 2005/06, the year starts on 1 April 2005 and ends on the 31 March 2006. 
Some data in this report relate to calender year, whilst other relate to financial year. Similar 
references are used to refer to financial year. 
15 All conversion rates used in this report will use the exchange rate of £1 equals €1.4629; 
based on the Bank of England annual average (1 January to 31 December 2005) spot 
exchange rate, Euro to Sterling, unless otherwise stated. Please see: 
http://213.225.136.206/mfsd/iadb/index.asp?Travel=NIxIRx&levels=2&C=DMD&FullPage=&F
ullPageHistory=&Nodes=X3790X3791X3873X33940X3801&SectionRequired=I&HideNums=-
1&ExtraInfo=true&G0Xtop.x=46&G0Xtop.y=10 for further details on exchange rates. 
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Scotland  
In 2005/06 €97.6 (£66.7) million was spent on tackling drug misuse.  This includes 
€34.7 (£23.7) million allocated to Health Boards specifically for drug treatment, an 
increase of 92 per cent from 2000/01.  This is in addition to €23.4 (£16) billion which 
is spent on other activities, such as police, courts, the National Health Service (NHS) 
and community justice authorities.  
1.4.2 Funding arrangements 
Local Area Agreements  
See section 1.3.3. 
 
In Scotland, funding is paid through NHS Boards to Alcohol and Drug Action Teams 
(ADATs) to tackle drug misuse.  ADATs allocate funding according to local needs 
and priorities, with a focus on achieving sustainable outcomes for drug misusers, 
their families and the wider community.  This is monitored on an annual basis 
through Corporate Action Plans (CAPs) which are submitted by ADATs to the 
Scottish Executive.  
 
The Scottish Executive is currently undertaking a stock-taking exercise which will 
measure the effectiveness and efficiency of ADATs against the principles of best 
value, including consideration of how best to improve current accountability and 
funding arrangements.   
1.5 Social and cultural context 
1.5.1 Public opinions of drug issues 
In Scotland, respondents to the Scottish Crime and Victimisation Survey (SCVS) 
2004 identified drug abuse as the biggest social problem in Scotland; 76 per cent 
rated it as a ‘big problem’, whereas 60 per cent rated alcohol as a ‘big problem’ and 
59 per cent, crime.  Other social issues such as unemployment, housing conditions, 
standards of education and public transport were rated as less of a problem (Hope 
2006). 
 
In England and Wales, 27 per cent of respondents to the British Crime Survey for 
2005/06 reported that people using and dealing drugs was a problem in their local 
area16 (Walker et al. 2006). 
1.5.2 Attitudes to drugs and drug users 
The majority of respondents to the SCVS thought that “a lot of young people take 
drugs nowadays” and that “young people start taking drugs to keep up with their 
friends”.  There was considerable agreement with the statement that “a lot of crimes 
are committed by people on drugs” and also agreement that “people who have drug 
problems need help not punishment”.  There was overwhelming agreement that 
“injecting drugs is very dangerous”, although around one in seven thought that 
“taking an illegal drug once won’t do you any harm” (Murray and Harkins 2006). 
                                                 
16 The British Crime Survey is a victimisation survey in which adults living in private 
households are asked about their experience of crime.  47,670 individuals were surveyed by 
face to face interview in England and Wales between April 2005 and March 2006.  The overall 
response rate was 75 per cent.  
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1.5.3 Initiatives in Parliament and civil society 
The drug classification system  
A report from the House of Commons Science and Technology Committee 
addressed the relationship between scientific advice and evidence and the 
classification of illegal drugs (House of Commons Science and Technology 
Committee 2006).  It made 50 wide ranging findings, including a number of strong 
criticisms of the drug classification system and the ACMD.  In particular, it suggested 
that the current classification system should be replaced with a more scientifically 
based scale of harm, separated from criminal penalties; that there are anomalies in 
the classification of individual drugs; and that there is a lack of consistency in the 
rationale used to make classification decisions.  It also sets out a number of concerns 
about the make-up, transparency and operation of the ACMD.  
 
In its response to the Committee’s Report, the Government has restated that the 
existing system continues to discharge its function fully and effectively; that the 
current 3-tier system allows for clear and meaningful evidence based distinctions to 
be made between drugs; and that the classification system is by its design a ranking 
of harms and that these harms will continue to be linked to the penalties attached to 
possession and trafficking offences.  Furthermore, the Government confirmed that it 
has faith in the advice provided by the ACMD, although acknowledged some issues 
of transparency could be addressed.  In addition, the Government reiterates that 
whilst legal control contributes to identifying the most harmful drugs, it is the 
Government’s Drugs Strategy incorporating prevention, treatment, education and 
enforcement, that is having the real impact on drug misuse and that it will not be 
distracted from these priorities.  In conclusion, the Government confirms that after 
careful consideration, it will not be proceeding with a review of the classification 
system at this time (Home Office 2006b).  
Public consultations 
A number of consultation exercises have been established, enabling the public and 
non-government organisations to comment on proposed changes to the law and to 
interventions.  These have included consultations in respect to thresholds for the 
amount of certain illegal drugs a person can possess without being charged with 
supply (DSD 2005b) and on the changes in the law on ketamine (Home Office 
2006a).  Responses to consultations are available from the Home Office website.17  
1.5.4 Media representations 
Government suggests that since 1998, when the United Kingdom Drug Strategy was 
first adopted, the result of combined efforts is that drug-related crime is falling and 
record numbers of drug-misusing offenders are accessing treatment. Although it is 
acknowledged that there is much more to be done, it is suggested that the strategy is 
well ahead of target and it is felt that media coverage of the issue does not always 
reflect the work being done.  In October 2005 the Drug Strategy Directorate launched 
the ‘Tackling Drugs Changing Lives campaign’ which provided local agencies with 
the tools to communicate the action being taken to tackle drugs in their areas. The 
campaign ran for eight months and achieved a significant amount of positive media 
coverage highlighting the achievements of local agencies and the positive impact of 
this action on local communities (CDSD – internal communication).  
                                                 
17 See: http://www.homeoffice.gov.uk/about-us/haveyoursay/responses/  
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2. Drug use in the population  
2.1 Overview  
A survey of drug use in the general population in England and Wales has been 
carried out since 199418, every two years until 2001 after which the survey has been 
continuous.  Less frequent surveys have also been carried out in Scotland19 and 
Northern Ireland20; however both surveys are to become continuous in the near 
future.  Combining these survey data, in 2005, it was estimated that in the United 
Kingdom just over a third of the adult population aged between 16 and 64 report 
having used an illicit drug in their lifetime.  Prevalence has been highest in England 
and Wales, but latest data show a decrease in use since the previous year.  
 
Young adults under 35 are significantly more likely to use drugs, and amongst those 
who are under 25 years old, recent (last year) and current (last month) prevalence is 
higher again.  In England and Wales amongst these young adults, figures for 
2004/05 showed a significant decline in lifetime prevalence for the first time, further 
declining in 2005/06. 
 
Amongst school children drug use increased markedly between 1998 and 2002, to 
around 20 per cent (based on lifetime prevalence), but appears to have stabilised 
over recent years.21  
 
Males are more likely to report drug use than females but the difference varies 
according to age group, tending to be more pronounced with age.  
 
Cannabis continues to be the most commonly used drug across all age groups, close 
to prevalence rates for use of any drug; though prevalence has declined in recent 
years.  Prevalence of all other drugs is considerably lower, no more than three per 
                                                 
18 The British Crime Survey is a crime and victimisation survey which gathers information 
about experience of crime, and is designed to provide a complementary measure of crime to 
police recorded crime statistics.  It also asks respondents about their use of drugs.  In 2002 it 
became a continuous survey.  
19 The Scottish Crime and Victimisation Survey (previously the Scottish Crime Survey) is a 
household survey which gathers information about experience of crime, and is designed to 
provide a complementary measure of crime to police recorded crime statistics. It also asks 
respondents about their use of drugs. Surveys were carried out, as part of the British Crime 
Survey (BCS) in 1982 and 1988, and as the independent Scottish Crime Survey in 1993, 
1996, 2000, 2003 and the face-to-face SCVS in 2004. 
20 The Northern Ireland Crime Survey is also a household survey which gathers information 
about experience of crime, and is designed to provide a complementary measure of crime to 
police recorded crime statistics.  It also asks respondents about their use of drugs. Surveys 
have been carried out in 1998, 2001, and annually since 2003.  A Drug Prevalence Survey, 
based on the EMCDDA model questionnaire, was carried out in 2002/03, a second such 
survey will be carried out in 2007. 
21 Amongst the school age population, surveys of drug use prevalence are undertaken in 
schools.  In England, a survey of the prevalence of smoking, drinking and drug use amongst 
young people (11 to 15 year old school children), has been undertaken annually since 1998.  
The Young Person’s Behaviour and Attitudes Survey was undertaken in Northern Ireland in 
2000 for the first time, and repeated in 2003.  It will be run again in 2007.  In Scotland, the 
Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS) is undertaken 
annually.  The Health Behaviour in School Age Children Survey (HBSC) provides Welsh data 
and is undertaken every four years with a two-year interim survey.  The most recent survey, 
the sixth in the series, was conducted in 2001/02. 
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cent for recent use.  In England and Wales, for which there is the most recent data, 
use of cocaine powder (cocaine), having remained stable since 2000, has risen.  The 
use of magic mushrooms, having risen sharply in 2004/05 fell in 2005/06.  Amongst 
school children in England, again providing the most recent data for this group, the 
prevalence of recent cocaine use increased in 2005 from 1.4 to 1.9 per cent, but it is 
not clear if this is just an artefact of sampling; and cannabis use remained lower than 
in 2003. 
2.2 Drug use in the general population 
Since submission of the 2005 United Kingdom Focal Point report, results from both 
the 2004/0522 and the 2005/0623 British Crime Survey (BCS) covering England and 
Wales have been published.  Data from the 2004 Scottish Crime and Victimisation 
Survey has also been published.24 
2.2.1 Drug use in the general population 
England and Wales: the British Crime Survey 
Prevalence and trends in drug use: England and Wales  
Following publication of the 2004/05 BCS in November 2005 (Roe 2005), a standard 
table based on it was provided to EMCDDA.  However, analysis of the data was not 
included in the 2005 United Kingdom Focal Point report.  
 
Prevalence estimates are shown in Table 2.1.  
 
Table 2.1: The proportion of 16-59 year olds reporting having used drugs in their lifetime, in 
last year and in last month, in England and Wales, 2003/04 to 2005/06 
 
Drug Lifetime Last year Last month 
 2003/4 2004/5 2005/6 2003/4 2004/5 2005/6 2003/4 2004/5 2005/6 
Any drug 35.6 34.5 34.9 12.3 11.3 10.5* 7.5 6.7 6.3* 
Amphetamines 12.2 11.2 11.5 1.5 1.4 1.3 0.6 0.5 0.6 
Cannabis 30.8 29.7 29.8 10.8 9.7 8.7* 6.5 5.6 5.2* 
Cocaine 6.7 6.0 7.2* 2.4 2.0 2.4* 1.1 0.9 1.2* 
Crack 0.9 0.8 0.9 0.2 0.1 0.2 0.1 0.1 0.1 
Ecstasy 6.9 6.7 7.2* 2 1.8 1.6 0.9 0.7 0.7 
LSD 6.1 5.1 5.5 0.2 0.2 0.3 0.1 0 0.1 
Magic 
Mushrooms 7.1 6.5 7.3* 0.8 1.1 1.0 0.3 0.4 0.2* 
Base 24,295 28,330 29,748 24,197 28,206 29,631 24,162 28,186 29,604 
*Significant change from 2004/05 to 2005/06   
Source: Roe and Man 2006 
                                                 
22 28,509 respondents completed the drugs module of the 2004/05 BCS and an extra 2,653 
16 to 24 year olds were also interviewed as part of the 2004/05 BCS youth boost.  The 
response rate for the core BCS sample was 75 per cent and 74 per cent for the 16 to 24. 
23 29,932 respondents completed the drugs module of the 2005/06 BCS and an extra 2,259 
16 to 24 year olds were also interviewed as part of the 2005/06 BCS youth boost 
24 The 2004 face-to-face SCVS interviewed 3,034 adults aged 16+.  A further 1,973 adults 
completed an abbreviated version of the main survey.  This consisted of a short face-to-face 
questionnaire with questions on fear of crime and demographics, and these respondents were 
also asked to undertake the self-completion questionnaire.  The overall response rate for the 
2004 survey was 67 per cent. Of the 5,007 adults who completed either the 2004 main survey 
or the 2004 shortened version, 4,424 undertook the self-completion questionnaire.  The 
response rate for the self-completion element of the 2004 survey was therefore 59 per cent 
(based on all of the eligible sample).  
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There was a significant fall in the lifetime use of amphetamines, cannabis, cocaine 
and LSD in 2004/05, and also in recent use of cannabis and cocaine, though there 
was a significant rise in the use of magic mushrooms. 
 
Analysis from the 2005/06 BCS (Roe and Man 2006) shows there had been a small 
rise in lifetime use of amphetamines, cannabis and LSD from the previous year while 
lifetime use of cocaine, ecstasy and magic mushrooms has risen significantly. There 
had also been a significant rise in the recent and current use of cocaine, however this 
followed falls in the previous year.  Recent cannabis use has fallen significantly and 
for the first time current and recent cannabis use is significantly lower than in 1996.  
Despite the rise in lifetime use of magic mushrooms, current use has fallen 
significantly since the previous year.  Recent and current use of ecstasy has 
remained stable (Table 2.1).  Figure 2.1 shows the changes over time since 1996 for 
recent use, indicating a fall in overall drug use and it also shows the rise in cocaine 
use.  
 
Figure 2.1: The proportion of 16 to 59 year olds reporting having used drugs in the last year in 
England and Wales, 1996 to 2005/06 
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Note that the first three time intervals in this graph are greater than a year 
Source: Roe and Man 2006 
The Scottish Crime and Victimisation Survey  
Prevalence and trends in drug use: Scotland   
Prevalence estimates from the 2004 Scottish Crime and Victimisation Survey are 
shown in Table 2.2.  
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Table 2.2: The proportion of 16 to 59 year olds reporting having used drugs in their lifetime 
and last year in Scotland, 2000 to 2004 
 
Drug Lifetime Last year 
 2000 2003 2004 2000 2003 2004 
Any drug 19.2 25.3 23.7 6.6 9.2 7.7 
Amphetamines 6.3 9.6 8.4 0.5 1.4 1.0 
Cannabis 17.4 22.8 21.9 5.5 8 6.3 
Cocaine 2.5 4.8 4.6 0.7 1.4 1.5 
Crack 1.0 1.2 1.2 0.0 0.2 0.2 
Ecstasy 3.7 6.0 5.4 1.0 1.7 1.2 
Base 2,886 4,665 2,955 2,886 4,665 2,955 
Source: Murray and Harkins 2006 
 
This shows that, as in England and Wales, there had been a reduction in lifetime and 
recent use of any drug since the previous year (2003), and a reduction in use of 
cannabis and amphetamines.  
Gender 
Men continue to be more likely than women to have used any illicit drug in England 
and Wales and in Scotland (Table 2.3).  
 
Table 2.3: Use of any drug by gender in England and Wales, 2004/05 and 2005/06 and 
Scotland, 2004 as a percentage 
 
Drug Lifetime Last year Last month 
 Male Female Male Female Male Female 
England and 
Wales 2004/05  
(aged 16 to 59) 
40.3 29.0 14.3 8.3 8.8 4.5 
England and 
Wales 2005/06 
(aged 16 to 59) 
40.6 29.4 13.7 7.4 8.6 4.0 
Scotland 2004  
(aged 16 to 64) 
 
25.7 18.9 8.1 6.2 4.9 2.6 
Source: Standard Table prepared for United Kingdom Focal Point based on crime surveys 
Frequency of use 
Analysis of the SCVS found that of the 4 per cent (n=129) who indicated they had 
currently taken any drugs, a substantial minority reported taking drugs very 
frequently; 34 per cent had taken drugs ‘every day or almost every day’ and a further 
47 per cent at least once a week.  A fifth (19%) had only taken drugs ‘once or twice’ 
in the previous month.  Cannabis was the drug used most often (Murray and Harkins 
2006). 
2.3 Drug use amongst young adults  
2.3.1 Young People 16 to 34 
Prevalence and trends in drugs use in England and Wales   
Prevalence estimates from the 2004/05 and 2005/06 British Crime Survey, for young 
people aged 16 to 34 are shown in Table 2.4.  
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Table 2.4: The proportion of 16 to 34 year olds reporting having used drugs in their lifetime, 
last year and last month in England and Wales, 2003/04 to 2005/06 
 
Drug Lifetime Last year Last month 
 2003/4 2004/5 2005/6 2003/4 2004/5 2005/6 2003/4 2004/5 2005/6 
Any drug 48.2 46.9 46.6 22.1 20.6 19.4 13.6 12.7 11.7 
Amphetamines 18.4 16.5 16.8 3 2.7 2.6 1.1 1.0 1.1 
Cannabis 43.4 41.4 41.5 19.5 17.9 16.3 12 10.6 9.6 
Cocaine 
(including 
crack)* 
11.6 10.5 12.1 4.9 4.1 4.9 2.4 1.8 2.3 
Ecstasy 13.6 12.7 13.3 4.1 3.7 3.4 1.9 1.4 1.4 
LSD 9.2 7.3 7.6 0.5 0.5 0.6 0.2 0.1 0.2 
Magic 
mushroom 9.7 8.7 10 1.8 2.2 2.1 0.5 0.7 0.5 
* As data for 16 to 34 years olds is taken from Standard Tables, figures for cocaine include 
crack and may therefore be higher than if they were for cocaine only as in tables for 16 to 59 
year olds and tables for 16 to 24 year olds. 
Source: Standard Table prepared for United Kingdom Focal Point based on crime surveys 
 
A fall in lifetime use of all drugs between 2003/04 and 2004/05 can be seen (Table 
2.4).  Similarly for recent use, a fall is seen in all but magic mushrooms; the same for 
current use.  Between 2004/05 and 2005/06 lifetime use of most drugs continued to 
fall but use of cocaine and magic mushrooms increased.  Recent and current use of 
all drugs apart from cocaine remained stable or decreased. 
Prevalence and trends in drugs use in Scotland  
Estimates of prevalence for 2004 from the Scottish Crime and Victimisation Survey, 
for adults aged 16 to 34 are shown in Table 2.5.  There has been a fall in lifetime 
prevalence of all drugs except LSD since the previous survey.  
 
Table 2.5: The proportion of 16 to 34 year olds reporting having used drugs in their lifetime, 
last year and last month in Scotland, 2003 and 2004 
 
Drug Lifetime Last year Last month 
 2003 2004 2003 2004 2003 2004 
Any Drug 38.5 36.2 18 15 10.4 7.8 
Amphetamines 16.5 14.4 2.3 2.1 0.6 0.8 
Cannabis 35.9 34.4 16.5 12.8 9.5 6.6 
Cocaine (including crack)* 8.7 8.1 3.2 2.9 0.9 0.7 
Ecstasy 12.5 11.4 3.8 2.6 1.6 0.8 
LSD 7.8 7.9 0.2 0.5 0.1 0.2 
Magic Mushrooms 7.0 6.2 0.4 0.3 0.0 0.0 
* As data for 16 to 34 years olds is for Standard Tables, figures for cocaine include crack and 
may therefore be higher than if they were for cocaine only as in tables for 16 to 59 year olds 
and tables for 16 to 24 year olds. 
Source: Standard Table prepared for United Kingdom Focal Point based on crime surveys 
2.3.2 16 to 24 year olds  
Prevalence and trends in drug use in England and Wales  
Following a recent review of the data processing procedures for the BCS youth boost 
dataset, it was discovered that there were inconsistencies in the calculation of 
calibration weights for the youth boost compared with the main BCS dataset (Roe 
and Man 2006).  Revised estimates of young people’s drug use are included in this 
report.   
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Prevalence estimates from the 2003/04, 2004/05 and 2005/06 British Crime Survey, 
for young people aged 16 to 24 are shown in Table 2.6.  
 
Table 2.6: The proportion of 16 to 24 year olds reporting having used drugs in their lifetime, 
last year and last month in England and Wales, 2003/04 to 2005/06 
 
 Lifetime Last year Last month 
 2003/ 04 
2004/ 
05 
2005/ 
06 
2003/ 
04 
2004/ 
05 
2005/ 
06 
2003/ 
04 
2004/ 
05 
2005/ 
06 
Any Drug 47.5 46 45.1 28.3 26.5 25.2 17.5 16.4 15.1 
Amphetamines 13.1 11.6 11.3 4.0 3.2 3.3 1.6 1.3 1.6 
Cannabis 42.2 41.1 40.1 25.3 23.6 21.4 15.8 14.1 13 
Cocaine  
(not including 
crack) 
9.7 9.1 10.6 5.2 5.1 5.9 2.7 2.1 3.0 
Crack 1.6 1.1 1.3 0.4 0.1 0.4 0.2 0.1 0.2 
Ecstasy 11.3 10.8 10.4 5.5 4.9 4.3 2.6 1.9 2.0 
LSD 4.8 3.5 3.7 0.9 0.5 0.9 0.4 0.2 0.2 
Magic 
Mushrooms 7.0 7.0 8.3 2.7 3.0 3.0 0.8 0.9 0.7 
Base 5,387 6,240 5,929 5,351 6,196 5,892 5,327 6,182 5,876 
Source: Roe and Man 2006 
 
The decrease in lifetime use of any drug among 16 to 24 year olds in England and 
Wales since 1998, when the Drug Strategy commenced, continued in 2004/05 and 
2005/06 with significant falls in the use of cannabis, amphetamines, LSD and magic 
mushrooms (Figure 2.2).  Following a period of increasing use prior to 2000, cocaine 
use had broadly stabilised until 2005/06, which saw increases in cocaine use 
amongst 16 to 24 year olds for all recall periods which were statistically significant for 
lifetime and current use but not recent use. Lifetime prevalence of ecstasy use has 
remained essentially stable since 1996. 
 
Figure 2.2: The proportion of 16 to 24 year olds reporting having used drugs in the last year 
and percentage change in England and Wales, 1996 to 2005/06 
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Note that the first three time intervals in this graph are greater than a year 
Source: Roe and Man 2006 
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A similar pattern to that seen for lifetime prevalence was found when recent use was 
considered.  There has been a consistent decline in the use of any drug since 1998, 
which is mirrored by most individual types of drugs, in particular cannabis and 
amphetamines.  Recent use of ecstasy has remained generally stable in recent years 
but between 2004/05 and 2005/06 use of crack and LSD rose significantly. 
 
The trends in current use are similar to those for other recall periods, with the 
exception of a significant decrease in current use of cocaine and ecstasy in 2004/05 
compared with the previous year.  Cocaine use again rose significantly in 2005/06 
above 2003/04 figures, but ecstasy use remained stable. 
Prevalence and trends in drugs use in Scotland   
Prevalence estimates from the 2004 Scottish Crime and Victimisation Survey, for 
young people aged 16 to 24 are shown in Table 2.7.  
 
Table 2.7: The proportion of 16 to 24 year olds reporting having used drugs in their lifetime, 
last year and last month in Scotland, 2003 and 2004 
 
Drug Lifetime Last year Last month 
 2003 2004 2003 2004 2003 2004 
Any Drug 39.8 35.2 25.9 19.0 15.6 9.2 
Amphetamines 13.0 10.3 3.0 2.6 0.7 1.0 
Cannabis 37.7 33.9 23.1 16.4 14.3 7.8 
Cocaine  10.8 5.6 5.1 3.0 1.3 0.5 
Ecstasy 14.3 7.0 5.2 2.4 2.5 1.4 
LSD 6.1 3.8 0.3 0.7 0.0 0.3 
Magic Mushrooms 5.6 4.0 0.3 0.3 0.0 0.0 
Base 619 330 619 330 619 330 
Source: Standard Table prepared for United Kingdom Focal Point based on crime surveys 
Trends in drugs used 16 to 24 year olds: Scotland  
In Scotland there has been a decrease in lifetime use of all drugs and current use of 
most drugs has declined (Tables 2.7).  
Frequent use 
Questions on frequency of use (used more than once a month) in the last year were 
first asked to 16 to 24 year olds in the BCS in 2002/03.  Frequent use of any drug in 
the last year among all 16 to 24 year olds, has decreased significantly since 2002/03, 
with further decreases seen in the following two years (Table 2.8).  Looking at 
frequent use of individual drugs, the drug that young users are most likely to use 
frequently is cannabis (41.2%), followed by amphetamines (26.1%).  Frequent 
cocaine use rose sharply in 2005/06 to 22.3 per cent, ecstasy has remained stable at 
16.1 per cent and frequent use of magic mushrooms has fallen to 1.8 per cent (Table 
2.9).  
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Table 2.8: Frequency of use in the last year: proportion of 16 to 24 year olds (all respondents) 
who use more than once a month in England and Wales, 2002/03 to 2005/06 
 
Drug Year 
 2002/03 2003/04 2004/05 2005/06 
Any Drug 11.3 12.4 10.3 9.5* 
Base 4,292 5,234 6,070 5,768 
*Statistically significant change 1998 to 2005/06 
Source: Roe and Man 2006 
 
Table 2.9: Frequency of use in the last year: proportion of 16 to 24 year olds (last year drug 
users) who use more than once a month in England and Wales, 2003/04 to 2005/06 
 
Drug % More than once a month 
 2003/04 Base 2004/05 Base 2005/06 Base 
Any Drug 53.6 1,381 41.6 1,470 40.3 1,333 
Amphetamines 18.8 191 25.4 198 26.1 164 
Cannabis 46.9 1,267 41.1 1,348 41.2 1,164 
Cocaine 17.2 253 14.2 275 22.3 321 
Crack .. 18 .. 9 .. 17 
Ecstasy 21.4 264 16.9 274 16.1 227 
LSD .. 31 .. 31 .. 33 
Magic 
Mushrooms 4.5 120 6.0 163 1.8 135 
.. Sample size too small to analyse 
Source: Roe 2006; Roe and Man 2006 
Gender  
For the most part men continue to be more likely than women to have used any illicit 
drug recently.  However, in Scotland in 2004, results from the SCVS suggest that 
amongst young people, females are more likely to report recent use than are males 
(Table 2.10).  
 
Table 2.10: Use of any drug by gender and age group (16 to 24 and 16 to 34) in England and 
Wales, 2004/05 and 2005/06 and Scotland, 2004 
 
Lifetime Last year Last month Drug Male Female Male Female Male Female 
England and Wales 2004/05 
16 to 34 53.1 40.9 26.1 15.3 16.6 8.9 
16 to 24 51.2 40.8 32.3 20.6 20.5 12.2 
England and Wales 2005/06 
16 to 34 52.0 41.3 24.9 14.1 15.6 7.9 
16 to 24 49.2 40.9 29.9 20.6 19.2 11.1 
Scotland 2004 
16 to 34 39.0 33.5 15.9 14.1 9.8 5.8 
16 to 24 35.6 34.7 17.7 20.3 11.1 7.3 
Source: Standard Table prepared for United Kingdom Focal Point based on crime surveys 
 
In Scotland, amongst 16 to 24 year olds 35.6 per cent of males reported having ever 
used compared to 34.7 per cent females.  For recent and current use, 17.7 per cent 
of males compared to 20.3 per cent of females, and 11.1 per cent of males compared 
to 7.3 per cent of females reported use of any drug.  
 
Figures from 2005/06 BCS, however, show that lifetime and recent use remained 
stable for women aged 16 to 24 but decreased amongst men of the same age.  
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2.4 Drug use in the school and youth population  
The latest published survey of school children in Northern Ireland (DHSSPSNI 2004) 
is for 2003 and has been referred to in previous United Kingdom Focal Point reports.  
A research report based on a secondary analysis of this survey, the 2003 Young 
Persons Behaviour and Attitudes Survey25 and findings from the 2000 survey showed 
that there had been a significant decrease in lifetime prevalence of illegal drugs 
although there was a significant increase in the use of cannabis (SMR 2005).  This 
analysis is referred to more extensively in chapters 11 and 12 of this report.  The next 
survey to be carried out in Northern Ireland will be in 2007. 
 
In Scotland the latest published survey is for 2004 (Corbett et al. 2005) and again 
was referred to in the previous United Kingdom Focal Point Report; the next survey 
will be carried out in 2006.  In Wales, the Health Behaviour in School Children 
(HBSC) survey is supplemented by questions relevant to the situation in Wales, and 
unlike the basic HBSC survey all questions are asked of all age groups in school.  A 
survey was carried out in 2004 and a further survey began in May 2006.  Results of 
the 2004 survey will be published in the autumn of 2006. 
 
Results from a new school survey in England, conducted in 2005, are available 
(NatCen/NFER 2006)26.  These showed that amongst school children aged 11 to 15: 
• 27.5 per cent reported using one or more drug in their lifetime; 
• 19.1 per cent reported using one or more drug in the last year; and  
• 10.9 per cent reported using one or more drug in the last month.  
 
There are large differences between age groups, with major increases in use being 
seen from one age to the next (Figure 2.3). 
 
Figure 2.3: Last year and last month prevalence by age in England, 2005 
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Source: NatCen/NFER 2006 
                                                 
25 The Young Persons Behaviour and Attitudes Survey (YPBAS) assesses the behaviour and 
attitudes of school children in years 8-12 towards a range of different topics including school, 
general health and the environment. The survey was first conducted in 2000 and repeated in 
2003.  This survey was conducted with a sample of 7223 students aged 11-16 in Autumn 
2003. 
26 Over 9,000 pupils in 305 schools in England completed questionnaires in the 2005 autumn 
term. 
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Frequency  
Six per cent of pupils reported that they usually took drugs once a month, five per 
cent once or twice a month, two per cent at least once a week and one per cent on 
most days.  
Availability of drugs: offered drugs  
A larger proportion of pupils reported being offered drugs (39%) than reported having 
used them (27%).  The proportion offered drugs increases sharply with age (18% of 
11 year olds and 63% of 15 year olds). 
Drug used  
As with adults, cannabis remains the most used drug; most other drugs having a 
much lower prevalence (Table 2.11).  However there are differences in drugs used 
by age, with volatile substances being by far the most prevalent substances used 
recently and currently by 11 and 12 year olds, but cannabis being used recently by 
near equal numbers of 13 years olds.  At age 13 cannabis is more frequently used 
than volatile substances, currently.  At 14, recent use of cannabis increases 
significantly, though volatile substances are still used, in addition to a much wider 
range of substances.  At 15, prevalence of all types of drug increases, except for 
recent and current use of volatile substances (Table 2.11).  
 
Table 2.11: Whether had taken individual drugs in the last year and last month, by age in 
England, 2005 as a percentage 
 
Age Drug 11 12 13 14 15 Total 
Last year  
Cannabis 0.7 2.6 7.6 17.2 27.1 11.7 
Cocaine 0.4 0.4 1.0 2.8 4.3 1.9 
Crack 0.3 0.4 0.9 1.6 1.5 1.0 
Ecstasy 0.3 0.1 0.8 2.2 3.6 1.5 
Amphetamines 0.1 0.2 0.7 2.0 2.5 1.2 
LSD 0.2 0.3 0.4 0.9 1.3 0.6 
Magic mushrooms 0.3 0.4 1.2 3.0 3.8 1.8 
Heroin 0.3 0.5 0.8 1.3 1.0 0.8 
Volatile substances*  4.5 5.9 7.1 8.7 6.8 6.7 
Any drug 6.2 9.4 14.8 26.3 33.9 19.1 
Last Month  
Cannabis 0.6 0.7 4.3 10.9 15.6 6.8 
Cocaine 0.3 0.2 0.6 1.8 2.1 1.1 
Crack 0.2 0.2 0.4 0.6 0.8 0.5 
Ecstasy 0.3 0.1 0.3 0.8 1.2 0.5 
Amphetamines 0.1 0.0 0.3 0.9 0.9 0.5 
LSD 0.1 0.1 0.2 0.4 0.5 0.3 
Magic mushrooms 0.3 0.1 0.5 1.3 1.3 0.7 
Heroin 0.3 0.2 0.5 0.7 0.4 0.4 
Volatile substances* 2.1 2.9 2.9 3.9 3.0 3.0 
Any drug 3.3 4.2 7.8 16.1 20.3 10.9 
Base 1,341 1,685 1769 1,794 1,887 8,476 
*includes glues, gas, aerosols and solvents 
Source: Standard Table prepared for United Kingdom Focal Point  
 
Figure 2.4 shows the extent to which volatile substance abuse contributes to levels of 
drug use amongst young people. 
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Figure 2.4: Whether had taken any drug, volatile substance and cannabis in the last year, by 
age in England, 2005 as a percentage 
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Source: NatCen/NFER 2006 
Gender  
There are differences in use by gender; boys tending to use more than girls (Table 
2.12).  
 
Table 2.12: Whether school children had used individual drugs in the last month, in the last 
year and in lifetime, by gender in England, 2005 
 
Drug Male Female Total 
 In 
last 
month 
In last 
year 
In 
Life 
time 
In 
last 
month 
In 
last 
year 
In 
Life 
time 
In 
last 
month 
In 
last 
year 
In 
Life 
time 
Cannabis 8 12 15 6 11 14 7 12 14 
Cocaine 1 2 3 1 2 2 1 2 2 
Crack 0 1 1 0 1 1 0 1 1 
Ecstasy 1 1 2 0 2 2 1 1 2 
Amphetamines 0 1 1 1 1 2 0 1 1 
Amyl nitrate/ 
Poppers 1 3 6 2 4 6 1 4 6 
LSD 0 1 1 0 1 1 0 1 1 
Magic 
mushrooms 1 2 3 1 2 2 1 2 3 
Ketamine 0 1 1 0 0 0 0 0 1 
Heroin 0 1 1 0 1 1 0 1 1 
Methadone 0 0 0 0 0 0 0 0 0 
Volatile 
substances* 3 6 3 3 7 15 3 7 14 
Any drug 11 19 28 10 19 27 11 19 28 
Any drug 
(excluding 
volatile 
substances) 
9 15 19 8 15 18 9 15 18 
Base 4,667 4,667 4,667 4,507 4,507 4,507 9,174 9,174 9,174 
*includes glues, gas, aerosols and solvents 
Source: NatCen/NFER 2006 
 
For a more in depth analysis of drug use amongst minors based on this data, as well 
as surveys for Scotland and Northern Ireland carried out in previous years, see 
Chapter 11: Drug use and related problems among very young people.  
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Trends in drug use amongst school children in England  
Drug use steadily increased until 2001 (NatCen/NFER 2006), but seems to have 
stabilised since then with perhaps signs of a recent fall (See Figure 2.5).  However, in 
2005, there was an increase in current use of cocaine from 1.4 per cent to 1.9 per 
cent but it is too soon to judge if this is the start of a trend since estimates of such low 
prevalence can be subject to considerable variation. 
 
Figure 2.5: Drug use amongst school children in England, 2001 to 2005 
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Source: NatCen/NFER 2006 
 
Table 2.13: Prevalence of drug use in the last year amongst school children in England, 2001 
to 2005 
 
Drug 2001 2002 2003 2004 2005 
Cannabis  13 13 13 11 12 
Cocaine 1 1 1 1 2 
Crack 1 1 1 1 1 
Ecstasy 2 1 1 1 1 
Amphetamines 1 1 1 1 1 
Poppers 3 4 4 3 4 
LSD 1 1 1 1 1 
Magic Mushrooms 2 1 2 2 2 
Ketamine**  - - - - 0*** 
Opiates 1 1 1 1 1 
Volatile substances*  7 6 8 6 7 
Base  8,799 9,146 9,658 9,086 8,408 
* Includes glues, gas, aerosols or solvents 
**Ketamine was measured separately for the first time in 2005 
*** = less than 0.5% but not zero 
Source: NatCen/NFER 2006 
A survey of drug use in primary schools 
A survey of drug and alcohol use among primary school children had been carried 
out in schools in Northern Ireland; results are expected to be made available in the 
autumn of 2006. 
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The Offending Crime and Justice Survey 2004  
Drug use identified in the Offending Crime and Justice Survey (OCJS)27 for 2004 
mirrors findings from the British Crime Survey.  Nearly a quarter (22%) of young 
people aged 10 to 25 said they had taken a drug in the preceding 12 months.  The 
most commonly used drug was cannabis.  Males were more likely to report having 
taken a drug recently compared with females; a quarter of males had taken a drug 
compared with less than a fifth of females.  Young people aged 18 to 25 reported 
significantly higher drug use than young people aged 10 to 17.  Prevalence of drug 
use remained stable between 2003 and 2004 (Budd et al. 2005). 
2.5 Drug use among specific groups  
2.5.1 Conscripts 
NO NEW INFORMATION AVAILABLE  
2.5.2 Minorities 
NO NEW INFORMATION AVAILABLE  
2.5.3 Sex workers 
NO NEW INFORMATION AVAILABLE  
2.5.4 Ethnic groups 
Sharp and Budd (2005) looked at ethnicity and drug use in their analysis of the 2003 
OCJS.  It was found that overall, for 10 to 65 year-olds, White respondents and those 
of mixed ethnic origin have the highest levels of recent drug taking (Table 2.14). 
 
                                                 
27 The Offending, Crime and Justice Survey (OCJS) is the national longitudinal, self-report 
offending survey for England and Wales.  The survey, covering people living in private 
households, was first conducted in 2003 and will be repeated annually until 2006.  The main 
aim is to examine the extent of offending, anti-social behaviour and drug use among the 
household population, particularly among young people aged from 10 to 25.  It covers 
offences against households, individuals and businesses.  In addition to ‘mainstream’ 
offences such as burglary, shoplifting and assault, it also covers fraud and technology 
offences.  The survey will also collect longitudinal data (that is information from the same 
individuals over time) to allow researchers to examine the pathways into and out of 
delinquency and the impact various risk and protective factors have on these pathways.  It 
gathers evidence to support the effective targeting of resources for reducing levels of crime 
and illegal drug use, providing: 
• measures of self-reported offending; 
• indicators of repeat offending; 
• trends in the prevalence of offending; 
• trends in the prevalence and frequency of drug and alcohol use; 
• evidence on the links between offending and drug / alcohol use; 
• evidence on the risk factors related to offending and drug use; and 
• information on the nature of offences committed, such as the role of co-offenders and the 
relationship between perpetrators and victims. 
 
UNITED KINGDOM FOCAL POINT REPORT 2006 
 
 40
Table 2.14: Percentage of 10-65 year olds who have taken drugs in the last year by ethnicity 
in England and Wales, 2003 
 
Drug White Mixed Asian or 
Asian 
British 
Black or 
Black 
British 
Other 
Amphetamines 2 2 <0.5* <0.5* <0.5* 
Cannabis 12 16 4* 10 6* 
Cocaine 3 3 <0.5* 1* <0.5* 
Crack <0.5 <0.5 <0.5 <0.5 - 
Ecstasy 3 3 <0.5* 1* 1* 
Heroin <0.5 - - <0.5 - 
LSD/magic 
mushrooms 
1 1 <0.5* <0.5 2 
Amyl nitrite 2 1 <0.5 <0.5* 1 
Glue <0.5 - <0.5 <0.5 <0.5 
Any drug 13 17 4* 11 9* 
Base 9,160 415 1,091 723 334 
- indicates that there was no response in that category 
* significantly different from the White group at 5% level 
Source: Sharp and Budd 2005 
 
2.5.5 Vulnerable young people  
In the previous United Kingdom Focal Point Report, analysis of drug use by 
vulnerable young people identified in the OCJS 2003 was reported28, suggesting that 
drug use was more prevalent among vulnerable young people, especially those who 
were in more than one vulnerable group (Becker and Roe 2005).  Drug use amongst 
these groups was again considered in analysis of the 2004 OCJS.  It was again 
found that they reported higher levels of drug use (44%), Class A use (18%) and 
frequent drug use (26%) compared with those who were not vulnerable (13%, 3% 
and 5% respectively).  Those having more than one vulnerable characteristic 
reported higher levels of drug use (46%), Class A use (26%) and frequent use (30%) 
than those who were only in one vulnerable group (33%, 12% and 14% respectively).  
Further, they reported higher levels of use for all of the individual drugs listed in the 
survey (Table 2.15). 
 
                                                 
28 Identified as those who had ever been in care, ever been homeless, truants, those 
excluded from school and serious or frequent offenders 
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Table 2.15: Vulnerability and use of drugs in England and Wales, 2004 as a percentage  
 
 Vulnerability status 
Drug Not Vulnerable Vulnerable 1 vulnerable group only 
More than 1 
vulnerable 
group 
Cocaine 1.8 12.6* 7.0 13.6 
Crack - 0.8* 0.3 2.9 
Ecstasy 1.6 12.7* 7.3 18.3* 
Hallucinogens 0.6 7.3* 3.3 12.5* 
Heroin - 0.3 0.3 1.9 
Amphetamines 0.9 8.0* 2.7 13.6* 
Cannabis 11.5 41.0* 30.5 42.3 
Amyl nitrite 2.1 7.5* 4.7 13.5* 
Solvents 0.6 2.3* 1.3 3.8 
Class A drug 3.2 18.1* 11.9 26.2* 
Any drug 13.0 43.7* 33.4 45.6 
Frequent user 4.8 26.2* 14.4 30.1* 
Base: Frequent 
user 1,128 1,055 300 115 
* indicates a significant difference between vulnerable and not vulnerable and between member of one 
vulnerable group and member of more than one vulnerable group. 
Source: Budd et al. 2005 
Other Research 
The Joseph Rowntree Foundation has funded research into what constitutes 'heavy' 
cannabis use amongst young people.  The research will examine how such use 
impinges on friendship networks, relationships and educational/career choices at a 
key stage of youth transitions.  A longitudinal approach will be adopted using a 
combination of focus groups, questionnaires and repeat in-depth interviews. 
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3. Prevention 
3.1 Overview 
Prevention of young people’s drug use is one of the four elements of the United 
Kingdom Drugs Strategy.  The 2004 Spending Review Public Service Agreement 
(PSA) stated that by 2008 there should be a reduction of use of all Class A drugs and 
the frequency of use of any illicit drugs among all young people under the age of 25, 
especially by the most vulnerable. 
 
The Every child matters: change for children programme (2004)29 aims to reform 
children's services to enable children to reach their full potential.  The programme is 
measured across a range of outcomes for children and young people, namely: being 
healthy, staying safe, enjoying and achieving, making a positive contribution and 
economic wellbeing.  One of the aims under the be healthy outcome seeks to ensure 
that young people ‘choose not to take illegal drugs’.  
 
Drug prevention initiatives in the United Kingdom have grown markedly since 1998.  
One of the most high profile of these is the FRANK communications initiative30, an 
intervention that offers substance related information to users, contemplators, and 
their friends and family.  In Scotland, Know the Score31, and in Northern Ireland, 
Drugs Website Northern Ireland32, provide similar information.  In 2006 it was 
announced that FRANK communications would have an extra focus on vulnerable 
young people. 
 
In England, drug education is a statutory part of the national curriculum; the majority 
of primary (80%) and secondary schools (95%) have adopted drug education policies 
(DfES 2004b).  Drug education in schools is now widely available and is a part of the 
Personal, Social and Health Education (PHSE) curriculum, and the National Healthy 
Schools Programme33, which includes drug education as one of its core themes.  In 
2006 Ofsted reported on the scope and quality of drugs prevention in schools (Ofsted 
2006).  In Northern Ireland drug education is also a statutory part of the national 
curriculum and in Scotland almost all schools provide drug education as an integral 
part of health education. 
 
The Connexions Service, which, as part of its wider activities, identifies young people 
with drug problems and provides appropriate referral or support, covers most of 
England (80%).  Key priorities, established in 2002, are intended to be achieved by 
2006.  These include increasing the proportion of 16 year olds who transfer into 
further learning, and the proportion of 16 to 18 year olds who are either in learning or 
work.  According to Connexions estimates, in November 2005, 7.7 per cent of 16 to 
18 year olds in England were not in education, employment or training.  In line with 
the priorities of Every Child Matters and Youth Matters it has been announced that, 
by April, 2008 funding that currently goes to the 47 Connexions partnerships will go 
                                                 
29 See: http://www.everychildmatters.gov.uk/aims/ for more information 
30 See: http://www.talktofrank.com  
31 See: http://www.knowthescore.info/  
32 See: http://www.nics.gov.uk/drugs/index.htm  
33 The National Healthy School Standard (see: http://www.wiredforhealth.gov.uk) has three 
strategic aims; to reduce health inequalities; to promote social inclusion; and to raise 
educational standards. Themes include PSHE; Citizenship; Drug education (including alcohol 
and tobacco); emotional health and wellbeing; healthy eating; physical activity; safety; sex 
and relationship education. 
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directly to each of the 150 local authority areas. Despite a change in funding status, 
Connexions is expected to contribute to young people’s services. 
 
Positive Futures34 continues to offer inclusionary sports and art activities to young 
‘vulnerable’ people. Management and delivery of Positive Futures was taken over by 
Crime Concern in 2006.  Although Positive Futures (see section 3.3.2 below) 
primarily targets people in deprived communities, there is no assumption of the 
existing level of drug use.  Moreover participants are allowed to self refer; in effect, 
drug education incorporates universal prevention approaches.  
 
There is no specific national universal prevention campaign aimed at families.  
However, D(A)ATs (and their Welsh and Northern Irish equivalents) support family 
based drug prevention through Tier 135 activities.  The FRANK and Know the Score 
campaigns offer free drugs information resources for parents and carers for use in 
(informal) prevention activities.  
 
In 2005/06 the National Collaborating Centre for Drug Prevention (NCCDP)36 was 
commissioned by the Evidence Based Steering Group of the National Young People 
and Drugs Board to produce briefings on recent Government work on drug 
prevention.  This series of studies reported on drug prevention in universal and 
vulnerable populations and is summarised in the relevant sections below.37   
3.2 Universal prevention 
Universal prevention targets the general population regardless of individual levels of 
risk, for example through the classroom. 
 
In the context of Every Child Matters (DfES et al. 2005), any professional group in 
contact with young people, given sufficient experience and skill, is expected to deliver 
universal drug prevention services. 
3.2.1 Evidence reviews 
The National Institute for Health and Clinical Excellence (NICE) published reviews by 
the NCCDP in 2006.  Drug use prevention among young people: a review of reviews 
(McGrath et al. 2006) provided an update to the former Health Development 
Agency’s review of reviews published in 2004 (Canning et al. 2004).  This was 
accompanied by Drug use prevention among young people: Evidence into Practice 
Briefing (Sumnall et al. 2005) which provided guidance to different professional 
groups on how to access and implement evidence based drug prevention practice.  
Review of grey literature on drug prevention among young people (McGrath et al. 
2006), reviewed drug prevention materials not traditionally included in academic 
reviews.  These publications are available on the NICE website.38   
 
The NCCDP has reported the findings of a review of Government sponsored 
universal drug prevention (Jones et al. 2006).  This work was considered in the 
context of the wider drugs literature.  The report concluded that Government funded 
                                                 
34 See: http://www.drugs.gov.uk/young-people/positive-futures/?version=1 
35 Tier 1 consists of services offered by a wide range of professionals (e.g. primary care 
medical services, generic social workers, teachers, community pharmacists, probation 
officers, housing officers, homeless persons units). Tier 1 services work with a wide range of 
clients including drug users, but their sole purpose is not simply substance misuse. 
36 See: http://www.drugpreventionevidence.info 
37 Available from: http://www.drugpreventionevidence.info/web/NCCDP_Reports164.asp  
38 See: http://www.nice.org.uk 
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community-based prevention initiatives have tended to target deprived communities 
and that universal prevention programmes delivered in this setting have not been 
widely assessed.  School-based interventions were the most popular and widely 
researched method of delivering universal drug prevention programmes.  Review 
evidence suggested that Life Skills Training (LST), or approaches based upon it, was 
one of the few programmes that has demonstrated a small but positive effect on 
reducing drug use.  However, only those schools particularly dedicated to drugs 
education and eager to have pupils take part in this type of education see benefits. 
Multi-component programmes and those based on the social influence model 
showed the most consistently positive outcomes, but even these programmes were 
limited in their effects on reducing drug use.  In addition, research was found to be 
lacking into which components contribute to the overall effectiveness of multi-
component programmes.  
 
The report also identified a need for evaluation and long-term follow-up of drug 
education programmes targeted at primary school aged children.  A review of the 
limited literature available suggested that primary school interventions should focus 
upon family intervention and parent education, school organisation and behavioural 
management.  In addition, families were found to play an important role in young 
people’s choices around drug use with research from the United States showing that 
family components may enhance the effectiveness of universal programmes.  
Currently, United Kingdom-based evidence is lacking about which interventions work 
most effectively with parents and how best to engage parents in drug prevention 
activities.  Although international research has shown early evidence that provision of 
generic health and educational services may have a positive effect on drug use 
behaviours, a lack of United Kingdom-based research in this area was identified. 
 
The Advisory Council on the Misuse of Drugs (ACMD) published its report, Pathways 
to Problems; Hazardous use of tobacco, alcohol and other drugs by young people in 
the UK and its implications for policy (ACMD 2006b).  The report makes a number of 
recommendations including that there should be a careful reassessment of the role of 
schools in drug misuse prevention.  It places an emphasis on providing all pupils with 
accurate, credible and consistent information about the hazards of tobacco, alcohol 
and other drugs, including volatile substances (ACMD 2006b, p.6).  The 
Government’s response to this report’s recommendations is forthcoming. 
3.2.2 School 
In England, Ofsted currently monitors the provision and quality of drugs education in 
schools, and last reported in 2005 (see United Kingdom Focal Point Report 2005). In 
a supplementary examination of a purposive sample of 18 schools, Ofsted criticised 
them for not placing enough emphasis on the negative social consequences of 
substance use (Ofsted 2006).  Schools which Ofsted believed delivered good drugs 
education made extensive use of external contributors.  However, in an earlier review 
commissioned by the Department for Education and Skills (DfES), White et al. (2004) 
argued that although it was important to combine the contributions of external 
contributors with class teachers in order to increase pupil engagement, there was 
little guidance available on how to do this effectively.  Furthermore, although external 
contributors were well received there was little evidence available to suggest that 
external contributors had any impact upon drug using behaviours.  
 
At the time of writing, the evaluations of drug education in Scotland (Evaluation of the 
impact of drugs education in Scottish schools) and Wales (Evaluation of the All 
Wales School Programme) were not available.  
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In England, the National Healthy Schools Standard (NHSS), which encourages a 
whole school approach towards drugs and drug prevention education,39 has been 
reported in previous United Kingdom Focal Point Report.  Although achieving NHSS 
is not a statutory requirement, from September 2005, Ofsted has expected that all 
schools demonstrate how they contribute towards the five national outcomes for 
children outlined in Every Child Matters.  Achieving Healthy School status will allow 
schools to show good evidence of this. Healthy School status is also a Beacon 
Council theme for 2006/200740.  The Beacon Scheme was introduced in 1999 by the 
Office of the Deputy Prime Minister41 to identify centres of excellence in local 
government. In January 2006 the NHSS Programme Board agreed a new marketing 
strategy that recommended rebranding of the Healthy Schools programme.  
Consultation is currently underway with young people and key stakeholders. 
 
A practice development resource pack for school nurses offers a framework to 
support the development of a modern school nurse role (DH and DfES 2006).  It 
identifies key national policies that are currently shaping developments in children's 
services and sets out a child centred public health approach for school nursing 
teams.  
 
The Blueprint research programme is continuing to examine the effectiveness of a 
multicomponent approach to drugs education and prevention in schools (Baker 
2006).  Data collection has ended and a full evaluation is due to be published in 
2007.  In 2005/06 the following research themes were addressed: 
• observation of Year 8 (pupils aged 12 to 13) lessons in Blueprint Schools; 
• qualitative interviews with teachers; 
• 2nd impact survey of Year 8 in all Blueprint schools; 
• parent survey in all Blueprint schools; 
• qualitative interviews with pupils and parents in all pilot schools; and 
• 2nd and 3rd lifestyle surveys. 
 
Also see the ACMD report mentioned in the previous section.  
Drug testing in schools  
While there is no policy to encourage drug testing in schools, DfES guidance for 
schools states that the decision is for each school.  However in 2006 it was 
announced that the DfES would evaluate the results of a pilot random drugs testing 
scheme in Kent (England) schools, although no further details are as yet 
forthcoming.42   
 
The Scottish Executive has announced that it has no plans to introduce random drug 
testing into schools.43  
                                                 
39 The National Healthy School Standard has three strategic aims: to reduce health 
inequalities; to promote social inclusion and to raise educational standards.  The Department 
of Health and the Department for Education and Skills have agreed new national targets for 
the NHSS: all schools with 20% + Free School Meal Eligibility (approximately 7000) to 
achieve NHSS level three status by 2006 and all schools in England to continue to be 
provided with the opportunity to access the services of a nationally accredited local healthy 
schools programme 2003 to 2006.  See: www.wiredforhealth.gov.uk 
40 See: http://www.communities.gov.uk/pub/443/Round8ApplicationBrochure_id1164443.pdf  
41 Now the Department for Communities and Local Government 
42 See: 
http://www.teachernet.gov.uk/teachers/issue45/secondary/news/Randomdrugtestsforpupils/  
43 See: 
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Campaigns  
An evaluation of the Know the Score cocaine campaign in Scotland, aimed at 16 to 
26 year olds, who socialise once a week or more, has been published (Binnie et al. 
2006).  In 466 interviews conducted in December 2005, there was high reported 
awareness of the different campaign strands (TV, radio, print) and, although the 
majority could not report specific campaign themes (51%), after prompting 91 per 
cent were aware of at least one strand of the campaign.  Thirty percent said that they 
were less likely to take cocaine after seeing the advertisements.  Fifty six percent 
reported that the campaign did not alter intentions to use cocaine and 11 per cent 
that they were more likely to use.  Impact was greatest amongst existing cocaine 
users, those respondents believed to be most likely to be exposed to cocaine and 
females.  A greater percentage of the latter group reported that they were less likely 
to use cocaine after seeing the advertisements.  The results of the evaluation should 
be placed in the context of recent figures published by the Scottish Executive from 
the Scottish Crime and Victimisation Survey indicating that in 2004 cocaine was the 
second most popular drug amongst 20 to 24 year olds (7.1% reported lifetime use, 
3.5% recent use) (Murray and Harkins 2006).  
 
Also see the FRANK campaign below (3.2.3). 
3.2.3 Family 
In 2006, FRANK launched a new communications initiative aimed at families and 
parents, All about drugs: does your child know more than you?44.  Know the Score 
provides similar information targeted at parents.   
3.2.4 Community 
In England, New Deal for Communities partnerships aimed to integrate drug 
prevention into community regeneration strategies.  Evaluation was completed at the 
end of 200545, but at the time of writing only one publication examining the impact 
upon drug prevention has been published (Peters et al. 2003).  However, this study 
did not describe specific interventions or outcomes.  
 
In April 2006, the functions of Scotland Against Drugs (SAD), an organisation that 
provided support to community based services, were transferred to the Scottish 
Centre for Healthy Working Lives (SCHWL).  SCHWL will be responsible for taking 
forward the employability and employment of drug misusers as part of their overall 
business plan.  The existing Scottish Drugs Challenge Fund has been integrated into 
the activities of SCHWL, but its purpose will be subject to a forthcoming review.  In 
Scotland in 2005/06, 31 projects shared €863,000 (£590,000) from the fund.  This 
scheme aims to promote partnership working between the public, private, and 
voluntary sector to support community based drug prevention.  Funded projects have 
included inclusionary/diversionary activities and skills training.  Only those other 
activities of SAD pertaining to employability have been transferred to SCHWL; drugs 
education and prevention activities have been transferred to NHS Scotland.   
 
Youth Matters: Next Steps (DfES 2006) builds upon the green paper Youth Matters 
(2005) and follows from the results of consultation with around 19,000 young people.  
Drug prevention falls under proposals supporting the objective of improving physical 
and emotional health. The Youth Capital Fund is intended to improve and develop 
                                                                                                                                            
http://www.ltscotland.org.uk/sharednews/2006/educational/september/news_tcm4375198.asp  
44 See: http://www.homeoffice.gov.uk/materials/Parents_Leaflet.pdf 
45 See: http://ndcevaluation.adc.shu.ac.uk/ndcevaluation/Home.asp  
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facilities for young people, and the Youth Opportunity Fund will allow young people to 
prioritise spending for activities in their local area.  The funding guidance notes46 do 
not specifically refer to substance use, but allow for spending on diversionary and 
inclusionary activities.  
 
The National Institute for Health and Clinical Excellence (NICE) has commissioned 
the NCCDP to conduct a systematic review into the effectiveness of community 
based drug prevention in vulnerable young people.  This is due to be published, with 
associated guidance, in early 2007.47 
3.3 Selective/indicated prevention 
Selective or indicative prevention initiatives target those groups identified as being 
high risk such as truants or young offenders. 
3.3.1 Recreational settings 
A poster campaign focusing on the risks of illegal drugs was launched in December 
2005 by the Health Promotion Agency for Northern Ireland48.  The posters were 
aimed at 18 to 30 year olds and were displayed in pubs and nightclubs.  The 
campaign also covered general risks such as purported drink spiking, contaminated 
preparations, polysubstance use and interactions with other risky behaviours.   
3.3.2 At-risk groups 
The ACMD has written to all D(A)ATs49 informing them of statutory guidance for 
Local Safeguarding Children’s Boards (LSCB)50 to be included in Working Together 
to Safeguard Children (HM Government 2006).  D(A)ATs are expected to form close 
links with LSCBs over matters of child protection, especially where concerning 
children in drug using families (see ACMD,2003). 
 
The Drug Interventions Programme’s pilots for children and young people aim to 
address substance related issues such as accommodation, family, or mental health 
problems.51  At various points of the youth justice system they identify children and 
young people who have, or are at risk of developing, substance misuse problems.  
Their needs are assessed in order to facilitate appropriate support and treatment 
services. 
 
Positive Futures (PF)52, the national sports-based social inclusion programme aimed 
at marginalised 10 to 19 year olds with projects in most deprived areas in the 
country, as identified by the Index of Multiple Deprivation.53  In April 2006 the charity 
Crime Concern took over responsibility for continuing the programme. In its third and 
final impact report (DSD 2006) it was reported that 109,456 young people had been 
involved in regular PF activities since its inception in 2002, 26,586 since the 
beginning of 2005.  No formal outcome assessment has yet been made of the 
                                                 
46 See: guidance notes at: 
http://www.everychildmatters.gov.uk/_files/6619BB0981484D39AC878329AB10B7F5.pdf  
47 See: http://www.nice.org.uk/page.aspx?o=SubstanceMisuseInt&c=publichealth for details 
48 See: http://www.drugsalcohol.info/Home.aspx  
49 See: http://www.drugs.gov.uk/publication-search/young-people/acmd-letter-
lscb?view=Standard&pubID=321609  
50 LSCBs are new organisations taking on the responsibilities of the old Area Child Protection 
committees 
51 See: http://www.drugs.gov.uk/drug-interventions-programme/strategy/children-yp/  
52 See: http://www.drugs.gov.uk/young-people/positive-futures/  
53 See: http://www.communities.gov.uk/index.asp?id=1128444 
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programme, although surveys suggest that project facilitators believe that 
participation was beneficial for young people.  New participatory monitoring and 
evaluation systems are currently being piloted and are due to be introduced 
nationally in summer 2006. 
 
The Common Assessment Framework (CAF) was introduced in 2005/06 and is due 
to be implemented across all areas in England before 2008. CAF is a shared 
assessment tool used across services coming into contact with young people in 
England. It has been designed to help practitioners assess needs at an earlier 
stage.54  It is envisaged that information sharing through the CAF will allow better 
identification and service response to children with additional needs, including 
substance use.  A common assessment will be performed whenever a child is 
thought unlikely to achieve the five Every Child Matters outcomes without additional 
services.  
 
In a review of recent Government sponsored research into drug prevention in 
vulnerable young people, Edmonds et al. (2005) concluded that school engagement 
was an important factor against harmful drug use and as an important medium for 
prevention delivery.  These authors also argued that training in drug use issues, 
particularly screening and appropriate use of external educators, was needed for all 
non-specialist groups who may come into contact with vulnerable young people.  
Many research gaps were identified, particularly the lack of outcome evaluations of 
interventions targeted at this population, and the interaction between different 
vulnerabilities and drug use. 
 
The Scottish Executive has published an Evaluation and Description of Drugs 
Projects Working with Young People and Families funded by Lloyds TSB Foundation 
Partnership Drugs Initiative (PDI) (McIntosh et al. 2006).  This report provides case 
study process and outcome evaluation of four projects in Scotland.  Positive changes 
were reported by young people in both use of substances and risk factors for use. 
PDI is a funding initiative providing grants to voluntary sector organisations working 
with children and young people affected by drugs and alcohol misuse.  The Scottish 
Executive provided €5.1 (£3.5) million funding to the PDI between 2000 and 2005, 
with a further €1,010,000 (£750,000) agreed for financial year 2006/07. 
3.3.3 At-risk families 
Sure Start is a United Kingdom Government programme supporting children and 
their families from birth up to age 14 (up to age 16 for children with special needs or 
disabilities).  The programme aims to increase the supply of good quality early 
learning, childcare and health, and family support, as well as encouraging the 
development of integrated and joined up services.  Early evaluation of the 
programme in England and Wales has indicated that Sure Start Local Programmes 
(SSLP) were more than twice as likely to show evidence of better than expected 
functioning across multiple outcomes related to child development and parenting 
(National Evaluation of Sure Start, 2004).  Although substance use has not been 
reported in the national evaluation, Sure Start supports local drugs prevention work, 
and local evaluations have included this outcome.  Sure Start also runs in Scotland 
and Northern Ireland, although recent evaluations are not yet forthcoming.55  The 
evaluation phase ends in 2007. 
                                                 
54 See: 
http://www.everychildmatters.gov.uk/_files/EE0F4CD8CFC720A63D04988B32F4FC44.pdf  
55 Refer to: http://www.scotland.gov.uk/Publications/2005/12/21153916/39170 for a Sure Start 
Scotland mapping exercise undertaken in 2004 
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The DfES has commissioned research from the University of Stirling to explore the 
responses of child protection practices and procedures for children exposed to 
domestic violence, and parental substance use within families. 
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4. Problem drug use  
4.1 Overview 
Population-based surveys56, because of the often hidden nature of problem drug use, 
are considered to be of limited use in estimating the full extent of problem drug use in 
the United Kingdom.  More reliable estimates have been derived from alternative 
methods, such as the capture-recapture method and the multiple indicator method 
(also known as the multivariate indicator method).57  An estimate based on studies in 
the public domain as of September 2006 suggests that in the United Kingdom there 
were 357,160 problem drug users aged 15 to 64, 9.26 per thousand population.  
Estimates of injecting drug users for the United Kingdom suggested prevalence of 
injecting drug use of 117,722, 3.05 per thousand population.  There are wide 
variations in the prevalence of problem drug use, and injecting drug use between the 
four constituent parts of the United Kingdom (see United Kingdom Focal Point Report 
2005).  There are also wide local variations ranging from, for example, 1.6 per 
thousand in Orkney and to 33.1 in Glasgow.  
 
There are variations between countries regarding the characteristics of clients 
presenting to treatment and this reflects the definitions of problem drug use between 
countries.  While, on the whole, heroin is the main drug used throughout the United 
Kingdom, benzodiazepines are the second most used drug in Scotland; in Northern 
Ireland, just over a quarter reported the use of opiates as their primary drug but 
cocaine is seen as a problem, and nearly half report cannabis.  Cannabis as the 
primary drug used by those presenting to services is reported less often elsewhere in 
the United Kingdom, though it is the second most reported main drug; at around ten 
per cent in England.  Crack use is identified as more problematic in England than 
elsewhere.  The proportion entering treatment who report injecting as main route of 
administration also varies with just over a quarter of clients reporting having ever 
injected in Northern Ireland and Scotland, but nearly two thirds in England and 
Wales. 
 
For all new presentations (presentations where the individual has not previously been 
in treatment during the reporting period), approximately a third are under 24 years of 
age and a quarter of clients are aged between 25 and 29 years old; nearly three 
quarters are male.  
4.2 Prevalence and incidence estimates 
The only new problem prevalence estimates to be published are those for Northern 
Ireland, where two sets of estimates were obtained, for opiate use and for problem 
opiate use and/or cocaine use.  A large-scale study to estimate the prevalence of 
problem drug use (defined as opiate and/or crack cocaine use) is currently being 
carried out, to obtain prevalence estimates for England, along with 149 local 
estimates at the Drug and Alcohol Action Team (D(A)AT) area level for three 
successive years; 2004/05, 2005/06 and 2006/07.  That study will also provide 
estimates of opiate use, crack cocaine use and drug injecting for each local area.   
                                                 
56 Such as the British Crime Survey, Northern Ireland Crime Survey or Scottish Crime Survey. 
57 For information on this see Frischer et al. 2004. 
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4.2.1 England  
Research into problem prevalence estimates for England using the multiple indicator 
method, first published through the Home Office in 2004 (Frischer et al. 2004), have 
been reported in a scientific journal (Frischer et al. 2006). The capture-recapture 
estimates from three cities that were used to inform the multiple indicator estimates 
for England in 2001 were also published in a scientific journal (Hickman et al. 2006); 
these capture-recapture estimates were compared with estimates derived using 
multiplier methods. 
Estimates of crack cocaine in London  
Estimates of prevalence of crack cocaine in 12 London boroughs, for 2000/01 were 
published in 2005 (Hope et al. 2005a)58.  Results suggest that prevalence was 
approximately 15.4 per thousand population (20,972) in 12 boroughs and 
approximately 13 per thousand (47,000) in London as a whole.  The authors used a 
slightly different approach to obtain those estimates than the approach used in the 
original publication, where the corresponding prevalence for the 12 boroughs was 8.1 
per thousand.  
4.2.2 Northern Ireland. 
Research has been completed to provide estimates of the number of problem drug 
users in Northern Ireland using the capture – recapture method, (Hay et al. 2006).59  
Estimates are for opiate users and opiate and/or problem cocaine use for 2004.  
National estimates and estimates for the four Health and Social Service Boards 
(HSSB) were provided.  The research suggested prevalence of 1,395, 1.28 per 
thousand population for opiate users (95% CI = 1.21 to 1.75).  A wider estimate for 
problem opiate and/or problem cocaine use suggested there were 3,303 problem 
opiate or problem cocaine users, a rate of 3.03 per thousand population (95% CI = 
2.84 to 3.95).  Results are shown in Table 4.1.  
 
Table 4.1: Estimated number of opiate users and opiate and/or problem cocaine users aged 
15 to 64 years old and rate per thousand population, by HSSB area in Northern Ireland, 2004 
 
HSSB 
Area 
Opiate users Opiate and/or problem cocaine 
users 
 Estimate Rate 95% CI Estimate Rate 95% CI 
Eastern 725 1.68 1.07 3.04 1,612 3.74 2.75 5.40 
Northern 360 1.29 1.04 1.70 663 2.38 1.85 3.09 
Southern 130 0.65 0.27 2.41 4666 2.34 0.76 3.31 
Western 180 0.99 0.48 3.60 562 3.08 1.75 7.00 
Northern 
Ireland  
1,395 1.28 1.21 1.75 3,303 3.03 2.84 3.95 
Source: Hay et al. 2006b 
 
The revised estimates for Northern Ireland (1,395, 95% CI = 1,316 to 1,910) suggest 
a higher estimate than previously reported for 2001/02 (828, 95% CI = 695 to 1,018) 
(McElrath 2002). However, care must be taken in comparing prevalence estimates 
within Northern Ireland, particularly due to the relatively small numbers of individuals 
using drugs such as heroin. 
                                                 
58 The capture-recapture method was used. Applied to three data sets: specialist drug 
treatment, arrest referral and an accident and emergency and community survey. 
59 The capture-recapture method was used.   
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4.2.3 Scotland 
No new estimates are reported. 
4.2.4 Estimates for problem drug use in Wales  
In Wales, work is being undertaken to provide cyclical problem prevalence data.  
Results of the first study are expected late 2006.  Prevalence estimates will be made 
for heroin, cocaine, crack and amphetamine users.   
4.2.5 By substance used 
Each prevalence study in the United Kingdom uses a slightly different case definition 
for problem drug use than those suggested by the EMCDDA.  The new study in 
England will provide estimates for opiate and/or crack cocaine use and separate 
estimates for opiate use and crack cocaine use.  The previous Scotland estimate 
looked at opiate and/or benzodiazepine use, however the large majority of problem 
drug users in that case definition were opiate users.  The newer estimates for 
Northern Ireland included two definitions, problem opiate use and problem opiate 
and/or problem cocaine use.  
4.2.6 By injecting drug use (ever and current) 
The only prevalence estimates for drug injecting in the United Kingdom focus on 
current injecting.  Published estimates of the prevalence of injecting drug use in 
England are for 2000/01, however a current study will provide estimates of injecting 
drug use for 2004/05, 2005/06 and 2006/07.  There were too few data to provide a 
meaningful estimate in the 2004 prevalence study in Northern Ireland.  
4.3 Profile of clients in treatment 
4.3.1 By substance used 
Based on Treatment Demand Indicator (TDI) data for 2004/05, in the United Kingdom 
there has been a large increase (25%) in the proportion reported to be using cocaine 
as a main drug of use and cannabis as a main drug of use (50%), with 
correspondingly relatively modest increases in the proportion using opiates as a main 
drug of use (6%).  Table 4.2 shows the number and percentage of drug treatment 
presentations in 2003/04 by primary drug of use in the United Kingdom and in each 
country. 
 
Table 4.2: Number and percentage of drug treatment presentations in 2003/04 in the United 
Kingdom by primary drug of use and by country 
 
Drug England Northern Ireland 
Scotland Wales United 
Kingdom 
 n % n % n % n % n % 
Amphetamines 3,045 3 19 1 269 2 398 13 3,731 3 
Benzodiazepines 1,395 1 182 10 791 6 135 4 2,503 2 
Cannabis 12,021 12 810 46 1,593 11 377 12 14,801 13 
Cocaine 4,637 5 126 7 278 2 52 2 5,093 4 
Crack 5,715 6 3 0 48 0 76 2 5,842 5 
Opiates 60,030 61 360 21 8,162 57 1,627 53 70,179 60 
Other/ NK 11,841 12 246 14 3,143 22 402 13 15,632 13 
Total 98,684  1,746  14,284  3,067  117,781  
Source: Standard Tables prepared for United Kingdom Focal Point based on treatment 
monitoring systems 
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4.3.2 By centre types 
In 2004/05 there were 111,436 reported new treatment demands for outpatient 
treatment, 2,945 for inpatient treatment and 3,402 for treatment in general practice.  
4.3.3 By gender 
In 2004/05 72 per cent (84,527) of demands were by males and 28 per cent (33,254) 
by females. 
4.3.4 By age 
There was an increase in the proportion of young people reported, with a 37 per cent 
increase in 15 to 19 year olds and a 8 per cent increase in 20 to 24 year olds. 
4.3.5 By injecting 
Overall numbers of those said to be injecting have increased, but the proportions 
said to be currently injecting have fallen from 34 per cent to 28 per cent. 
 
The proportion said to be injecting opiates has reduced for all treatments from 51 per 
cent to 43 per cent; and for first treatment demands from 44 per cent to 38 per cent. 
There have also been modest reductions in those reporting injecting of cocaine. 
Additional information is available for Northern Ireland where a treatment census was 
undertaken in 2005 and the Northern Ireland Addicts Index.  
Treatment Census Northern Ireland  
The first census of Drug and Alcohol Treatment Services in Northern Ireland was on 
the 1st March 2005 (DAIRU 2005).  This showed that there were 5,064 individuals in 
treatment for drug and/or alcohol misuse.  Approximately 6 in 10 (61%) of all those in 
treatment on 1 March 2005 were attending for alcohol-only related problems. Two in 
10 people (20%) were in treatment for drug-only related problems and just under one 
fifth (19%) were in treatment for both drug and alcohol related problems.  
Northern Ireland Drug Addicts Index 
Northern Ireland also retains an Addicts Index.60  People are registered on this 
database if they are known to be, or if a medical practitioner considers them to be, 
addicted to one or more of 14 controlled drugs.  Published statistics for 2005 relate to 
people registered on the Northern Ireland Drug Addicts Index on the 31st December 
2005 (DAIRU 2006).  Statistics show that: 
• there were 239 persons registered, a decrease of 20 from 259 persons registered 
at 31st December 2004; 
• there were 178 re-notifications in 2005, compared to 157 in 2004; 
• 78 cases were removed from the Addicts Index 2005: 
• the gender profile has remained relatively unchanged since 2004, with seven out 
of every 10 addicts being males (71% males and 29% females); 
• the age profile has remained relatively unchanged, with 38 per cent of registered 
addicts aged 29 years and under in 2005, compared to 39 per cent in 2004; 
• heroin was the most frequently reported notifiable drug, used by 70% of all 
addicts registered at 31st December 2005, methadone (28%) and cocaine (11%) 
remained the next most commonly reported drugs; 
• in 2005, more than a third (38%) of those registered addicts whose injecting 
behaviour was known reported currently injecting. The corresponding figure for 
2004 was 49 per cent;  
• of the 239 addicts on the Index, 61 were registered within the last year; and  
                                                 
60 The Addicts Index in the rest of the UK closed in April 1997. 
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• 120 addicts have been registered for between one and five years.  
4.4 Main characteristics and patterns of use from non-treatment sources 
4.4.1 By substance used 
NO NEW INFORMATION AVAILABLE  
4.4.2 Injecting drug users 
NO NEW INFORMATION AVAILABLE  
4.4.3 Other specific sub-populations 
For information on minors in treatment see Chapter 11: Drug use and related 
problems among very young people.
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5. Drug-Related Treatment  
5.1 Overview 
United Kingdom drug strategies identify treatment as being effective in tackling 
problem drug use and, therefore, indicate a need to increase its availability and 
quality.  The provision of treatment has been devolved and therefore each 
administration is responsible for it.  In England, increasing the participation of 
problem drug users in treatment programmes is one of eight Public Service 
Agreement targets for the Department of Health (HM Treasury 2004) which is also 
translated into a corresponding target for the National Health Service areas (DH 
2002a; DH 2004a).  Within the devolved administrations an increase in treatment 
provision is also a priority (DHSSPSNI 2006a; Scottish Executive 2004; Welsh 
Assembly Government 2003a). 
 
Drug misuse and dependence: guidelines on clinical management and England’s 
Models of care for treatment of adult drug misusers: update 2006 provide the basic 
framework for drug treatment, offering guidance around the structure and range of 
services to be commissioned in each area, as well as guidelines on clinical practice 
(DH and Home Office 2006).  Treatment providers are expected to offer advice and 
information, needle exchange, care planned counselling, structured day care 
programmes, community prescribing, inpatient drug treatment and residential 
rehabilitation.  In addition, drug misusers are to be offered relapse prevention and 
aftercare programmes, hepatitis B vaccinations, and testing and counselling for 
hepatitis B and C, and HIV (DH 2002b).  Oral methadone maintenance is the most 
common method used in treating heroin addiction; but buprenorphine and injectable 
methadone and heroin are also available. 
 
Co-ordination and integration between a range of providers is seen as key in helping 
problem drug users reintegrate into society.  While providing treatment remains a 
priority, the role of providers of housing, employment, education and training has also 
become important, leading to the concept of Wrap Around Services.61  This 
integrated approach is best seen through the introduction of the Drug Interventions 
Programme in England and Wales, and the establishment of Criminal Justice 
Intervention Teams which have been developed to improve referral into treatment 
through the criminal justice system and whilst in prison (see Chapter 9). 
 
Improving treatment for young people was also prioritised in 2005.  
 
With access to effective treatment being a priority of United Kingdom drug strategies, 
treatment capacity has increased substantially.  This has been accompanied by 
significant financial investment.  However, there remain issues around workforce 
capacity, which are being addressed.  Research initiatives are funded centrally to 
help improve the effectiveness of treatment, and there are also a number of other 
initiatives to increase the capacity and improve the effectiveness of treatment, for 
example nurse prescribing, guidance for pharmacists working with drug users, and 
                                                 
61 See:  
http://www.drugmisuse.isdscotland.org/eiu/pdfs/eiu_litreviewsum.pdf#search=%22Wrap%20A
round%20Services%20drug%20misuse%20%22, and 
http://www.nta.nhs.uk/frameset.asp?u=http://www.nta.nhs.uk/publications/mocpart2/chapter2
_5.htm  
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continued encouragement to expand the role of general practitioners in the treatment 
and care of drug misusers.  
5.2 Treatment system 
Based on the Treatment Demand Indicator a total of 117,783 individuals were 
reported as presenting for treatment during the period 2004/05, 36 per cent of whom 
were making their first ever treatment demand.  
 
There were 111,436 outpatient reports.  This represents an overall increase of 22 per 
cent over the previous period, largely accounted for by an increase of 46 per cent in 
first treatment demands. 
 
There has been a 27 per cent increase in the number of self-referrals and a 71 per 
cent increase in those referred from the criminal justice system.  
 
During 2005/06 there were 181,390 drug users in structured treatment in England62, 
this is an increase of 13 per cent from 2004/05 (160,450)63.  
 
Also, in England, 141,511 individuals (78% of those treated in the year) either 
successfully completed treatment in 2005/06 or were retained in treatment on 31 
March 2006.  2004/05 figures reported 120,700 (75%).  
5.2.1 Access to treatment in the criminal justice system  
Required assessment and treatment for drug using offenders  
With many drug misusing offenders required to access treatment (see 1.3.2 and 
9.3.2) the following additional performance indicators will apply in intensive Drug 
Interventions Programme (DIP) areas in England and Wales: 
• assessment by criminal justice intervention team (CJIT) within 24 hours; 
• care plan agreed with client within five working days; and 
• substitute medication (if required) available within five working days (Home Office 
– internal communication).   
Drug treatment in prison  
Comprehensive drug treatment services are to be available in prisons in England 
(NTA, DH and Home Office 2006) and Scotland (SPS 2006) (See Chapter 9). 
5.2.2 Strengthening the treatment system  
There have been a number of initiatives in the United Kingdom to strengthen the 
treatment system.  
Revision of Models of Care  
Models of care for treatment of adult drug misusers: update 2006 (NTA, DH and 
Home Office 2006) revises the 2002 document in the light of a number of initiatives, 
changes in the drug treatment system, the introduction of a Treatment Effectiveness 
Strategy and the Drug Interventions Programme (see United Kingdom Report 2005).  
The update explains more clearly the concept of the tiered approach, pointing out 
that there has been confusion amongst commissioners as to its nature.  It also brings 
together new concepts such as treatment journeys (see below), and re-emphasises 
the need for care planning, harm reduction services and aftercare. 
                                                 
62 See: http://www.nta.nhs.uk  
63 An interim figure of 163,985 was suggested in previous UK Focal Point report. 
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It is stated that ‘tiers’ provide a conceptual framework, not a rigid blueprint for 
provision, referring to interventions provided, not provider organisations.  It is also 
noted that some harm reduction activities have been marginalised into being 
provided only by what have been called “Tier 2 services” (such as needle exchange 
services), at a time when there is evidence that rates of infection of blood borne 
viruses are rising.  It is also suggested that care planning is frequently not 
undertaken (this is now a key tenet of the Treatment Effectiveness Strategy); all 
individuals in treatment should have an identifiable written care plan, which tracks 
their progress, and is regularly reviewed with them, by 2008. 
 
Care Planning Practice Guide (NTA 2006a) and the report on the current evidence 
base for effective treatment by Gossop (2006) reported below, accompanies the 
Models of care for treatment of adult drug misusers: update 2006. 
Updated guidance on needs assessment  
New guidance on the development of a needs assessment process for D(A)AT 
partnerships has been published (NTA 2006b). 
Updated guidance for reporting waiting times for treatment services  
Revised guidance on reporting waiting times in 2006/07 clarifies definitions and 
processes by which drug treatment service providers and D(A)ATs record waiting 
times and report them to the NTA through the National Drug Treatment Monitoring 
System (NDTMS) (NTA 2006c).  
Clinical guidance and technological appraisal  
The National Institute for Health and Clinical Excellence (NICE) report that they are 
to produce clinical guidance for: 
• Methadone and buprenorphine for the treatment of opiate misuse (March 2007). 
• Drug Misuse: Psychosocial management of drug misusers in the community and 
prison setting (September 2007).64 
• Opiate detoxification of drug misusers in the community and prison setting 
(September 2007). 
 
They are also to undertake a technology appraisal of naltrexone as a treatment for 
relapse prevention in drug misusers (March 2007). 
 
Drug misuse and dependence: guidelines on clinical management is to be updated 
over the coming year.  This will incorporate reference to the conclusions of the NICE 
technology appraisals on methadone, buprenorphine and naltrexone, and the NICE 
guidelines on opiate detoxification and psychosocial interventions. 
The management of drug users in primary care 
The Royal College of General Practitioners' (RCGP) Sex, Drugs & HIV Group issued 
a consensus statement from its national conference Management of Drug Users in 
Primary Care, suggesting that, “Effective care for drug users is being delivered in 
general practice, because we have inherent ability and flexibility to see the person 
rather than the drug.”65  The conference highlighted the developing role of shared 
care. 
                                                 
64 See: http://www.nice.org.uk/  
65 See: http://www.rcgp.org.uk/  
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The role of pharmacists in the treatment and care of drug misusers  
Guidance on commissioning pharmaceutical services for drug users has been 
published (NTA 2006c). 
New Legislation on Nurse Prescribing 
From 1 May 2006, the Nurse Prescribers' Extended Formulary was discontinued and 
qualified Nurse Independent Prescribers (formerly known as Extended Formulary 
Nurse Prescribers) are now able to prescribe any licensed medicine for any medical 
condition within their competence, including some controlled drugs66.  This extends 
the range of practitioners able to prescribe for problem drug users.  The Department 
of Health had provided the funding to pilot this (DH 2006b). 
Improvement reviews into substance misuse services  
The Healthcare Commission is currently undertaking improvement reviews into 
substance misuse services.  The 2005/06 reviews are looking at community 
prescribing services and care planning and co-ordination (see below).  In addition, 
the Healthcare Commission, in collaboration with the NTA, is also undertaking a 
review of systems management (across the key elements of risk management, 
patient choice, diversity and effective partnerships) and harm reduction provision.  A 
review is also planned, looking at Tier 4 treatment (inpatient and rehabilitation) and 
diversity in 2006/07.  This is expected to be published during 2007/08.67 
 
The first of a series of these reviews into treatment in England has been made 
available on line.68  This focused on two key aspects of drug treatment for 2005/2006, 
whether drug treatment services are prescribing drugs safely and appropriately and 
whether there is good treatment planning and co-ordination of services.  
Performance has been assessed against national standards.  The review covered all 
149 D(A)ATs; 56 mental health trusts and 303 primary care trusts (PCTs) within 
those D(A)ATs have also been rated. 
 
Seventy-one per cent of D(A)ATs were rated as fair, 23 per cent as good, 5 per cent 
as excellent and one per cent as weak.  At PCT level: one mental health trust and 13 
PCTs (4% of the total) received a score of excellent; twenty-one mental health trusts 
(38% of the total) and 73 PCTs (24%) received a score of good; thirty-four mental 
health trusts (61%) and 211 PCTs (70%) received a score of fair; and six PCTs (2%) 
received a rating of weak. 
 
Conclusions are that drug treatment services need to: 
• keep service users in treatment longer; at least 12 weeks; 
• improve methadone prescribing; while the majority (95%) of services have good 
policies on methadone prescribing, some services are still prescribing insufficient 
doses to maintain users and prevent the use of street drugs.  It is also suggested 
that there is a need to move away from standard policies, which prescribe the 
same amount for each service user and for prescribing to be linked more closely 
                                                 
66 See: http://www.york.ac.uk/inst/che/research/argprojnew.htm  
http://www.dh.gov.uk/PolicyAndGuidance/MedicinesPharmacyAndIndustry/Prescriptions/Non
medicalPrescribing/NursePrescribing/fs/en (England); http://www.scotland.gov.uk (Scotland); 
http://www.wales.gov.uk (Wales); http://www.dhsspsni.gov.uk (Northern Ireland)  
67 More detailed information on the review process can be found on the NTA website at: 
www.nta.nhs.uk and www.healthcarecommission.org.uk  
68 See: 
http://www.healthcarecommission.org.uk/serviceproviderinformation/reviewsandinspections/i
mprovementreviews/substancemisuse.cfm  
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to individual need.  In addition, it states that more patients need to be supervised 
during methadone consumption in the early stages of treatment;  
• involve service users more; 
• use individual care plans more consistently; the review found not enough service 
users have these, 48 per cent of D(A)ATs being weak in this area, and 32 per 
cent rated only as fair. The level of risk assessment was weak with 70 per cent 
found to be weak when assessing and managing risks for service users; and  
• improve commissioning; 63 per cent of D(A)ATs were rated as weak or fair when 
it came to assessing the detail of their specifications for community prescribing 
interventions. 
 
The Healthcare Commission will use the review in its annual rating of mental health 
and PCTs.  The Healthcare Commission and the NTA will also publish a national 
report detailing the overall findings later in the year.  
The Unit costs of substance misuse 
In July 2006 the NTA reported that it is working with the Department of Health, the 
Home Office, and HM Treasury to provide a better understanding of the costs of 
treatment.69  
Audit of prescribing in England  
An audit of prescribing has been undertaken to inform to the Healthcare Commission 
and NTA improvement reviews (see above) of care planning and prescribing services 
(Best and Campbell 2006).70  The aim of the audit was to produce a systematic 
analysis of prescribing for the management of drug use in a treatment context and to 
examine the implementation of Drug Misuse and Dependence: Guidelines on Clinical 
Management (DH, Scottish Office DH, Welsh Office, DHSSNI 1999).   
 
A survey of services found 74.5 per cent of clients were prescribed a substitute 
opiate; 81 per cent received a prescription for methadone and 17 per cent of clients, 
buprenorphine.  Amongst those prescribed methadone: 
• three quarters received methadone maintenance, a quarter received methadone 
on a reduction basis; 
• a majority (97%) of clients received oral methadone, 1.6 per cent ampoules and 
1.7 per cent in methadone in tablet form: 
• mean daily dose was 56.7mg, but ranged from 6.6mg to 127mg,;15 per cent 
received doses of less than 30 mg; 48 per cent, 31 to 60 mg; 28 per cent, 61 to 
90, mg; seven per cent, 91 to 120mg; and two per cent doses greater than 
120mg; and 
• 64 per cent had doses dispensed daily or near daily, 12 per cent 3 to 4 days a 
week, 22 per cent once or twice weekly and 2 per cent less than once a week. 
 
Nearly all services reported having some clients on supervised consumption; 73 per 
cent for the first week; a quarter of services continued to have all or nearly all clients 
                                                 
69 See: 
http://www.nta.nhs.uk/frameset.asp?u=http://www.nta.nhs.uk/programme/national/performanc
e_information.htm  
70 Three methods were used; data from the National Drug Treatment Monitoring System, data 
from Prescription Pricing Authority which provides information on the quantities of methadone 
and buprenorphine distributed in England, and a questionnaire survey of specialist services.  
Questionnaires were sent to 373 services, 242 responded (66%).  Information was received 
on 51,482 clients, of whom 38,335 were prescribed opioid substitutes.  
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supervised daily throughout their time on a prescription.  A majority of clients (60%) 
on methadone had been on a prescription for more than six months.   
 
Amongst those prescribed buprenorphine: 
• 60 per cent were on a maintenance basis and 40 per cent on a reduction 
prescription; 
• mean daily dose was 8.9 mg, with a range of 1.4mg to 24mg; 
• less than 20 per cent were supervised; and 
• 40 per cent had been on buprenorphine for over six months. 
 
Thirty-one per cent of services prescribed drugs other than methadone and 
buprenorphine as opioid substitutes, these included dihydrocodeine, diamorphine, 
morphine, lofexidine and codeine and morphine. 
 
The authors concluded that typical daily maintenance doses of methadone approach 
clinical guidelines but that mean daily maintenance doses of buprenorphine were 
suboptimal.  Further, the widespread use of daily supervised methadone 
consumption in some services for all clients after the first 12 weeks may be 
unnecessary. 
Implementing treatment strategy locally: treatment plans   
In England D(A)ATs are required to submit draft treatment plans for 2006/07 to the 
NTA.  Following a period of assessment and negotiation, plans are to be published in 
October 2006.71 
Shortfall in Availability of Diamorphine Injection 
There continues to be a shortfall in the availability of injectable diamorphine in the 
United Kingdom, with a further alert posted on the 9th July 2006 by the NHS 
Purchasing and Supply Agency.72  Based on manufacturing capacity, this shortfall is 
expected to continue throughout 2006, though it is hoped that the overall supply 
position might improve during 2007 (NHSPASA 2006). 
 
The Department of Health has funded research into an incremental cost-
effectiveness analysis of methadone maintenance as a baseline treatment, 
compared to adding a cognitive behaviour therapy (CBT) module to the therapy (DH 
– internal communication).  
 
A study of supervised methadone consumption has been commissioned by the NTA 
to demonstrate whether supervised consumption and good dispensing practice 
reduces the prevalence of drug-related deaths (owing to accidental overdose and 
leakage to the illicit market), and to make recommendations for clinical practice.  This 
has not been published at the time of writing.  
Survey of inpatient services in England 
A survey of inpatient services in England, conducted for the NTA, aimed to establish 
the current level of provision and to provide a snapshot of clinical practice, in terms of 
the number of services, location, availability of beds, types of cases managed, 
                                                 
71 See: 
http://www.nta.nhs.uk/frameset.asp?u=http://www.nta.nhs.uk/programme/main.htm  
72 For more information see: http://www.smmgp.org.uk/html/news.php#090706 
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available resources, types of services and ranges of outcomes for stabilisation or 
detoxification of patients (Day et al. 2005).73   
 
It was estimated that there were 10,771 admissions for detoxification in 2003/04.  
Access to inpatient services varied across England, as did the range of services 
provided.  A third of services do not require patients to have an aftercare plan in 
place prior to admission.  Only one-third are discharged to residential or day care 
rehabilitation services.  A large number of recommendations were made to improve 
services.  
Research into Tier 4 services in England 
In addition to the survey of inpatient services in England described above, the NTA 
also published a needs assessment of Tier 4 services in England that will feed into 
the forthcoming review by the Healthcare Commission referred to earlier.  This 
survey found that there were huge variations in levels of provision across regions 
(Best et al. 2005).74  It was found that a third of units provided detoxification service.  
Most residential rehabilitation services provide support groups for specific groups; 
e.g. gender-specific support groups, parenting groups and parenting support, while 
some also offer family therapy and counselling for children of clients, although the 
provision of such services is inconsistent.  Availability for specific groups, such as the 
disabled, young people, pregnant women, parents with children and stimulant users, 
was on the whole, regarded as inadequate.  Only one service offered a facility for 
mothers with children under the age of six months and one for mothers with children 
over the age of six months.  However, a majority (83%) offered culturally sensitive 
menu options and 44 (68%) offered support for religious needs or cultural beliefs.  
 
It was found that just over a third (35%) who entered residential rehabilitation 
completed the treatment, compared to 43 per cent of those entering inpatient 
detoxification units.  The report suggested that this may, in part, be because only 69 
per cent of those referred for residential rehabilitation received an assessment, 
compared to 92 per cent of those referred to inpatient detoxification units.  The 
average residential rehabilitation waiting time was 3.7 weeks.  The average annual 
number of residential rehabilitation places was estimated at 33 per D(A)AT (20 males 
and 13 females).  
 
Only 34 per cent of the commissioners had carried out local needs assessments for 
inpatient detoxification units and 31 per cent for residential rehabilitation. 
 
It was estimated that 12,485 inpatient detoxification and 10,007 residential 
rehabilitation places are required annually in England and that therefore 51 additional 
places were needed for inpatient detoxification in each D(A)AT, and 33 additional 
places for residential rehabilitation per D(A)AT. 
                                                 
73 A database of inpatient services based on commissioning records, treatment services 
directories and specialists in the field, was constructed.  Units identified were then asked to 
complete a written survey.  
74 The primary data collection method was a survey of 105 services providing residential 
rehabilitation treatment, identified through the NTA residential directory.  Six of the listed 
services, which only provided supported accommodation, were excluded.  The questionnaire 
was partly based on the schedule used in the inpatient detoxification survey conducted by the 
University of Birmingham, amended to cover residential rehabilitation services.  The survey 
was posted out to each of the residential rehabilitation units identified, targeting the service 
manager, and was followed up by telephone contact to encourage completion. In total, 65 of 
the 105 identified residential rehabilitation units (61 per cent) returned the questionnaire.  
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Consultation on residential rehabilitation  
A consultation draft, Models of residential rehabilitation (NTA 2006d) states that 
residential rehabilitation may not be suitable for those who:  
• have needs that require supervision in a controlled medical environment;  
• want to continue to use some drugs or drink during treatment; and/or 
• cannot or will not comply with restrictions on liberty. 
 
The range of services which should be available are:  
• Rehabilitative programmes that provide accommodation and a structured, care 
planned programme of therapeutic and other activities, suitable for clients with 
medium or high dependence on drugs and medium to high care needs. Such 
programmes sub-divide into: 
 Long stay programmes run for 12 weeks or more, for clients whose drug use 
is long-term and entrenched, and who are socially-excluded, unemployed, in 
severe housing need, and persistent, prolific offenders. 
 Short stay programmes lasting less than 12 weeks, either: 
o Intensive programmes providing intensive medical and therapeutic 
interventions for clients likely to be in housing need, with complex medical 
needs and likely to need to go on to long stay residential treatment. 
o Standalone programmes providing lower intensity interventions for clients 
with shorter drug histories and who are more likely to be able to return to 
employment/housing with community/family support. 
• Supportive programmes that provide accommodation, often following treatment in 
a rehabilitative programme, with specialist drug and non-drug related support, or 
from which clients attend therapeutic drug and non-drug related interventions.  
These are suitable for clients with low dependence on drugs or who are abstinent 
and have low care needs. 
 
It is suggested that assisted withdrawal/detoxification provided in residential 
rehabilitation is important both as a standalone option for some clients returning to 
treatment in the community and for those entering a full residential rehabilitation 
programme.  
Guidance for commissioning in-patient and residential rehabilitation  
Guidance has been published on commissioning of in-patient treatment and 
residential rehabilitation interventions (HO, NTA and DH 2006). 
Audit of aftercare 
The NTA is undertaking an audit into aftercare.  This is part of the NTA's Treatment 
Effectiveness agenda and aims to provide a better understanding of aftercare 
support.  This has not been published at the time of writing. 
Workforce development 
There is recognition that the required expansion and improvement of the quality of 
treatment, as indicated in the Public Service Agreement on treatment, needs to be 
supported by expansion of the workforce and development of its skills.  Each D(A)AT 
is required to develop a workforce strategy, which will be part of their treatment plan. 
Workforce development plan  
A joint Home Office and NTA workforce development plan for the substance misuse 
field was published in 2006 (HO and NTA 2006).  The purpose is to provide a 
conceptual framework for the workforce required to implement national Drug 
Strategy, particularly given that a shortage of a skilled workforce has been identified 
as a risk to the its achievement.  It is suggested that in England 4,000,000 generic 
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workers have, albeit occasional, responsibility for substance misusers, a further 
200,000 generic workers have a substance misuse function as part of their portfolio 
and there are 36,000 specialist substance misuse workers and that the adult 
treatment workforce is 9,000.  A target is set to expand to 11,000 workers in the drug 
treatment sector by 2008. 
Occupational Map of the drug and alcohol sector 
Skills for Justice75 is currently updating an Occupational Map of drug (and alcohol) 
services, developed in 2001.  This w ill provide an overview of drug (and alcohol) 
services, describing: 
• the range of employers and key stakeholders, and their roles and responsibilities;  
• opportunities for career progression, typical career routes and qualifications;  
• the key trends and drivers for change within the sector ; 
• key characteristics of employment within the sector; and 
• numbers employed within the sector. 
 
The Occupational Map will also provide an analysis of drug and alcohol services by 
Standard Industrial Classification and Standard Occupational Classification codes76. 
Diversity 
Diversity assessment package 
The NTA has developed a Diversity Assessment Package (DAP), available on CD.77 
Changes to the drug treatment monitoring system  
New core items have been added to the National Drug Treatment Monitoring System 
(NDTMS).  These are; Employment Status, Accommodation Status and Parental 
Status; the latter two being mandatory fields.78  
 
A new NDTMS application, File Upload Portal (FUP)79 became operational in April 
2006.  This provides a secure mechanism to transfer data from treatment providers 
to NDTMS regions and instant validation feedback.  Wandsworth D(A)AT is acting as 
a pilot.  The system will become operational across much of England during 2006. 
User satisfaction survey 
The first NTA user satisfaction survey (Best et al. 2006a)80 found that for over 90 per 
cent of respondents illicit drug use and involvement in crime had reduced since 
starting drug treatment.  Responses also suggested that the vast majority were 
satisfied with the treatment they received in the following measured areas: 
• feeling respected; 
• believing that treatment had made a positive impact on their lives; and  
• being satisfied with the staffing and delivery of treatment. 
 
Nevertheless, there were some differences between respondents: 
                                                 
75 Skills for Justice is the dedicated Sector Skills Council and Standards Setting Body for the 
Justice sector. 
76 See: http://www.skillsforjustice.com/template01.asp?PageID=132  
77 For more information see: www.nta.nhs.uk/programme/national/diversity.htm  
78 See: http://www.dtmu.org.uk/Core%20Data%20Set.htm  
79 For more information see: 
http://www.nta.nhs.uk/frameset.asp?u=http://www.nta.nhs.uk/programme/national/monitoring.
htm  
80 Questionnaires were sent to 900 drug treatment services identified across England and 
6,770 service users completed and returned their questionnaires. 
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• higher levels of satisfaction were reported by women and by Black and White 
clients, compared to Asian clients or those of mixed race; 
• greater satisfaction scores were reported by clients attending residential services 
compared to community services; and  
• more satisfaction was expressed by clients who had shorter waiting times for 
treatment and had up-to-date care plans. 
 
The minority who were not satisfied reported problems in the following: 
• not receiving an optimal service; 
• feeling that their families are excluded; and  
• support services were not available.  
 
There was no relationship between the dose of methadone or buprenorphine a client 
received and the satisfaction reported. 
 
A second annual service user satisfaction survey is being carried out in August and 
September 2006 (NTA 2006e). 
Review of Voluntary and Community Sector 
A review of the Voluntary and Community Sector was announced in 2006 by the 
Home Office and the Department of Health to look at the part this sector plays in the 
delivery of the National Drug Strategy.  The review will:  
• identify and map relevant organisations involved; 
• consult key stakeholders on current and future needs in relation to the functions 
of the sector, e.g. representation, policy, support; 
• review best practice across the voluntary sector and highlight key learning points 
for the drugs sector; and  
• draw conclusions and put forward recommendations in relation to: (a) their roles 
and responsibilities; (b) their relationship with Government; (c) desired outcomes 
from and priorities for such organisation and appropriate accountability (Home 
Office 2006f).  
Evaluation of community addiction teams in Glasgow 
The Scottish Executive, through the Substance Misuse Research Team (SMRT) has 
commissioned a process evaluation of integrated Community Addiction Teams 
(CATs) in Glasgow.  This was not available at the time of writing.  
Quality Standard for Substance Misuse Services  
A consultation on national quality standards for substance misuse services was 
begun by the Scottish Executive in 2006 (Scottish Executive 2006a).  The Scottish 
Executive suggests that the principles which should underpin the development of 
quality standards and a framework in which these standards are set are that: 
• there should be a set of common standards across Scotland, published by 
Scottish Ministers but with local ownership; 
• there should be no added burden on services (in the form of another layer of 
inspections) without being of clear benefit; 
• any evaluation of the use of quality standards should be supportive and address 
those aspects of practice not covered in existing inspections; 
• the standards will cover both drug and alcohol services; 
• the implementation of the standards will seek to improve services; 
• development should build on existing good practice; and 
• there should be substantial service user and community input to any evaluation of 
the implementation of the standards. 
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Treatment in rural areas  
A major issue for Scotland is that of rurality81 and therefore a review of treatment in 
rural areas has been undertaken (Scottish Executive 2005a).82.  This suggests there 
are lower levels of drug use in rural areas; however, the gap is narrowing.  Particular 
problems are: 
• geography - the distances between centres where services are based; 
• travel and transport - irregular and infrequent public transport; 
• a smaller pool of staff with difficulties of recruitment and retention;  
• a limited range of services, both specialist and generic; 
• the high unit costs of providing services and perceived disadvantages in the 
funding formulae; 
• the lack of suitable premises; and  
• community attitudes. 
 
To address these issues, the review reiterated the need for partnership, training and 
monitoring, but also suggested that consideration should be given to the use of the 
internet and other information technology to reach clients, and to provide continuing 
communication and support. 
Waiting times for treatment in Scotland 
Quarterly reports are now published on waiting times for treatment in Scotland, the 
latest report is for the period January to March 2006 (ISD 2006).  This is based on a 
National Waiting Times Information Framework for Scotland designed to enable 
ADATs to monitor service capacity within local areas and the key client/patients 
waiting times during their treatment.  ADATs are therefore able to calculate key 
waiting times, for example, the time between referral and first assessment 
appointment offered, the end of the assessment process and beginning of the first 
treatment, the total time a client is in contact with an agency.  ISD Scotland receive 
quarterly aggregate reports from ADATs and publish various summary statistics.  
Enhancement of the Scottish Drug Misuse Database 
The Scottish Drug Misuse Database (SDMD) currently collects information from 
clients/patients at the point when they enter treatment; with around 300 drug 
treatment agencies reporting on 14,000 new episodes of care in 2005.  
Demographic, drug misuse and health behaviour data are collected.  The current 
enhancement of the database aims to provide new information in key areas: 
• total number of clients/patients in treatment; 
• types of interventions received; 
• total length of time in treatment; and 
• changes in drug misuse and wider health behaviours. 
 
The new initial report (SMR25a) was launched on paper on the 20th April, however, 
follow-up reporting will not begin until electronic data submission is available. 
                                                 
81 The Scottish Executive core definition of rurality: rural is a settlement of 3,000 or less 
people. The classification also distinguishes between ‘accessible’ and ‘remote’ rural areas, 
based on drive time to a settlement of 10,000 or more people.  According to the core 
definition above, 98 per cent of Scotland’s landmass and 18.7 per cent of its population is 
classified as rural.  
82 This review draws upon evidence from a number of sources including primary research, a 
literature review and includes examples of current practice and consultations with key 
individuals. 
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Procurement of the IT system is currently underway and it is anticipated that follow-
up recording will be launched in the spring of 2007. 
Review of Scotland’s methadone programme 
Following the death of a two year old child after drinking his parents’ methadone the 
Scottish Executive announced a review of methadone treatment in Scotland.83  
5.2.3 Young people  
Universal and targeted services for young people 
In England, to support the delivery of Every child matters: change for children and the 
Updated National Drugs Strategy, in 2005 the Department for Education and Skills, 
the Home Office and the Department of Health have agreed a joint approach to the 
development of universal and targeted specialist services to prevent drug harm and 
to ensure that all children and young people reach their full potential.  As part of this 
programme of delivery the NTA has agreed a clear role for its work with children and 
young people on seeking to ensure that high quality, targeted treatment 
interventions, able to meet young people's needs are readily accessible throughout 
England.  
 
The national target is to increase the participation of young people aged under 18 
entering, receiving and completing treatment programmes by 50 per cent between 
2004 and 2008.  The NTA and Youth Justice Board also states that: 
• within five working days of coming into contact with a youth offending team, a 
young person with substance misuse treatment needs should receive appropriate 
specialist assessment; 
• within ten working days of this assessment, the young person should have been 
given access to early intervention or treatment services; and 
• waiting times targets for all services will be announced in 2006.84 
 
All local areas in England are expected to make progress towards meeting these 
objectives from April 2005 with more rapid and sustained progress in 30 high focus 
areas.   
Audit of the skills of those working with young people and families 
Skills for Justice is working with the Home Office Crime and Drug Strategy 
Directorate (CDSD) and the NTA to support the implementation of a joint workforce 
development plan in three key areas; improving competence, increasing capacity and 
mainstreaming.  This work is expected to contribute to the attainment of specific NTA 
targets by 2008: 
• 75 per cent of non professionally trained staff undertaking, or have achieved, 
NVQ Level 3 or equivalent; 
• 6 per cent of professionally trained staff undertaking a programme of continuous 
professional development, including professional development awards; and  
• 90 per cent of managers undertaking, or have completed, an appropriate 
management training programme as defined by their employers (HO and NTA 
2006).  
                                                 
83 See: http://news.bbc.co.uk/1/hi/scotland/4776998.stm  
84 See: 
http://www.nta.nhs.uk/frameset.asp?u=http://www.nta.nhs.uk/programme/national/young.htm  
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Directory of residential services for young people  
In 2006 the NTA published a directory of residential services for young people.  This 
should support substance misuse and children's workers in finding residential 
services (Tier 4) for young people under 18.  The directory is still in development and 
is therefore not a comprehensive list of services.  All the services listed are 
residential services for young people, ranging from generic children's homes, crisis 
placements and specialist substance misuse services.  Services have been asked to 
help in updating it.85 
Young people’s treatment needs  
In a recent paper, Crome (2006) suggests that young people who use drugs 
problematically have different treatment needs, and require different interventions 
and services to those of adults.  Interventions that appear most fruitful are those 
based on learning theory, e.g. cognitive behavioural therapy and family therapy.  
However, the evidence base is almost entirely from the United States, and cannot  
necessarily be extrapolated to United Kingdom healthcare settings.  It is suggested 
that the restricted treatment service network for young people in the United Kingdom 
makes the potential for undertaking studies on treatment effectiveness extremely 
limited, but because there is evidence of a growing number of young people requiring 
treatment, such specialist drug services require evaluation.  
5.2.4 Budget  
In England, the Department of Health, supported by €32 million (£22 million) of 
funding from the Home Office, will provide D(A)ATs with €562.6 million 
(£384.6million) in 2006/07, an increase of 28 per cent from 2005/06.  This funding will 
be used to invest in personnel, day-to-day running of services, and building and 
refurbishment of premises.  D(A)ATs will also be able to bid for a portion of a further 
€80.3 million (£54.9 million), for the development of inpatient and residential 
rehabilitation services in 2007/08 (DH 2006c).  
5.2.5 Research  
The following describes research not referred to in the previous sections.   
The Drug Misuse Research Initiative  
In December 2005 the Department of Health completed the commissioning of a 
number of pieces of research as part of the second phase of the Drug Misuse 
Research Initiative (DMRI).  The research aims to provide evidence to support the 
development and delivery of effective services and interventions in the field of drug 
misuse.  The focus of this phase is on understanding the experience of treatment and 
service provision.  Most of the research will be completed within one to two years.  
The projects are: 
1. Barriers to the effective treatment of injecting drug users. 
2. Routes out: estimating and explaining early exit from drug treatment. 
3. A national survey of care co-ordination in drug treatment services: a multi-
method observational study of implementation, model development, treatment, 
process and service-based outcomes. 
4. User involvement in efforts to improve the quality of drug misuse services: factors 
that promote and hinder successful working. 
5. Cost and cost effectiveness of treatment in drug misuse services. 
                                                 
85 For information see: 
http://www.nta.nhs.uk/programme/national/Young%20people%20directory.pdf 
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6.  A randomised trial of an assessment led brief intervention with young people 
who use cocaine powder. 
7. Exploring young people's views and experiences of drug treatment services: a 
qualitative study. 
8. Interventions supporting and meeting the needs of children and young people 
who have drugs misusing carers. 
9. Interventions for children and families where there is problematic drug use: the 
development and evaluation of an inter-agency model of good practice in Devon. 
10. Good practice in working with family members: disseminating and evaluating a 
model and methods in culture-based communities in Birmingham. 
Overview of the first phase of the DMRI 
An overview of the first phase of the DMRI suggested that the initiative showed the 
value of research in building an understanding of the causes and consequences of 
drug misuse, and, also, the value of specific interventions, and that the DMRI 
programme has been an effective vehicle for strengthening the evidence basis for 
prevention and treatment (MacGregor 2005).   
Brief motivational interviewing among cocaine and ecstasy users 
Marsden et al. (2006) reported an investigation as to whether a stimulant and 
alcohol-focused brief motivational intervention induces positive behaviour change 
among young, regular users of MDMA, cocaine and crack.86  It was found that there 
were no significant differences in abstinence between the experimental and control 
groups and that therefore brief motivational interventions were no more effective at 
inducing behaviour change than the provision of information alone.  
Neurotransmitters in opiate and alcohol addiction  
The Medical Research Council has commissioned research looking at 
neurotransmitters in opiate and alcohol addiction.  The research has a tenure of three 
years.87 
 
A number of pieces of research have looked at the evidence base for treatment, and 
also, factors which should be taken into account in helping drug users become drug 
free.  
The evidence base of treatment  
A report on the evidence for treatment effectiveness looks closely at the many factors 
which might determine treatment outcomes, including the social characteristics of the 
users, therapies available, the treatment process and services issues such as 
delivery and setting (Gossop 2006). 
                                                 
86 This was a randomised trial of the intervention versus a control group who received written 
health risk information materials only.  Participants completed a self-assessment 
questionnaire before the trial.  Outcome measures were for self-reported period prevalence 
abstinence from ecstasy, cocaine powder and crack cocaine and the frequency and amount 
of stimulant and alcohol use in the previous 90 days, recorded at 6-month follow-up via self-
completion questionnaire and personal interview.  A total of 342 adolescent and young adult 
stimulant users (aged 16–22 years) were recruited and 87% were followed-up.  The 
intervention was delivered by a team of 12 agency youth drug workers and two researchers at 
five locations in Greater London and south-east England. 
87 For more information see: http://www.mrc.ac.uk/prn/index/current-research/current-
research_portfolio_search/current-research_portfolio_results/current-
research_portfolio_grant_details.htm?GFR=G0400575&SD=01/03/05  
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Treatment effectiveness: Treatment Journeys 
The concept of a service user’s treatment journey is described in a briefing paper that 
emphasises that treatment is a process, rather than an event, usually involving 
engagement with different services, perhaps over many years (NTA 2005a).  It is 
suggested that this process of progression through drug treatment can be divided 
into four overlapping segments: 
• treatment engagement; 
• treatment delivery; 
• treatment completion; and 
• community integration.   
Addiction careers 
Best et al. (2006b), in a review of the evidence supporting the theory that most drug 
misusers will “mature out” of their drug use, albeit, in some cases, after many years, 
and recognising that some will never end their “addiction careers”, looked at the 
evidence from major outcome studies in the United Kingdom and the United States.  
It is suggested that drug dependence, particularly heroin dependence, is not 
irreversible and that the majority of drug users will overcome their dependence 
eventually and, even among those with problems severe enough to enter treatment 
services, around two-thirds are likely to achieve stable and enduring abstinence 
around twenty years after initiation.  For the vast majority of heroin users whose use 
does not lead them to seek treatment, their careers are likely to be markedly shorter. 
 
It is suggested that those who voluntarily enter services are also those who have the 
most severe and entrenched problems, not only in relation to their heroin use, but 
also an array of life problems.  For those who seek treatment, while the average 
length of the opiate-using career may be around 20 years, much shorter drug using 
careers are likely for those with lower severity and higher motivation.  On the basis of 
this they argue that attempting abstinence can be risky in that, if timed incorrectly, it 
may precipitate dropout, relapse, and a return to a range of drug-using problems.  On 
the other hand, if maintenance is never challenged there may be no acute risks to the 
client, but there may also be an unsatisfactory bind and compromise that users may 
feel prevents them from getting on with their lives. 
 
Nevertheless, the researchers conclude that addiction careers are not irreversible, 
but are slow and unpredictable in their reversibility, and while the vast majority of 
those who become dependent will ultimately overcome that dependence, services 
should be configured in such a way that completing the treatment journey is the long-
term objective. 
Reasons for ceasing or continuing heroin use 
Mullen and Hammersley (2006) looked at reasons for ceasing or continuing heroin 
use in mid-life, examining the contribution of drug treatment and social factors to 
this.88  It was found that successful cessation occurred after repeated attempts and 
repeated treatments, often in the context of major life changes.  Relapse occurred 
because of quitting without adequate mental preparation; returning to old haunts and 
life circumstances, life difficulties, the tedium of a life without heroin, and an inability 
to cope with normal emotions previously blocked by heroin use.  Men’s lives could be 
understood as a set of tensions between the deviant subculture of heroin injecting 
and the conventional neighbourhood.  The balance of these tensions affected their 
                                                 
88 A semi-structured qualitative interview discussing drug-using history was conducted with 
Glasgow men who had previously received treatment for drug problems. 
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behaviour and generally there needed to be both a push away from the subculture 
and a pull towards the neighbourhood for long-term cessation to occur.  They 
conclude that, “Treatment of heroin dependence may be better regarded as the 
management of a chronic problem, rather than as a single intervention with a 
quantifiable outcome.  Treatment needs to consider both the benefits and problems 
of heroin use and the benefits and problems of conventional living.” [p.90] 
Estimating and explaining early exit from drug treatment  
Research is being undertaken by the Institute for Criminal Policy Research, Kings 
College London and the European Institute of Social Service, University of Kent, and 
aims to estimate and explain the problem of people dropping out of treatment.89 
User involvement in treatment decisions 
The Joseph Rowntree Foundation has commissioned research into user involvement 
in treatment decisions; this is due to be completed in October 2006.  The rationale for 
this is that there is evidence to suggest that client satisfaction with drug services is 
associated with retention in treatment, reduction in drug consumption, and 
stabilisation of drug use, safer drug use and abstinence. 
Self-detoxification 
Day et al. (2006) compared the motivation for, and process of attempting, self-
detoxification from opioids between White and Asian groups attending a drug 
treatment service.90  The results suggest that Asian clients used different strategies 
for self-detoxification than the White population.  Both groups reported avoidance 
and distraction as helpful strategies, but Asian clients were more likely to move away 
from their home than White clients were.  Asian clients reported concerns about 
physical and mental health and pleasing their family, with White clients expressing 
concerns about crime.  White clients reported that they were likely to relapse 
because of use of other drugs more often than Asian clients were. 
Cocaine treatment pilots 
An evaluation of the NTA pilots on cocaine treatment referred to in the previous 
United Kingdom Focal Point has not been published at the time of writing. 
Psychostimulant service pilots 
An evaluation of a pilot psychostimulant service in Scotland has not been published 
at the time of writing. 
5.3 Drug-free treatment 
A breakdown by type of treatment for 2005/06 was not available at the time of writing.  
5.3.1 Inpatient treatments 
Based on the Treatment Demand Indicator, in 2004/05 2,945 drug users entered 
inpatient treatment in the United Kingdom. 
5.3.2 Outpatient treatments (specialist community based drug services) 
Based on the Treatment Demand Indicator, in 2004/05 111,436 presented for 
treatment to specialist community based drug services in the United Kingdom.  
                                                 
89 For more information see: http://www.kcl.ac.uk/schools/law/research/icpr/research.html  
90 Eighty-nine clients, 41 Asians and 48 Whites attending a community opioid detoxification 
took part in the study.  A questionnaire was administered to all those attending the service 
who agreed to take part in the study.  98 of the 114 attendees who had made at least one 
attempt at self-detoxification took part.  
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5.4 Medically assisted treatment 
5.4.1 Withdrawal treatment  
NO NEW INFORMATION AVAILABLE  
5.4.2 Substitution treatment 
For England see Prescribing Audit above. 
Numbers in substitution treatment in Scotland 
In Scotland, it is estimated that 19,227 people were prescribed methadone mixture in 
2004.  The cost per patient per year in 2004 was €985 (£673); this includes the cost 
of the medication and dispensing, and any clinical costs.  The cost of dispensing 
methadone mixture (dispensing fees and ingredients) was €3,726 (£2,547) per 1,000 
population in 2004.  
 
Methadone prescribing rates rose by 53 per cent over the last five years, from 53 
prescriptions per 1,000 population in 2000/01 to 81 prescriptions per 1,000 
population in 2004/05 (it is noted that higher prescription rates do not necessarily 
mean more volume of methadone, actual doses prescribed could be smaller).  
Estimates for the number of people receiving prescriptions show an increase 
between 2002 and 2004 (from 16,401 to 19,227).  Thirty-four per cent of the 
individuals prescribed methadone in 2004 received their prescriptions in Glasgow 
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6. Health correlates and consequences  
6.1 Overview 
6.1.1 Drug-related death 
The United Kingdom submits two sets of tables to the EMCDDA based on each of 
three definitions of drug-related death (DRD); each is slightly different.  The 
EMCDDA definition refers to those deaths that are caused directly by the 
consumption of one or more illegal drugs and generally occurring shortly after the 
consumption of the substance(s)91.  The definition used by the Office for National 
Statistics (ONS) was established earlier and so provides the longest time series, but 
is a much wider definition than that used by the EMCDDA and includes legal drugs.92  
DRDs, according to the United Kingdom Drug Strategy, are where the underlying 
cause is poisoning, drug abuse or drug dependence and where any of the 
substances scheduled under the Misuse of Drugs Act 1971 were involved.  This 
definition has been adopted by the General Mortality Registers (GMRs) across the 
United Kingdom.  The Drug Strategy definition is a subset of the ONS definition, with 
the main differences lying in the fact that only controlled drugs are identified. 
 
Based on General Mortality Registers (GMR) DRDs in the United Kingdom rose 
steadily from 1996 until 2000, then fell until 2003, but rose again in 2004.93  However, 
the most up to date data, from the Special Mortality Register is for 2005, and again 
show a fall from the previous year.  Males are more likely to suffer DRDs than 
females, by over 4:1 with the difference closing over the last decade.  The overall 
average age at death fell in 2001 and 2002 to 34.0, rising in 2003 and again in 2004 
when it was 35.9 years.  Males were approximately four years younger than females 
at death (34.9 years and 39.0 years respectively).  Males are more likely to die at a 
younger age of accidental poisoning, drug dependence, or non-dependent abuse of 
drugs, and females by means of intentional/undetermined poisoning.  Most deaths 
are associated with opiates, chiefly heroin/morphine and methadone, often in 
combination with other drugs and/or alcohol.  In Scotland, diazepam is more likely to 
be involved than elsewhere in the United Kingdom; for example, in 2004, it was 
involved in 21 per cent of DRDs. 
                                                 
91 These deaths are known as 'overdoses', 'poisonings' or 'drug-induced deaths'.  This 
definition was agreed by the EMCDDA group of national experts: see methodological notes 
'Drug-related death EMCDDA definition' in the 2005 statistical bulletin and DRD standard 
protocol v3.0.   
92 The ONS definition uses ICD-10 codes equivalent to F11-F16, F18, F19, X40-X44, X60-
X64, Y85, Y10-Y14 from 2000, prior to that IC9 codes 292, 304, 305.2-9, E858-8, E950.0-.5, 
E980.0 -.5, E962.0. 
93 There are two main types of source in the UK for information on 'acute' deaths: three 
General Mortality Registers (GMRs - the General Register Offices for England and Wales 
(GRO), Scotland (GROS), and Northern Ireland (GRONI)) and one Special Mortality Register 
(SMR - the National Programme on Substance Abuse Deaths or np-SAD) based at St 
George’s Hospital Medical School, University of London.  The General Mortality (GMR) data 
are derived from medical death certificates.  Whilst the GMRs for England and Wales, and 
Scotland have established special databases to monitor DRDs, this has not yet happened in 
Northern Ireland.  The UK-wide use of ICD-10 in coding DRDs provides consistency in 
approach.   
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6.1.2 Infectious disease 
HIV94 prevalence among injecting drug users (IDUs) in the United Kingdom has been 
at around one per cent since the mid-1990s, although in London it has been higher, 
at or near, four per cent.  There is emerging evidence that suggests a possible 
increase in transmission in recent years. There were an estimated 2,000 people 
living with HIV infection acquired through injecting drug use in 2004, of whom 600 
were thought to be undiagnosed.  Prevalence of hepatitis C (HCV) has been much 
higher at around 40 per cent of IDUs, and there is evidence of increased incidence.  
Prevalence of antibodies for hepatitis B (anti-HBc) declined in the early 1990s, and 
has levelled off at around 20 per cent.  Outbreaks of other infections among IDUs 
have been increasingly reported,95 following reported increases in injecting risk 
behaviour. 
6.1.3 Dual Diagnosis  
Prevalence and attribution of dual diagnosis remain difficult to estimate.  Depression, 
anxiety disorders, personality and psychotic disorders are commonly reported, 
although prevalence varies with setting and specific sub-populations. It has been 
suggested that from 1993 to 1998 there were at least 195,000 co-morbid patients 
and 3.5 million general practitioner (GP) consultations involving such patients in 
England and Wales.  The level of co-morbidity is increasing at a higher rate among 
younger patients, which indicates that co-morbidity may increase in future years. 
Approximately one-third of psychiatric discharges involve a supplementary rather 
than a main diagnosis of drug use. In these cases, the most common diagnoses 
were schizophrenia, mood (affective) disorders and alcohol misuse.  
6.1.4 Other physical health problems 
Evidence of the extent of other physical health problems associated with problem 
drug use96 are not readily available. 
                                                 
94 Data on the prevalence of blood borne infectious diseases amongst injecting drug users 
(IDUs) are provided by a number of sources.  The Unlinked Anonymous Prevalence 
Monitoring Programme’s (UAPMP) surveys of IDUs in contact with drug services in England, 
Wales and Northern Ireland (Hope et al. 2001; Unlinked Anonymous Steering Group 2002); 
the Centre for Research on Drugs and Health Behaviour’s surveys of IDUs recruited from 
community settings in England (Hunter et al. 2000); and the Scottish Centre for Infection and 
Environmental Health's (SCIEH) surveys of IDUs attending community and drug agency 
settings in Glasgow (Taylor et al. 2000).  SCIEH also holds anonymous epidemiological data 
on all those who have had a named HIV antibody test in Scotland since 1989 (on the HIV 
Denominator Database).  All collect behavioural data and oral fluid for testing for antibodies to 
hepatitis C (anti-HCV).  The main sources of information on newly diagnosed HIV/AIDS 
infections are from voluntary cases reporting from laboratory reports of newly diagnosed 
infections by microbiologists and clinicians.  For England, Wales and Northern Ireland, reports 
are made to the Health Protection Agency’s Communicable Disease Surveillance Centre 
(CDSC) whilst new diagnoses in Scotland are reported to Health Protection Scotland.  
Laboratory report data for England and Wales, Scotland, and Northern Ireland are available 
from the following websites: http://www.hpa.org.uk for England and Wales; 
http://www.hps.scot.nhs.uk/ for Scotland; and http://www.cdscni.org.uk for Northern Ireland.  
95 Methicillin resistant Staphylococcus aureus (MRSA) as a cause of IDU-related sepsis (CDR 
Weekly 2003) and other serious Clostridial infections acquired through contaminated drugs 
have been reported (Jones et al. 2002; McGuigan et al. 2002). 
96 These includes thrombosis, blood clots and gangrene as well as health problems that are 
associated with problem drug users’ lifestyles including poor diet. 
UNITED KINGDOM FOCAL POINT REPORT 2006 
 
 74
6.1.5 Pregnancies and children born to drug users 
The impact of maternal drug use on unborn children is well known as is the fact that 
babies are affected by withdrawal from maternal drug use.  In the United Kingdom, 
there is little evidence of HIV transmission to babies through maternal infection 
specifically associated with drugs, but there is a risk of hepatitis transmission, 
particularly HCV, where the risk of transmission amongst babies whose mothers test 
positive is six per cent.  
6.2 Drug-related deaths and mortality of drug users 
6.2.1 Direct overdoses and indirect drug-related deaths 
Using the EMCDDA definition of drug related death, the total number of deaths in the 
United Kingdom in 2004 was 1,646 (Figure 6.1), an increase of 16 per cent since 
2003 (1,419).  However the 2004 figures remain lower than any of the three years 
preceding 2003.  The number of deaths per 100,000 population was 2.75.  
Differences exist between parts of the United Kingdom; in Scotland the rate was 
7.88, in England 2.34, in Wales 1.93 and in Northern Ireland 0.88.  
 
Figure 6.1: Number of deaths using EMCDDA DRD standard definition by country, United 
Kingdom, 1996-2004 
 
 
Source: Compiled by J Corkery 2006 
 
For the purposes of measuring the impact of the United Kingdom Drug Strategy, the 
slightly different definition shows the number of deaths in 2004 was 1,786, slightly 
higher than the EMCDDA definition.  The total number of deaths in 2004 using the 
ONS definition was 3,161, rising by 6.4 percent from the previous year, having 
steadily fallen since 2001.  Differences between the three definitions are shown in 
Figure 6.2. 
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Figure 6.2: Comparison of total number of deaths using three definitions, United Kingdom 
1996 to 2004  
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Source: Compiled by J Corkery 2006 
Age and Gender  
Based on the EMCDDA definition, 79.9 per cent (1,315) of deaths involved males 
and 20.1 per cent (331) females (Figure 6.3).  The highest proportion of males was in 
England and Wales (80.9%) and the lowest in Northern Ireland (73%).  The average 
age of those dying in 2004 was 35.9 years (SD 11.8), with males (34.9 years, SD 
10.6) tending to be about four years younger than females (39.0 years, SD 15.3).  
Age at death tended to be higher in Northern Ireland than in the rest of the United 
Kingdom.  Overall, the highest number of deaths occurred in the 30-34 age group; 
this was true for both males and females.  Figure 6.3 shows the number of deaths by 
age group and gender. 
 
Figure 6.3: Deaths by age and gender United Kingdom, 2004: EMCDDA definition  
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Source: Compiled by J Corkery 2006 
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Drugs mentioned on death certificates in the United Kingdom  
Table 6.1 shows that mentions of heroin and morphine on death certificates 
increased by 27 per cent in 2004, having declined between 2002 and 2003.  
Methadone deaths also increased (by 6%), having shown a decline between 2002 
and 2003, as did ecstasy deaths (by 32%) and cocaine (by 30%):  
 
Table 6.1 Drug mentions on death certificates in the United Kingdom, 2002 to 2004 
 
Drug  Year  
 2002 2003 2004 
Heroin/ Morphine 1,042 767 971 
Methadone 314 263 280 
Cocaine 171 142 185 
Ecstasy 75 50 66 
Source: Compiled by J. Corkery 2006 
6.2.2 Special Mortality Register: The National Programme on Substance Abuse 
Deaths (np-SAD)  
Data from the SMR (np-SAD) database are broadly consistent with those from the 
ONS. The np-SAD Annual Report for 2006 (Ghodse et al, 2006) shows that in 2005: 
• there were 1,644 drug-related deaths reported in 2005; 
• there was a decrease of about 10 per cent from the number recorded in 2004 
(1,820) ; 
• the demographic profile of np-SAD cases remains consistent with previous 
reports.  The majority of cases were males (74%) and under 45 years of age 
(73%), and White (95%); 
• throughout the period 1997 to 2005 about two-thirds of cases had a history of 
drug abuse or dependence, and on average death was 10 years or more earlier 
than for those without such a history; 
• 67 per cent of cases died at a defined residential address, 24 per cent in hospital, 
and 9 per cent elsewhere (e.g. a public place); 
• 50 per cent of those who died were unemployed; 
• 46 per cent lived with others, 37 per cent lived alone, and five per cent were of no 
fixed abode; 
• opiates/opioids (i.e. heroin/morphine, methadone, other opiates/opioid 
analgesics), alone or in combination with other drugs, accounted for the majority 
(70%) of fatalities; 
• heroin/morphine alone, or in combination with other drugs, accounted for the 
highest proportion (48%) of fatalities; 
• deaths involving methadone were more likely to be the result of illicit use (60% or 
more) rather than prescribed drugs; 
• over the period 1997 to 2005 there were considerable increases in the number of 
cases where cannabis, amphetamines and to a lesser degree, cocaine were 
mentioned; and  
• GHB was found in three cases. 
6.2.3 Death associated with Volatile Substance Abuse  
The most recent report on deaths associated with volatile substance abuse (VSA) 
throughout the United Kingdom, shows that in 2004 there were 47 deaths associated 
with VSA (53 in 2003) (Field-Smith et al. 2006).  This is the lowest figure since 1981 
and compares with a peak of 152 in 1990.  Of this total, there were 41 VSA related 
deaths in England, four in Wales, one in Northern Ireland and one in Scotland.  In 
Scotland this is the lowest level of VSA deaths since 1995.  
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6.2.4 AIDS 
Deaths of IDUs (including men who have sex with men who are also IDUs) with AIDS 
accounted for 7.7 per cent of the total number of AIDS deaths in England and Wales 
up to the end of the financial year in March 2006.  In Northern Ireland, the figure was 
5.1 per cent, but in Scotland it was 51.2 per cent.  The United Kingdom figure of 59 
for 2004 is about 28 per cent of the peak level in 1995 (212) (HPA personal 
communication to J. Corkery).  
Research  
A number of studies touching on drug related deaths in the United Kingdom are 
underway.  
Cohort mortality studies 
Early indicative findings from a cohort study of clients in drug treatment programmes, 
commissioned by the Home Office are expected in autumn 2006 with a full report 
later in 200797. 
 
As part of the Drug Outcomes Research in Scotland study (DORIS)98, a request has 
been made to the General Register Office for Scotland (GROS) to check on deaths 
among non-respondents between the original survey (DORIS1) and the fourth sweep 
(DORIS4) at 33 months.  Researchers are aware of 33 deaths amongst the original 
cohort, but expect this to rise when the information from GROS is received (personal 
communication to John Corkery). 
The extent and pattern of fatal injuries due to psychoactive drug intoxication  
Oyefeso et al. (2006) sought to determine the nature, extent and pattern of fatal 
injuries under the influence of psychoactive drugs (FIUI).  Their observational study 
covered the period January 1999 to December 2001.  A total of 3,803 drug-related 
deaths of persons aged 16 to 64 years were reported during the three year period.  
There were 147 FIUI cases (119 males, 28 females), giving a proportionate mortality 
ratio of about four per cent.  The majority of FIUI cases (84%) were aged 16 to 44 
years (median 33).  About half (56%) of FIUI occurred in urban areas of England.  
The leading mechanism for intentional FIUI was suffocation while the predominant 
mechanisms in unintentional FIUI were road traffic accidents and falls.  There was a 
significant difference in the pattern of drug-specific risk between FIUI and fatal 
poisoning.  Risks of intentional FIUI are elevated among Black and Minority Ethnic 
groups.  The researchers suggest that the differences in the nature, extent and 
pattern of intentional and unintentional FIUI necessitate targeted prevention 
strategies.  
Trends in cocaine/crack cocaine deaths for 1990 to 2004 
Schifano and Corkery (2006) used a number of key indicators to examine United 
Kingdom trends in deaths involving cocaine and crack for 1990 to 2004.  
Cocaine/crack was the sole drug mentioned in 36 per cent of the 1,022 cocaine death 
mentions during this period.  The number of cocaine/crack fatalities showed a year-
on-year increase and correlated positively with last year use, number of offenders and 
number of seizures, but correlated negatively with price.  Furthermore, number of 
cocaine/crack death mentions correlated positively with number of crack offenders 
and seizures, but correlated negatively with both crack purity and price over time.  It is 
                                                 
97 For more information see: http://www.dtors.org.uk 
98 For more information see: 
http://www.gla.ac.uk/centres/drugmisuse/project%20details.html#doris and 
http://www.gla.ac.uk/drugmisuse/dorisreports.html 
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suggested that decreases in cocaine/crack cocaine prices may have facilitated an 
increase in consumption levels and this, in turn, may have determined an increase in 
number of cocaine/crack cocaine-related fatalities.  
Ecstasy deaths  
Schifano et al (2006) used the same range of key indicators as the above report on 
cocaine/crack cocaine deaths in their study of ecstasy in the United Kingdom, 1994 
to 2003. Ecstasy was the sole drug mentioned in 42 per cent of 394 ecstasy death 
mentions identified.  Overall, number of fatalities showed a year-on-year increase 
and positively correlated with last year use, number of offenders and number of 
seizures, but negatively correlated with price.  Price negatively correlated with last 
year use and number of seizures; but positively correlated with average MDMA 
dosage per tablet. Increasing production with a concomitant decrease in ecstasy 
price may have facilitated an increase in consumption levels and this, in turn, may 
have determined an increase in the number of ecstasy deaths mentions.  
The relative toxicity of co-proxamol in overdose  
Afshari et al (2005) assessed the relative toxicity of co-proxamol in overdose in 
comparison to two other paracetamol-opioid combination products, co-codamol and 
co-dydramol.  National Scottish data for July 2000 to June 2002 were used to 
estimate the frequency of overdose and death for these paracetamol-opioid 
compound analgesics.  When related to prescription volume, overdoses involving co-
proxamol in Scotland were found to be ten times more likely to be fatal when 
compared with co-codamol or co-dydramol.  In contrast there was no difference in 
the presentation rate or enquiry rates for these analgesics when corrected for 
prescriptions.  The researchers conclude that the excess hazard from co-proxamol is 
due to inherent toxicity rather than increased use in overdose.  They estimate from 
this study that withdrawal of co-proxamol would prevent 39 excess deaths per annum 
in Scotland alone.99 
6.3 Drug-related infectious diseases 
Infectious diseases continue to cause considerable morbidity and mortality among 
injecting drug users in the United Kingdom.  Results from the Unlinked Anonymous 
Prevalence Monitoring Programme (UAPMP) enhancement pilot study, which 
recruited IDUs in community settings at seven locations in England using 
fieldworkers and collected dried blood spot samples rather than oral fluids are now 
available.  They are presented alongside those from the UAPMP agency survey and 
other data on infections among IDUs in the current Shooting Up report (HPA et al. 
2006).  A summary of key trends and new data is given in the following sections. 
6.3.1 HIV 
The prevalence of HIV among IDUs has continued to increase.  The prevalence 
amongst current IDUs (those who reported injecting in the four weeks prior to taking 
part in the survey) in the UAPMP agency survey in England and Wales in 2005 was 
2.1 per cent (HPA et al. 2006).  This is the highest level ever seen amongst current 
IDUs in this survey, and indicates that the recent increase in HIV prevalence among 
current IDUs found when examining data from the UAPMP agency survey and the 
series of community recruited surveys undertaken by Centre for Research on Drugs 
and Health Behaviour (CRDHB) has continued (Hope et al. 2005b).  This study had 
found that HIV prevalence declined in the early 1990s from 5.6 per cent in 1990 to 
0.6 per cent in 1996 before increasing to 1.4 per cent in 2005.  
                                                 
99 Co-proxamol has been withdrawn for use in the UK 
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HIV prevalence among IDUs in London is higher than elsewhere in the United 
Kingdom.  The UAPMP agency survey100 found the HIV prevalence among current 
IDUs in 2005 was 4.3 per cent in London, which was similar to that seen in recent 
years (Figure 6.4).  Elsewhere in England and Wales the prevalence was 1.6 per 
cent, which is more than twice the prevalence seen in 2004 (0.66%). This was the 
highest HIV prevalence ever seen in the UAPMP agency survey amongst current 
IDUs in England and Wales outside of London (Figure 6.4), indicating that the recent 
increase in HIV prevalence is focused outside London. 
 
The rise in prevalence probably reflects increased levels of transmission.  The 
prevalence of HIV in those who began injecting in the last three years is a measure 
of recent transmission.  In 2005, among the participants in the UAPMP agency 
survey who began injecting in the last three years, HIV prevalence was 1.3 per cent 
(HPA et al. 2006) (Figure 6.4).  This was the highest prevalence ever seen among 
this group in this survey, and suggests a recent increase in transmission.  
Corroboration for this comes from the community recruited cohort study of recently 
initiated IDUs in London undertaken by the CRDHB in 2001/03 (Judd et al. 2005).  
This estimated that HIV incidence was 3.4 per cent per annum and also found that 
the incidence was similar to the prevalence, which is also suggestive of a recent 
increase in transmission.  The cohort study also found evidence that the incidence of 
HIV was higher among those who reported injecting crack (around 6%).  Results 
from the UAPMP enhancement pilot found a prevalence of 0.76 per cent among 
IDUs in England, outside London.  It also found that those who reported injecting 
crack-cocaine had a higher prevalence than those who did not (1.4% and 0.32% 
respectively).  
 
Figure 6.4: Prevalence of HIV infection among injecting drug users in England, Wales and 
Northern Ireland: 1992 to 2005. 
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100 Drug users in treatment with specialist drug services. 
UNITED KINGDOM FOCAL POINT REPORT 2006 
 
 80
 
By the end of 2005 there had been a total of 4,434 HIV diagnoses reported in the 
United Kingdom where infection was thought to have been acquired through injecting 
drug use.  These accounted for 5.6 per cent of all the HIV diagnoses reported 
(78,639).  By end of June 2006 147 HIV diagnoses, where infection was thought to 
have been acquired through injecting drug use, have been reported in for 2005 (HPA 
et al. 2006). Where reported, 53 per cent (52) of infections diagnosed in 2005 were 
probably acquired within the United Kingdom and 47 per cent (46) outside, mostly in 
southern Europe.  In comparison, in 2003 only 34 per cent (53/95) of infections were 
probably acquired in the United Kingdom, whilst in 2004 the figure was 47 per cent 
(37/81), where reported (HPA et al. 2006). 
6.3.2 Viral hepatitis 
Data indicate that overall more than four in ten IDUs have been exposed to hepatitis 
C infection in the United Kingdom (HPA et al. 2006).  There is also evidence that 
suggests that the prevalence has increased, for example, among current IDUs (those 
who had injected in the four weeks prior to taking part in the survey).  In the UAPMP 
agency survey in England the prevalence has increased from almost 40 per cent in 
1998, the year hepatitis C testing was added to this survey (Hope et al. 2001), to 46 
per cent in 2006.  The regional variations in prevalence of hepatitis C previously seen 
remained (HPA et al. 2006); in England, from 20 per cent in the North East to 55 per 
cent in London and 58 per cent in the North West (data from 2004 and 2005 
combined).  The prevalence in Wales and Northern Ireland was lower than most of 
the English regions: combining data from 2004 and 2005, hepatitis C prevalence in 
Wales was 18 per cent (45 of 253), and in Northern Ireland it was 28 per cent (69 of 
248).   
 
Results from the UAPMP enhancement pilot found that 53 per cent of the 
participating current IDUs at the seven sites in England were anti-HCV positive.  This 
is comparable to the UAPMP agency survey after allowing for the differences in test 
sensitivity and recruitment areas.  Those who reported injecting crack had a much 
higher prevalence than those who did not (67% and 44% respectively). 
 
In Scotland a high prevalence was found in Glasgow during 2005.  A survey of 435 
current IDUs recruited at syringe exchanges in Glasgow found the prevalence of 
hepatitis C was 68 per cent.  This compares to a prevalence of 77 per cent among 
531 current IDUs recruited during a community-wide survey in Glasgow in 2004 
(Taylor 2006).  Among 34 IDUs surveyed in 2005 who had commenced injecting in 
the previous two years, the prevalence of hepatitis C was 30 per cent; this 
prevalence was lower than that detected among equivalent IDUs surveyed in 
2001/2002 (43%) and 2004 (50%) (HPA et al. 2006).  A recent review of 
epidemiological studies has indicated that the incidence of hepatitis C among IDUs in 
many parts of Scotland remains high (in the range 12 to 29 per 100 person-years) 
(Roy et al. in press). 
 
The prevalence of oral fluid antibodies to anti-HBc remains stable among IDUs 
participating in the UAPMP agency survey in England, Wales and Northern Ireland.  
The outbreaks of hepatitis A seen among IDUs and the homeless in parts of the 
United Kingdom appear to have waned. (HPA et al. 2006). 
6.3.3 Sexually transmitted infections 
NO NEW INFORMATION AVAILABLE 
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6.3.4 Tuberculosis 
NO NEW INFORMATION AVAILABLE 
6.3.5 Other infectious morbidity 
There is a continuing problem with bacterial infections among IDUs, including on-
going problems with group A streptococcal infections.  Enhanced surveillance data 
gathered during the strep-EURO programme101 has identified injecting drug use as 
one of the most important risk factors for severe group A streptococcal infections in 
the United Kingdom, with just over one fifth of reports being in injecting drug users 
(Lamagni et al. 2006). 
 
There has also been a continuing occurrence of wound botulism and tetanus cases 
among IDUs.  During 2005, 28 suspected cases of wound botulism among IDUs in 
the United Kingdom were reported (25 in England, two in Scotland, and one Northern 
Ireland), and in two cases the patient died.  Four of six tetanus cases reported to the 
HPA in England were confirmed to have been IDUs, indicating that tetanus continues 
to affect IDUs, albeit at lower numbers than in 2003 and 2004 (25 cases reported 
between 2003 and 2004). 
6.3.6 Research  
Two studies, one in Glasgow (University of Paisley) and one in London (CRDHB), 
which video taped injecting events, have recently been undertaken and the results 
are now available (Taylor et al. 2004; Rhodes et al. 2006)  These studies provide a 
useful insight into injecting practice and hygiene (for details of the research by 
Rhodes et al. see Chapter 7.3.4). 
Female injecting drug users  
Tompkins et al. (2006) looked at the consequences for women of receiving injections 
from other drug users. 102  Findings suggest that their reliance on others to administer 
injections meant they had less control over their drug use.  Exchanging drugs as 
currency for being injected was common.  Women appeared to be confused about 
the risks associated with being injected and the perceived risks were often complex 
and polarised.  
 
There are number of new and ongoing research projects.  These include: 
• A cohort study of injectors in Wales to estimate the incidence of HCV (led by 
National Public Health Service Wales (NPHSW) with CRDHB and HPA); results 
will be available shortly.  
• DORIS, Health Protection Scotland (HPS) and the Centre for Drug Misuse 
Research, Glasgow) will look at prevalence and incidence of HCV among IDUs 
attending drug services in Scotland.   
• CRDHB and HPA is looking at whether collecting dried blood samples rather than 
full blood will increase the uptake of HCV testing among IDUs; a report will be 
available shortly. 
• The first series of community recruited UAPMP enhancement surveys of IDUs 
has been completed in England (CRDHB and HPA).  Initial results are available 
and further findings will be published shortly. 
                                                 
101 strep-EURO is a three-year Europe-wide project whose primary aim is to improve our 
understanding of severe group A streptococcal (Streptococcus pyogenes) disease. 
102 Methods: In-depth interviews with 45 women injecting drug users who have been injected 
by other people, recruited from a needle exchange programme. 
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• Community recruited unlinked anonymous surveys of IDUs has recently been 
completed at a single location in England using respondent driven sampling and 
Computer Assisted Interviewing (CRDHB and HPA); analysis is currently 
ongoing.  
• A pilot companion unlinked anonymous survey has been developed and piloted in 
Scotland (HPS with University of Paisley and HPA) which will focus on those 
using needle exchanges.  Initial results are given above. 
• A pilot study of the impact of visual cues to enhance the accuracy of self reported 
injecting risk behaviour and increase knowledge amongst IDUs (Liverpool John 
Moores University and University of Paisley) 
 
The Scottish Executive has recognised the importance of tackling the hepatitis C 
epidemic through the publication of its first Hepatitis C Action Plan (Scottish 
Executive 2005c).  A number of initiatives have been funded as part of the Action 
Plan, including: 
• A survey of hepatitis C prevalence among injecting drug users attending needle 
exchange services across Scotland (led by HPS and University of Paisley, in 
collaboration with HPA). 
• A two-year modelling study to estimate the cost of the current and future burden 
of hepatitis C virus infection in Scotland (HPS).   
• A two-year study to determine the cost-effectiveness of different screening 
approaches for hepatitis C (HPS). 
6.4 Psychiatric co-morbidity (dual diagnosis) 
6.4.1 Prevalence  
NO NEW INFORMATION AVAILABLE  
The relationship between cannabis use and mental health  
The report by the Advisory Council on the Misuse of Drugs (ACMD) on the 
association between cannabis use and mental health issues (ACMD 2005a) has 
been referred to in Chapter 1.  The Beckley Foundation published a report looking at 
the issue, coming to the same conclusions as the ACMD, that the evidence is mixed 
(Hunt et al. 2006).  In another article in the Lancet, Macleod et al. (2006) also caution 
about the epidemiological evidence that cannabis use causes schizophrenia, 
suggesting that premature conclusions around causality are likely to be 
counterproductive and could hinder the overall endeavour to find ways to effectively 
improve population mental health. 
6.4.2 Personality disorders 
NO NEW INFORMATION AVAILABLE  
6.4.3 Depression 
NO NEW INFORMATION AVAILABLE  
6.4.4 Anxiety 
NO NEW INFORMATION AVAILABLE  
6.4.5 Affective disorders 
NO NEW INFORMATION AVAILABLE  
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6.5 Other drug-related health correlates and consequences 
6.5.1 Somatic co-morbidity 
Abscesses and sepses 
Information from Scotland for acute hospital discharges where there has been a 
diagnosis (main or secondary) of drug misuse shows that:  
• the rate was 106 per 100,000 population; 
• in the majority of cases (96%, 4,993 discharges), the main reason for admission 
was not drug misuse, the most common primary diagnoses were phlebitis103, 
cutaneous abscesses and cellulites; 
• males were much more likely than females to have a diagnosis of drug misuse, 
with over two-thirds (3,538) of such discharges being men; 
• discharges involving drug misuse increased steadily up to 34 year olds (1,102 
amongst 30 to 34 year olds) and then declined; very few discharges (234) were 
seen in those aged 50 and over; 
• approximately half of all cases (2,856) were admitted to general medicine, with a 
further 13 per cent (695) being admitted to general surgery and nine per cent 
(447) to orthopaedics; 
• admissions most often occurred as an emergency rather than an elective intake;  
• the vast majority (89%, 4,616) of admissions involved a stay of less than a week; 
and 
• the drug type most often recorded was opioids, being explicitly mentioned in over 
half (3,007) of all acute hospital discharges involving drug misuse. 
 
It is reported that between 2000/01 and 2004/05, there was a nine per cent increase 
(from 4,789 to 5,204) in the number of discharges involving drug misuse (ISD 2006). 
Endocarditis 
NO NEW INFORMATION AVAILABLE 
Dental health 
NO NEW INFORMATION AVAILABLE 
6.5.2 Non-fatal drug emergencies 
NO NEW INFORMATION AVAILABLE 
Research  
In a study of drug use amongst typical patients attending an emergency department 
in Bristol, Binks et al. (2005)104 found that: 
• 36.2 per cent had used illegal drugs in their lifetime and 16.1 per cent in the 
previous month; 
• 9.9 per cent had used drugs within the previous 24 hours; 
• 5.7 per cent had injected drugs; 
                                                 
103 Phlebitis is an inflammation of a vein. 
104 A representative sample of patients attending an inner city Emergency department 
covering a 168 hour week were asked if they would be interviewed face to face.  Of 1,070 
those approached (patients were excluded if they had a life threatening illness, chronic mental 
impairment, were unable to understand/give verbal consent, or did not speak English).  801 
responded.  Additional information collected from the treating clinician indicated whether each 
presentation was directly or indirectly related to illegal drug use.  
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• 6.9 per cent (55) of all patient attendances were directly (3.0%) or indirectly 
(3.9%) related to drug use, and hospital admission was required in nearly half of 
these, 2.9 per cent (23) required admission; 
• the commonest diagnoses directly related to illegal drug use were deliberate self 
harm/psychiatric problems (11 out of 24 patients) and acute medical conditions 
such as cellulitis, chest pain, and deep venous thrombosis (12 out of 24 patients). 
6.5.3 Other health consequences 
NO NEW INFORMATION AVAILABLE  
6.5.4 Driving and other accidents 
See Chapter 13: Drugs and driving. 
6.5.5 Pregnancies and children born to drug users 
NO NEW INFORMATION AVAILABLE  
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7. Responses to health correlates and consequences 
7.1 Overview 
Drug-related deaths (DRDs), infectious diseases, co-morbidity and other health 
consequences are key policy issues within the United Kingdom Drug Strategy (DSD 
2002). 
7.1.1 Drug related death 
A Government target to reduce DRDs in England by 20 per cent by 2004, from a 
baseline of 1,568 deaths was set in 1999.  A strategy for England and Wales was 
published in 2001, focusing on promoting treatment, with service providers expected 
to provide information and advice on how to reduce DRD, to educate drug users and 
their families on resuscitation, educate prisoners on the risk of overdose on release 
from prison, and training of paramedical and Accident and Emergency (A&E) staff.  
This was accompanied by guidance for both generic and specialist services, and a 
range of materials and training for drug users.105  In Scotland a strategy and action 
plan to reduce DRD was published in 2005.   
 
The Scottish Executive and the Health Promotion Agency in Northern Ireland ensure 
that young people, parents and retailers are aware of the dangers of abusing 
products such as cigarette lighter refills, aerosol sprays and glue.  In Scotland 90 per 
cent of Scottish schools include advice on the risks from volatile substance abuse.  
The Scottish Executive part funds a Scottish Solvent Abuse Field Worker, based at 
Re-Solv.106  The worker offers support to community groups by providing VSA 
awareness videos and literature, and runs formal and informal sessions at local 
venues on the dangers of VSA.  Throughout the United Kingdom there is information 
about volatile substances available on drug information websites. 
7.1.2 Infectious disease 
In the 1980s, United Kingdom drug policy was led by a public health approach aimed 
at containing HIV transmission.  The subsequent action, based on a harm reduction 
approach, is regarded as having been successful in containing HIV amongst injecting 
drug users (IDUs); providing free needles and syringes, promoting the safe disposal 
of used equipment, information campaigns on safer sex and safer injecting; and 
HIV/AIDS counselling, support and testing. The Hepatitis C Action Plan for England 
was developed in 2004, prioritising prevention of infection and disease progression. 
Treatment for infectious diseases is provided as part of the National Health Service 
(NHS), including the provision of anti-retroviral treatment for HIV and HCV.  
Treatment for wound infections is available through primary care, Accident and 
Emergency (A&E) departments, and in some areas, through needle exchange 
schemes and specialist drug services.  Those in prison have access to HIV and 
hepatitis testing, and vaccination against HBV. 
7.1.3 Dual diagnosis 
Standards of care for problem drug users with mental health problems were agreed 
in 2001 (HAS 2001).  Guidance on good practice (DH 2002c) and the provision of 
services were developed in England (DH 2002b).  The Department of Health (DH 
2002a) highlighted the need for generic health services to work in partnership with 
                                                 
105 See: http://www.nta.nhs.uk/programme/drd3.htm 
106 See: www.re-solv.org  
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other agencies, such as drug services.  Local Implementation Teams (LITs) 
implement the policy requirements described in the guidance, and work in 
partnership with Drug (and Alcohol) Action Teams (D(A)ATs). 
7.1.4 Children born to drug users 
Maternity services are expected to provide appropriate facilities for the needs of 
pregnant women drug users and their babies, although the approach varies across 
the country.  The Advisory Council on Misuse of Drugs (ACMD 2003) highlighted 
concern in its report of Hidden Harm of parental drug use for their children.  Since 
then a number of initiatives have been undertaken to address problems identified 
throughout the United Kingdom, including a Scottish Executive Action Plan. 
7.2 Prevention of drug-related deaths  
7.2.1 Overdose prevention  
Specialist needle and syringe exchange schemes  
An audit of needle and syringe exchange schemes in England found that the 
provision of interventions to prevent overdose was limited (Abdulrahim et al. 2006) 
(see section 7.3).  
Scotland: Action to reduce drug-related deaths 
Following the publication of the National Investigation into Drug-related Deaths in 
Scotland 2003, in July 2005, the Scottish Advisory Committee on Drugs Misuse 
(SACDM) produced a report and recommendations focusing on reducing drug-
related death in Scotland (SACDM 2005).  In response to the SACDM report the 
Scottish Executive published an Action Plan (Scottish Executive 2005b) which looked 
at each of the recommendations in turn and promoted similar actions to those 
identified in England:  
• providing awareness materials; 
• increasing access to treatment so that substance misusers have access to a 
range of evidence based treatments; particularly the most vulnerable; 
• training of GPs; 
• training of generic staff; and 
• overdose training for prison staff and prisoners. 
 
In addition, the Action Plan includes the following action points: 
• ensuring police action is consistent with resuscitation; 
• the Scottish Crime and Drug Enforcement Agency (SCDEA) is to  produce 
Special Alerts and Health Alerts when problems such as contaminated drugs are 
identified;  
• funding appropriate research;  
• the Scottish Executive is to produce a half-yearly newsletter to share with ADATs 
and others information on drug deaths obtained at a national level.  This may 
include new research, new information materials and examples of good practice; 
• the SCDEA is to  produce a monthly spreadsheet showing year to date figures on 
the number and distribution of drug-related deaths in each police force and ADAT 
area, compared to the same period the previous year; and  
• establishing a new National Forum to look at trends, causes and good practice in 
preventing drug-related deaths.   
 
A further recommendation by SACDM was that, 
”In order to enable a long term, meaningful interpretation of post-mortem 
toxicological data, Procurators Fiscal, who instruct autopsies on these deaths, 
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should insist that the pathologists carrying out the autopsies follow a nationally 
agreed protocol based on an agreed best practice model.” (SACDM 2005 p.29) 
 
The Scottish Executive states that it will explore this further. 
 
The first issue of the newsletter was published in July 2006 (Scottish Executive 
2006b).  It reported that the National Forum held its first meeting on 12 May 2006.   
 
The Scottish Executive is providing funding for research into how to reduce death by 
drug related overdose.  
 
Issuing heroin users with naloxone  
In Scotland, Lanarkshire ADAT is currently running a pilot project involving Naloxone 
the anti-overdose drug.  This involves the training of ten front line addictions staff, ten 
clients and ten family/friends currently living with an injecting drug user.  Each group 
is being trained by the Scottish Ambulance Service on Naloxone administration, 
basic life support and the unconscious patient.  After successful completion of the 
course the participants are issued with a 400 mcg pre-filled Naloxone syringe, sharps 
bin and harm reduction/health promotion material.  The pilot will be monitored after 
two months to assess both the effectiveness of the training and the impact of the 
Naloxone.  A similar pilot project is also being run in Greater Glasgow (Scottish 
Executive - internal communication).  
 
Wales 
A review group to conduct confidential local reviews into drug related deaths has 
existed in North Wales for some time and is reported to be working well.  Currently 
action is being taken to replicate the system throughout Wales.  It is expected that 
reporting will help identify best practice and disseminate lessons learned to help 
reduce, and ultimately prevent many drug-related deaths across Wales (Welsh 
Assembly Government – internal communications). 
 
NTA has provided funding for a psychological autopsy study of acute fatal heroin-
related overdose.  The aim is to investigate the psychological and social antecedents 
(lifestyle, personality, psychological and social circumstances, events and 
behaviours) of fatal heroin overdose.107  
Safer use training 
See above with respect to the Scottish Action Plan on drug-related death. 
First aid training 
See above with respect to the Scottish Action Plan on drug-related death. 
Consumption rooms 
The debate over consumption rooms is currently topical, see research below.  
Research report on drug consumption rooms 
A report from an Independent Working Group set up and funded by the Joseph 
Rowntree Foundation suggests drug consumption rooms should be piloted in the 
United Kingdom (Joseph Rowntree Foundation 2006) as they offer a "unique and 
promising way" to help lessen fatal overdoses as well as take drug use off the streets 
and reduce numbers of discarded needles in public places.  
 
                                                 
107 For more information see: http://www.shef.ac.uk/scharr/sections/gp/research/innovations  
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In response NTA suggest, 
"Any new treatment provision must be evidence based and cost effective. Further 
evidence is needed that there would be enough demand for drug consumption 
rooms to justify the use of scarce resources, when funding could be better spent 
on other treatment services.” (NTA 2006f). 
 
The Home Office has rejected the recommendation.108 
Antagonists 
NO NEW INFORMATION AVAILABLE 
Volatile substance abuse  
In a review of the evidence relating to volatile substance abuse (VSA) in Scotland, 
commissioned by the Scottish Executive, it was suggested that VSA has, in the last 
20 years, become part of a secondary research agenda and is often poorly 
understood as a drug misuse problem among care professionals (Skellington Orr and 
Shewan 2006).  Also, there is a lack of presence of VSA in drug education 
programmes, professional training packages and treatment services.  In addition, it is 
suggested that death risks associated with VSA appear to present unique challenges 
to the drug education agenda with the drug education literature suggesting that scare 
tactics do not work well with young people and that stories of first time death risks are 
often not believed. Fear of raising awareness of VSA methods is also cited in the 
literature as a reason that VSA has not, in recent years, been targeted specifically as 
part of drug education in the United Kingdom.  Whilst some of those working in the 
field have argued for specific VSA education, including for primary school children, 
traditional drug education debates regarding the suggestibility of younger children 
may continue to act as a barrier to it. 
7.3 Prevention and treatment of drug-related infectious diseases 
7.3.1 Counselling and testing 
HIV 
There is evidence that suggests an increasing proportion of IDUs may be unaware of 
their HIV infection.  Only 47 per cent of those participating in the UAPMP agency 
survey who had antibodies to HIV were aware of their infection in 2005.  This is the 
lowest level of awareness seen in this survey since this was first asked about in 1995 
(the average between 1995 and 2003 was 74%) (HPA et al. 2006). 
Hepatitis C. 
Increasing the proportion of injectors with hepatitis C who are aware of their infection 
is one of the aims of the Hepatitis C Action Plan for England (DH 2004b) and whilst 
most IDUs who took part in the UAPMP agency survey in England reported having 
accepted the offer of a test, 29 per cent of IDUs reported never having had a 
voluntary confidential test for hepatitis C in 2005, this compares with 51 per cent in 
2000 (HPA et al. 2006).  Of those who were infected with hepatitis C, 48 per cent 
were unaware of their infection, compared to 60 per cent in 2000.  Of participants 
from Wales, 45 per cent reported never having a voluntary confidential test for 
hepatitis C in 2004/05, with almost three quarters of those with hepatitis C being 
unaware of their infection (HPA et al. 2006).  Thirteen percent of the participants from 
                                                 
108 For more information see: 
http://www.politics.co.uk/issueoftheday/drugs-foundation-government%e2%80%99s-drug-
policy-irresponsible-$440680$440605.htm  
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Northern Ireland in 2004/05 reported not having been tested for hepatitis C, and just 
over one quarter of the participating IDUs with hepatitis C in the province were 
unaware of their hepatitis C infection (HPA et al. 2006). 
7.3.2 Prevention 
Vaccination 
In England, Drug (and Alcohol) Action Teams have their performance rated through 
the NTA on hepatitis B prevention targets.  A benchmarking exercise is planned to 
enable improvements in lowest performing D(A)ATs to be identified. 
 
The uptake of the vaccine against hepatitis B by IDUs continues to improve.  The 
numbers of IDUs participating in the UAPMP agency survey self-reporting109 that they 
had taken up the offer of the hepatitis B vaccination has more than doubled from 25 
per cent in 1998 to 59 per cent in 2005 (HPA et al. 2006).  Of those who reported 
vaccination, just over half self-reported having received three or more doses of the 
vaccine (56%).  However, in 2005, among those who had first injected in the previous 
three years 46 per cent reported uptake of the vaccine, lower than in 2004 (51%) 
(HPA et al. 2006).  
 
In April 2005 NTA began a review of hepatitis testing and vaccination against 
hepatitis B of all clients in structured drug treatment; this was not published at the 
time of writing. 
Syringe provision programmes 
Survey of needles and syringe exchanges 
Two reports based on the United Kingdom audit of needle and syringe exchange 
provision in the United Kingdom have been published.110 
 
England  
The report for England found both pharmacy and agency based services provided 
syringe exchange in the overwhelming majority of (D(A)AT) areas though, overall, 
pharmacies constituted 80 per cent of facilities (Abdulrahim et al. 2006).  On 
average, two agency based services and eight pharmacies provided facilities in each 
D(A)AT area.   
• The median number of visits by injectors to all needle exchange facilities in a 
D(A)AT area (pharmacies and specialist services), between April 2004 and March 
2005, was 8,000; 
• the median number of clients who used needle exchange facilities in each 
D(A)AT area was 700, though this number has not been adjusted for double 
counting; and . 
• a median number of 150,000 syringes were distributed per D(A)AT area.  
 
There was, however, wide variation in activity between both services and D(A)AT 
areas. 
 
                                                 
109 Vaccination uptake data should be interpreted with caution as they are based on self-
reports. 
110 The survey comprised three separate questionnaires sent to commissioners (74% 
responded), specialist needle and syringe exchange services (55% responded) and 
pharmacy based schemes (48% of pharmacy exchange scheme co-ordinators responded) 
(see previous UK Focal Point report).  
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It is suggested that a range of interventions and measures necessary to reduce drug-
related harm and blood-borne viruses was limited in pharmacy exchanges, 
suggesting that the latter should be developed as complementary to specialist 
services rather than as an alternative to them.  
 
Also, many specialist services did not provide comprehensive harm reduction and 
hepatitis B prevention measures.  When assessing new clients, 40 per cent did not 
address vaccination and testing for infectious disease.  In half of the D(A)AT areas 
viral testing was not available on site in needle exchange services, and 40 per cent of 
areas did not offer immunisation on site.  Approximately a third did not address 
hygiene and safer injecting techniques. 
 
Finally, the report suggested that management of needle exchange activity was poor, 
few D(A)ATs were able to provide data on number of visits, number of clients and 
quantities of equipment distributed or returned. 
Scotland  
This report is much more detailed than the summary for England (Griesbach et al. 
2006).  Some form of needle exchange was available in every D(A)AT area.  There 
were 188 exchanges; 136 pharmacy exchanges, 43 specialist exchanges, six police 
custody suite exchanges and three hospital A&E exchanges; nearly half of specialist 
service provision was through mobile/outreach facilities.  The ratio of pharmacy to 
specialist exchanges was 3:1.   
 
In non-pharmacy services the median number of transactions per service was 1,054 
(mean: 2,289): 
• the mean number of transactions per pharmacy was 1,458; 
• the median number of clients per service was 221 (mean: 491); and  
• the mean number of clients per pharmacy was 479.  
 
A roughly equal number of syringes were distributed by pharmacy and non-pharmacy 
services overall, though there was wide geographical variation.  It is estimated that at 
least 1,563,312 syringes were returned to needle exchange services across 
Scotland, 849,113 to non-pharmacy services and 714,199 to pharmacy services; 
pharmacies having fewer returns than non-pharmacy exchanges.  
 
Only about half of non-pharmacy services offered on-site interventions related to 
hepatitis C; commonly pre- and post-test counselling.  Less than half provided key 
working, structured counselling, care for minor infections or complementary 
therapies.  Fewer provided overdose prevention training for clients, housing, social 
welfare or legal advice, nutritional advice, primary care sessions or well-woman 
clinics. 
 
Compared to England, services in Scotland were less likely to distribute filters, sterile 
water, stericups and Vitamin C to their clients, though more likely to distribute wipes 
or swabs.  Services were less likely to provide on-site hepatitis B immunisation than 
in England.  English services were much less likely to limit the number of syringes 
they gave out during any single needle exchange transaction; this is probably 
because of guidance in Scotland which limits the number given out.111  Scottish 
services were more likely than those in England to provide injecting equipment to 
                                                 
111 This suggests a maximum of 20 needles/syringes on a client’s first visit; a maximum of 60 
needles/syringes on subsequent visits; and an exceptional upper limit of 120 for holiday 
periods when facilities are closed or are difficult to access.  
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young people aged 16 or 17.  As in England, pharmacy schemes offered a smaller 
range of interventions. 
 
As in England, monitoring was poor, particularly with respect to the number of 
transactions, number of clients, number of syringes distributed and number of 
syringes returned.  
Northern Ireland 
Northern Ireland is the only country within the United Kingdom with a national syringe 
exchange database.  Nine pharmacies offer syringe exchange.  In 2004/05: 
• 86,056 exchanges were made; there were 7,400 contacts, compared to 7,508 in 
the previous year : 
• the overall rate of transactions involving the return of used equipment fell in 
2004/05 to 54 per cent compared to 59 per cent in the previous year; 
• just over half (54%) of all visits were made by clients aged 31 and over;  
• just under one in 20 visits (4%) were by clients reporting themselves to be new 
users of the needle and syringe exchange scheme;  
• twelve (0.2%) visits were by clients reporting to have shared needles (DHSSPSNI 
2006b).  
Monitoring low threshold services 
The value of syringe exchange and other low threshold services (tier 2) is shown by 
the analysis of the Merseyside Inter Agency Drug Misuse Database (Chandler 2006).  
This report also shows that monitoring is both feasible and useful to commissioners, 
and also enables monitoring of care pathways. 
Guidance on providing needle exchange for young people 
DrugScope has published guidance on providing needle and syringe exchange 
services to young people (DrugScope 2005a). 
Paraphernalia and condom provision 
The Scottish Executive has commissioned a study looking into safety, risks and 
outcomes from the use of injecting paraphernalia among IDUs.  This is due for 
publication in Spring 2007. 
Information materials 
NO NEW INFORMATION AVAILABLE 
Educational approaches 
NO NEW INFORMATION AVAILABLE 
7.3.3 Counselling and testing 
NO NEW INFORMATION AVAILABLE 
7.3.4 Infectious disease treatment 
In 2005, a total of 45,171 individuals were seen for HIV-related treatment or care in 
England, Wales and Northern Ireland, of these 1,005 were HIV-infected IDUs, a 15 
per cent increase since 2000 when 872 IDUs were seen for care (total number seen 
in 2000 was 21,717).  Whilst 30 per cent of IDUs were not receiving antiretroviral 
therapy in 2005, 53 per cent were on a combination of three drugs and 15 per cent 
were receiving four or more drugs (only 23 individuals were receiving mono or dual 
drug combinations) (HPA et al. 2006). 
7.3.5 Specialist drug service treatment  
Models of care for treatment of adult drug misusers: Update 2006 states that a 
greater emphasis is required on improving service users’ physical and mental health, 
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importantly for those with hepatitis C infection and for those misusing alcohol. (NTA, 
DH and Home Office 2006). 
 
Research 
A pilot visual assessment of injecting drug use used ethnographic methods to 
capture drug injecting in the context of polydrug use and in particular heroin and 
crack (Rhodes et al. 2006).112  The report of this concluded that public injecting 
environments compromise the maintenance of injecting hygiene: 
• there is a preference among many polydrug users of crack and heroin for groin 
injecting; 
• the shared use of cookers is common; 
• general injecting hygiene is poor and; 
• there remains scope for accidental equipment sharing, a considerable amount of 
blood was observed in the environment, including spillage as well as blood 
transfer between partners. 
 
Further, they noted a large amount of vein damage, as well as common and severe, 
often untreated, injecting related bacterial tissue infections amongst injectors.  In 
addition, they suggest that crack use may compromise and complicate risk 
management and safety routines, especially given that many speedball113 injectors 
also smoke crack, some immediately prior to injecting. 
 
The research suggests a further project is required, designed to generate evidence 
on: 
• how injecting environments mediate risk, and the scope for interventions in public 
injecting environments; 
• how crack injection complicates health risk management in relation to blood-
borne hepatitis C and HIV, bacterial and surface infections related to injecting, 
blood safety, and injecting hygiene; 
• health risk management in relation to groin injection; and  
• the scope and feasibility of interventions specifically targeting risk management 
among polyinjectors of crack and heroin. 
7.4 Interventions related to psychiatric morbidity 
Changes to the way mental disorder is defined 
Changes to the way a mental disorder is defined are proposed through the Mental 
Health Bill; this has implications for dual diagnosis.  The Bill is intended to make the 
Mental Health Act 1983 easier to use and clearer to those to whom it applies.  The 
Department of Health will reword references to alcohol and drugs, to make it clear 
that the Act is not to be used to force people who are suffering from no other mental 
disorder, to accept treatment for substance dependence.  However, it will also make 
clear that people who are dependent on alcohol and drugs are not excluded from the 
scope of the Act, if they also suffer from another mental disorder.  The Act will not 
                                                 
112 The research team obtained access to multiple injecting scenes in a variety of injecting 
environments in London and Bristol, having established contact with drug injecting networks. 
Approximately half of injecting users contacted through fieldworkers agreed to participate in 
the study.  Fourteen separate cases were recorded, of which ten were selected involving 20 
participants.  Injecting practices were recorded with consent of all participants and field notes 
recorded. 
113 injecting the two drugs serially or by combining the drugs in solution and taking them 
simultaneously. 
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apply to substance misuse by itself, as this is not classed as a mental disorder (DH 
2006d). 
Provision in Scotland 
A report on the provision of health and social care services for those with co-existing 
mental health and substance misuse problems commissioned by the Scottish 
Executive aimed to identify the broad range of health and social care needs of such 
problems; and their experiences of accessing and receiving services from health, 
social care, and voluntary organisations114 (Hodges et al. 2006).  The report suggests 
that, 
 “The picture that emerged from this study was one of a group of people who 
struggled daily with the realities of living with co-morbid mental health and 
substance misuse problems and for whom existing support services were often 
inappropriate, inadequate and which could further undermine their already fragile 
self esteem and coping strategies.” (p 48) 
 
There were some examples of good practice.  However, there was a lack of 
awareness of available help, lack of clarity about pathways for help and a lack of 
ongoing support.  The study also uncovered considerable training needs across all 
professional groups and agencies.   
 
Work has already gone into identifying the needs of service users affected by both 
mental health and substance misuse problems, as well as assessing current service 
provision and identifying areas for action.  Recommendations have been made for 
improving awareness, support and service provision for people who have both 
mental health problems and problems associated with alcohol and substance misuse 
– particularly through the Mind the Gap and A Fuller Life reports.    
 
The Executive is now supporting additional work on the next steps required to take 
these recommendations forward to help inform, support and shape the future of 
services for those users affected by both mental health and substance misuse 
problems.  An Advisory Group with a strong delivery focus, with membership drawn 
from across the mental health and substance misuse fields, has been established to 
draw these recommendations together and translate them into practical measures to 
support their implementation.  
The response in Wales  
Co-occurring substance misuse and mental health problems is one of five key 
modules, launched in 2004, as part of the Substance Misuse Treatment Framework 
for Wales (Welsh Assembly Government 2004).   To support the implementation of 
the module a series of workshops have taken place bringing together professionals 
from mental health and substance misuse services to consider the working practices 
between the services to seek a seamless pathway of treatment.  A review of the 
impact of these is to be undertaken and consideration given to providing further 
events to assist in the development of robust protocols (Welsh Assembly 
Government – internal communications). 
Responses to the evidence base on the relationship between cannabis and mental 
health  
A report from the Beckley Foundation looked at the responses to the evidence base 
on the relationship between cannabis and mental health problems (Hunt et al. 2006).  
                                                 
114 The researchers interviewed commissioners, service providers and service users to obtain 
a range of perspectives on these issues. 
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It suggests possible adverse effects of chronic, heavy cannabis use remain to be 
confirmed, and suggests research in the following areas: 
• a decline in occupational performance marked by underachievement in adults in 
occupations requiring high level cognitive skills; 
• impaired educational attainment in adolescents; and  
• subtle forms of cognitive impairment, most particularly of attention and memory, 
which persist while the user remains chronically intoxicated, which may or may 
not be reversed by prolonged abstinence from cannabis. 
 
Regarding effective policies, it is suggested that: 
“no simple solutions exist. However, an evidence-based response to cannabis-
related harms - including those to mental health - would seem to require a multi-
faceted, developmental approach that resists populist solutions” (p.11). 
Exploration of healthcare provision for people with a dual diagnosis (co-morbidity) 
United Kingdom researchers are collaborating on a research project funded by the 
European Union.  This will explore the healthcare provided to those with dual 
diagnosis in urban settings in Denmark, Germany, Italy and the United Kingdom.  A 
prospective cohort design is being used with three cohorts from each centre using a 
consecutive admission technique.  All will have a diagnosis of acute psychosis, but 
one cohort will consist of those who test positive only for cannabinoids, a second of 
those with a positive test for drugs excluding cannabinoids, and a third of those who 
test negative for all drugs.  
Services for prisoners with dual diagnosis on release 
In a review of primary health care and social care services for people recently 
released from prison in the United Kingdom for the Sainsbury Centre for Mental 
Health, Williamson (2006) asks what development work is currently being undertaken 
or planned in the area, what are the national policy drivers covering wider health care 
which may relate to and affect prisoners, how are they enabled to access primary 
care services and what organisational issues affect this access?  Also, what are the 
gaps which require research, training or service development?   
 
Amongst a number of issues addressed, the report suggests that services to meet 
the needs of substance misusing prisoners will, because of the high prevalence of 
dual diagnosis, have to be effectively delivered in partnership with mental health 
providers.  
7.5 Interventions related to other health correlates and consequences 
7.5.1 Somatic co-morbidity 
NO NEW INFORMATION AVAILABLE  
7.5.2 Non-fatal drug emergencies and general health related treatment  
NO NEW INFORMATION AVAILABLE  
7.5.3 Prevention and reduction of driving accidents related to drug use 
See Chapter 13: Drugs and driving.  
7.5.4 Other health consequences reduction activities 
NO NEW INFORMATION AVAILABLE 
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7.5.5 Interventions concerning pregnancies and children born to drug users 
In the United Kingdom, all governments have undertaken further work to address the 
problems associated with being the children of drug using parents.  This work, 
undertaken as part of what is referred to as the Hidden Harm agenda includes 
provision for improving maternity services for drug users who are pregnant, and for 
their babies.  Policy in this area and provision of services for drugs users and their 
children, from birth to adulthood, relates to social as well as health consequences. 
 
In England, Models of care for treatment of adult drug misusers: Update (2006) 
states that the children, carers or significant others of service users should also be 
considered during care-planned treatment and that the needs of the children of drug-
misusing parents also require greater attention (NTA, DH and Home Office 2006). 
Addressing the problems of living with substance misusing parents: Scotland  
In response to the Hidden Harm Report (ACMD 2003) on the impact on family 
members, and particularly children, living with substance misusing parents, the 
Scottish Executive commissioned a number of pieces of research and a scoping 
Looking Beyond Risk (Templeton et al. 2006).  
 
The Scottish Executive published Hidden Harm – Next Steps: Supporting Children – 
Working with Parents (Scottish Executive 2006c).  This identifies the range of actions 
and initiatives underway to improve the way in which young people in substance 
misusing households are supported and protected, outlining work already underway 
and areas for further action: 
• more effective identification of children at risk, including at the stage of pregnancy 
- enabling appropriate support at the earliest possible stage; 
• ensuring that drug users with children undergo a multi-agency assessment, so 
that decisions can be taken on parental capability and care plans with timetables 
that can be agreed and implemented - with the possibility of 'contracts' between 
service providers and parents; 
• more effective communication between agencies, particularly between those 
dealing with adults and children, and including the sharing of information - 
building on proposed legislation to introduce a duty to share information for child 
protection purposes; 
• to consider how barriers, including a culture of confidentiality, act as an 
impediment to sharing information can be broken down; 
• re-training of social workers and other frontline staff in child protection; 
• examining governance, capacity and training to ensure that those working in this 
area have adequate support and advice, that they are clear about their own and 
others' responsibilities and that they have the skills to do their jobs well; and 
• developing a new national fostering strategy, to build on work already going on to 
help support fostering even more effectively in the future. 
 
The Scottish Cabinet’s Delivery Group on Children and Young People is overseeing 
implementation of a number of actions as it covers a wide range of Scottish 
Executive Departments.   
 
The Aberlour Childcare Trust, a charity working for children and young people and 
families who need additional support to promote their development and well being, 
led a Think Tank together with the Scottish Association of Alcohol and Drugs Action 
Teams looking at children affected by parental substance abuse.  The Think Tank 
was drawn from the knowledge and expertise of people working in the drugs and 
alcohol field, including those working directly with parents and drugs.  A report, Have 
We Got Our Priorities Right (Russell 2006) has been published. 
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Drug tests for parents 
One area for future action, identified in Hidden Harm – Next Steps: Supporting 
Children – Working with Parents, is contracts through which parents would commit to 
changing chaotic lifestyles and improving care for their children in return for intensive 
support plans to help them, and their children.  Drug testing is being looked at as part 
of these contracts, as only one way of demonstrating commitment to what is agreed 
in a contract.  Consideration of how contracts might be developed is at an early 
stage.   
Addressing the problems of living with substance misusing parents: Wales 
In Wales there are a number of actions related to addressing the issues for the 
children of drug using parents.  Some initiatives are specific to substance misuse 
policy development; others are in collaboration with other Welsh Assembly policy 
initiatives.  Two of the most significant developments at a national level are as 
follows: 
• the establishment of the all Wales network and collaborative centre for the 
promotion of excellence for education, training and development in substance 
misuse; the All Wales Network and Collaborative Centre for the Promotion of 
Education, Training and Development in Substance Misuse.115  It is considered 
that the establishment of this centre will help ensure that the health and social 
care workforce is better equipped to understand and respond to the needs of 
substance misusers; and  
• the inclusion in Guidance for Local Safeguarding Children’s Boards (LSCB) of  
specific reference to the children of substance misusing parents.  This is to  
encourage close collaboration between LSCB, and local Community Safety 
Partnerships and their  Substance Misuse Action Teams to ensure that the need 
to safeguard the children of problem substance misuse is taken fully into 
account.116 
 
At a local level, the 22 Community Safety Partnerships (CSPs) across Wales are 
expected to develop and implement Local Substance Misuse Action Plans.  In 
deciding what to incorporate in their plans, CSPs are expected to have regard to any 
guidance issued by the National Assembly.  Guidance states that plans should reflect 
any relevant expert advice and direction of the Wales Advisory Panel on Substance 
Misuse and other national bodies e.g. the Advisory Council on the Misuse of Drugs.  
All 22 CSPs have produced action plans and all contain actions relevant to the 
Hidden Harm agenda.117 
Resource book for professionals on substance misuse in pregnancy 
A resource book for professionals on substance misuse in pregnancy has been 
developed by DrugScope (Drug Scope 2005b).  Increasingly, guidance on working 
with pregnant drug users and their children is being made available at the local level, 
for example in Lambeth (Lambeth Drug and Alcohol Action Team 2005).  
                                                 
115See: 
http://www.information.wales.gov.uk/content/decisionreports/education/education/establishme
nt%20of%20an%20all%20wales%20network%20and%20collaborative%20centre%20for%20t
he%20promotion%20of%20excellence%20for%20education%20training%20and%20develop
ment%20in%20substance%20misuse.rtf 
116 See: 
http://www.everychildmatters.gov.uk/_files/99A633771D7DFE72CCEDC6B7B89C9B08.pdf  
117 See, for example: http://www.wlga.gov.uk/content.php?nID=42;lID=1  
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Research 1 
Treatment for pregnant opiate users  
A retrospective review of pregnant opiate users registered with a pregnant drug-
users service between January 2001 and October 2002, aimed to identify the 
obstetric and neonatal characteristics of these high-risk pregnancies, the level of 
contact with the service and the relationship between level of attendance and 
pregnancy outcome (Crome et al. 2005)118.  It was reported that there were no 
pregnancy losses during the studied period.  The birth weights of 27 of 39 babies 
were below the 10th percentile for gestational age.  Associations between different 
antenatal variables and pregnancy outcomes were tested.  The positive association 
between attending 70 per cent of expected antenatal visits to the service and the 
birth weight centile was significant (p = 0.012). 
Identifying babies with neonatal abstinence syndrome and visual impairment 
The Scottish Executive is currently in discussions with NHS Health Scotland and 
other stakeholders about commissioning a piece of investigative work to establish the 
number of babies who are born to alcohol and drug misusing mothers, (rather than 
specifically the number of babies actually born with neonatal abstinence syndrome 
(NAS).  This piece of work came about in response to the 2003 ACMD Hidden Harm 
report which recommended that drug and alcohol use should be routinely recorded at 
antenatal clinic appointments and linked to stillbirths, congenital abnormalities and 
subsequent developmental abnormalities.  The Scottish Executive suggests that at 
present, national statistics on drug and alcohol misuse in pregnancy are under-
reported and that alcohol usage in particular is difficult to record.  The aim of this the 
work is to: 
• conduct an audit of the current level of recording this data; 
• to explore staff attitudes to questioning patients about such an issue; and  
• to identify what does and does not work in relation to gaps in staff training and 
support and gaps in information systems, and to recommend actions for 
improvement (Scottish Executive – internal communication). 
 
 
 
                                                 
118 All the pregnant opiate users registered with the service between January 2001 and 
October 2002, 50 women. 
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8. Social correlates and consequences  
8.1 Overview  
8.1.1 Social exclusion  
A number of studies in the United Kingdom have shown that there is a strong 
association between problem drug use and social exclusion: drug problems are most 
serious in those communities where social exclusion is acute.  Established drug 
markets are an impediment to regeneration, damaging community confidence and 
adding to the poor reputation of the area.  In some parts of the United Kingdom over 
90 per cent of problem drug users are unemployed, a high proportion of the 
homeless are problem users, (evidence suggesting up to 80 percent), and lacking 
educational qualifications (studies suggest up to 40 per cent lack any GCSEs119).  
Also vulnerable young people (those in care, the homeless, truants, school 
excludees and young offenders) are more likely to use drugs, use more often, and 
use a wider range of drugs.  
8.1.2 Drugs and crime 
Drug use per se is not a crime in the United Kingdom, but possession, dealing and 
trafficking are specific offences under the Misuse of Drugs Act 1971.  The number of 
persons dealt with has continued to rise since 2001.  The main drug concerned is 
cannabis.   
 
General criminal offences routinely recorded by the police do not contain information 
on the offenders’ drug habits, neither do specific drug law offences.  It is therefore not 
possible to provide an accurate estimate of the number of offences that are drug 
related, but there is substantial research evidence of the link between drug use, 
particularly use of heroin and crack cocaine, and acquisitive crime.  Around three 
quarters of the users of these drugs admit to committing crime to support their habit.  
Over two-thirds of those in custody are reported to be problematic drug users.  
However, in England and Wales, acquisitive crime, to which drug-related crime 
makes a substantial contribution, has continued to fall in recent years.  
8.1.3 Social and economic costs 
Latest cost estimates are based on the study by Godfrey et al. (2002) and are for 
2000.  It was estimated that drugs cost United Kingdom society between €16.2 and 
€29.3 (£11.1 and £20) billion a year; these include health as well as social costs; the 
costs of crime however are estimated to be by far the highest.  
 
There is evidence that drug use can give rise to dangers associated with safety in the 
workplace and productivity.  However, in the United Kingdom the full nature and 
extent of the problem is unknown.  Other issues include the public nuisance 
associated with dealing and drug related litter (discarded needles and syringes). 
 
                                                 
119 The General Certificate of Secondary Education (GCSE) is the principal means of 
assessing pupil attainment at the end of compulsory secondary education. 
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8.2 Social exclusion  
8.2.1 Homelessness 
Research 
In a study of homelessness among problem drug users based on the Drug Outcome 
Research in Scotland (DORIS) cohort120, Kemp et al. (2006)121  found that 36 per 
cent of problem drug users had been homeless at some time, seven times that of the 
general population.  Recent drug injection was found to be a risk factor (OR = 1.40; 
95% confidence interval (CI) = 1.01-1.96) associated with homelessness.  The 
research also found that becoming homeless was associated with recently losing 
custody of children (OR = 2.28; 95% CI = 1.27-4.08), other recent family problems 
(OR = 1.88; 95% CI = 1.21-2.94) and worsening general health (OR = 2.17; 95% CI = 
1.15-4.09).  No longer being homeless was associated with not having recent family 
problems (OR = 0.43; 95% CI = 0.24-0.79).  
8.2.2 Unemployment 
NO NEW INFORMATION AVAILABLE 
8.2.3 School drop out 
England 
For the first time, in the survey on, Smoking, drinking and drug use among young 
people in England for 2004 pupils were asked whether they had ever truanted or 
been excluded from school.122  This analysis adds to the substantial evidence from 
the United Kingdom (see previous Focal Point reports) that truants and those 
excluded from school are more likely to use drugs than the general school population 
(NatCen/NFER 2006).  
Truancy  
In 2005: 
• thirteen per cent of pupils had truanted at least once in the last year;  
• pupils who had played truant in the last year were much more likely than those 
who had never truanted or those who had last truanted more than 12 months ago 
(past truants) to have taken drugs in the last month, 37 per cent compared with 
23 per cent of past truants and 6 per cent of those who had never truanted; and 
• these patterns existed for girls and boys. 
 
Amongst pupils who had truanted in the last 12 months, the prevalence of drug use 
(and of smoking and drinking) increased with frequency of truanting.  Twenty-nine 
per cent of those who had stayed away from school once or twice had taken drugs in 
the last month compared with 42 per cent of those who had truanted more than three 
times. 
                                                 
120 The Drug Outcome Research in Scotland (DORIS) study is based at the University of 
Glasgow’s Centre for Drug Misuse.  It examines the effectiveness of Scotland’s drug 
treatment services and how evidence of what works can be incorporated into treatment.  The 
researchers have recruited 1,007 drug users who are starting a new drug treatment episode 
from across Scotland. For more information see: 
http://www.gla.ac.uk/centres/drugmisuse/DORIS.html 
121 This report is based on 877 problem users recruited to DORIS. 
122 For methodology used see chapter 2. 
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Exclusion from school 
There was also a relationship between exclusions and drug use (and smoking and 
drinking): 
• Ten per cent said they had been excluded from school at least once; and  
• pupils who had been excluded in the last 12 months were more likely than other 
pupils to have taken drugs in the last month, 36 per cent compared with 26 per 
cent of those who were last excluded more than a year ago and eight per cent of 
those who had never been excluded. 
Former truants and excludees 
In 2005/06 the British Crime Survey included questions for 16 to 24 year olds on 
whether they had ever truanted or been excluded from school. 36.4 per cent of 
respondents reported they had truanted and 16.2 per cent of respondents reported 
that they had been excluded (Roe and Man 2006).   
 
Analysis again showed a relationship between truancy and drug use: 
• former truants were almost twice as likely to have used drugs in their lifetime than 
non-truants, 65.8 per cent and 34.0 per cent respectively; and 
• former truants were also much more likely to have used drugs recently (39.8%) 
and be current users (26.1%) than non-truants (17.6% and 9.1% respectively). 
 
The relationship was similar between exclusion and drug use: 
• excludees were over one and a half times more likely to have ever used drugs or 
used drugs recently than non-excludees; and 
• they were also more than twice as likely to be current drug users. 
 
Differences were even more striking looking at Class A drugs.  Analysis showed that, 
although there was a considerable overlap between truants and those excluded, 
those who had truanted only were more likely to have used drugs across all recall 
periods than those who had been excluded only. Those who had both truanted and 
been excluded were the most likely to have used Class A drugs. 
8.2.4 Financial problems 
NO NEW INFORMATION AVAILABLE  
8.2.5 Social network 
NO NEW INFORMATION AVAILABLE  
8.2.6 The effect of drug misuse on the family of users  
NO NEW INFORMATION AVAILABLE  
8.3 Drug-related crime 
8.3.1 Drug offences 
Drug related offences can be identified through the police, courts and HM Revenue 
and Customs.  In 2004/05 there were 186,783 incidents involving alleged drug 
offences recorded by the police in the United Kingdom, an increase of 0.5 per cent 
from the 185,924 offences reported in 2003/04  
 
The latest data on persons dealt with (persons found guilty, given a fiscal fine or dealt 
with by compounding) for drug offences is available for 2004 (Table 8.1).  The total 
number of persons dealt with was 122,459.  This is an increase of 4 per cent from the 
previous year (117,532).  Eighty-eight per cent of persons were dealt with for drug 
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possession offences.  Trafficking and dealing offences (i.e. supplying or possession 
with intent to supply, and unlawful import or export), accounted for 12 per cent of all 
drug offences in 2004.   
 
Sixty-eight per cent of offences (82,845) (not persons dealt with) related specifically 
to cannabis, eight per cent to cocaine and 10 per cent to heroin.  The proportion of 
offences related to cannabis has decreased from the previous year. 
 
Table 8.1: Persons found guilty, given a fiscal fine or dealt with by compounding for drug 
offences in the United Kingdom, 2000 to 2004 
 
Drug Year 
 2000 2001 2002 2003 2004 
Amphetamines 6,637 4,950 5,820 6,163 6,249 
Cannabis 75,989 72,691 83,152 85,768 82,845 
Cocaine 5,451 3,090 6,990 7,905 9,382 
Crack 1,216 1,460 1,830 2,270 2,450 
Ecstasy 6,630 7,880 6,590 5,940 6,209 
Heroin 12,297 12,380 11,860 11,277 12,412 
LSD 260 150 90 150 90 
Methadone 617 600 470 438 400 
Total 105,039 103,080 113,465 117,532 122,459 
Source: Standard Table prepared for Focal Point by John Corkery 2006 
 
8.3.2 Other drug-related crime  
Property and acquisitive crime  
In England and Wales acquisitive crime, to which drug-related crime makes a 
substantial contribution has continued to fall in recent years, falling by 12 per cent in 
the year to April 2005.  The 2005/06 British Crime Survey shows that overall 
household acquisitive crime in England and Wales has fallen by 55 per cent between 
1995 and 2004/05, then falling by 4 per cent between 2004/05 and 2005/06 (Walker 
et al. 2006). 
 
Also, the fall in the Drug Harm Index value between 2003 and 2004 from 104.8 to 
87.9, a drop of 16.9 points or 16.1 per cent (see Chapter 1.3.4) is mostly due to 
substantial falls in the number of drug-related crime types (e.g. burglary, shoplifting, 
robbery and vehicle theft) (MacDonald et al. 2006).  
 
A report from Her Majesty’s Inspectorate of Probation (2006) suggested that between 
40 and 60 per cent of cases inspected involved substance misuse (including alcohol). 
Problematic drug use was found in between 16 and 23 per cent of cases; though it is 
suggested that this is an underestimate. 
Research  
Budd et al. (2005) reported on the results from the 2004 Offending, Crime and 
Justice Survey.123  In this survey the majority who used drugs used recreationally and 
                                                 
123 The Offending, Crime and Justice Survey (OCJS) is the national longitudinal, self-report 
offending survey for England and Wales.  The survey, covering people living in private 
households, was first conducted in 2003 and will be repeated annually until 2006.  The 
sample size is 3,489 people; 3,363 were aged from 10 to 25 at the time of the 2004 
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amongst those who reported offending much was at a low level.  Nevertheless, over 
half (52%) who had taken a drug in the last year reported having committed an 
offence; this compared with 19 per cent who had not taken a drug.  However, 
frequent drug takers, that is, those having taken a drug two or three times a month or 
more, were more likely to have committed an offence (62%).  
Crime and treatment  
The Home Office also published findings from a study linking data on self-reported 
offending gathered as part of the National Treatment Outcome Research Study 
(NTORS) with convictions data held on the Home Office Offenders Index.124  The 
study adds to the evidence that criminal convictions reduced after admission to 
treatment, with further progressive reductions in criminal convictions across the five-
year follow-up period.  There was a statistically significant association between the 
conviction measures recorded in the Offenders Index and the self-reported offending 
measures used in NTORS (Gossop et. al. 2006). 
Concealment of drugs by those detained in police custody 
Havis et al. (2005) looked at concealment of drugs by those detained in police 
custody.  Much of the evidence was based upon deaths in custody.125  In half of the 
cases, the deceased was known, or believed, to have concealed drugs orally at the 
point of initial contact with police.  In four out of the 16 cases, the individuals first 
showed signs of medical distress in a public place, a further four collapsed on arrival 
at the police station; two more were subsequently found collapsed in their cell.  Drug 
toxicity was the most common cause of death (in 10 out of the 16), but in five cases 
death was caused by airway obstruction by swallowed packages.  Both cocaine (in 
14 out of 16) and cannabis (in 8 out of 16) traces were found in post-mortem 
samples.  The authors suggest that police officers be trained to reflect this risk and 
police forces develop a policy for life preservation in the case of swallowing, and for 
the management and detection of other forms of drug concealment.  It is suggested 
that when there is a suspected swallowing immediate hospitalisation without 
attending custody is essential.  When a detainee’s health deteriorates between arrest 
                                                                                                                                            
interviews.  The main aim is to examine the extent of offending, anti-social behaviour and 
drug use among the household population, particularly among young people aged from 10 to 
25.  It covers offences against households, individuals and businesses.  In addition to 
‘mainstream’ offences such as burglary, shoplifting and assault, it also covers fraud and 
technology offences.  The survey will also collect longitudinal data (that is information from 
the same individuals over time) to allow researchers to examine the pathways into and out of 
delinquency and the impact various risk and protective factors have on these pathways.  It 
gathers evidence to support the effective targeting of resources for reducing levels of crime 
and illegal drug use, providing: 
• measures of self-reported offending; 
• indicators of repeat offending; 
• trends in the prevalence of offending; 
• trends in the prevalence and frequency of drug and alcohol use; 
• evidence on the links between offending and drug / alcohol use; 
• evidence on the risk factors related to offending and drug use; and 
• information on the nature of offences committed, such as the role of co-offenders and the 
relationship between perpetrators and victims. 
124 This holds information about convictions for individuals. 
125 The study was based on 16 cases of internal drug concealment drawn from 43 drug-
related deaths in custody in England and Wales between 1997 and 2002.  These data were 
supplemented by three case studies from a county force involving non-fatal drug concealment 
to illustrate practical custody issues.  
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and booking in, or whose health deteriorates suddenly, or when a detainee has 
convulsions or collapses in a cell, drug concealment should be suspected.  
Illegal prostitution 
Prostitution is not illegal in the United Kingdom; soliciting for such purposes is an 
offence.  
Research  
Gilchrist et al. (2005)126, interviewing 29 prostitutes, 23 of whom had used cocaine 
and 15 of whom had used crack, found no evidence to suggest that they were first 
introduced to cocaine use through prostitution; most believed that using cocaine did 
not affect how they worked.  However, respondents suggested that other prostitutes 
were prepared to take more risks to support their cocaine habit and worked longer 
hours to finance cocaine than to finance heroin use. 
The reinforcement between drug use and sex work 
Cusick and Hickman (2005)127 examined the reinforcement of sex work and drug use.  
Half of sex workers involved in the study had sold sex before the age of 18 and 
three-quarters of participants had used drugs.  Half had been in care; half had been 
homeless and a fifth (21%) had run away or left home before the age of 16.  
Researchers suggest that none of the above experiences explain ‘trapping’, that is 
sex workers remaining trapped as a result of their drug use.  However, they suggest 
that there were “strong associations between being trapped and convictions (81%); 
and being trapped and outdoor/drift sex work (92%).  After adjustment for the other 
vulnerabilities in the logistic regression only outdoor/drift sex work remained 
significant with sex workers involved in outdoor/drift sex-work having an adjusted 
odds ratio of over 7 (95% CI 1.7 - 28.3) of being trapped.”  It is concluded that 
outdoor/drift sex markets may reinforce vulnerability, sex work and problematic drug 
use.  They recommend that interventions should seek to reduce the sex industry's 
potential for exploitation and abuse by disentangling sex and drugs markets.  
Violence under the influence 
Evidence from the Offending Crime and Justice Survey suggests that in three per 
cent of violent offences committed, the offender had taken a drug (but not alcohol), 
and in four per cent of cases both drugs and alcohol; however they note that 
causality cannot be assumed (Table 8.2).  
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
126 Participants interviewed attended three street services for women involved in prostitution.  
In depth semi-structured questionnaires were used. 
127 Several recruiting strategies were used simultaneously to interview 92 sex workers; these 
included, services providing for sex workers, advertising space on the web and contact 
magazines and snowballing.  A structured questionnaire was used to gather quantitative data 
on: drug use; sex work; use of services and offending.  These topics were explored further in 
semi-structured interviews.  
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Table 8.2: Proportion of offenders who had taken alcohol or drugs at the time of an incident in 
England and Wales, 2004  
 
 Assault 
without 
injury 
Assault 
with 
injury 
All 
violent 
offences 
Vehicle 
related 
Thefts 
Criminal 
damage 
Other 
thefts 
All 
property 
offences 
Drugs only  1 4 3 4 3 2 2 
Alcohol only  13 24 18 8 27 2 7 
Drugs and 
alcohol 2 6 4 10 6 1 3 
Neither  80 64 72 77 62 92 84 
Base 537 543 1,096 119 235 740 1,141 
Source: Budd et al. 2005 
Problem drug users and assault 
In research based on the DORIS study, Neale et al. (2005) found that one in five 
(18%) had committed assault in the previous three months and a quarter had been 
assaulted in the previous six months.128  Factors associated with committing an 
assault were: being male; having used crack in the last 90 days; having slept rough 
or in a hostel in the previous six months; and having been physically abused.  Of 
those factors associated with committing an assault, four out of five were associated 
with being assaulted.  Researchers state that these findings suggest that treatment 
services have a role in addressing both violent tendencies amongst clients and high 
levels of victimisation experienced.  
Perceptions of the association between crime and violent crime 
According to the 2005/06 British Crime Survey, victims believed the offender to be 
under the influence of drugs in just under a quarter (23%) of incidents of violence, an 
increase from 18 per cent since 2004/05 (Walker et al. 2006). 
Research in progress 
The Economic and Social Research Council has commissioned research which aims 
to investigate the nature of current forms of street violence.  In particular, it seeks to 
explore areas where there are notable gaps in knowledge, for example situational 
factors, such as the role of drug misuse, drug markets, and individual factors, such 
as gender and ethnicity, in explaining: (1) specific aspects of violence in relation to 
violent offences, and (2) general aspects of violence.  The research method will 
involve conducting interviews with offenders currently serving sentences for violent 
offences in prisons and young offender institutions. 
Driving offences 
See Chapter 13: Drugs and driving.  
8.4 Drug use in prison 
8.4.1 Drug use in the prison population 
Mandatory drug testing  
In England and Wales, from April 2005 to March 2006 random Mandatory Drug 
Testing (rMDT) positives’ levels were 10.3 per cent, indicating that the target of 
achieving 11.7 per cent (or less) by 31st March 2006 was achieved.  Overall, positive 
rMDT levels have fallen by approximately 58 per cent since the programme’s 
introduction in 1996/97, when 24.4 per cent of tests proved positive.  Over this period 
                                                 
128 Interviews were conducted with 560 drug users entering treatment. 
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positive tests for opiates have decreased by more than 40 per cent (National 
Offender Management Service (NOMS) Drug Strategy Unit 2006 – internal 
communication).  
 
In Scotland, the rate of positive results for Mandatory Drug Testing in prison over the 
past five years has slightly increased from 15 per cent in 2000/01 to 18 per cent in 
2004/05.  In 2004/05 the drugs most frequently detected by rMDT were cannabis 
(15%), opiates (14%), and methadone (14%).  Since 2000/01 methadone has been 
detected in an increasing proportion of random drugs tests (from 1% in 2000/01 to 
14% in 2004/05). 
Drug use by prisoners assessed under Counselling, Assessment, Referral, Advice 
and Throughcare services in England and Wales 
A report129 on prisoners accessing Counselling, Assessment, Referral, Advice and 
Throughcare services (CARATs)130 in England and Wales while in custody looked at 
drugs used, injecting behaviour and treatment prior to custody as well as crime 
committed (May 2005).  This report confirmed evidence that heroin was the most 
commonly used drug prior to custody (62% of prisoners assessed by CARATs in 
2004/05 had used in it in the 30 days before custody).  Crack (49%) and cannabis 
(42%) were also reported.  However, the recorded use of both heroin and crack by 
CARAT clients in the 30 days before custody fell significantly between 2003/04 and 
2004/05: heroin use fell from 70 per cent to 62 per cent and crack use from 55 per 
cent to 49 per cent.  This is consistent with a fall in positive rMDT tests for heroin, 
reported in the previous section. Seventy-four per cent took two or more different 
drugs in the month before custody, with 39 per cent taking both heroin and crack in 
this period.  Amongst this group, 43 per cent considered heroin to be their main 
problem drug prior to custody, though this proportion had fallen from 49 per cent in 
the previous year.  Alcohol was the next most common main problem substance, 
mentioned by 14 per cent, then crack, mentioned by 10 per cent. 
 
Excluding unknowns, 35 per cent said they had injected in the 30 days before 
custody.  
 
Excluding unknowns, 57 per cent had previously received treatment for a drug 
problem.  However, as the proportion of unknowns was high (nearly a quarter of all 
cases), the results must be viewed with caution.  
 
The most common main offences in 2004/05 were theft/handling (24%) and burglary 
(17%), pointing to a link between drug use and, in particular, acquisitive crime.  
Eleven per cent were convicted of a drug offence.  On average, before going into 
prison, those who recorded a weekly spend on drugs, were spending nearly €878 
(£600).  The highest expenditure was by users of crack. 
 
There was also an association between type of offence and injecting behaviour prior 
to custody.  Of those with theft/handling as their main offence, 52 per cent had 
                                                 
129 There were 27,962 cases in the data for the first year (2002/03), 35,454 for the second 
(2003/04), and 48,675 for the third (2004/05).  These figures represent 54 per cent, 65 per 
cent and 82 per cent respectively of the number of CARAT cases reported for management 
purposes as a key performance indicator. 
130 The CARAT service was established in 1999 as a universal drug treatment service in 
every prison establishment across England and Wales.  CARAT services are a major element 
of the National Offender Management Service (NOMS) Drug Strategy.  The results are based 
on the third year of data, 2004/05, unless otherwise stated. 
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injected compared to much lower rates for those who committed drugs offences 
(26%), robbery (24%), or violence (18%).  Of those who had injected in the 30 days 
before custody, 72% gave heroin as their main problem drug. 
The Scottish Prison Survey 2005  
The Scottish Prison Survey 2005131 shows that of those who responded, half of 
prisoners (50%) reported that they had used drugs in prison at some point in the past 
(Scottish Prison Service 2006).  The majority of these individuals (81%) reported that 
their drug use had changed during their current period in prison.  Three quarters 
(76%) reported a decrease in drug use in prison while less than a fifth (17%) reported 
an increase and less than a tenth (7%) indicated a similar level of drug use but with 
different drugs.  Two-thirds (66%) reported that they had not used any illegal drugs in 
the month prior to the survey, while a third had used.  The most common drugs 
reported by users in the last month were: cannabis (77%) and heroin (67%).  A third 
of prisoners (33%) reported using benzodiazepines (e.g. Valium, Ativan), and a 
quarter opiates other than heroin (23%).  Smaller proportions reported using cocaine 
(14%), methadone (12%) (not on prescription), ecstasy (8%), temazepam (9%) and 
amphetamines (4%). 
 
A minority of prisoners (3%; n=126) reported injecting drugs in prison in the last 
month.  Of these, 78 prisoners stated that they had shared their injecting equipment.  
Over half of prisoners (55%) reported that their drug use was a problem for them on 
the outside and that they were under the influence of drugs at the time of their 
offence (56%).  A third (33%) indicated that they committed their offence to get 
money for drugs.  Regarding help for drug problems, two thirds (66%) reported that 
they would take help for their drug problem on the outside while a slightly higher 
proportion (70%) would take help in prison, if offered. 
Drug use amongst the prison population in Northern Ireland  
A survey was undertaken of drug use amongst prisoners in Northern Ireland in 
Hydebank Prison, a medium to low security young offender centre and prison, 
accommodating male remand prisoners and sentenced young offenders.  Inmates 
were aged between 17 and 21.132   In this survey it was reported that over three 
quarters (77%) had used drugs in the month prior to custody, including cannabis 
(73%), cocaine (45%), heroin (3%), ecstasy (52%) and LSD (17%).  Forty per cent 
reported drug use while in custody; cannabis (38%), cocaine (4%), ecstasy (15%) 
and LSD 4%) (O’Mahony et al. 2005).  
                                                 
131 This survey, which is undertaken in each of the 15 Scottish prisons, involves all Scottish 
prisoners.  The survey is designed to a number of objectives: to make use of prisoners’ 
perceptions of service-delivery and service-quality in its business planning; to provide 
prisoners with an opportunity to comment on a range of issues that impact on their experience 
in prison; to allow staff to get a better understanding of how the halls or areas they manage 
compare to equivalent areas and halls and in so doing to provide a tangible way to help share 
items of ‘best practice’; and to allow the Service, through annual repeats of the same 
questions, to track progress (or the lack of it) across the various dimensions that are included 
in the survey.  The evening prior to the survey, each prisoner was given a leaflet informing 
them of the survey and its aims.  On the day of the survey, each prisoner was issued with a 
survey form personally by a member of the survey team (after being given the chance to 
complete the questionnaire in the privacy of their cell).  This is the 8th annual prison survey 
reporting on prisoner perceptions. 
132 The sample frame was the total population (190 inmates), 182 were available for interview, 
only two refused. 
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8.5 Social costs 
Updated and improved estimates of the costs of Class A drug use have been 
undertaken but were not published at the time of writing. 
8.6 Drug use in the workplace 
In a reference book on drug misuse in the workplace aimed at managers (Ghodse 
2005) it is suggested that “more than 60 per cent of drug users hold some form of 
employment, it is essential that the workplace plays its role in combating all forms of 
substance misuse”.  The evidence for this statement, however, is based on a report 
from 1998 (Ghodse 1998). 
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9. Responses to social correlates and consequences 
9.1 Overview  
9.1.1 Social reintegration  
Social reintegration is a key element of the national Drug Strategy.  Responsibility for 
responding to the social correlates and consequences discussed in Chapter 8 rests 
with a number of Government departments and agencies.  In England, the 
Department for Education and Skills (DfES) has particular responsibility for ensuring 
that children and young people achieve their potential.  The Places and Communities 
Group, situated within the Department for Communities and Local Government 
(DCLG)133 is responsible for the National Strategy for Neighbourhood Renewal.  A 
comprehensive programme of neighbourhood renewal was launched in 2001 to 
address deprivation in the poorest 10 per cent of neighbourhoods so that within 10 to 
20 years no one should be seriously disadvantaged by where they live.  The strategy 
is reflected in two long-term goals: 
• in all the poorest neighbourhoods, to have common goals of lower unemployment 
and crime, and better health, skills, housing and physical environment; and 
• to narrow the gap on these measures between the most deprived 
neighbourhoods and the rest of the country. 
 
The Housing Strategy and Support Directorate (HSSD), also part of DCLG, 
coordinates policy nationally.  Homelessness issues are also addressed in the United 
Kingdom Drug Strategy and the Government’s Homelessness Strategy published in 
March 2005.  There has been joint working between HHSD and the National 
Treatment Agency to build treatment services which are responsive to the needs of 
homeless people.  In Scotland, the Homelessness Task Force aims to improve 
interventions for drug users.  The Supporting People Programme, introduced in 2003, 
provides housing related support to vulnerable groups, including people with drug 
problems, and is delivered through local authorities working in partnership with other 
support organisations. 
 
Various projects have been established to help drug users and ex-drug users 
reintegrate.  Progress2work (p2w), initiated in 2002, supports those who are drug 
free or stabilised, but whose history of drug use can be an important factor in 
preventing them from getting or keeping a job; this is a United Kingdom wide 
initiative.  The Building Safer Communities Fund aims to build communities that are 
resistant to drugs.  Social inclusion programmes such as Positive Futures bridge the 
gap between universal and targeted services (see Chapter 3).  Drug (and Alcohol) 
Action Teams (D(A)AT)s in England, Alcohol and Drugs Co-ordination Teams 
(ADCTs) in Northern Ireland.  Community Safety Partnerships (CSPs) and their 
Substance Misuse Action Teams (SMATS) in Wales and Alcohol and Drug Action 
Teams (ADATs) in Scotland coordinate responses at the local level. 
9.1.2 Reducing drug related crime  
The Drug Interventions Programme (DIP), established in England and Wales in 2003 
to reduce drug-related crime, is a major programme designed not only to ensure that 
offending problem drug users access not only treatment services, but also other 
services addressing other needs, for example accommodation and employment, to 
assist in reintegration.  Drug using offenders are helped to do this through multi-
                                                 
133 Previously the Office of the Deputy Prime Minister.  
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disciplinary Criminal Justice Integrated Teams (CJITs) at the local level, including 
links through Counselling, Assessment, Referral, Advice and Throughcare services 
(CARATs) to the prison system.  Until 2005, interventions within the criminal justice 
system were based on voluntary referral, with access to assessment for treatment 
and support not obligatory (such as through Arrest Referral schemes, which have 
now been subsumed within CJITs).  However, with the Drugs Act there have been a 
number of important changes, with drug testing on arrest, required assessment and 
referral to treatment. 
9.1.3 Reducing drug use in the prison population 
HM Prison Service considers that it is unrealistic to expect prisons to be entirely drug 
free as this would entail overly draconian measures.  Instead a balance is struck 
between deploying robust security measures and maintaining a humane environment 
that supports the rehabilitation of offenders.  However, drug use in custody has 
reduced considerably (see Chapter 8).  This reduction is due to the co-ordinated 
supply reduction, treatment and throughcare measures that prisons have in place.  
Measures to prevent drugs entering prison include: clearly-defined searching 
procedures covering all possible routes; passive and active drug dogs; with passive 
dogs available to all prisons; CCTV surveillance of all social visits’ areas and low-
level fixed furniture in Category C (low security) prisons and above; comprehensive 
measures to tackle visitors who smuggle or attempt to smuggle drugs including 
closed visits, visit bans and police arrest; and in England and Wales, use by all 
prisons of the Supply Reduction Good Practice Guide.134 
9.1.4 Other social correlates and consequences 
Current attention is also focused on the impact of the drug use of parents on their 
children.  In addition, there is a growing number of responses to neighbourhood 
problems associated with problem drug use, including dealing.  For example, the 
Anti-Social Behaviour Act 2003 seeks to stop the use of premises for drug dealing.  
Also, there is guidance to tackle the inappropriate disposal of drug paraphernalia. 
9.2 Social reintegration 
9.2.1 Accommodation 
In November 2005, DCLG, the Home Office and National Treatment Agency (NTA) 
jointly wrote to D(A)ATs, local authorities and other local stakeholders to encourage 
effective joint working around relevant support services.  This concerned data from 
the Supporting People Single Client Record Form collected by DCLG about service 
use, and will allow work at the local level to look at the extent to which capacity of the 
existing services is being fully used. 
 
Approximately €44 (£30) million of the national Supporting People budget is recorded 
as being used to deliver services for those with substance misuse problems.  
According to statistics this equates to some 741 services nationally with around 
25,500 people making use of them each year. 
 
Work to develop a strategy for the Supporting People programme is allowing further 
consideration of how best to take forward support for all vulnerable groups including 
drug misusers.  The initial Supporting People Strategy consultation ended on 31st 
March 2006.  A document entitled, Supporting Independence: Next Steps in our 
                                                 
134 See:  
http://www.hmprisonservice.gov.uk/prisoninformation/prisonservicemagazine/index.asp?id=44
80,18,3,18,0,0  
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Supporting People Strategy was published in July 2006 following the consultation 
and sets out some preliminary conclusions and areas where further work and 
discussions will be carried out (DCLG 2006).   
Comprehensive Rent Deposit Model 
The DIP team at the Home Office has worked in partnership with DCLG, NOMS, NTA 
and a range of other partners to promote practice and solutions which can contribute 
to preventing homelessness for drug misusers.  Work with the private rented sector 
was identified as an opportunity to increase local capacity, however it was 
recognised that support for a rent deposit by itself was not enough.  From April 2005 
13 D(A)AT areas were funded by DIP for two years to build on existing practice 
relating to working with the private rented sector and develop a Comprehensive Rent 
Deposit Model targeting those drug misusing offenders on the CJIT caseload leaving 
prison or residential provision.  Funding is available for two years (until March 2007).  
Local partnerships have been encouraged to plan and develop provision alongside 
their local Homelessness Strategy, Supporting People and D(A)AT Treatment Plans. 
 
Practice seminars alongside summaries of progress updates are seen as promoting 
good practice and emerging learning.135  Findings so far suggest that this project has 
helped to provide a focus and catalyst for change in these selected areas including 
improved strategic and operational working between drug and housing providers, 
appropriate assessments of individual need and provision of related support through 
joint working between CJITs, specialist tenancy/housing support workers, housing 
benefit advisors and other providers of support.  Critical elements have also included 
the work local partnerships have developed to improve working arrangements with 
the private rented sector and the development of approaches to practically support 
clients to prevent loss of their accommodation building on skills and experience they 
already have.  This may include help through ‘start up packages’ (i.e. a kettle and a 
microwave), support to manage previous rent arrears and overall budgeting which 
may include support with both shopping and cooking (Home Office 2006g). 
9.2.2 Education, Training and Employment 
Education, training and employment (ETE) provision is seen by the Government as 
an important factor in supporting and sustaining the recovery and resettlement of 
former or stabilised drug misusers.  It is now expected that planning and delivery of 
ETE provision should be integrated into treatment pathways, and that pathways from 
treatment into aftercare should include planning for ETE provision.136  
The DIP Aftercare Team has worked in partnership with Jobcentre Plus, NOMS, the 
London Drug Policy Forum (LDPF), the Centre for Economic and Social Inclusion 
and the NTA to produce a practice paper which summarises and promotes existing 
practice that creates and sustains partnerships between education, training and 
employment provision and D(A)AT partnerships/CJITs for DIP clients (Home Office 
2006h).  The paper looks at nine projects, identifying and highlighting key elements 
which can progress integration and implementation of ETE provision for clients. 
Research  
A longitudinal study of families living in low income neighbourhoods will examine the 
dimensions of exclusion and inclusion, exploring the impact of area initiatives (e.g. 
                                                 
135 This information is available on www.drugs.gov.uk.   
136 For more information see: http://www.drugs.gov.uk/drug-interventions-
programme/guidance/throughcare-aftercare/?version=2  
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Sure Start and New Deal for Communities), looking in more detail at education and 
health, race relations, social networks and social capital, the role of community and 
community involvement, crime, drugs, disorder, and coping strategies, income, work 
and benefits.137 
 
The Department for Work and Pensions has commissioned research aimed at 
improving understanding of the problems that drug and alcohol misuse poses to job 
search, and in gaining and retaining employment amongst working age benefit 
clients.  The research will draw together existing evidence and aims to generate 
better insight into the types of support services needed by people with substance 
abuse problems.138  
 
An evaluation is currently being undertaken of a scheme which aims to increase 
employment opportunities for offenders with issues around their drug and alcohol use 
and mental health.139 
9.2.3 Basic social assistance 
See above. 
9.2.4 Community involvement 
A report on involving the community in crime and disorder problem-solving looked at 
the evidence from problem-solving initiatives that have been subject to evaluation 
and from practitioner assessment of the effectiveness of community involvement in 
problem-solving initiatives that have not been formally evaluated (Forrest et al. 2005).  
The report is intended as a resource for front-line practitioners and their managers.  
Its aim being to give practitioners: 
• a range of types of involvement in problem-solving that might be appropriate in a 
given community; 
• advice on devising a strategy to facilitate community involvement; and 
• specific ideas about how to involve the community in a range of practical 
problem-solving activities. 
9.2.5 Interventions for families affected by drug misuse by parents 
See the Scottish Executive report Hidden Harm Next Steps Supporting Children – 
Working with Parents (Scottish Executive 2006c) in Chapter 7. 
9.3 Prevention of drug related crime 
9.3.1 Assistance to drug users in prison 
Prevention 
For 2005/06 the Voluntary Drug Testing (VDT) programme target in England and 
Wales was to maintain 28,000 prisoners on VDT compacts.  The target was 
exceeded with around 34,000 of compact prisoners participating (NOMS Drug 
Strategy Unit 2006 – internal communication).  
 
Also see the section in Chapter 8 on Mandatory Drug Testing in England and Wales 
and Scotland. 
                                                 
137 For further information see: http://sticerd.lse.ac.uk/dps/case/cr/CASEreport6.pdf  
138 For further information see: http://www.crsp.ac.uk/publications/2000_for_2005.htm  
139 For further information see: http://www.kcl.ac.uk/schools/law/research/icpr/research.html  
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Supply Reduction 
2005/06 saw additional measures introduced in England and Wales, including; use of 
mobile phone detectors, research conducted into methods and patterns of supply to 
help establishments further develop their supply reduction strategies, and work 
commenced on updating the Supply Reduction Good Practice Guide (NOMS Drug 
Strategy Unit 2006 – internal communication). 
Harm reduction 
It is reported that in England and Wales, 1,200 prisoners received hepatitis B 
vaccinations each month and 40 per cent of intravenous drug users in the wider 
community who report receiving one or more hepatitis B vaccination received them in 
prison (HM Prison Service 2006).  
Treatment 
At the end of 2005/06, in England and Wales, 116 drug rehabilitation programmes 
(including Therapeutic Communities) were running in 103 out of 139 prisons; of these 
40 were high-intensity Short Duration Programmes (SDP) aimed primarily at those 
spending only a short time in custody.  In 2005/06 there were more than 10,700 
entrants onto prison drug rehabilitation programmes, with more than 8,000 
successfully completing the courses, a 75 per cent completion rate (the 2005/06 
target was to achieve a 65% completion rate, based on 5,850 entrants) (NOMS Drug 
Strategy Unit 2006 – internal communication). 
 
In 2005/06 the target for HM Prison Service was to deliver 5,250 programmes, 
representing a 41 per cent increase over the target for the previous year.  This was 
more than met, 7,280 drug treatment programmes were completed in 2005/06, a 58 
per cent improvement in performance compared to 2004/05 (NOMS Drug Strategy 
Unit 2006 – internal communication). 
 
The target for CARATs was to ensure that 61,400 offenders received a substance 
misuse triage assessment (SMTA).  This target was exceeded, with 74,588 
assessments conducted (this includes juvenile substance misuse service 
assessment) (NOMS Drug Strategy Unit 2006 – internal communication). 
Integrated Drug Treatment System  
An Integrated Drug Treatment System (IDTS) programme for prisons in England is 
being developed involving clinical, CARAT and treatment programme resources.  
IDTS aims to increase the volume and quality of treatment available to prisoners, 
with particular emphasis on early custody (the first 28 days in custody), and will start 
to address better integration between clinical and CARAT services and reinforce 
continuity of care between prisons and on release into the community.  Key elements 
are: 
• treatment based on Models of Care (NTA, DH and Home Office 2006) and the 
treatment effectiveness strategy (NTA 2005b);  
• ensuring that following triage and comprehensive assessment, a range of fully co-
ordinated and structured services is available; 
• improved clinical management with greater use of maintenance prescriptions; 
• an increase in the number of treatment/stabilisation programmes in 2007/08 in 
prisons identified as part of the first wave where the programme will be 
introduced;  
• intensive CARATs support during the first 28 days of intense clinical management 
for all patients;  
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• greater integration of drug treatment generally, but a particular emphasis on 
clinical and CARATs services, with the objective of creating multi-disciplinary 
teams;  
• better targeting of interventions to match individual need; and 
• strengthening links with community services including Primary Care Trusts 
(PCTS), CJITs and drug treatment providers.  
 
To support these developments two documents have been produced:  
• Clinical Management of Drug Dependence in the Adult Prison Setting describes 
how clinical services for the management of substance misusers in prison should 
develop during the next two years as increasing resources permit.  The aim is to 
address the current challenges facing the care and treatment of substance 
misusers in prisons.  This guidance is an addendum to Prison Service Order 
3550140; and  
• Integrated Drug Treatment System the first 28 Days: Psychosocial Support. First 
wave model describes how psychosocial (CARAT) services will be delivered 
during the first 28 days of custody under the Integrated Drug Treatment 
System.141 
 
In the first instance IDTS will only be introduced in full to 17 prisons; a further 28 
prisons are being funded to provided enhanced clinical treatment (NOMS Drug 
Strategy Unit; HM Prison Service and DH 2006).  
Social reintegration 
Throughcare/community links 
Throughcare initiatives142 are a part of DIP (See 9.3.2), delivered through CJITs in 
the community, and CARAT teams in prison.  Guidance for CARAT teams and prison 
staff has been developed between the Home Office and the NOMS Drug Strategy 
Unit.  This guidance provides an overview of the programme and the contribution 
prison and probation services make to interventions (Home Office 2006i).   
 
An evaluation of the Scottish Prison Service Transitional Care Initiative was 
published in 2006 (Macrae et al. 2006).143  This scheme, introduced in 2001, aimed 
to effectively manage the transition between prison and the community.  Transitional 
Care was to support short-term prisoners (that is, those serving less than four years) 
and remand prisoners with an identified substance misuse problem.  The main aim of 
Transitional Care was to facilitate access to pre-existing community services based 
on an individual’s assessed needs.  This was done through the provision of support 
during a 12-week period immediately following a prisoner’s return to the community.  
                                                 
140 See: 
http://www.dh.gov.uk/PublicationsAndStatistics/LettersAndCirculars/DearColleagueLetters/De
arColleagueLettersArticle/fs/en?CONTENT_ID=4137552&chk=iT2JD5   
141 See: 
http://kc.nimhe.org.uk/upload/IDTS%2028-ay%20psychosocial%20FINAL%20April%2006.pdf  
142 “Throughcare” is the term used to describe arrangements for managing the continuity of 
care provided to a drug misuse from the point of arrest through to sentence and beyond. 
143 A combination of quantitative and qualitative research methods was employed in this 
study. This included the analysis of Transitional Care monitoring data; surveys of prisoners 
four and seven months following release; in-depth interviews with ex-prisoners in three areas 
of the country with different demographic characteristics and varying arrangements for the 
delivery of Transitional Care; and interviews with prison and community based staff 
associated with Transitional Care. Interviews with prisoners included both those who had 
attended Transitional Care on release from prison and those who had not. 
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The evaluation suggested that the scheme was reasonably effective at linking clients 
with services.  However, the extent to which it linked them with services they would 
not in any case have accessed by some other means was unclear and there were no 
apparent differences in short-term outcomes among those who attended Transitional 
Care and those who did not.   
 
The Throughcare Addiction Service (TAS) in Scottish prisons was implemented in 
August 2005, replacing the Transitional Care Initiative (see evaluation of this initiative 
below) (Scottish Executive 2006d).  The new service aims to prevent reoffending 
through improving continuity of care for prisoners, and also to reduce drug related 
deaths among newly-released prisoners.  Local authority Criminal Justice Social 
Work groupings will replace the Scottish Prison Service (SPS) as the lead agency in 
the delivery of the scheme, working with ADATs, SPS, community services and other 
partners including the voluntary sector.  TAS works with the offender in the six week 
period prior to release from custody and through the six week period post release.  
 
It is reported by the Scottish Prison Service that in 2004/05: 
• of the 23,206 prison receptions, 14,282 (62%) were referred to Throughcare 
Addictions Services.  
• of these, 65 per cent were offered an assessment, with 6,869 (48%) undertaking 
an assessment.  
• of the 4,686 individuals referred to the Transitional Care Initiative (the 
predecessor of Throughcare Addiction Services) at time of discharge, 1,098 
(22%) attended a first Transitional Care appointment (ISD 2005).  
9.3.2 The Drug Interventions Programme: England and Wales 
In April 2006 approximately 2,800 offenders were engaged in treatment through DIP, 
this was the highest monthly total since DIP began (Home Office – internal 
communication). 
Tough Choices Project: drug testing on arrest, Required Assessment and 
Restrictions on Bail 
The Tough Choices Project, initiated in December 2005 as part of DIP, describes the 
expansion of the programme to include three new elements; Testing on Arrest, 
Required Assessment and Restriction on Bail (DSD 2005a).  Operational guidance 
for intensive and non-intensive areas is available (Home Office 2005f).  Training 
courses have been organised for police officers, drugs workers and other staff.  
Drug testing  
Drug testing of offenders charged with a range of specific “trigger” offences was 
introduced in three phases from April 2003 onwards.  It is now operational in 108 
police Basic Command Units with high levels of acquisitive crime. 
 
Testing on Arrest, a provision of the Drugs Act 2005 that is an alternative to drug 
testing after charge, has this year been phased in across all DIP intensive areas in 
England.  This provides an opportunity to screen up to three times as many people at 
some stage of their detention. 
 
From April 2005 to April 2006 104,000 tests were completed.  In April 2006, 17,420 
tests were completed, an increase of 203 per cent on April 2005 (5,622).  
 
A total of 175 police custody suites now conduct drug testing on arrest and on 
charge.  Testing on charge will continue where it currently exists, in nine custody 
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suites across seven police forces in England and Wales (Home Office internal 
communication). 
Required Assessment 
Those testing positive for drugs will be required to attend an initial assessment of 
their needs (treatment and support); failure to comply without good cause is an 
offence in its own right.  Required Assessment has been implemented in all the DIP 
intensive areas in England since March 2006.  The required follow-up assessment 
provisions of the Drugs Act 2005 have not been introduced at this time, although 
follow-up appointments and activities, and agreement of care plans will continue with 
those clients wishing voluntarily to access treatment and support.  The Home Office 
review of the criminal justice system Rebalancing the Criminal Justice System in 
favour of the Law-Abiding Majority announced that the required follow-up 
assessment would be introduced.  Over 80 per cent of those testing positive for 
drugs are attending assessments (Home Office 2006 – internal communication). 
Restriction on bail  
The Restriction on Bail (RoB) provision restricts access to court bail for individuals 
who have tested positive for a specified Class A drug either on arrest or after charge.  
By March 2006 restriction on bail was introduced in all local justice areas across 
England.  This means that any adult who appears before a court in England, after 
testing positive in police detention for a specified Class A drug in connection with the 
offence for which they are charged, could be eligible.  By the end of April 2006, there 
have been almost 10,000 episodes of RoB since it was introduced (Home Office 
internal communication). 
 
Operational guidance for intensive144 and non-intensive areas is available.  Training 
courses have been organised for police officers and staff and drugs workers.  A 
guide to prosecutors was made available by the Crown Prosecution Service (CPS) in 
March 2006 (Crown Prosecution Service 2006). 
Drug Treatment and Testing Orders (DTTOs) and Drug Rehabilitation Requirements 
(DRRs) 
A new Drug Rehabilitation Requirement (DRR), a community order that replaces the 
Drug Treatment and Testing Order (DTTO), and other community orders, for adults, 
has been introduced.  The new order, with individual requirements selected by the 
court, can be more closely tailored to the seriousness of the offence and offence-
related needs of the individual as it will consist of a “menu” of requirements including 
the DRR for different types and levels of drug treatment.  The community order 
applies to offences committed on or after 4th April 2005.  The DTTO will continue for 
16 and 17 year olds (until April 2007) and for adults in respect of offences committed 
before 4th April 2005 (Home Office – internal communication). 
 
From April 2005 to March 2006, 14,001 DTTOs and DRRs have commenced and 
3,987 successfully completed.  Between October 2000 and April 2006, 46,144 were 
commenced.  In April 2006 there were 1,056 commencements, and 346 completions 
(Home Office – internal communication). 
Probation report on treatment  
A report from Her Majesty’s Inspectorate of Probation (2006) found that the 
expansion of treatment availability had led to all areas of probation to be able to 
deliver treatment promptly; 14,000 beginning treatment as part of DTTOs/DRR in 
                                                 
144 See: http://www.drugs.gov.uk/drug-interventions-programme/guidance/tough-choices  
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2005/06.  However, guidance on DRRs, particularly concerning the introduction of 
the Criminal Justice Act 2003 and the offender management model, was complex 
and needed to be simplified.  Also, in many probation areas a full range of treatment 
provision was lacking and was largely determined by pre-existing provision.  It was 
noted that the provision of treatment for alcohol use remained problematic.   
Conditional Cautioning 
Conditional Cautioning, introduced in 2005 in selected early implementation areas, 
and described in the previous United Kingdom Report, is becoming available 
nationally.  This is being managed by a central Home Office Project Team and will be 
delivered locally through the relevant Local Criminal Justice Boards (LCJBs).  The 
current aim is that all police forces will have at least one police BCU operating 
Conditional Cautioning by mid-2007.  This disposal145, introduced by the Criminal 
Justice Act 2003, allows, for the first time, for a condition that is conducive to 
restoration or rehabilitation to be attached to a police caution.  Where the condition is 
not met, the offender may be charged with the original offence.  This type of 
cautioning, including its use in engaging drug-misusing offenders in treatment 
through a drug rehabilitative condition, has been operated in a small number of early 
implementation areas from early 2005 (Home Office 2006j).  
However, it is reported that take up of the scheme has so far been low.  DIP is 
working with the Home Office project team and other partners to increase the 
throughput and consequential benefits of the drug rehabilitative condition.  Guidance 
on the drug rehabilitation condition has been updated and the condition made more 
measurable.  An Early Implementation Evaluation report is due to be published in late 
2006. 
Prolific and Priority Offenders  
DIP has established strong links to the national Prolific and other Priority Offender 
(PPO) programme (launched in September 2004).  Through Crime and Disorder 
Reduction Partnerships (CDRPs), the PPO programme has established schemes to 
cover each CDRP geographical area.  Using a matrix tailored to suit local priorities, 
local PPO schemes identify, target, monitor and rehabilitate those offenders who 
cause most harm to themselves and the local community.  Each scheme deals with a 
minimum of 15 offenders (Home Office 2006k).  
 
In many high crime areas, initial scoping indicates that as many as 85 per cent of 
offenders targeted under PPO schemes have drug treatment needs.  It is therefore 
seen as imperative that PPO schemes, CJITs (see section on these teams below), 
drug treatment providers and criminal justice agencies work together to manage and 
support these individuals.  It is considered that effective information sharing between 
agencies is key to successful partnerships.  The Home Office is working with the 
Department of Health to develop a common message on this issue, so that 
necessary data are appropriately exchanged between PPO schemes and health 
workers.  Schemes are funded using existing core resources but DIP has funded 12 
D(A)AT partnerships to act as pilot sites (see below).   
 
DIP therefore works with the Home Office Prolific and Other Priority Offenders 
Programme to ensure the two initiatives operate to maximise the benefit of both.  To 
facilitate collaborative working, guidance has been published to address issues 
around information sharing, case management and treatment provision.  DIP is also 
funding pilots in 12 D(A)AT areas to identify good practice in building healthy 
                                                 
145 How a perpetrator of a crime is dealt with.  
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partnership between CJITs and PPO schemes.  Further guidance and learning from 
good practice will be published on an ongoing basis.146  
Evaluation of the Prolific and Other Priority Offenders programme 
An evaluation of the PPO programme147 found that amongst the 7,801 offenders on 
the scheme during its first six months 61 per cent misused drugs; this compared with 
26 per cent amongst non-prolific offenders identified through the Offender 
Assessment Scheme (Dawson 2005).  In the first six months of the scheme there 
was a 10 per cent reduction in recorded convictions for the first PPO cohort 
compared to the six months prior to the start.  However, this evaluation was unable to 
disentangle the effects of the PPO programme from other factors (such as changes 
in the overall levels of crime and offenders brought to justice).  Follow-up work is 
currently being undertaken. 
Drug Interventions Record (DIR) 
A Drug Interventions Record (DIR), used to gather data about DIP processes, has 
replaced the Integrated Team Monitoring Data Form (ITMDF) in intensive areas and 
the Arrest Referral Monitoring Form in others.  During the initial assessment of clients 
who come into contact with DIP, information about their needs is gathered using this 
form (DSD 2005c).  The DIR is used by both community agencies and prisons to 
improve information sharing, avoid duplication and thereby improve continuity of care 
of drug-misusing offenders. 
 
This is considered to be a major improvement over the previous form as it includes 
additional fields, has removed redundant fields and has improved the wording.  It is 
therefore better able to support continuity of care and improves the consistency and 
quality of data collected for monitoring and research purposes.  It gathers 
comprehensive and accurate information from all areas, particularly by formalising 
and standardising arrangements in non-intensive areas. 
 
Comprehensive guidance supports the use of the form and training was delivered at 
the time of its introduction in 2005, and again in 2006.  Over 1,500 workers and 
partners have been trained in its use between January and March 2006. 
Criminal Justice Integrated Teams  
Criminal Justice Integrated Teams are now operating in every area in England and 
Wales comprising both community and prison treatment providers.  Overall the 
numbers receiving a full CJIT assessment has increased by over 200 per cent 
between March 2004 and March 2006.   
 
To enhance support by CJITs, responsible for the implementation of DIP, 24-hour 
single point of contact phone numbers are now available for clients.148 
Throughcare and Aftercare149 
Aftercare is seen as an important part of DIP.  The Home Office states that: 
                                                 
146 See: http://www.drugs.gov.uk/drug-interventions-programme/strategy/police-custody/  
147 It is estimated that 10 per cent of all active offenders are responsible for half of all crime. 
148 See: http://www.drugs.gov.uk/drug-interventions-programme/strategy/throughcare-
aftercare/  
149 ‘Aftercare’ is the term used to describe what happens after drug using offenders are 
released from custody, complete community sentences and/or leave treatment. It is accepted 
that drug treatment plays only one part in supporting rehabilitation and re-integration. 
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“There is not one simple discrete process and aftercare can involve several 
important factors, such as housing, support with benefits, managing finances, 
employment, education and training opportunities, access to mental health 
services, rebuilding family relationships and so on.  CJIT workers will provide, or 
broker the provision of, appropriate wrap-around services in relation to each of 
these factors supported by the local Drug Action Team.  This work will also be 
informed by, as well as influence, delivery of the Regional Reducing Re-offending 
Action Plan.  At a regional level Regional Offender Managers are working with 
Regional NTA and Government Office Drug Teams” (Home Office 2006k). 
Peer Led Support 
The Home Office suggests that there is limited information on how peer-led support 
is best delivered to meet the diverse needs of those who have left prison or 
completed treatment and need help with the transition back to the community.  With 
local partnerships expected to develop an appropriate continuum of care and levels 
of support for drug users throughout their treatment journey and beyond, and help 
support meeting their diverse needs, the Home Office has commissioned a practice 
guide to provide a resource for local partnerships that draws on practical approaches 
of peer-led support in England from the substance misuse sector as well as other 
associated sectors such as mental health and HIV services (Home Office 2006l). 
Race Equality and Diversity in DIP 
DIP is taking forward a number of pieces of work to ensure that race equality and 
diversity issues are addressed across all areas of activity.  Specific activities include: 
• working with the University of Central Lancashire, which ran ten community 
engagement projects in high crime DAT areas with the aims of improving 
engagement with services, building a more representative workforce, raising 
awareness of partners’ responsibilities and learning what works so the community 
engagement lessons may be shared nationally; 
• providing guidance to D(A)ATs on operating standards and management of 
contracts so they include diversity issues and supporting this through the work of 
the DIP Performance Interventions Team; 
• setting up a multi-agency scrutiny panel to drive and challenge DIP’s approach to 
race and diversity and, especially, to define the way forward for the DIP Race 
Equality and Diversity Strategy; and  
• aiding adoption and implementation of the DIP Race Equality and Diversity action 
plan and strategy.  The action plan has been written to ensure DIP meets its 
statutory duty in regards to race equality and diversity and to help drive up overall 
performance on the ground, and to identify and assist areas that are performing 
less well. 
Funding  
Government has invested about €244 million (£167m) in the Drug Interventions 
Programme in the financial year 2005/06.150  This is on top of the additional funding 
for treatment through the Pooled Treatment Budget and funding for additional 
measures, such as the increased target for commencing community orders linked to 
treatment.  This funding is used to meet the costs of all aspects of the programme – 
with by far the majority spent on workforce. 
                                                 
150 See: http://www.drugs.gov.uk/drug-interventions-programme/guidance/Programme-
delivery-and-funding  
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Interventions for young people 
DIP has piloted a range of interventions in ten areas to engage young people early in 
their substance misuse and offending and to facilitate appropriate support and 
treatment services.  These interventions include: 
• drug testing for specified Class A drugs in 22 custody suites of 14 to 17 year olds 
who are charged with those crimes most often linked to drugs.  The purpose is to 
identify those young people who may be at risk of developing a problem with 
drugs and offending, in order to intervene early; and 
• working with the Youth Justice Board on Drug Treatment and Testing Sentence 
Requirements to target young people who have, or are at risk of developing, 
substance misuse problems and who may benefit from structured care planned 
treatment as part of a community sentence. 
Race and diversity in the criminal justice system 
A Home Office document published in July 2006, Rebalancing the Criminal Justice 
System in Favour of the Law-Abiding Majority: Race Equality Impact Assessment 
Report examines the functions of the criminal justice system and suggests that 
individuals from certain ethnic groups are disproportionately more likely to be 
arrested.  It sets out what can be done to redress any potential imbalance within the 
criminal justice system (Home Office 2006m).  A joint Race Equality Impact 
Assessment (REIA) is proposed for the Prolific and Other Priority Offenders 
programme and DIP (see above).  REIAs systematically assess the effects that a 
policy has, or is likely to have, on people, depending on their racial group.151 
9.3.3 Other interventions relating to drug users in the criminal justice system in 
England and Wales 
Drug courts 
Two dedicated drug courts will pilot a new framework for dealing with offenders who 
carry out crimes often committed to feed a drug habit.  When an offender is found 
guilty and is referred to the dedicated drug court (DDC) for sentence, the same 
magistrates or district judge will sentence the offender and provide continuity and 
stability in reviews of offenders on drug treatment orders.152   The pilot will run until 
late 2006 and is being independently evaluated. 
9.3.4 Criminal justice interventions for drug users in Northern Ireland 
DTTOs are being initiated in Northern Ireland adopting the model currently used in 
Scotland (Probation Board Northern Ireland 2005). 
9.3.5 Criminal justice interventions for drug users in Scotland 
Arrest referral 
Following an evaluation of arrest referral pilots (Birch et al. 2006) funding is being 
provided to run existing piloted schemes up until 2008 and to set up a new scheme in 
Aberdeen.  Annual funding of €2 (£1.4) million will allow the scheme to be introduced 
across Glasgow, where it currently operates out of only one police station.  Additional 
national funding totalling €878,000 (£600,000) is also being made available to 
increase the provision of treatment places needed to support arrest referral work.  
Between February 2004 and December 2005 a total of 2,791 people consented to 
referral into appropriate services.  The evaluation found that 84 per cent of arrestees 
                                                 
151 For more information see: http://www.cre.gov.uk/duty/reia/what.html#creres  
152 For more information see: http://www.cjsonline.gov.uk/the_cjs/whats_new/news-3275.html   
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accessing the arrest referral schemes said they would recommend it (Scottish 
Executive 2006e). 
Drug Courts 
Drug courts in Glasgow and Fife will run for a further three years.  This follows 
evidence that half of offenders had not committed crime within one year of being 
dealt with while 29 per cent had not re-offended within two years (McIvor et al. 
2006).153 
9.3.6  Research into the prevention of drug related crime 
The link between drug and crime 
Early findings of two major research programmes on how and why young people 
become criminals, and what can be done to change their lives are to be published. 
Pathways into and out of Crime: Risk, Resilience and Diversity, is being undertaken 
by a network of six universities exploring aspects of young people's lives linked to 
crime and anti-social behaviour.  The research was due to be concluded in April 
2006.  It involved two years of intense work with more than 1,000 10 to18 year olds.  
A separate programme, the SCoPiC Network (Social Contexts of Pathways into 
Crime) is a major five-year investigation into what kind of people in which sort of 
circumstances turn to crime.  Researchers are following a sample of 707 boys and 
girls who were 12 years old in March 2003, right through until they reach the peak 
age for criminal activity at 14 to 15.  The aim is to examine how far crime can be 
explained, on the one hand by adolescents' morality and ability to exercise self-
control, and on the other by the social and moral environments in which they develop 
and operate. 
The findings, at the time of writing only available as a summary online, call into 
question some commonly held views about why young people become involved in 
crime and show that situations often thought of as leading to problem behaviour can 
actually be the opposite.  For instance, a parent being in prison may provide a respite 
from what may have been a chaotic home life. Similarly, they question the 
inevitability of the link between drug use and crime, showing the complexity of this 
relationship and how offending can stop even though some kinds of drug use may 
continue (ESRC 2005). 
Systematic review of the effectiveness of criminal justice and treatment programmes 
The Home Office commissionioned a systematic review of the literature to examine 
the links between drug use and offending, and the literature covering the 
effectiveness of interventions to break these links.  The results of the studies 
reviewed were generally positive with 44 out of 52 studies reviewed showing a 
reduction in crime on at least one measure.  A meta-analysis of 28 studies for which 
raw data were available found that the odds of a reduction in criminal behaviour were 
41 per cent higher among the experimental groups (those that had undertaken a 
treatment intervention) than in the comparison groups (the non-treatment group or 
comparison intervention).  The review also found that methadone treatment, heroin 
treatment, therapeutic communities, and psycho-social approaches are effective in 
reducing drug-related crime, as are the use of drugs courts, probation and parole 
                                                 
153 A variety of qualitative and quantitative research methods were employed. They included: 
interviews with professionals associated with the Drug Courts and with Drug Court clients; 
collection of information from Drug Court records; observation of the Drug Courts in action; 
and the completion of individual client questionnaires by members of the supervision and 
treatment team 
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supervision.  High intensity programmes were 50 per cent more likely to bring about 
a reduction in criminal behaviour than low intensity programmes, meaning that 
intensive programmes are more likely than non-intensive programmes to reduce 
crime (Holloway et al. 2005). 
Research by Beynon et al. (2006) has identified less positive outcomes for drug 
users entering treatment through the criminal justice system.154  This research found 
that increasing numbers in treatment is associated with an increased proportion 
dropping out and an ever smaller proportion of those leaving treatment drug free.  In 
addition, it was found that rates of drop out were significantly higher for those who 
entered treatment via the criminal justice system.  
Quasi-compulsory treatment of drug-dependent offenders 
As part of a European study, McSweeney et al. (2006) reported findings from a study 
of drug users who entered treatment through the criminal justice system, and might 
therefore be regarded as coerced into it.155  Those recruited to the study were all 
asked standardised and validated questions about their health, education, substance 
use, offending, victimisation, any pressure they felt to be in treatment and their 
motivation to change their drug-using behaviour.  It was reported that there were 
sustained reductions in self-reported illicit drug use and offending behaviours over an 
18-month follow-up period for both groups, with: 
• substantial reductions in reported expenditure on illicit drugs; 
• modest improvements in mental health; 
• reductions in reported risk behaviours (e.g. sharing injecting equipment); 
• improvements in housing and personal relationships; but 
• no change in (very high) rates of unemployment. 
 
Importantly, it was reported that there were no differences between those considered 
to be coerced into drug treatment and the comparison group of ‘volunteers’ in 
retention rates and other outcomes.  
9.3.7 Interventions related to offences under the Drugs Misuse Act 1971 
Presumption of intent to supply 
Under the provisions of the Drugs Act 2005 a number of laws have been 
implemented.  Drug dealers who target schools or get children to act as couriers will 
face stiffer jail terms.  Police have also been given powers to request x-rays from 
suspects they believe may have swallowed drugs to avoid detection.  Also, 
suspected drug "mules" can be held for 192 hours, as opposed to the previous 96 
hours, to allow extra time for drugs to pass through their systems (see Chapter 1.2.2) 
(Home Office 2005c). 
Prostitution 
It should be noted that prostitution is not an offence per se in the United Kingdom.  A 
strategy for prostitution in England and Wales has been published (Home Office 
2006n).  The strategy seeks to disrupt street prostitution and all forms of commercial 
sexual exploitation, and provides a framework for local authorities to enable them to 
                                                 
154 A longitudinal dataset of drug users (1997 to 2004/05, n = 26,415) was used to identify 
people who dropped out of, and were Discharger Drug Free from, services for years 1998 to 
2001/02, and representations of these people in years to 2004/05. 
155 A random sample of 157 people who entered community-based drug treatment at one of 
ten sites between June 2003 and January 2004.  Just over half of the eligible clients offered 
treatment across the ten sites were interviewed  Eighty-nine (57%) had entered treatment as 
part of a DTTO. 
UNITED KINGDOM FOCAL POINT REPORT 2006 
 
 122
disrupt sex markets and suggests that a “coherent and coordinated strategy has a 
good chance of significantly improving lives of many of those at risk of or involved in 
prostitution, and reducing the impact of those affected by the existence of a sex 
market in their neighbourhood.” (p.12). 
 
The strategy includes: 
• prevention – awareness raising, prevention and early intervention measures to 
stop individuals, particularly children and young people, from becoming involved 
in prostitution; 
• tackling demand – responding to community concerns by deterring those who 
create demand and reducing the opportunity for street prostitution by linking 
enforcement with support; 
• developing routes out – proactively engaging with those involved in prostitution to 
provide a range of support and advocacy services to help individuals leave 
prostitution; 
• ensuring justice – bringing to justice those who exploit individuals through 
prostitution, and those who commit violent and sexual offences against those 
involved in prostitution; and  
• tackling off-street prostitution – targeting commercial sexual exploitation, in 
particular, where victims are young or have been trafficked. 
 
The strategy suggests that every area in which street prostitution is an issue should 
have a dedicated support service to ensure access to a range of services, including 
healthcare, drug treatment where required and appropriate supported housing.  
Where individuals are unable or unwilling to accept help voluntarily offered, arrest 
referral and court diversion schemes will also provide a route into support 
programmes. 
 
Additionally, the Government proposes to introduce a new order, as an alternative 
penalty for the offence of loitering or soliciting for the purposes of prostitution, which 
will consist of a series of assessment sessions to address the underlying causes of a 
person’s involvement in prostitution. 
9.4 Responses to other social correlates and consequences  
9.4.1 Drug related litter 
The Department for the Environment, Food and Rural Affairs has published guidance 
on dealing with the issue of drug related litter (DEFRA 2005). 
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10. Drug markets 
10.1 Overview 
The United Kingdom Threat Assessment of Serious Organised Crime 2006/07 report 
suggests that, “The United Kingdom is one of the most lucrative markets in the world 
for traffickers in Class A drugs (heroin, cocaine powder, crack cocaine, ecstasy)”.  
The overall picture is one of ready availability throughout the United Kingdom (SOCA 
2006).  
 
Heroin: Most identified supply chains to the United Kingdom follow well-established 
trafficking routes.  The primary trafficking route is overland from Afghanistan to 
Europe, transiting from Iran to Turkey, where the majority of opiates are processed 
before being moved to the Balkans, and then overland to Europe.  In addition, a large 
amount of Afghan heroin arrives directly by air routes from Pakistan, via couriers and 
parcels. 
 
Cocaine: The Iberian Peninsula, predominantly Spain and the Netherlands, continue 
to be the main entry points into Europe for shipments of cocaine from the South 
Americas (primarily Colombia and Venezuela).  Shipment routes transiting the 
Caribbean and West Africa are also common with organised crime groups.  Cocaine 
mainly enters the United Kingdom via ports in the South East of England.  
 
Ecstasy: Almost all of the ecstasy consumed in the United Kingdom is manufactured 
in the Netherlands or Belgium, and commonly enters by sea through Harwich, 
Felixstowe and Dover.  A greater number of sites making up tablets have been found 
than laboratories, mostly in the North of England.   
 
Cannabis: Cannabis is imported into the United Kingdom from Europe in bulk by 
serious organised criminals, sometimes in mixed loads alongside Class A drugs, and 
in smaller amounts for sale and for personal use.  In addition, there are indications 
that intensive hydroponic cultivation of cannabis is occurring in the United Kingdom. 
 
The overall picture of United Kingdom drugs distribution appears increasingly 
complex and diverse.  However London, Birmingham and Liverpool continue to be 
important centres for the distribution of all types of drugs to all areas of the United 
Kingdom.  Dual supply of heroin and crack cocaine are now well established in most 
parts of the United Kingdom and not solely at street level.  
 
In general the quantity of seizures has been rising in the United Kingdom; cannabis 
being the most seized drug.  However, SOCA reports that arrests and seizures 
mainly in Class A drugs have achieved short-term disruptions rather than a sustained 
reduction in the size of the United Kingdom drugs market.  
10.2 Availability and supply  
10.2.1 Availability in the adult population 
The Drug Misuse in Scotland: Findings from 2004 Scottish Crime and Victimisation 
Survey (Hope 2006), indicates that overall 12 per cent of respondents had been 
offered drugs in the last year.  The proportion of respondents who had been offered 
drugs in the last year decreased with age; 28 per cent of respondents aged between 
16 and 29 had been offered drugs as opposed to 5 per cent of those aged 30 or over.  
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10.2.2 Availability amongst school children 
The school survey for England asked pupils about whether they had been offered 
drugs (NatCen/NFER 2006)156.  Results show that: 
• in 2005, 39 per cent of pupils had ever been offered drugs, an increase from 36 
per cent in 2004; 
• boys were more likely to have been offered drugs than girls, 41 per cent 
compared with 38 per cent; 
• pupils were most likely to have been offered cannabis; 25 per cent saying they 
had ever been offered it; 
• 18 per cent of pupils had been offered volatile substances, 12 per cent had been 
offered poppers and 11 per cent had been offered magic mushrooms; and 
• as with use of drugs, likelihood of having ever been offered drugs increased 
sharply with age, from 18 per cent among 11 year olds to 63 per cent among 15 
year olds. 
10.2.3 Production, sources of supply and trafficking patterns within the country and 
from and towards other countries 
SOCA (2006) suggests that United Kingdom based White British criminals involved in 
supply, particularly of heroin, are increasingly bypassing London-based ethnic 
Turkish traffickers who have been their traditional suppliers and are importing directly 
from Europe, mostly the Netherlands, but also Belgium and France. 
10.3 Seizures 
Data on seizures for the United Kingdom as a whole were not available at the time of 
writing.  In England and Wales the number of seizures in 2004 was reported to be 
down by two per cent.  Cannabis continues to be the most seized drug.  Seizures of 
heroin and cocaine rose (Mwenda and Kaiza 2006). 
10.4 Price/purity 
10.4.1 Price of drugs at street level 
In 2005, the average street price of heroin, ecstasy and cocaine was lower than 
2004, while the price of cannabis, crack cocaine and LSD has remained stable.  
Having fallen in recent years the price of amphetamines increased by more than ten 
per cent in 2005 (Table 10.1).  
                                                 
156 For information on the methodology see Chapter 2.4. 
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Table 10.1: The mean price of illegal drugs in Pounds and Euros in the United Kingdom, 2003 
to 2005. 
  
2003 2004 2005 Drug  
(price per gram) Exchange rate: 
€1.4246* = £1 
Exchange rate: 
€ 1.4401* = £1 
Exchange rate: 
€ 1.4725* = £1 
£9.00 £8.00 £10.00 Amphetamines €12.82 €11.52 €14.73 
£2.54 £2.54 £2.64 Cannabis herb €3.62 €3.66 €3.89 
£2.32 £2.00 £1.94 Cannabis resin €3.31 €2.88 €2.86 
£55.00 £51.00 £49.00 Cocaine €78.35 €73.45 €72.15 
£19.00 £18.00 £19.00 Crack (per 0.2g) €27.07 €25.92 €27.98 
£5.00 £4.00 £4.00 Ecstasy** 
€7.12 €5.76 €5.89 
£62.00 £55.00 £54.00 Heroin €88.33 €79.21 €79.52 
£3.00 £3.00 £3.00 LSD €4.27 €4.32 €4.42 
*Conversion rates are the monthly rates quoted by the Bank of England (December monthly 
averages – spot exchange rate) Euro to Sterling.  The source data in pounds (£) are provided 
in whole pounds. 
** Average price per tablet 
Source: Law Enforcement Agencies 
10.4.2 Purity of drugs at street level and composition of drugs/tablets 
Information on the purity of drugs and composition of tablets is from the Forensic 
Science Service Ltd, covering most of England and Wales.  Latest data are for 2005 
and are shown in Table 10.2.  Potency of cannabis resin rose slightly in 2005, having 
fallen in the previous year, and potency of herbal cannabis continues to rise, though 
only slightly.  The purity of heroin continues to increase, though not by much and 
there has been no clear long-term trend since at least 1984.  Purities rise and fall 
almost randomly over short (months) and longer periods (1 to 2 years) with the long-
term mean around 40 to 45 per cent for heroin (L. King - personal communication).  
There was no data available for white heroin in 2003 and 2005.  Whilst there were 
drops in the level of purity for cocaine, crack and amphetamines in 2004, there are 
signs of small increases for 2005.  Ecstasy decreased slightly in 2004 after a rise in 
the previous year; data for ecstasy refer to actual drug content.  There was no data 
available for white heroin in 2003 and 2005 (Table 10.2).  It is of note that while the 
average purity of cocaine seized by the police has also fallen in this time, the purity of 
cocaine seized by HM Revenue and Customs, including seizures at ports, has 
remained more stable, suggesting increased adulteration of the drug within the 
United Kingdom (Mwenda and Kaiza 2006).  
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Table 10.2: Street level mean percentage of purity of drug in the United Kingdom, 2003 to 
2005 
 
Drug*  Year 
 2003 2004 2005 
Cannabis resin 9.8 3.4 5.3 
Herbal Cannabis 10.7 12.7 13.5 
Heroin (brown) 32.7 39.9 46.5 
Heroin (white) - 50.0 - 
Cocaine  51.2 42.4 42.7 
Crack 69.6 63.7 64.8 
Amphetamines 10.8 9.0 10.1 
Ecstasy 64.5 66.7 66.3 
*For cannabis products the % THC content is shown; for ecstasy mg of MDMA base per 
tablet/unit is shown; and for other illicit drugs the % of pure substance is shown. 
Source: Forensic Science Service Ltd 2006 
 
It should be noted that the small increases in purity of amphetamine, cocaine and 
crack in 2005 are of doubtful statistical significance; the same applies to ecstasy (L. 
King - personal communication). 
 
The Central Drugs Trafficking Database (CDTD) is being developed by the 
Metropolitan Police Service to provide intelligence regarding drug trafficking in 
London.  Detailed information is recorded regarding drug seizures, what police tactics 
were used, locations, details of those suspected and the outcome of the case. 
Various analysis techniques are being developed, including the use of artificial neural 
networks.  Dr Les King is involved in this work and uses drug seizure data from the 
CDTD to analyse drug price and purity trends (Metropolitan Police – personal 
communication).  
10.5 Interventions to disrupt drug markets 
Powers to seize smaller cash sums  
The threshold for seizing suspect sums of money under the Proceeds of Crime Act 
2002 was lowered from €7,320 to €1,460 (£5,000 to £1,000).  The lower threshold 
aims to give the police the opportunity to tackle those at the lower end of organised 
criminal networks, often operating within local neighbourhoods. It adds to a package 
of measures the Government has introduced to disrupt organised criminals at every 
level.157 
10.6 New research on United Kingdom drug markets  
The size of the United Kingdom Drug Market  
New research into the size of the United Kingdom drug market is expected to be 
published in the Autumn of 2006.  
Engaging communities to tackle crack cocaine-related harm 
In a review of the literature by Webster and Hough (2006), the objectives were to 
review national and international literature on crack-related harms; provide an 
overview of community engagement strategies that have been implemented in 
England and Wales to reduce crack-related harm; review national and international 
                                                 
157 See: 
http://www.gnn.gov.uk/content/detail.asp?ReleaseID=217758&NewsAreaID=2&NavigatedFro
mSearch=True  
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evidence from evaluations of community engagement programmes tackling crack-
related harm; and discuss policy and research implications and provide 
recommendations.  The study found that: 
• there was no clear evidence base about effective practice; and 
• there was not one British impact evaluation examining community action against 
drugs. 
 
Nevertheless, using evidence predominantly from the United States, they suggest 
that community involvement is an essential element in reducing local drug markets 
and, in particular, the amount of collateral damage, in terms of crime, violence and 
nuisance, suffered by local people. 
Understanding drug selling in local communities 
Findings from a study examining drug dealing in four English communities highlight 
the ambiguities that exist in the relationships between local drug markets, drug 
sellers and their 'host' communities.  The authors questions the effectiveness of 
policies based exclusively on punishing those who sell drugs (May et al. 2005)158. 
The study found that: 
“The four drug markets were, to different degrees, linked with both the legal and 
illegal economies of the neighbourhoods in which they were situated. They had 
varying relationships with their communities – sometimes symbiotic, sometimes 
parasitic.” 
 
It is suggested that police and campaigners against the spread of illegal drugs, 
should beware of stereotypes of drug-dealing areas as unpopular, socially divided 
neighbourhoods.  Although drug dealers find ways to exploit run-down areas, this 
research shows that they can also thrive in neighbourhoods with a strong sense of 
community.  
Low level Heroin Markets  
In a study of low level drug markets a detailed picture of the buying and selling of 
heroin within three areas in Scotland is provided (Cyster and Rowe 2006).  The aim 
of the study was to: 
• provide a description of the extent, breadth and culture of heroin markets; 
• assess the impact of heroin dealing on the local communities; 
• assess the nature and impact of policing, and other interventions, on low level 
heroin dealing; and  
• generate research evidence that identifies lessons for improved practice in 
tackling the problems of low-level heroin markets in Scotland. 
 
It was found that markets in each area were remarkably similar.  The availability of 
heroin was considered high, users had multiple possible contacts to obtain heroin 
and therefore numerous choices as to where they took their custom.  This means 
that markets become more open, as user/dealers become more desperate to sell.  In 
addition, method and location of delivery were also seen to change, corresponding to 
the perceived or actual threat of police activity.  However, the visibility of heroin 
markets in public spaces appeared to be the exception rather than the rule.  It was 
acknowledged that some heroin users commit crime, but not all; some funding their 
habit through state benefits or working.  For those committing crime, shoplifting or 
                                                 
158 The study examined the relationship between street-level sellers and the local 
communities in which they sold drugs, in four areas of England. In all, 68 drug sellers, 124 
professionals and 800 local residents were interviewed. Data from these interviews were 
supplemented by published statistics. All fieldwork was carried out during 2003/04. 
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low-level dealing were the principal crimes.  Violent crime or crimes against the 
person were less frequent, but did occur.  It is suggested that police are able to 
contain the size of the market, but not reduce it, other than for short periods of time.  
The impact of the reclassification of cannabis 
Following on from previous research on the policing of cannabis (May et al. 2002) the 
Joseph Rowntree Foundation has commissioned further research following 
reclassification of cannabis from Class B to Class C.  The research is due to be 
completed in late 2006.  
Merseyside middle market drugs unit evaluation  
An evaluation of the Merseyside Middle Market Drugs Unit (MMDU) has been 
commissioned.159  
Street Level Up evaluation 
An evaluation of the impact of the Street Level Up approach to tackling drug supply 
and identifying best practice has been commissioned by the Home Office.  
Drug trafficker debrief  
Research is to be commissioned on looking at the best practice in gaining 
information from drug traffickers who have been arrested.  This is seen as a means 
to identify how traffickers and dealers operate and to provide information which will 
help to describe the relationship between the supply and demand for drugs and a 
better understanding of risks associated with trafficking and dealing.  
 
 
 
                                                 
159 See: http://www.matrixrcl.co.uk/casestudies/oldweb/cs20.htm  
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PART B: SELECTED ISSUES 
SUMMARY 
11. Drug use and related problems among very young people  
Consideration of the evidence of drug use amongst very young people suggests a 
very small minority experiment with drugs at a very early age, a few as young as 10 
or less.  Regular use is rarer still amongst the very young but becomes increasingly 
prevalent by the age of 15.  Amongst those who start using substances preteen, 
evidence suggests that early experimentation leads to longer term use.  In addition, 
there is strong evidence of progression from occasional use of one substance to both 
regular use of the same and other substances.  The greatest increase in prevalence 
occurs between the ages of 13 and 14 as it does in the use of alcohol and tobacco.  
 
Amongst the very young volatile substances are the ‘drug’ of first choice but cannabis 
becomes more prevalent amongst older children.  Amyl nitrate is the second most 
commonly used drug in England and joint third with ecstasy in Scotland amongst 15 
year olds.  
12. Cocaine and crack – situation and responses  
Lifetime prevalence of cocaine (including crack) is approximately 6.5 per cent, recent 
and current use is much lower at 2.3 and 1.0 per cent respectively.  Latest 
information is for England and Wales for 2005/06 and shows a significant increase 
both in lifetime and recent use amongst adults since 2004/05.  This increase was not 
observed amongst young people aged 16 to 24 for recent (last year) use.  Latest 
information amongst school children is for England for 2005.  Amongst this group, 
however, recent use has increased in the last year (2004 to 2005) from 1.4 to 1.9 per 
cent.  As with all drugs, males are more likely to use than women are. 
 
Prevalence of cocaine (powder) is highest in urban, inner city areas that are 
described as ‘rising’, amongst those who are single and cohabiting couples who are 
more likely to visit pubs and wine bars, live in private rented accommodation, and 
belong to semi-skilled, skilled and managerial and technical occupations.  The 
majority of cocaine users report beginning use in their early twenties.  
 
Crack use is considerably less prevalent, less than one per cent of adults reporting 
lifetime use and appears to be used by those in deprived inner city areas, suffering 
unemployment.  Amongst young people, the more vulnerable are more likely to use.  
 
Major issues are with criminal activity associated with crack use and public health 
issues associated with injecting; with crack users showing high levels of risk 
behaviour.  
 
Government effort has been to tackle the problem of crack, through information 
campaigns, supply reduction and improved treatment.  As for the latter, there remain 
problems in attracting users into treatment and providing them with effective 
treatment, though there has been an increase in treatment demand in recent years.  
13. Drugs and driving  
There is no explicit mention of driving under the influence of drugs in the national 
Drug Strategy or within other United Kingdom drug strategies.  However, it is an 
offence to be unfit to drive while impaired by drink or drugs.  Convicted offenders 
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face a minimum one year driving ban, a fine of up to €7,315 (£5,000) and six months 
imprisonment. 
 
However, in the Government’s strategy for improving road safety between 2000 and 
2010 specific focus is placed upon driving under the influence of drugs.  The current 
laws do not permit random or mandatory enforcement testing of drivers, and there is 
currently no indication that such schemes  (i.e. random testing) will be introduced.   
 
Most work on providing estimates of drivers who have recently used drugs has been 
undertaken in Scotland where nine per cent of respondents reported ever having 
driven under the influence of any illegal drugs, most commonly cannabis.  Drivers are 
most likely to be young males aged between 20 and 24; most believed cannabis use 
had little or no impact upon driving skills or performance.  However, in Scotland 
around 53 road fatalities were associated with drug use in 2004. 
 
Work is being undertaken to develop devices to detect drugs.  A Field Impairment 
Test led to a sensitivity of 65 per cent (proportion of true positives that were correctly 
identified by FIT).  A portable objective detection device proposed for screening of 
drug related impairments is being tested and work is being undertaken to investigate 
the feasibility of the development of a handheld impairment device which is expected 
to be able to detect all drugs, including illicit drugs, prescription and over-the-counter 
medicines. 
 
UNITED KINGDOM FOCAL POINT REPORT 2006 
 132
11. Drug use amongst very young people  
11.1 Drug use and problematic drug use amongst very young people  
Estimates of prevalence of drug use amongst minors in most areas of the United 
Kingdom can be obtained through surveys of health behaviour undertaken in 
schools.  In England, surveys of smoking, drinking and drug use have been 
undertaken annually since 1998 amongst 11 to 15 year olds.  In Northern Ireland, the 
Young Person’s Behaviour and Attitudes Survey160 was undertaken in 2000 for the 
first time; a second survey was carried out in 2003.  This is conducted amongst 11 
to16 year-olds.  In Scotland, the Schools Adolescent Lifestyle and Substance Use 
Survey (SALSUS) has been undertaken since 2002.  England, Scotland and Wales 
also take part in the Health Behaviour in School-aged Children161 (HBSC) study 
organised through the World Health Organisation (WHO).  This study began in 1982 
and is carried out at four-year intervals; the latest survey was in 2001/2002.  The 
target population of the HBSC study is young people attending school, aged 11, 13 
and 15.  For the first time in 2001/02, 15 year olds were asked about their use of 
cannabis.  The United Kingdom also participates in the European School Survey 
Project on Alcohol and Other Drugs (ESPAD), undertaken every three years, but this 
samples 15 and 16 year olds only. 
 
Information on drug use amongst minors in England and Wales is also available from 
the Offending, Crime and Justice Survey162, and in Scotland from the Edinburgh 
Study of Youth Transitions and Crime (known as the Youth Transitions Survey).163  In 
Northern Ireland a similar cohort study, the Belfast Youth Development Study164 has 
been undertaken.  In addition, the Children’s Mental Health Survey, undertaken in 
1999 and in 2004 (Green et al. 2005) provides information about drug use165.   
Prevalence of drug use by age  
Survey data on drug use amongst school children is primarily concerned with young 
people up to and including age 15 and therefore 15 years olds are included in much 
of the following analysis.  It should also be noted that in law, 15 year olds are minors.  
Latest estimates of prevalence of drug use from school surveys are shown in Figure 
11.1; prevalence is for recent (last year) use.  This is based on surveys undertaken in 
different years, and using different methodologies, and therefore caution is required 
                                                 
160 For more information see: http://www.csu.nisra.gov.uk/surveys/survey.asp?id=11  
161 For more information see: http://www.hbsc.org/index.html  
162 The Offending, Crime and Justice Survey (OCJS) is the longitudinal, self-report household 
survey for England and Wales.  It was first conducted in 2003 and will be repeated annually 
until 2006.  The main aim is to examine the extent of offending, anti-social behaviour and drug 
use among the household population, particularly among young people aged 10 to 25. 
163 The Edinburgh Study of Youth Transitions and Crime is a longitudinal study of criminal 
offending and anti-social behaviour among young people.  The study follows a single year 
group of approximately 4,300 young people who started secondary schools in Edinburgh in 
1998.  
164 The aim of the study is to investigate the risk and protective factors associated with 
adolescent drug use.  The study comprises a core sample of approximately 4,500 young 
people who entered secondary school in 2000. 
165 Research suggests that children interviewed at home systematically under-reported their 
smoking, drinking and drug use compared with those interviewed in school and therefore 
rates presented in the report by Green et al. should not be taken as true estimates of 
prevalence.  Their main value is in enabling comparisons to be made between children with a 
mental health disorder and other children (see 11.3.8). 
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in comparing the three areas.  For England data are for 2005 (NatCen/NFER 2006), 
for Scotland for 2004 (Corbett et al. 2005) and for Northern Ireland for 2003 (CSU 
2004). 
 
Figure 11.1: Percentage prevalence of last year drug use by age in England, Northern Ireland 
and Scotland  
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*percentage for Northern Ireland is for 12 years and under at secondary school. 
In Scotland data is for 13 and 15 year olds only  
Source: Corbett et al. 2005; SMR 2005 ; NatCen/DFER 2006 
 
This figure shows that older pupils are far more likely to have used drugs than 
younger pupils; Scottish data is only available for 13 and 15 year olds, but English 
data show a large increase in prevalence between age 13 and age 14 and a further 
large increase by age 15.  However, it should also be noted that a majority of young 
people had never used a drug. 
Other evidence of drug use amongst young people is from the Edinburgh Youth 
Transitions Survey (EYTC).  This study confirms evidence from the school survey 
undertaken in England of a rise in prevalence between the age of 13 and 14 followed 
by another significant rise at age 15 over all recall periods (McVie and Bradshaw 
2005). 
Similarly, the Offending, Crime and Justice Survey for 2004 (OCJS) shows that at 
age 10 and 11 very few young people report recent drug use (0.3%), amongst 12 to 
13 year olds the proportion rises to just over one per cent, but for those aged 14 to 
15 there was a sharp increase to 6.6 per cent (Budd et al. 2005). 
Prevalence of drug use by gender  
Table 11.1 shows that girls are only slightly less likely to have used drugs than boys 
in England but in Northern Ireland the difference is greater. Totals are not available 
for Scotland.  
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Table 11.1: Percentage prevalence of lifetime, last year and last month drug use by gender in 
England, 2005 and Northern Ireland, 2003  
 
Gender Prevalence Male Female Total 
Lifetime 
England (11 to 15 years) 27.8 27.2 27.5 
Northern Ireland (11 to 16 years)  25.1 19.7 22.3 
Last year 
England (11 to 15 years) 19.3 18.8 19.1 
Northern Ireland (11 to 16 years)  15.8 12.8 14.2 
Last month 
England (11 to 15 years) 11.5 10.3 10.9 
Northern Ireland (11 to 16 years)  7.9 5.8 6.8 
Source: Standard Tables prepared for United Kingdom Focal Point based on school surveys 
11.1.1 Patterns of drug use by age and gender  
Patterns of drug use by age 
Figure 11.2 shows recent use of drugs by age in England in 2005.  Amongst 11 to 12 
year olds volatile substances are the main drugs used, at age 13 cannabis is used by 
a slightly greater number and by age 14 cannabis is the main drug used. It is of note 
that, amongst 14 year olds, volatile substances remains the second most used drug.  
Patterns of use amongst minors in Northern Ireland show a similar pattern to England 
with the youngest age groups being more likely to use volatile substances and the 
older age groups more likely to use cannabis.   
 
This is consistent with data from the EYTC.  This found that volatile substance use 
declines markedly at the age of 15 but use of cannabis increases, noting that by the 
age of 15, 97 per cent of the drug users reported recent use of cannabis (McVie and 
Bradshaw 2005).  In this report, as well as finding that the biggest increase in 
prevalence is seen between 13 and 14, use of some drugs showed a much greater 
increase; ecstasy by six times and poppers (amyl nitrite) by 24 times.  The most 
commonly reported other drugs at age 14 and 15 were magic mushrooms, poppers, 
amphetamines and ecstasy, all of which were taken by one in ten drug users. 
 
In addition, the Offending, Crime and Justice Survey confirms the use of drugs in the 
last year (recent use) by a very small proportion of young people aged 10 and 11, 
0.35 per cent reported use of volatile substances; at age 12 to 13, 2.6 per cent 
reported use of any drug, but amongst those aged 14 and 15 prevalence is much 
higher at 16.9 per cent (Budd et al. 2005). 
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Figure 11.2:  Percentage of young people who had used drugs in the last year, by age in 
England 2005 
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Source: Standard Table prepared for United Kingdom Focal Point based on school surveys 
 
Patterns of use by age and sex 
 
Table 11.2: Percentage prevalence of lifetime drug use by age and sex in England, 2005 
 
Age Drug 11 12 13 14 15 
 M F M F M F M F M F 
Cannabis 1.8 0.5 3.8 2.8 9.4 7.9 21.8 19.6 35.6 32.5 
Cocaine powder 0.3 0.6 0.7 0.7 1.8 1.3 4.4 2.6 5.2 4.8 
Crack 0.5 0.4 0.7 1.1 1.6 1.0 1.6 2.5 1.7 2.1 
Ecstasy 0.1 0.4 0.1 0.2 1.0 1.0 2.7 2.6 4.3 4.6 
Amphetamines 0.1 0.1 0.3 0.1 0.6 1.3 2.3 2.4 3.3 3.4 
LSD 0.3 0.3 0.2 0.5 0.7 0.2 0.9 1.4 1.8 1.2 
Magic 
mushrooms 0.5 0.5 0.6 1.1 1.4 1.7 4.6 3.6 6.9 4.6 
Heroin 0.4 0.5 1.0 0.8 1.0 1.0 1.5 2.0 1.4 1.1 
Volatile 
substances 11.0 11.6 11.0 11.3 12.7 16.3 15.8 18.8 15.4 18.0 
Any drug 15.0 13.4 16.4 14.6 21.6 23.3 35.5 35.5 45.8 43.6 
Base 680 670 864 836 904 877 881 929 967 940 
Information on amyl nitrate by age and sex is not available  
Source: Standard Table prepared for United Kingdom Focal Point based on school survey 
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Table 11.3: Percentage prevalence of last year drug use by age and sex in England, 2005 
 
Age Drug 11  12  13  14  15  
 M F M F M F M F M F 
Cannabis 1.1 0.3 2.8 2.4 8.0 7.0 17.5 16.9 28.3 25.9 
Cocaine powder 0.3 0.6 0.6 0.1 1.0 1.0 3.4 2.2 4.6 4.0 
Crack 0.3 0.3 0.4 0.5 0.9 0.9 1.3 1.9 1.4 1.6 
Ecstasy 0.1 0.4 0.1 0.1 0.7 1.0 2.2 2.3 3.6 3.5 
Amphetamines 0.0 0.1 0.2 0.1 0.5 1.0 1.7 2.2 2.3 2.7 
Amyl Nitrate 
(Poppers)* 
0 0 0 1 2 3 5 7 8 10 
LSD 0.1 0.3 0.2 0.3 0.5 0.2 0.8 1.0 1.6 1.0 
Magic 
mushrooms 
0.3 0.4 0.4 0.3 1.1 1.3 3.3 2.7 4.2 3.4 
Heroin 0.3 0.3 0.5 0.5 0.8 0.8 1.0 1.7 1.0 1.9 
Volatile 
substances 
4.0 5.0 6.4 5.3 6.7 7.4 7.5 9.9 5.5 8.2 
Any drug 6.5 5.8 10.6 8.2 15.1 14.4 26.0 26.6 33.9 33.9 
Base 673 668 858 827 899 870 867 927 956 931 
*Information on amyl nitrate is from the published report on the 2005 school survey for 
England as this information is not asked for by EMCDDA in the Standard Table and is 
therefore only provided as a rounded figure.  
Source: Standard Table prepared for United Kingdom Focal Point based on school survey. 
 
Table 11.4: Percentage prevalence of last month drug use by age and sex in England, 2005 
 
Age Drug 11  12  13  14 15  
 M F M F M F M F M F 
Cannabis 0.9 0.3 0.7 0.6 4.4 4.1 11.5 10.2 18.0 13.1 
Cocaine powder  0.1 0.3 0.1 0.1 0.4 0.4 1.8 1.3 1.9 1.5 
Crack 0.1 0.3 0.2 0.1 0.5 0.2 0.5 0.7 0.8 0.8 
Ecstasy 0.1 0.4 0.0 0.1 0.4 0.1 1.0 0.6 1.4 1.0 
Amphetamines 0.0 0.1 0.0 0.0 0.2 0.4 0.9 0.9 0.9 0.9 
LSD 0.1 0.1 0.0 0.2 0.2 0.1 0.4 0.3 0.6 0.3 
Magic 
mushrooms 
0.3 0.3 0.1 0.1 0.5 0.4 1.5 1.1 1.6 0.9 
Heroin 0.3 0.3 0.3 0.1 0.6 0.4 0.3 1.1 0.4 0.3 
Volatile 
substances 
1.8 2.4 3.1 2.7 2.9 2.9 3.9 3.8 2.4 3.5 
Any drug 3.7 2.8 4.6 3.8 8.1 7.5 16.4 15.9 21.9 18.7 
Base 672 667 851 825 891 865 853 921 941 922 
Information on amyl nitrate by age and sex is not available  
Source: Standard Table prepared for United Kingdom Focal Point based on school survey 
 
Looking at data for England, in the case of volatile substances, females are more 
likely to have ever used than males at all ages (Table 11.2).  For cannabis use it is 
the opposite, with males being more likely to have ever used than females.  For 
recent and current cannabis use the pattern is the same as lifetime use, though 
prevalence is lower.  Although females have higher prevalence rates for current and 
recent volatile substance use, at age twelve this pattern is reversed. (Table 11.3 and 
11.4) It is of note that the third most common drug amongst all pupils is reported as 
amyl nitrate (poppers), though information is only available on recent use by age and 
sex (Table 11.3).  It is not possible to look at gender differences in Northern Ireland 
for very young people, as gender analysis is only undertaken for all pupils at 
secondary school. 
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In Scotland, by age 13 both boys and girls are more likely to have recently used 
cannabis than volatile substances recently and amyl nitrate is the second most used 
drug amongst 15 year olds (Table 11.5).  
 
Table 11.5: Percentage of individuals who have used drugs in the last year, by age group and 
gender in Scotland, 2004 
 
Drug 13 years 15 years 
 Males Females Total Males Females Total 
Cannabis 11 8 10 28 28 28 
Cocaine 1 1 1 2 2 2 
Crack 1 1 1 1 1 1 
Ecstasy 1 1 1 3 3 3 
Amphetamines 1 1 1 3 3 3 
Amyl nitrate/ 
Poppers 1 1 1 7 6 7 
LSD 1 0 1 1 1 1 
Magic 
mushrooms 1 1 1 3 2 2 
Heroin 1 1 1 1 1 1 
Methadone 0 0 0 1 0 0 
Volatile 
substances 
2 3 2 4 4 4 
Tranquillisers 1 1 1 2 1 1 
Base 1843 1756 3599 1702 1761 3463 
Source: Corbett et al. 2005 
 
The pattern of use described earlier is confirmed by EYTC; it is reported that while 
patterns of drug use between the sexes is very similar, there is a slight gender 
difference in the types of drug used, with boys more likely to have used cannabis 
than girls at age 12 (55 per cent compared with 31 per cent, respectively), but 
thereafter girls and boys were equally likely to use cannabis.  Girls, on the other 
hand, were more likely to report using volatile substances than boys up to age 12 
(p<.01) and at age 15 (p<.001).  There was no significant gender difference in the 
use of other types of substance. Similarly, there was little difference in the variety of 
drugs used or the frequency of drug use.  Boys, at age 12, were more likely than girls 
(p<.05) to report using more than one type of drug (1.7% and 1.3%, respectively) and 
to have used drugs on more than one occasion (3.3% compared with 2.3%, 
respectively); thereafter, there was no significant difference. (McVie and Bradshaw 
2005). 
Age of first use  
The EYTC looks at age of onset of drugs, showing the trend in age: 
• around a quarter (27%) of drug users (10% of the cohort) said that they had tried 
a drug or volatile substance by age 13; 
• a third of all drug users in the survey reported that they had used their first drug 
between the ages of 13 and 14; and  
• 37 per cent of drug users reported using their first drug between age 14 and 15 
(McVie and Bradshaw 2005).   
 
However the Northern Ireland survey suggests that the peak age of onset is between 
13 and 14 (SMR 2005). 
Frequency  
A number of surveys ask young people about their frequency of use, asking slightly 
different questions and therefore making an overall United Kingdom estimate difficult.  
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However all surveys confirm that, even by age 14, very few pupils who report having 
used a drug have used recently and even fewer report current use.  Frequency of 
use for England is shown in Table 11.6 and for Scotland in Table 11.7.  The fact that 
a majority of those who report having ever used have not used recently suggests 
that, while a small number of children have experimented with drugs, many do not 
continue to use.  
 
Table 11.6: Frequency of drug use by school age children in England, 2005 as a percentage 
 
Frequency of use Age 
 11 12 13 14 15 
Most days  - 0 1 2 3 
At least once a week 0 1 1 3 3 
Once or twice a month  0 1 2 4 7 
At least once a month 1 2 3 8 13 
A few times a year  0 2 2 4 8 
Once a year or less often  1 1 2 3 3 
Taken drugs in last year, but only ever taken 
drugs once 
2 2 4 6 5 
Not taken drugs in last year  7 7 7 10 11 
Never taken drugs  89 87 81 70 60 
Base 1,440 1,785 1,841 1,831 1,887 
Source: NatCen/NFER 2006 
 
Table 11.7: Frequency of drug use amongst 13 and 15 year olds in Scotland, 2004 as a 
percentage 
 
Prevalence 13 year olds 15 year olds 
Never used 86 65 
Only used drugs once 6 10 
Used to take drugs 2 6 
A few times a year 2 6 
Used once or twice a month 2 6 
At least once a week 1 3 
Most days 1 4 
Base 3,451 3,315 
Source: Corbett et al. 2005. 
 
EYTC asks a rather different question, not when they last used, but how many times 
they had used.  Amongst those pupils who reported having ever used, the majority 
(66%) of 12 year olds had used only once or twice, and even by age 15, 71 per cent 
had used no more than four times (Table 11.8).   
 
Table 11.8: Frequency of lifetime drug use amongst drug users, by age in Scotland as a 
percentage  
 
Number of times used drugs Age 
 12 13 14 15 
Once  39 29 22 18 
Twice  27 24 20 20 
Three times  3 10 6 3 
Four times  16 19 24 30 
Five times or more  16 19 29 30 
Base 187 241 652 1,048 
Source: McVie and Bradshaw 2005 
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Variety or number of types of drugs taken  
The EYTC looked at the ‘variety’ or numbers of drugs taken, reporting that the 
average number of types of drugs taken was 1.5 at age 12, rising to just under two 
each year after.  However, a significant minority had used two or more types of 
substance and the likelihood of doing so increased with age (McVie and Bradshaw 
2005) (Table11. 9).  
 
Table 11.9: Percentage of drug users using a variety of drugs by age in Scotland, 
 
Number of types of drug taken Age 
 12 13 14 15 
One 73 66 60 64 
Two  14 20 19 19 
Three 6 5 10 7 
Four 3 2 5 3 
Five or more  4 7 7 8 
Base 187 241 652 1,048 
Source McVie and Bradshaw 2005 
11.1.2 Social and geographical profiles 
Location of drug use by age  
The SALSUS (Scotland) asks young people about where they used drugs (Table 
11.10).  Outdoors was by far the most common location amongst the younger pupils, 
with use at someone else’s house the second most favoured location.  However, 
over time use at someone else’s house, particularly for girls becomes more usual. 
 
Table 11.10: Percentage of drug users using in each location by age and gender in Scotland, 
2004 
 
Location 13 year olds 15 year olds 
 Males Females Total Males Females  Total 
Outdoors 49 45 48 39 33 36 
Someone else’s house 16 23 19 26 36 31 
At a party 10 9 9 15 16 16 
At school 8 10 9 9 4 7 
Own home 5 9 7 8 9 8 
At a club/disco 4 6 5 3 4 4 
Other 5 2 4 3 3 3 
Base 291 220 511 611 631 1,242 
Corbett et al. 2005 
Leisure time pursuits 
SALSUS also asked young people about leisure time pursuits and findings suggest 
that pupils who reported current use were more likely to report spending most 
evenings with friends.  Also, pupils were asked how often they engaged in a range of 
activities in which young people in this age group commonly participate, previous 
research having indicated that adolescents who have the strongest ‘street based’ 
leisure orientation also have the highest levels of substance use.  78 per cent of 
pupils who reported current use “hang around the street” at least weekly; this 
compared with 41 per cent of pupils who had never used drugs (Corbett et al. 2005). 
 
In EYTC data on lifestyle and leisure activities were separated into two types: 
organised or conventional leisure activities (stay at home most evenings, going to 
organised clubs, groups or sports centres most days, going shopping or out for 
something to eat at least once a week) and unorganised or unsupervised leisure 
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activities (going to amusement arcades at least once a week, going to discos, 
nightclubs or raves at least once a week and hanging around most evenings).  It was 
found that non-users were the most likely of all the groups to stay at home most 
evenings and that the likelihood of staying in significantly diminished with increased 
variety of substance use at all three age bands (McVie and Bradshaw 2005). 
Peer influence  
EYTC also looked at the influence of peers suggesting that there was a dramatic 
incremental rise in the proportion of young people who said that most or all of their 
friends took these substances according to the extent of their own substance use. 
Overall, prevalence patterns for friends showed a similar pattern to those of the users 
themselves, although no causal relationship can be determined (McVie and 
Bradshaw 2005). 
Parental supervision 
SALSUS looked at the relationship between parental monitoring and drug use.166  
Pupils who reported current use were more likely to perceive lower than median 
levels of parental monitoring.  Over two thirds (69%) of 15 year olds who reported 
current use had a lower than median level of monitoring by their mothers, compared 
with 43 per cent of pupils who had never used drugs. The same pattern was found 
for fathers monitoring, 56 per cent of 15 year olds reporting current use had a lower 
than median level of monitoring compared with 36 per cent of 15 year olds who had 
never used drugs.  Researchers suggest that these findings reflect those of other 
studies which indicate that a lack of parental monitoring is associated with illicit drug 
use (Corbett et al. 2005).  In the EYTC three aspects of parental supervision were 
measured.167  Researchers report that non-users had a significantly higher (p<.001) 
parental supervision score than any of the substance user groups at all three sweeps 
(McVie and Bradshaw 2005). 
Relative family wealth 
SALSUS suggests that lower family affluence is also associated with drug use168 
(Table 11.11). 
 
Table 11.11: Percentage using drugs by family affluence level and age in Scotland, 2004  
 
Affluence level Drug use status 13 year olds 15 year olds 
 Low Medium High Low Medium High 
Used in last 
month 10 7 6 24 22 16 
Used drugs, not 
in last month 7 5 5 14 12 12 
Never used drugs 84 89 89 62 67 72 
Base 626 1,540 1,171 637 1,621 926 
Source: Corbett et al. 2005 
                                                 
166 Pupils’ responses to a series of questions on how much knowledge they perceived their 
parents to have about their friends and activities (who their friends were, where they went to 
when they were out, what they spent their money on) were used to assess levels of parental 
monitoring.  Each pupil was given a parental monitoring score, which was then compared with 
the overall median (mid-point) score for their age group and gender. 
167 Young people were asked, “When you went out during the last year, how often did your 
parents know where you were going, who you were going out with, and what time you would 
be home?”  Response options were: always, usually, sometimes and never. 
168 HBSC Family Affluence Scale was used as a measure of wealth. 
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Truancy and exclusion from school 
In their review of drug prevention amongst school excludees, the National 
Collaborating Centre for Drug Prevention (Edmonds et al. 2005) state that it is 
estimated that everyday around 50,000 children in England miss school through 
truancy and that in 2002/03 there were 9,290 (12 in 10,000 pupils) permanent 
exclusions in England (DfES, 2004a).  There is also a great deal of evidence from the 
United Kingdom suggesting a strong association between truancy and exclusion and 
drug use, though there is no evidence of causality.  It has also been found that there 
is an association between lack of involvement with the education system and 
elevated levels of criminality and illicit drug use (MORI 2004; Powis et al. 1998).  In 
addition, there is strong evidence to suggest that school attendance is a protective 
factor against drug misuse.  Furthermore, individual students are more likely to 
initiate drug use in schools where truancy is high. 
 
In England, the 2004 school survey asked pupils for the first time about the number 
of truancies or exclusions in the last 12 months.169  It is noted that despite an 
additional visit being undertaken if four or more pupils were absent when the survey 
was first administered, it is likely that regular truants and those excluded from school 
during the fieldwork period will be under-represented in the sample.  
Truancy  
Data from the 2005 English school survey shows that: 
• thirteen per cent of pupils had truanted at least once in the last year; 
• pupils who had played truant in the last year were much more likely than those 
who had never truanted or those who had last truanted more than 12 months ago 
(past truants) to report current use, 37 per cent compared with 23 per cent of past 
truants and 6 per cent of those who had never truanted; and 
• these patterns existed for girls and boys. 
 
Amongst pupils who had truanted in the last 12 months, the prevalence of drug use 
(and of smoking and drinking) increased with frequency of truanting.  Twenty-one per 
cent of those who had stayed away from school once or twice reported current use 
compared with 42 per cent of those who had truanted more than three times. 
 
In Scotland, SALSUS provides a more detailed look at this. 
• thirty-two per cent of 13 year olds and 47 per cent of 15 year olds had truanted at 
least once in previous year; 
• these young people were more likely to report recent use, 56 per cent, compared 
to 28 per cent of non truants; and 
• seventy-eight per cent of 15 years olds who reported current use had also 
truanted in the current school year compared with 34 per cent of 15 year olds 
who had never used drugs.  Pupils who reported current use also reported a 
higher frequency of truancy; 26 per cent of 15 year olds reporting current use had 
truanted ten times or more, compared with only three per cent of 15 year olds 
who had never used drugs. 
Exclusion from school 
In the 2005 English school survey there was also a relationship between exclusions 
and drug use (and smoking and drinking): 
• ten per cent of pupils said they had been excluded from school at least once; and  
                                                 
169 For methodology used see chapter 2. 
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• pupils who had been excluded in the last 12 months were more likely than other 
pupils to report current use, 36 per cent compared with 26 per cent of those who 
were last excluded more than a year ago and eight per cent of those who had 
never been excluded. 
 
In Scotland, based on SALSUS, information on the proportion excluded and the 
relationship between exclusion and drug use is not available for 13 year olds.  
Amongst 15 year olds: 
• Exclusion from school was more frequent amongst pupils reporting current use 
than amongst pupils who had never used drugs; a third (30%) of 15 year olds 
reporting current use had been excluded compared with seven per cent of 15 
year olds who had never used drugs.  
Victimisation  
Analysis of EYTC suggests that there is a strong association between victimisation170 
and substance use, with only occasional non-significant differences between 
substance user sub-groups (those who took drugs, drank alcohol and smoked 
cigarettes).  Non-users were significantly less victimised than all of the other groups 
(p<.001).  Single users were also consistently victimised to a lesser extent (p<.01 or 
above) than the multiple users, whereas the triple users proved to be more highly 
victimised than any other group (McVie and Bradshaw 2005). 
Sibling drug and alcohol use 
Analysis of the Youth Lifestyle Survey (Goulden and Sondhi 2001)171 found that rates 
any drug use in the last year were up to eight times higher for 12 to 16 year olds with 
a sibling drug-user compared to those without, but less than twice as high for those 
aged 17 and over.  Having an older sibling using drugs recently meant that higher 
rates were also observed among the younger siblings for recent use, with the rates of 
drug use by those with an older sibling who had never used drugs being very low.  
SALSUS, asking about the source of drugs, found that six per cent of 13 year olds 
and four per cent of 15 year olds obtained drugs from a sibling (Corbett et al. 2005). 
Problem drug use amongst the very young 
There remains very little information about the extent of problem drug use amongst 
the very young (excluding the issue of volatile substance abuse).  Surveys provide 
some evidence of the use of opiates and cocaine (see Figure 11.2 in section 11.1).  
Latest survey data (for England in 2005) suggest that prevalence of recent and 
                                                 
170 Two measures of victimisation were included the EYTC: variety of victimisation (a count of 
the number of different types of victimisation the respondent reported experiencing); and 
volume of victimisation (the cumulative frequency of victimisation across all the types asked 
about).  Five items of victimisation were used to create both of these measures.  Pupils were 
asked, During the last year, did anyone: threaten to hurt you?; actually hurt you by hitting, 
kicking or punching you (fighting with you)?; actually hurt you with a weapon?; steal 
something of yours that you left somewhere?; use threats or force to steal or try to steal 
something from you?  Response options: yes/no. 
171 The 1998/99 YLS sample was generated from the 1998 BCS, which sampled individuals 
aged over 16 living in private households but also captured information on non-interviewees 
living there. Of 14,947 BCS households interviewed in 1998, 5,117 were eligible for inclusion 
in the YLS core sample, of which 3,643 led to successful interviews (a response rate of 71%). 
A further 6,884 addresses next door to the BCS sample households were contacted (a 
process known as ‘focused enumeration’) with weighting towards high-crime areas. These 
households contained 1,895 addresses with at least one person aged between 12 and 30, of 
which 1,205 (64%) were interviewed as a booster sample for the YLS.  In total, the response 
rate for the whole sample was 69 per cent.  
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current use of heroin is around 0.8 and 0.4 per cent, cocaine around 1.9 and 0.8 per 
cent respectively and crack use around one and 0.5 per cent respectively.  Of 
particular note is the increased use of cocaine identified amongst school aged 
children in England in 2005 (from 1.4% in 2004 to 1.9% in 2005).  Children as young 
as 11 report recent use of heroin (0.3%), cocaine (0.4%) and crack (0.3%) (NatCen 
and NFER 2006).  
 
There are also a number of studies of vulnerable young people which point to the use 
of drugs associated with problematic use, though amongst the very young this 
remains rare.  When the very young are identified as using drugs such as heroin this 
has been extensively reported by the media. In the United Kingdom there have been 
two such high profile incidents in 2006, the case of an 11 year old in Glasgow172 and 
a nine year old boy173, both provided with drugs by a parent.   
 
McKeganey et al. (2004) also looked at use of drugs amongst pre-teen children in 
Glasgow and Newcastle and found that, among the 2,000 participants aged 10 to 12 
years, whilst 4 per cent had used drugs only a very small number had used heroin. 
11.1.3 Trends in the last ten years 
Trends in drug use in England are shown in Table 11.12.  Current prevalence has 
remained stable since 2001 and has shown signs of a decrease in the last two years.  
The trends for recent use of individual drugs are shown in Figure 11.3. 
 
Table 11.12: Percentage of pupils who had taken drugs in the last month by gender and age 
in England, 1998-2005 
 
Year Gender/ 
Age 1998 1999 2000 2001 2002 2003 2004 2005 
Boys 
11 yrs 0 1 3 4 4 4 4 4 
12 yrs 2 2 2 4 5 5 4 5 
13 yrs 4 4 6 11 9 11 8 8 
14 yrs 10 12 14 17 20 17 17 16 
15 yrs 19 21 23 25 26 25 21 22 
Total 7 8 10 13 14 13 11 11 
Base  2,273 4,769 3,545 4,360 4,673 4,840 4,664 4,208 
Girls 
11 yrs 0 1 2 2 3 3 1 3 
12 yrs 2 2 3 4 3 5 4 4 
13 yrs 3 5 5 9 8 8 7 8 
14 yrs 9 9 11 15 15 18 13 16 
15 yrs 16 17 19 22 19 22 20 19 
Total 6 7 8 11 10 12 9 10 
Base 2,293 4,539 3,314 4,439 4,473 4,818 4,422 4,200 
Total 
11 yrs 0 1 3 3 4 4 3 3 
12 yrs 2 2 3 4 4 5 4 4 
13 yrs 4 5 5 10 8 9 7 8 
14 yrs 10 11 13 16 18 17 15 16 
15 yrs 18 19 21 24 23 23 21 20 
Total 7 7 9 12 12 12 10 11 
Base  4,566 9,308 6,859 8,799 9,146 9,658 9,086 8,408 
Source: NatCen/NFER 2006 
                                                 
172 See: http://news.bbc.co.uk/1/hi/scotland/4659092.stm  
173 See: http://news.bbc.co.uk/1/hi/england/4797631.stm  
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Figure 11.3: Percentage of pupils who had taken individual drugs in the last year in England, 
2001 to 2005 
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Source: NatCen/NFER 2006 
11.2 Treatment demand indicator data  
In 2004/05 2,217 young people under the age of 15 were reported as entering 
treatment across the United Kingdom (2% of the total TDI population), of whom 64 
per cent were known to be first treatment demands. (1,835 from England; 214 from 
Scotland; 95 from Wales; 75 from Northern Ireland). 
 
Of the 2,217, two per cent were 10 year olds, three per cent were 11 year olds, nine 
per cent were 12 year olds, 28 per cent were 13 year olds and 58 per cent were 14 
year olds; 68 per cent were boys and 32 per cent girls. 
 
Boys and girls differed quite substantially in their declared drug use.  Whilst the vast 
majority were cannabis users, 88 per cent of boys and 72 per cent of girls, other 
proportions were as follows: opiates, two per cent of boys, five per cent of girls; 
stimulants, two per cent of boys, eight per cent of girls; volatile substances, five per 
cent of boys, ten per cent of girls; cocaine one per cent of boys, two per cent of girls. 
11.3 Profile of the main groups of young people at risk of drug use and of 
problematic drug use 
11.3.1 Children of drug users 
Children affected by parental drug use were the subject of a major piece of work by 
the Advisory Council on the Misuse of Drugs (ACMD 2003).  This report estimated 
that in the United Kingdom there were, at the time of the study, between 250,000 and 
350,000 children living with parental drug misuse. 
 
Research by Edinburgh University into children of substance misusing parents (drugs 
and alcohol), suggests that children who have parents with substance misuse 
problems are found across a wide range of the country's socio-economic groups, 
though parental drug misuse is more likely to be restricted to those from socio-
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economically disadvantaged groups.  It is noted that three times as many children 
live with parents who have a drink problem than with parents who misuse drugs 
(Bancroft et al. 2004).  
 
Analysis of SALSUS found that one per cent of both 13 and 15 year olds reported 
obtaining drugs from a parent (Corbett et al. 2005). 
 
McVie and Holmes (2005) report, based on the EYTC and looking at family 
functioning, found that at age 15 young people whose parent(s) had used drugs 
during the previous year were more than twice as likely to have used a drug 
themselves in the same period than those whose parent(s) had not used a drug 
(Table 11.13).  
 
Table 11.13: Percentage of 15 year olds who have used drugs in the last year by parental 
drinking and drug use, Scotland 
 
 ‘Any’ drug use at age 15 
Yes 38 
No 26 
Parents drink excessively 
in an average week 
Significance =p<.001 
Yes 55 
No 26 
Parents used drugs in the 
last year 
Significance =p<.001 
Source: McVie and Holmes 2005 
11.3.2 Children living in problematic families  
McVie and Holmes (2005) in the above mentioned report on family functioning, show 
that family characteristics and parenting styles play a significant role in the substance 
using behaviour of young people174.  They suggest that there was evidence of a 
causal link with family related factors at age 15, predicting substance use at age 17.  
It was found that ineffective parenting consistently predicted involvement in drug use 
(and smoking and drinking alcohol), with ineffective parenting methods characterised 
by high levels of parent/child conflict, poor parental monitoring and lack of leisure 
time spent doing activities together.  Further, substance using children were likely to 
conceal information about their social activities from their parents.  They suggest that 
these findings are broadly supportive of social learning theory and indicate the need 
to provide information on methods of parenting which may be more effective in 
tackling various forms of problematic behaviour, including substance use.   
Alcohol or drug using siblings, 
See section 11.1. for evidence of the influence of siblings on drug use.  
11.3.3 Vulnerable groups  
Analysis of the Offending Crime and Justice Survey looked at patterns of drug use 
(especially Class A drugs) amongst young people identified as vulnerable (Becker 
and Roe 2005).  Five groups were identified: those who have ever been in care, 
                                                 
174 Parenting styles were assessed by: parental monitoring or supervision of the child’s 
activities while they were not at home; parental autonomy or lack of constraint afforded to the 
young person in certain aspects of their decision making; parent/child conflict in the form of 
verbal arguments; amount of time spent by the parent and child doing activities together 
(shared leisure time); propensity of the child to share information with the parents or keep 
secrets from them (child disclosure); frequency of parental punishment; extent to which 
negotiation is used to resolve conflict by both parents and child; and  consistency of parental 
control over the child. 
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those who have ever been homeless, truants, school excludees and serious or 
frequent offenders. Key findings were that: 
• although those identified as vulnerable represented only 28 per cent of young 
people in the sample, they accounted for nearly two thirds (61%) of those using 
Class A drugs in the last year; 
• five per cent of those who were not identified as vulnerable used drugs frequently 
during the last year compared to 24 per cent for those identified as vulnerable; 
• those identified as being in more than one vulnerable group had higher levels of 
drug use than those in just one vulnerable group.  Frequent drug use in the last 
year for the former was 39 per cent, compared to 18 per cent for the latter; 
• those who had been in care or had been homeless reported the lowest levels of 
drug use while serious or frequent offenders and truants showed the highest; and  
• Class A drug use in the last year was five per cent for those who had been in 
care or had been homeless, but 13 per cent for serious or frequent offenders and 
16 per cent for truants. 
 Predictive and risk factors amongst vulnerable young people 
Beckett et al. (2004)175 suggested a relative hierarchy of such factors, which predict 
increased levels of problematic drug use among young people:  
1. perceived lack of parental discipline; 
2. whether the respondent’s peers are using drugs; 
3. their age during the interview; 
4. whether they have a history of running away from home; 
5. if there is a parental lack of concern about smoking or alcohol issues; 
6. if there are problems in the area (such as assault or burglary); 
7. perceived lack of local amenities; 
8. the age at which substance use began; 
9. if they have a poor school attendance (or left school before they were 16 years 
old); and 
10. if they are not living in a household with adults. 
Children living in local authority care 
There have been a number of studies which have shown that ‘looked after’ young 
people are more likely than those living in private households to take drugs (and to 
smoke and drink alcohol) (Meltzer et al. 2003, Williams et al. 2001), and also tend to 
start using drugs at an earlier age, use at higher levels and do so more regularly than 
those not in care (Big Step Social Inclusion Partnership 2002; Newburn and Pearson 
2002; Ward 1998; Save the Children 1995).  In addition they are more likely to have 
experienced parental drug and alcohol misuse and may view excessive drugs and/or 
alcohol use as ‘normal’ (Ward et al. 2003, Newburn and Pearson 2002).  There is no 
specific information on those aged 14 and younger.  
Early school leavers 
There is no information available  
Homeless children 
The National Collaborating Centre for Drug Prevention (NCCDP) (Edmonds et al. 
2005) reports that studies conducted on behalf of the Department of Health, Home 
Office, and the charity Crisis have indicated that whilst drug use was the same as in 
the general population, amongst homeless young people, prevalence and frequency 
of use was greater (Adamczuk 2000; Fountain and Howes, 2002; Wincup et al. 
                                                 
175 103 young drug users (response rate 95%) completed a structured questionnaire in two 
study centres in England.  Forty-six parents (response rate 70%) were also interviewed.   
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2003).  Drug use was the second most common explanation for homelessness in one 
sample but this was not always perceived or treated as problematic use (Wincup et 
al. 2003).  These reports focus on children of all ages under 18. 
Youth offenders and delinquents 
There have been a large number of studies that show a strong association between 
delinquency, offending and drug use.  Most studies, however, suggest that rather 
than directly causing offending, these may simply be other expressions of a general 
tendency to delinquency (Goulden and Sondhi 2001; Lloyd et al. 1998; Hammersley 
et al. 2003; Borrill et al. 2003; Budd et al. 2005). 
 
EYTC and the OCJS both looked at drug use and offending amongst young people, 
however only the former provides analysis, allowing consideration to be given to 
young people less than 15.176  This suggests that there is an incremental increase in 
both variety and frequency of offending from the non-user group to the multiple user 
group, with the scale of difference being least between the double and triple user 
groups.  This is true for each age group (McVie and Bradshaw 2005).  
 
A separate report on the EYTC looked at patterns of referral to Children’s Hearings in 
Scotland (McAra 2005).177  Ten per cent of the cohort were referred to a reporter for 
drug and alcohol misuse and a further three per cent for offences under the Misuse 
of Drugs Act.  In another 11 per cent of cases drug and/or alcohol was raised as an 
issue.  The report does not provide an analysis by age. 
Young refugees and asylum seekers 
Patel et al. (2004) examined the vulnerability of young refugees and asylum  seekers 
to drug use.178  Approximately one third of their interviewees reported lifetime use of 
an illegal drug, only three out of 67 were aware of the drug services available.   
Children living in deprived places/neighbourhoods 
There is a consensus of opinion that children living in deprived neighbourhoods are 
more vulnerable to drug use than other children (McVie and Norris 2006).  However, 
information by age is not available.  
                                                 
176 In this study two measures of delinquent behaviour were used: variety of offending (a 
count of the number of different offending behaviours the respondent had engaged in) and 
volume of offending (the cumulative frequency of offending across all the offending 
behaviours asked about).  Fifteen items of anti-social or delinquent behaviour were used to 
create both of these measures.  These were: fare dodging; shoplifting; noisy or cheeky in 
public; joyriding; theft from school; carrying a weapon; graffiti; vandalism; housebreaking; 
robbery; theft from home; fire-raising; assault;  theft from vehicle; and truanting from school.  
The four substance use sub-groups (non- regular users, single substance users, two 
substance users and three substance users) were compared in terms of their mean variety 
and volume of self-reported delinquency at ages 13 to 15.   
177 The Scottish children’s hearings system is based on a coherent vision of criminal and 
social justice known as the “Kilbrandon” philosophy. According to this philosophy juvenile 
offending and other troublesome behaviours (including drug or alcohol misuse) should be 
regarded as manifestations of deeper social and psychological malaise and/or failures in the 
normal upbringing process.  The aim is to address the needs of the child.  The system deals 
with young people aged between 8 and 16 years referred on offence grounds and from birth 
to age 16 referred on a range of care and protection grounds.  
178 Patel et al. (2004) interviewed 67 young people (aged between 16 and 25 years old) who 
were born in countries such as Nepal, Iraq or Zimbabwe and who had been in the UK for 
between six months and 13 years.  
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Children with Attention Deficit (and Hyperactivity) Disorders and Conduct Disorders 
A Children’s Mental Health Survey carried out in 2004 describes the prevalence of 
mental disorders among 5 to 16 year olds in 2004 providing profiles of children in 
each of the main disorder categories (emotional, conduct, hyperkinetic and autistic 
spectrum disorders) and, where the sample size permits, profiles of subgroups within 
these categories (Green et al. 2005).179 
Hyperkinetic disorders 
Young people with hyperkinetic disorders180 were more likely than other young 
people to take drugs.  Forty-five per cent of young people aged 14 to 16 who had a 
hyperkinetic disorder had used drugs compared with 16 per cent of other young 
people.  Among the younger age group, 11 to 13, eight per cent of those with 
hyperkinetic disorders had used drugs compared with three per cent of those with no 
such disorder.  Cannabis was the most commonly used drug, taken by 18 per cent of 
young people with a hyperkinetic disorder and seven per cent of other young people.  
Among the former, four per cent had taken amphetamines and three per cent had 
used inhalants. These substances were taken by only one per cent of other young 
people (Green et al. 2005). 
Conduct disorders 
Young people with conduct disorders181 were much more likely than other young 
people to take drugs (and to smoke and drink alcohol).  As was the case with 
emotional disorders, the largest differences were in smoking and drug taking.  28 per 
cent of young people with a conduct disorder had taken drugs at some time 
compared with only eight per cent of other young people.  Differences were large 
even in the youngest age group; 13 per cent of 11 to 13 year olds with a conduct 
disorder had taken drugs compared with two per cent of other young people.  Among 
14 to 16 year olds, the difference was very marked, 43 per cent compared with 15 
per cent.  Cannabis was the most commonly used drug, taken by 23 per cent of 
young people with a conduct disorder and six per cent of other young people.  
Among the former, five per cent had taken amphetamines and four per cent had 
taken inhalants.  These substances had been taken by less than one per cent of 
other young people (Green et al. 2005). 
Emotional Disorder  
The survey found that young people with an emotional disorder182 were more likely to 
take drugs (and to smoke and drink alcohol) than other children.  20 per cent of 
young people with an emotional disorder had used drugs, mainly cannabis, 
compared with eight per cent of other young people (Green et al. 2005). 
                                                 
179 The surveyed population consisted of children and young people, aged 5–16, living in 
private households in Great Britain. The sample was drawn from Child Benefit records held by 
the Department for Work and Pensions’ Child Benefit Centre (CBC).  The set sample 
consisted of 12,294 families. 10,496 families were approached for interview.  7,977 were 
interviewed; 75 per cent of those approached, and 65 per cent of all cases.  
180 Hyperkinetic disorder is characterised by hyperactive, impulsive and inattentive 
behaviours.  This type of disorder is sometimes referred to as Attention Deficit Hyperactivity 
Disorder (ADHD), which is the name for a broader (and therefore commoner but milder) 
disorder defined by the American Psychiatric Association. 
181 Conduct disorders are characterised by aggressive, disruptive or antisocial behaviour. 
182 Emotional disorders include separation anxiety, specific phobias, social phobias, panic 
disorder, agoraphobia, post traumatic stress disorder, obsessive-compulsive disorder and 
depression.  
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Children from ethnic minorities 
Analysis of the 2005 school survey for England183 suggested that pupils of mixed 
ethnicity were more likely than any other group to have used recently (25%) and 
were current users (16%).  The prevalence of current drug use among other groups 
ranged from eight per cent of Asian pupils to 11 per cent of White pupils; in the last 
year the proportions of pupils who had taken drugs ranged from 12 per cent of Asian 
pupils to 19 per cent of White pupils (NatCen/NFER 2006). 
11.4 Correlates and consequences of substance use among very young people 
11.4.1 Early alcohol and tobacco use 
In Scotland, analysis of SALSUS shows that prevalence of reported drug use in the 
last month was higher among pupils who were regular smokers or weekly drinkers 
than among all pupils.  Seven per cent of all 13 year olds and 20 per cent of all 15 
year olds reported that they had used drugs in the last month.  Among regular 
smokers, 59 per cent of 13 year olds and 64 per cent of 15 year olds reported that 
they had used drugs in the last month. Among weekly drinkers, 34 per cent of 13 
year olds and 45 per cent of 15 year olds reported that they had used drugs in the 
last month, a lower prevalence than among regular smokers (Corbett et al. 2005). 
 
The EYTC also looked at the relationship between alcohol, tobacco and drug use, 
reporting quite distinct patterns and trends (McVie and Bradshaw 2005).  Analysis 
focused on those who were classed as ‘regular’ users (i.e. those who smoked at 
least once a week, drank alcohol at least once a month or had either taken more than 
one type of drug or had used drugs on at least four occasions).  Single substance 
users were predominantly alcohol users, this group accounted for only three per cent 
of the cohort up to age 12 but steadily increased to 26 per cent at age 15.  
Importantly, those who reported using all three substances showed the greatest 
increase in prevalence over time.  
 
The proportion of the cohort who both drank alcohol and took drugs increased from 
0.5 per cent at age 12 to 16 per cent at age 15; drinking alcohol and drug use proved 
to be strongly inter-connected, although drinking alcohol was far more common 
amongst drug users, than drug use was amongst alcohol users.  
 
Table 11.14: Inter-relationship between alcohol and illicit drugs 
 
Of the regular drinkers: % regular  drug users 
% occasional  
drug users 
% non-drug  
users 
Up to age 12 15 12 73 
At age 13 15 11 74 
At age 14 23 18 59 
At age 15 30 20 50 
Of the regular drug users % regular  drinkers 
% occasional  
drinkers 
% non-drug  
drinkers 
Up to age 12  28 63 9 
At age 13  73 25 3 
At age 14 84 13 2 
At age 15 84 14 2 
Source: McVie and Bradshaw 2005 
 
                                                 
183 The survey used the 2001 census ‘Level 2’ classification of ethnicity.    
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Also, regular drug users were more likely to also drink and smoke regularly.  It is 
suggested that this is likely, in part, to be due to the method of drug use itself, since 
most cannabis use involves smoking it together with tobacco (Table 11.4).   
Developmental progression of substance use 
Table 11.15: Percentage of regular users who reported earlier occasional use in Scotland 
 
Earlier use  Regular  drinker 
Regular  
smoker 
Regular  
drug user 
Occasional drinker  91 84 87 
Occasional smoker  19 86 74 
Occasional drug user  45 35 64 
Source: McVie and Bradshaw 2005 
 
The EYTC report shows a temporal progression of substance using behaviour (Table 
11.15).  It is however noted that the results do not demonstrate that occasional use of 
one substance ‘caused’ progression to regular use of that substance or of another.  
Furthermore, regular drug users were the least likely to report occasional use at an 
earlier age, which might indicate that progression from occasional to regular drug use 
occurs more quickly amongst drug users than for those reporting drinking or smoking 
(McVie and Bradshaw 2005). 
 
The 2005 school survey for England also looked at the correlation between smoking, 
drinking and drug use, though only amongst 15 year olds.  As with those surveys 
referred to previously, it found that the relationship between recent use of all 
substances was positive.  The strongest predictor of recent cannabis use was alcohol 
use with those having drunk alcohol in the last week twelve times more likely to have 
used cannabis recently than those who had never drunk alcohol. Smoking and the 
use of Class A drugs were also significant predictors of cannabis use.  Pupils who 
had smoked cannabis in the last month had odds of using Class A drugs 17 times 
greater than those who had never smoked cannabis.  Volatile substance use was the 
second strongest predictor of Class A drug use. (NatCen/NFER 2006).   
11.4.2 Psycho-social and health problems related to substance use  
Deaths related to inhalation of volatile substances 
In a report on trends in death associated with volatile substance abuse (VSA), Field-
Smith et al. (2006)184 define volatile substance abuse as the deliberate inhalation of a 
volatile substance.  In the United Kingdom, among those aged 10 to 14 years, the 
number of deaths associated with VSA was higher than the number associated with 
drug misuse for each year from 2000 to 2004, (30 VSA deaths, compared with four 
deaths from drug misuse over this period).  Amongst 15 year olds, based on deaths 
in England and Wales from 2000 to 2004, the number of deaths associated with VSA 
was also higher than the number associated with drug misuse (18 compared with 
13).  In 2004, among those aged 10 to 15 years there were eight deaths associated 
                                                 
184 Information for England and Wales was provided from the following main sources: HM 
Coroners, Office for National Statistics, the Medical Toxicology Laboratory, Guy’s and St 
Thomas’ Hospital Trust, and press clippings agencies.  For Scotland, information was 
supplied by the Crown Office and the General Register Office for Scotland.  Details of 
Northern Ireland deaths were provided by the State Pathologist’s Department, HM Coroner 
for Northern Ireland, and the General Register Office for Northern Ireland.  The Deputy 
Viscount in Jersey, HM Greffier in Guernsey, and the High Bailiff in the Isle of Man supplied 
information for their areas.  Data on “all cause” mortality and population estimates were 
supplied by ONS, and the General Register Offices for Scotland and Northern Ireland. 
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with VSA compared with three from drug misuse.  At age 16 years, although the 
pattern was reversed (12 VSA deaths compared with 22 from drug misuse), VSA 
deaths were still of consequence. 
Acute and chronic mental health problems 
See 11.3.3  
Problems directly attributed to alcohol and drug use 
Studies from the United Kingdom suggest that while there is a strong association 
between drug and alcohol, attribution has not been shown (see 11.4.1).  
Problems at school and in family 
See 11.3.1 
11.4. 3 Exposure to other drugs and drug use 
See section 11.4.1. 
11.4.4 Criminal behaviours  
See section 11.3.3 
Drug Offences 
Analysis of the 2004 Offending, Crime and Justice Survey (Budd et al. 2005) 
provides information about the involvement of minors in perpetrating drug offences, 
suggesting such offending is very rare (Table 11.16).   
 
Table 11.16: Percentage drug offending in last 12 months, by age and sex in England and 
Wales, 2004 
 
Age 10 to 11 years 12 to 13 years 14 to 15 years 
Male - 1 3 
Female - <1 2 
Total  - 1 3 
Source: Budd et al. 2005 
11.5 Responses to drug problems among minors 
11.5.1 National and legal developments  
There are a number of developments in the area of drug use amongst minors.  Not 
least are the policies around drug prevention, both universal and around school 
prevention (see below).  The main focus of work is around major initiatives designed 
to improve the health and well-being of all children.  These include; Every Child 
Matters (see below) and in particular Every child matters: change for children, young 
people and drugs (DfES, HO and DH 2005); The Children’s National Service 
Framework185 (DH 2005), Children at risk cross cutting review186, Extended Schools 
(DfES 2005) Sure Start187 and Youth Matters (DfES 2006), Choosing Health: making 
                                                 
185 The Children’s National Service Framework is a 10-year programme intended to stimulate 
long-term and sustained improvement in children’s health. Setting standards for health and 
social services for children, young people and pregnant women, the NSF aims to ensure fair, 
high quality and integrated health and social care from pregnancy, right through to adulthood.  
186 See: http://www.hm-treasury.gov.uk/spending_review/spend_ccr/spend_ccr_child.cfm  
187 See: http://www.surestart.gov.uk  
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healthy choices easier (DH 2004c), the National Behaviour and Attendance 
Strategy188, National Health and Schools Programme and Blueprint189.  
 
In Wales, the Welsh Assembly Government has set out its vision for children and 
young people in three key documents; Children and Young People: The Framework 
for Partnership190, Extending Entitlement: supporting young people in Wales191, and, 
most recently, Children and Young People: Rights to Action.192  There is also the    
National Service Framework Children, Young People and Maternity Services (Welsh 
Assembly Government 2005) and the Children’s Commissioner for Wales193.  In 
addition, the Welsh substance misuse strategy (National Assembly for Wales 2000) 
includes supporting the children of problem substance misusers as an important 
objective. 
 
In Scotland, Children: Better Integrated Children’s Services (Scottish Executive 2001) 
highlighted the major impact of parental problem drug use on children and stresses 
that helping children with drug misusing parents is a task for health education and 
social services.  Also, The Changing Children’s Services Fund194 was expected to be 
used, in part, to fund initiatives designed to help the children of problem drug users.  
The Drugs Action Plan: Protecting Our Future (Scottish Executive 2000) identified the 
children of drug misusing parents as a priority group.  Good practice guidance for 
working with children and families affected by substance misuse were published in 
2003.  All Alcohol and Drug Action Teams (ADATs) and Area Child Protection 
Committees were required to have in place local policies on support to drug misusing 
parents and their children in line with national guidance.  In addition Sure Start 
Scotland195, Social Inclusion Partnerships196 and Starting Well were initiatives, all 
designed to improve the well-being of children in disadvantaged areas 
 
In Northern Ireland the Children (Leaving Care) Act 2002, the Protection of Children 
and Vulnerable Adults Order 2003 and a new drug strategy for Northern Ireland, New 
Strategic Direction for Alcohol and Drugs 2006-2011 (DHSSPSNI 2006a), has 
prevention as a core aim and also, in order to ensure effective and co-ordinated 
implementation has established a new Strategic Direction for Alcohol and Drugs 
Steering Group (NSDSG) to maintain an overview of the strategy; reporting to which 
will be four advisory groups, one of which will be concerned with children, young 
people and families.  
Every Child Matters 
In December 2003, the Government published the Green Paper, Every Child Matters  
(HM Treasury 2003).  This set out the need to ensure that every child is properly 
protected from risk and is supported in reaching their full potential.  The Children Act 
                                                 
188 See: http://www.dfes.gov.uk/behaviourandattendance/index.cfm  
189 See: http://www.drugs.gov.uk/young-people/blueprint/  
190 See: http://new.wales.gov.uk/topics/childrenyoungpeople/frameworkpartnership/?lang=en  
191 See: 
new.wales.gov.uk/topics/childrenyoungpeople/publications/reports/extendingentitlement?la
ng=en -   
192 See: http://www.wales.gov.uk/assemblydata/N0000000000000000000000000016990.pdf  
193 See: http://www.childcom.org.uk/english/index.html  
194 See: http://www.scotland.gov.uk/Topics/People/Young-People/children-
services/17842/10263  
195 See: http://www.surestart.gov.uk/aboutsurestart/help/contacts/scotland/  
196 See: 
http://www.communitiesscotland.gov.uk/stellent/groups/public/documents/webpages/cs_0063
69.hcsp  
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2004 has helped to embed its principles in legislation.  Although the Green Paper 
and the legislation go beyond drug prevention, the Paper’s five key outcomes are:  
• being healthy;  
• staying safe;  
• enjoying and achieving;  
• making a positive contribution to the community and society; and 
• economic well-being.   
 
The exposure of young people to drug use is one of a number of issues the Green 
Paper under the ‘being healthy’ outcome addresses.  This paper and a consultation 
which followed, Every child matters: next steps (DfES 2004a), culminated in Every 
child matters: change for children (DfES 2004b), which sets out the national 
framework for local change programmes.  These are intended to build services 
around the needs of children and young people so as to shift the focus from dealing 
with the consequences of difficulties in children’s lives to preventing things from 
going wrong in the first place. 
 
Every child matters: change for children, young people and drugs (DfES, HO and DH 
2005) outlined the Government’s strategy of linking the delivery of Every Child 
Matters to the National Drug Strategy by developing universal, targeted and 
specialist services to prevent drug harm and to ensure that children and young 
people are able to reach their potential.  Local authorities are expected to progress 
towards meeting the required objectives and Drug (and Alcohol) Action Teams 
(D(A)ATs) and Directors of Children’s Services are required to agree priorities and 
set targets with respect to young people.   
 
Every Child Matters: change for children young people and drugs outlined the links 
between the Young People’s strand of the Drug Strategy and Every Child Matters 
and highlighted three priorities to reduce drug use amongst young people: 
• Reforming delivery and strengthening accountability. 
• Ensuring provision is built around the needs of vulnerable children and young 
people through a greater focus on prevention and early intervention by all 
agencies providing services for children. 
• Building service and workforce capacity. 
 
The Young People’s Substance Misuse Grant, pooling funding from a number of 
government departments, was introduced nationally in 2004 and is used, in addition 
to mainstream funding, to aid the provision of a comprehensive range of support for 
young people as outlined in Every Child Matters: change for children young people 
and drugs.  Joint teams197 based in Government Office (GO) regions are supporting 
and driving the implementation of this strategy locally.  These teams are responsible 
for identifying local problems and challenges, provide performance management and 
interventions, and are involved in negotiating targets.  
 
A number of High Focus Areas have been selected, which are expected to make 
more rapid and sustained progress in implementing the vision and priorities set out in 
this plan during 2005/06.  The twin objectives of the work in the high focus areas are: 
• to develop and test a Best Practice Model for wider dissemination; and 
                                                 
197 With staff from Government Office drug and crime teams, the DfES, the Youth Justice 
Board, the National Treatment Agency for Substance Misuse, Public Health and various 
regional bodies. 
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• to make an early and sustained impact on delivery of drug services for children 
and young people.  
 
High focus areas have been selected on a range of criteria based on local need and 
levels of current service provision and include deprived/high crime areas where drug 
misuse problems are prevalent (DfES, HO and DH 2005). 
Youth Matters 
Following on from Every Child Matters, the Government also published a Youth 
Green Paper called Youth Matters (DfES 2005); this was a consultation document, 
seeking views on how to reform services in England to improve outcomes for all 
young people aged 13 to 19, especially those who are vulnerable.  It aims to 
restructure young people’s services so that they have more choice and influence, 
encourage young people to participate in voluntary and community work, provide 
better information to them on the subjects that interest them and in a way that suits 
them, and to provide better support to those who need it.  Following consultation, the 
Government response, Youth Matters: Next Steps (DfES 2006) was published in 
March 2006 and sets out the vision for empowering young people, giving them 
somewhere to go, something to do and someone to talk to.  Subject to Parliamentary 
approval, a new duty on local authorities will seek to ensure that young people have 
access to a wide range of positive activities. Statutory guidance on how national 
standards relate to the new duty is expected to be issued in late 2006.  
National Healthy Schools Standard 
In England, all schools in the most disadvantaged areas are to become ‘Healthy 
Schools’ by 2006 with all schools working towards Healthy School status by 2009/10 
(see United Kingdom Focal Point Report 2004).  The percentage of schools 
achieving the National Healthy Schools Standard (NHSS)198 is one of the Key 
Performance Indicators of Every Child Matters (DfES et al. 2005).  
Drugs education in schools 
Drugs education is a key component of the United Kingdom drug strategy; guidance 
for schools has been published (DfES 2004c).  In England and Northern Ireland, it is 
a statutory part of the national curriculum. The aim is to develop children’s 
knowledge, skills, attitudes and understanding about drugs in order to resist them. In 
Scotland, while there is no statutory curriculum, the majority of schools provide drug 
education (Scottish Executive 2003).  Guidance on drug education for schools in 
England (DfES 2004c) and in Northern Ireland (DENI 2004) was published in 2004. 
In these countries drugs education is teacher led.  However, in Wales, the police-led 
All Wales Schools Programme encourages Police School Liaison Officers to work 
together with schools and Personal, Health and Social Education teachers under this 
aspect of prevention. 
 
The Office for Standards in Education (Ofsted) is responsible for inspecting the 
quality of drugs education in schools in England and Her Majesty’s Inspectorate of 
Education in Scotland.  
 
                                                 
198 The NHSS aims to support schools in creating an enjoyable, safe and productive learning 
environment. It covers eight areas: Personal, Social and Health Education (PSHE); 
citizenship; drug education (including tobacco and alcohol); emotional health and well being 
(including bullying); healthy eating; physical activity; safety; sex and relationship education; 
and local healthy school programmes. Health partnerships support schools in enabling them 
to become healthier places. Please see: http://www.standards.dfes.gov.uk for further details. 
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Two initiatives have been developed by Government to inform prevention work.  
Blueprint, launched in 2003 is a prevention based research programme examining 
the effectiveness of a multi-component approach to drug education (Baker 2006).  
The National Collaborating Centre for Drug Prevention (NCCDP), a research 
partnership between the National Institute for Health and Clinical Excellence (NICE) 
and the Centre for Public Health at Liverpool John Moores University has been 
funded to build the evidence base for drug prevention.  By identifying the most 
effective characteristics of programmes and interventions, which have the most 
impact upon preventing drug misuse, the NCCDP informs national and local policy 
and practice on drug misuse prevention and provides guidance for those delivering 
front line drug prevention services.  The NCCDP has already conducted reviews of 
non-traditional evidence and scholarly articles, developed guidance on putting 
evidence into practice, assisted with the development and evaluation of prevention 
programmes and continues to provide a national information service.199  
 
Several schools in Kent are introducing random drug testing of pupils in September 
2006 as part of a pilot scheme to evaluate this approach to identifying drug use at an 
early stage.  The scheme was introduced in one school in Kent in 2005.  It is reported 
that the school saw an improvement in behaviour and exam results.  DfES are now 
working with the former headmaster of this school to produce guidelines for other 
schools who may wish to adopt the scheme.200  National policy remains unchanged 
on drug testing and it remains for individual head teachers in partnership with local 
agencies and in the context of appropriate provision to decide how to approach drug 
use in their schools.  It is reported that the Scottish Executive is not considering drug 
testing in schools.201 
Specific regulations and level of enforcement of alcohol and tobacco restrictions 
The current legislation covering the sale of tobacco products is contained in The 
Children and Young Persons (Protection from Tobacco) Act 1991.  This imposes 
penalties for the sale of tobacco to persons under the age of 16 years.   
The Licensing Act 2003 brought about changes in the law on the sale of alcohol to 
anyone under the age of 18.  This Act made it an offence to sell acohol to young 
people anywhere, not just on licensed premises, or for a club to supply alcohol on 
club premises to a person under 18.  It is also an offence for someone under 18 to 
purchase, or attempt to purchase alcohol, or be supplied with alcohol in a club; to 
send anyone under the age of 18 to obtain alcohol; to buy, or to attempt to buy 
alcohol for a young person under 18 or for that latter to consume alcohol on licensed 
premises. This does not apply if the purchase is for someone aged 16 or 17 and it is 
either beer, wine or cider and it is consumed at a table meal on the premises, and 
they are accompanied by someone aged 18 or over. Table meals do not include bar 
snacks. 
In the case of both tobacco and alcohol, retailers are expected to be shown evidence 
of age, either through a photo driving license or a passport, or an accredited proof of 
age card, such as a Citizen Card, the Portman Card, or the Connexions Card. 
                                                 
199 See: http://www.drugpreventionevidence.info/  
200 See: 
http://www.teachernet.gov.uk/teachers/issue45/secondary/news/Randomdrugtestsforpupils/ 
and http://news.bbc.co.uk/1/hi/education/5032902.stm and 
http://www.timesonline.co.uk/article/0,,2-2204492,00.html  
201 See: http://news.bbc.co.uk/1/hi/scotland/5341700.stm  
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Specific regulations on volatile substances 
Volatile substance abuse is not an offence in itself, but the supply or sale of any 
product to a person under the age of 18 with the knowledge that they are going to 
inhale it for the purposes of abuse is an offence.  The sale of butane is a priority; 
regulations under The Consumer Protection Act 1987 (Section 12) regarding 
offences of selling butane lighter refills are nationwide, although there are some 
differences in Scottish law; shopkeepers can be prosecuted under common law if it 
can be proved that they knew that the product would be abused by the purchaser 
irrespective of age.  The Cigarette Lighter Refill (Safety) Regulations 1999 banned 
the supply or sale of butane cigarette lighter refills to people under the age of 18.  
The penalties for selling butane gas lighter refills to anyone under 18 are a sentence 
of up to six months imprisonment, or a maximum fine of €7,315 (£5,000), or both.  
Also in Scotland, the Solvent Abuse (Scotland) Act 1983 amended the 1968 Act and 
made VSA in itself a specific ground for referral to the Children's Reporter.  Where 
statutory intervention is considered necessary, the Children's Reporter will arrange a 
Children's Hearing to consider what action is required.  There is also a system of 
voluntary warning labels for aerosols and other products that can be abused. 
Strategies and policies for social exclusion, ADD etc that refer to drug use among 
minors 
See Every Child Matters and High Focus Areas referred to previously in this section. 
11.3.2 Prevention and treatment  
Specific treatment options for young problematic drug users 
Provision is made available locally for young people through mainstream funding and 
the Young People’s Substance Misuse Partnership Grant.  Local areas are asked to 
ensure that comprehensive support is available for young people.  In addition, for 
drug misusers identified through the criminal justice system, specific responses are 
being piloted for young people. 
Drug testing pilots for 14 to 17 year olds  
Twenty-two custody suites in police stations are piloting drug testing for 14 to 17 year 
olds who are charged with those crimes most often linked to drugs.  The purpose is 
to identify those young people who may be at risk of developing a problem with drugs 
and offending, in order to intervene early.  If a young person does test positive for a 
specified Class A drug after charge, the arrest referral scheme will be able to 
facilitate access to appropriate interventions or services, following an assessment of 
their needs.  
10 to 17 year olds 
From the 1st December 2004, there have been pilots of two community sentences for 
young people (Action Plan Orders and Supervision Orders), under new legislative 
powers within the Criminal Justice Act 2003.  This new provision is targeted at young 
people who have or are at risk of developing substance misuse problems and who 
may benefit from structured care planned treatment as part of a community sentence.  
It provides the courts with a sentencing option for young offenders specifically 
designed to tackle their drug misuse, providing an alternative to custody.  The pilots 
are being independently evaluated and will contribute to the evidence base of 
working with children and young people exhibiting risk-taking behaviour. 
UNITED KINGDOM FOCAL POINT REPORT 2006 
 157
Institutional responses  
Responses through social reintegration 
See, Every Child Matters and High Focus Areas in section 11.3.1.  In addition there 
are specific initiatives to encourage young people to undertake activities seen as 
alternatives to drug use.  In Scotland 31 projects are to share €863,000 (£590,000) 
from the Scottish Drugs Challenge Fund.  This scheme aims to unite the public, 
private and voluntary sector in helping communities stand up to the problems of drug 
misuse in Scotland at grassroots level (Scottish Executive 2006f).  Projects include 
football based diversionary activities, helping young people with a drug problem to 
acquire skills, music and film-based diversionary projects; one project aims to teach 
young people fly-fishing.  In England and Wales, Positive Futures is a national social 
inclusion programme using sport and leisure activities to engage with disadvantaged 
and socially marginalised young adults.  It is delivered across 119 partnership 
projects.202  Also see Chapter 3.2.2. 
Trends and changes in recent years 
There has been a strong focus on vulnerable young people in the United Kingdom in 
recent years as seen in the Every Child Matters agenda, both in terms of prevention, 
through targeted responses, and in the provision of specialist treatment, separate 
from adult treatment services, which should provide a holistic range of interventions 
(see below). 
Early intervention strategies and indicated prevention for at risk children 
Targeted interventions for young people foresee:  
• Early assessment of all vulnerable children and young people in key risk groups 
for drug misuse problems, as part of wider needs assessment.  Drug misuse 
issues are part of the Common Assessment Framework for children and young 
people, to enable practitioners’ first assessments of need to pick up on drug 
misuse issues and to lead to effective intervention. 
• Care management and the appointment of a lead professional for all children and 
young people who need support and intervention for their drug misuse, in line 
with Every child matters: change for children. 
• Integrated information systems to help agencies work together to track 
interventions with individual children and young people with particular 
consideration given to provision for the following ‘at risk’ groups.  It is expected 
that protocols will be in place to provide prompt access to specialist services 
where required. 
 
Vulnerable young people identified as at risk of developing problems around drugs 
are: children of problem drug users; persistent truants and school excludees; ‘looked 
after’ children; young offenders and others, including homeless young people, young 
people abused through prostitution, teenage mothers and young people not in 
education, employment or training.  
Care Matters 
The Looked After Children Green Paper published in 2006 includes proposals to 
ensure that drug use is identified through health assessments with looked after 
children and training is provided on drug issues to foster carers. 
                                                 
202 See: http://www.drugs.gov.uk/young-people/positive-futures/  
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Volatile substance abuse 
A national framework for VSA published July 2005 (DH et al. 2005) sets out an action 
plan aimed specifically at reducing deaths and harms associated with VSA.  It aims 
for: 
• a progressive decline in the number of deaths from VSA by children, young 
people and adults; 
• a reduction in the incidence of harm from accidents and trauma as a result of 
abusing volatile substances; 
• an increase in public awareness of VSA and its risks; 
• increased identification of children and young people abusing or at risk of abusing 
volatile substances; and 
• a reduction in illegal under-age sales of volatile substances to children and young 
people.  
 
Specific actions are to:  
• provide effective education on VSA to all children and young people, including the 
most disadvantaged;  
• provide effective targeted interventions for children and young people abusing or 
at risk of abusing volatile substances; 
• reduce the availability and accessibility of volatile substances, with a focus on 
butane gas lighter refills;  
• build the capacity of parents, carers and practitioners to identify and work 
effectively with children and young people who are abusing or at risk of abusing 
volatile substances; and  
• increase the evidence base with regard to what works in reducing deaths and 
harm from VSA.  
 
The effectiveness of the work will be monitored principally by the number of VSA 
deaths among children and young people each year. 
 
The action plan also identifies new interventions.  A key priority area is to provide 
better information about VSA, including through the FRANK information helpline. 
 
The Scottish Executive has also developed a comprehensive programme of action 
that includes providing advice on solvents through the Know the Score information 
line, the distribution of materials to retailers in 2005 to raise awareness of the law 
governing sales of the items in question and the provision of drug education, 
including about solvents, in nearly all schools.  
 
In addition, throughout the United Kingdom Governments support proof-of-age cards. 
Training for general practitioners, paediatricians, social services and families to 
identify and respond to risk profiles such as ADD, CD, ODD 
Identifying these is part of the training offered to medical practitioners. 
Early identification and treatment for Attention Deficit Disorders 
Child and Adolescent Mental Health Services are expected to consider issues around 
substance misuse in the diagnosis and treatment of all referrals (see Common 
Assessments Framework referred to in the above section on early intervention 
strategies and below).  
Selective prevention for families at risk 
In response to Hidden harm: responding to the needs of children of problem drug 
users (ACMD 2003), specific reference has now been made to the children of drug 
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using parents in Local Safeguarding Children’s Board Guidance.  The ACMD 
recommends that DfES writes to Local Safeguarding Children’s Boards (LSCBs) and 
the Home Office to D(A)ATs to ensure this is highlighted and also that this guidance 
is supported by specific reference being made to this group of children in other key 
documents.203  In particular they are concerned that the Every Child Matters: Core 
Common Assessment Framework (CAF) includes specific trigger questions in 
guidance and checklists, as this has been seen to identify a higher number of 
children at risk of parental substance misuse.  It wishes DH to: 
• screen all pregnant women for substance misuse and routinely record such 
information – this is not currently the case; and 
• provide specific guidance and protocols to support specialist care for pregnant 
drug users needs to be in place in all maternity hospitals. 
  
Further, that Primary Care Trusts need to ensure that the health needs and well 
being of the children of problem drug users are being met through the Single Plan for 
Children and Young People, under the ’being healthy’ outcome of Every Child 
Matters, as well as contributing to ensuring their safety under the ‘staying safe’ 
outcome.  Appropriate responses to this group of children are required within 
developing Children’s Trusts and across mainstream health services.  For children of 
drug using parents Sure Start 204 is also expected to play a key role. 
 
The Scottish Executive commissioned a number of pieces of research and a scoping 
study by Templeton et al. (2006).  It also established a Think Tank on the impact of 
parental drug use (Russell 2006).  Following this work, a strategy has been published 
(Scottish Executive 2006c).  Key actions include: 
• initiating across Scotland, by March 2007, a framework for automated messages 
to be sent to all practitioners involved whenever the social work system records a 
formal child protection activity; 
• through the Social Work Inspection Agency, conducting a pilot multi-agency 
inspection of substance misuse services, which will include the impact of these 
services on the children of clients; 
• ensuring all ADATs and Child Protection Committees have in place local 
protocols and policies for joint working across agencies with children and families 
affected by substance misuse;  
• promoting partnerships between local statutory agencies and voluntary 
organisations; 
• continuing to encourage agencies, including those whose primary focus is on 
adults, to ensure staff have access to appropriate training, including multi-agency 
training where appropriate; 
• monitoring the impact of the extra €18 (£12) million provided to local authorities 
for investment in local fostering services to ensure it meets the aims of improving 
recruitment, retention and placement choice; 
• considering the findings of the audit of foster care commissioned from The 
Fostering Network205, which includes recommendations about training, placement 
limits and allowances, and action as appropriate; and 
• developing a new national fostering strategy in 2006-2007. 
 
                                                 
203 See: http://www.drugs.gov.uk/publication-search/young-people/acmd-letter-
lscb?view=Binary#search=%22Local%20%20Safeguarding%20Children's%20Board%20Guid
ance.%20%20ACMD%20%22  
204 Sure Start is the Government programme to deliver the best start in life for every child. It 
brings together, early education, childcare, health and family support. 
205 For more information see: www.fostering.net  
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In addition, the Scottish Executive and local agencies are to explore the possibility of 
providing facilities for children and young people so that they can access direct help 
for themselves. 
Drug tests for parents 
It has been reported by the BBC that drug tests for parents are being discussed and 
suggests that if parents can prove they are drug free their children will be returned to 
them.206 
                                                 
206 For more information see: http://news.bbc.co.uk/1/hi/scotland/4824122.stm 
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12. Cocaine and crack  
12.1 Prevalence, patterns and trends of cocaine and crack use 
12.1.1 Cocaine use among the general population 
15 to 64 years olds 
A United Kingdom estimate of drug use in the general population, aged 15 to 64, 
produced in 2005 (Hay 2005), is based on the British Crime Survey (BCS)207 for 
2003/04, the Northern Ireland Drug Prevalence Survey (NIDPS)208 for 2002/03 and 
the Scottish Crime Survey (SCS)209 for 2003. 
 
Table 12.1 shows that lifetime, recent and current use in England and Wales is 
considerably higher than in Northern Ireland and Scotland, 6.8, 2.5 and 1.1 per cent 
respectively.  Based on the Northern Ireland Crime Survey210 for 2004, Northern 
Ireland has the lowest prevalence.  Based upon the Northern Ireland Drug 
Prevalence Survey for 2002/03, estimates for lifetime, recent and current use are 
even lower; 1.6, 0.5 and 0.1 respectively. 
 
Table 12.1: Percentage prevalence of lifetime, last year and last month drug use by drug and 
country amongst 15 to 64 year olds in the United Kingdom 
 
BCS 
2003/04 
NICS 
2003/04 
NIDPS 
2002/03 SCS 2003 UK* Drug 
16 to 59 16 to 59 15 to 64 16 to 64 15 to 64 
Lifetime prevalence 
Any drug 35.6 27.4 20.0 23.4 34.1 
Cocaine 
(including crack) 6.7 3.3** 1.6 4.6 6.5 
Last year prevalence 
Any drug 12.3 9.7 6.4 8.5 11.8 
Cocaine 
(including crack) 2.4 1.1** 0.5 1.4 2.3 
Last month prevalence 
Any drug 7.5 6.2 3.4 4.7 7.1 
Cocaine 
(including crack) 1.1 0.6** 0.1 0.4 1.0 
Base 24,422 3,104 3,516 4,665 35,707 
                                                 
207 In England and Wales, the British Crime Survey (BCS) is a crime and victimisation 
household survey.  It questions respondents, aged 16 to 59, about a number of crime-related 
topics including their experience of illicit drugs.  In 2002, it became a continuous survey, 
reporting quarterly.  The sample size for the drugs module was 24,422 in 2003/04.  
208 The Northern Ireland Drug Prevalence Survey is based on the European Model 
Questionnaire and recommended methodology.  The 2002/03 was the first such survey 
carried out in Northern Ireland.  3,516 people completed the Drug Prevalence Survey and 
3,104 people completed the drugs component of the Northern Ireland Crime Survey. 
209 The Scottish Crime Survey (SCS) is a crime and victimisation survey.  It asks comparable 
questions to those in the BCS but surveys all adults aged 16 years and over.  4,665 people 
completed the drugs section of the survey in 2003. 
210 The Northern Ireland Crime Survey is a crime and victimisation household survey.  It 
questions respondents, aged 16 to 59, about a number of crime-related topics including their 
experience of illicit drugs. 
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* The United Kingdom estimate is achieved by combining the data from the British Crime 
Survey, the Northern Ireland Drug Prevalence Survey and the Scottish Crime Survey.   
** These figures for the Northern Ireland Crime Survey are for cocaine only (and do not 
include data for crack). 
Source: Standard Tables prepared for United Kingdom Focal Point  
Young people  
Young people have a higher prevalence of use in all three recall periods, with the 
wider age group (15 to 34) having higher lifetime and recent prevalence, but the 
younger age group (15 to 24) being more likely to have used currently. (Table 12.2) 
 
Table 12.2: Percentage prevalence of lifetime, last year and last month drug use by drug and 
country amongst 15/16 to 24 and 15/16 to 34 year olds in the United Kingdom 
 
BCS 
2003/04 
NICS 
2003/04 
NIDPS 
2002/03 SCS 2003* UK* Drug 
16/24 16/34 16/24 16/34 15/24 15/34 16/24 16/34 15/24 15/34 
Lifetime prevalence 
Any drug 46.6 48.2 40.1 41.7 28.5 30.9 39.8 38.5 45.4 46.9 
Cocaine 
(including crack) 9.1 11.6 5.4** 5.9** 2.6 2.9 10.8 8.7 9.0 11.1 
Last year prevalence 
Any drug 27.8 22.1 24.0 18.3 14.5 11.6 25.9 18.0 27.2 21.4 
Cocaine 
(including crack) 5.0 4.9 2.5** 2.5** 1.4 1.0 5.1 3.2 4.9 4.7 
Last month prevalence 
Any drug 17.3 13.6 16.2 12.1 9.0 6.1 15.6 10.4 16.9 13.1 
Cocaine 
(including crack) 2.7 2.4 1.5** 1.5** 0.2 0.2 1.3 0.9 2.5 2.2 
Base 5,429 8,590 286 817 768 1,550 619 1,193 N/K N/K 
* The United Kingdom estimate is achieved by combining the data from the British Crime 
Survey, the Northern Ireland Drug Prevalence Survey and the Scottish Crime Survey.   
** These figures for the Northern Ireland Crime Survey are for cocaine only (and do not 
include data for crack). 
Source: Standard Tables prepared for United Kingdom Focal Point 
 
Lifetime use in England and Wales and Scotland is much higher than in Northern 
Ireland, though for recent and current use the difference between parts of the United 
Kingdom is narrower. 
12.1.2 Trends in cocaine use  
Trends over time can be best seen through looking at data from each country 
individually. 
Trends in cocaine and crack use in England and Wales: 1996 to 2005/06  
The use of drugs in the general population in England and Wales has been 
measured since 1994 when the British Crime Survey first began to monitor drug 
prevalence; however published information based on the 1994 crime survey does not 
provide data on prevalence of cocaine (Ramsey and Percy 1996).  Table 12.3 shows 
trends in use of powder cocaine (cocaine) and crack cocaine (crack) between 1996 
and 2005/06 amongst the population aged 16 to 59 and Table 12.4 amongst the 
population aged 16 to 24.  
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Table 12.3: Percentage prevalence of adults aged 16 to 59 reporting having used any drug, 
cocaine and crack in England and Wales, 1996 to 2005/06 
 
Drug 1996 1998 2000 2001/
02 
2002/
03 
2003/
04 
2004/
05 
2005/ 
06 
Any Drug 
Lifetime 30.5 33.6 35.7 34.0 35.7 35.6 34.5 34.9 
Last year 11.1 12.1 11.9 11.9 12.2 12.3 11.3 10.5* ** 
Last month 6.7 7.1 7.2 7.4 7.4 7.5 6.7 6.3* 
Cocaine 
Lifetime 3.0 3.7 5.5 5.1 6.1 6.7 6.0 7.2* ** 
Last year 0.6 1.2 2.0 2.0 2.1 2.4 2.0 2.4* ** 
Last month 0.2 0.4 0.7 0.9 0.9 1.1 0.9 1.2* ** 
Crack 
Lifetime 0.7 0.7 1.1 0.7 0.9 0.9 0.8 0.9 
Last year 0.1 0.1 0.3 0.2 0.2 0.2 0.1 0.2 
Last month 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1* 
*Statistically significant change at the 5% level from 1998 to 2005/06 
**Statistically significant change at the 5% level from 2004/05 
Source: Roe and Man 2006 
 
Table 12.4: Percentage prevalence of 16 to 24 year olds reporting having used any drug, 
cocaine and crack in England and Wales, 1996 to 2005/06 
 
Drug 1996 1998 2000 2001 
/02 
2002 
/03 
2003 
/04 
2004 
/05 
2005 
/06 
Any Drug 
Lifetime 48.6 53.7 52.0 49.1 48.2 47.5 46.0 45.1* 
Last year 29.7 31.8 29.9 30.0 28.5 28.3 26.5 25.2* 
Last month 19.2 20.8 19.0 19.3 18.1 17.5 16.4 15.1* 
Cocaine 
Lifetime 4.3 6.8 10.4 8.6 9.3 9.7 9.1 10.6* ** 
Last year 1.3 3.1 5.2 5.1 5.1 5.2 5.1 5.9* 
Last month 0.5 0.9 1.8 2.2 2.1 2.7 2.1 3.0 * ** 
Crack 
Lifetime 1.7 1.5 2.3 1. 1.3 1.6 1.1 1.3 
Last year 0.2 0.3 0.9 0.5 0.5 0.4 0.1 0.4** 
Last month 0.2 0.0 0.2 0.1 0.3 0.2 0.1 0.2 
*Statistically significant change at the 5% level from 1998 to 2005/06 
**Statistically significant change at the 5% level from 2004/05 
Source: Roe and Man 2006 
 
A report based on surveys from 1994 to 1998 suggested that cocaine was the one 
specific substance for which there was a significant increase, for recent use, for all 
respondents, both male and female and that amongst young people there were 
significant increases in its use for all three recall periods between 1996 and 1998 
(Ramsey and Partridge 1999).  In 2000, a comparatively large increase in use was 
again reported (Ramsey et al. 2001).  From 2000 to 2003/04 recent use of cocaine 
remained broadly stable and in 2004/05 decreased amongst 16 to 59 year olds (as 
did the use of ‘any drug’) since the previous year (2003/04).  Over that year there 
was also a significant decrease in use by young people aged 16 to 24.  Nevertheless, 
amongst this group, in 2004/05 cocaine was the next most commonly used drug after 
cannabis, the latter used by 23.5 per cent recently, and 4.9 per cent currently.  In 
2005/06 the use of ‘any drug’ continued to fall but cocaine use increased significantly 
to 2003/04 levels or higher for lifetime and current use. 
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It is of note that the increase in use of cocaine may be related to the decrease in the 
use of amphetamines over the same period (see Figures 2.1 to 2.3 in Chapter 2).  
 
Reported use of crack in England and Wales has remained essentially stable since 
1996 but, after a significant fall in 2004/05, use amongst 16 to 24 year olds increased 
significantly in 2005/06 back to 2003/04 levels. (Tables 12.3 and 12.4) (Roe and Man 
2006). 
Trends in cocaine and crack use in Northern Ireland: 1998 to 2003/04 
Trends in cocaine use in Northern Ireland can be best identified through the Northern 
Ireland Crime Survey (NICS) which has been reporting drug use since 1995 (Table 
12.5).  This shows an increase in lifetime use for both adults and young people over 
time.  For 2002/03, data from the Northern Drug Prevalence Survey show lower 
prevalence.  This might suggest that prevalence estimates based on victimisation 
surveys produce higher estimates than results obtained from the European Model 
Questionnaire.  Prevalence is again higher amongst young people.  
 
Table 12.5: Percentage lifetime prevalence of any drug, cocaine and crack by age in Northern 
Ireland, 1998 to 2003/04 
 
Drug 1998 NICS  2001 
NICS  
2002/03 NIDPS 2003/04 
NICS 04 
Age 16-59 16-59 15-64 16-59 
Any drug  24 26 20.0 25.4 
Cocaine  2.0 2.0 1.6 3.3 
Crack  1.0 <1.0 0.2 0.8 
Young people  16-24 15-24 15-24 
Any drug  43  40.1 
Cocaine  3.0 1.6 5.4 
Crack  0.0 0.2 0.7 
Source: Hague et al. 2000; McMullan and Kerr 2003; McMullan and Ruddy 2005; NACD and 
DAIRU 2006 
Trends in cocaine use in Scotland: 1996 to 2004  
Scotland shows a rise in use, particularly between 2000 and 2003 (Table 12.6).  
Analysis has not been undertaken for current prevalence over this time period. 
 
Table 12.6: Percentage prevalence of illegal drug use amongst adults by drug in Scotland, 
1993 to 2004   
 
Drug 1993 1996 2000 2003 2004  %change 
1993 to 2004 
Lifetime prevalence 
Any drug  18.5 22.5 19.2 25.3 23.7 +5.2 
Cocaine powder 1.5 2.6 2.5 4.6* 4.6 +3.1 ** 
Crack  0.4 0.7 1.0 1.2 1.2 +.8 ** 
Last year prevalence 
Any drug 6.8 9.0 6.6 9.2 7.7 +0.9 
Cocaine powder 0.4 1.0 0.7 1.4 1.5 +1.1 ** 
Crack  - 0.2 - 0.2 0.2 +0.2 * 
Base 3,196 3,175 2,886 4,665 2,955  
Data for 1996 and 2000 are for those aged 16 to 59 reported by Fraser (2002), 2003 data are 
for those aged 16 to 64 and are derived from the Standard Table.  
*significant at the 95 per cent confidence interval 
 ** significant at the 99 per cent confidence interval 
Source: Murray and Harkins 2006 
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For those aged 16 to 34 and 16 to 24 data are only available for 2003 and 2004.  
This shows a decrease in use of cocaine from 2003 to 2004 (Table 12.7). 
 
Table 12.7: Percentage prevalence of illegal drug use amongst 16 to 24 and 16 to 34 year 
olds by drug in Scotland, 2003 and 2004  
 
16 to 24 years 16 to 34 years Drug 2003 2004 2003 2004 
Lifetime prevalence 
Any drug  39.8 35.2 38.5 36.2 
Cocaine (including crack) 10.8 5.6 8.7 8.1 
Last year prevalence 
Any drug 25.9 24.0 18.0 15.7 
Cocaine (including crack) 5.1 3.0 3.2 2.9 
Last month prevalence 
Any drug  15.6 13.1 10.4 8.4 
Cocaine including crack) 1.3 0.5 0.9 0.7 
Base numbers not known 
Source: Standard Tables prepared for United Kingdom Focal Point based on crime surveys 
Estimated number of users in England and Wales 2004/05 
Estimates of the actual number of cocaine and crack users are available for England 
and Wales (Table 12.8). 
 
Table 12.8: Estimates of number of people who used cocaine and crack in the last month 
aged 16 to 59 and 16 to 24 in England and Wales, 2004/05 and 2005/06 
 
16-59 years 16-24 years Drug 2004/05 2005/06 2004/05 2005/06 
Cocaine 
Best Estimate 279,000 368,000 127,000 188,000 
Lower Estimate 241,000 325,000 103,000 158,000 
Higher Estimate 324,000 418,000 155,000 223,000 
Crack 
Best Estimate 16,000 25,000 4,000 13,000 
Lower Estimate 9,000 16,000 1,000 7,000 
Higher Estimate 30,000 41,000 13,000 26,000 
Source: Roe 2005; Roe and Man 2006 
Gender differences  
As with use of most drugs, males are more likely to use than females (Tables 12.9 
and 12.10).  
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Table 12.9: Percentage prevalence of use of any drug and cocaine (including crack) amongst 
adults aged 16 to 59 by gender in England and Wales 2005/06, Northern Ireland 2003/04 and 
Scotland 2004  
 
BCS 2005/06 NICS 2003/04 SCS 2004 Drug Male Female Male Female Male Female 
Lifetime 
Any Drug 40.6 29.4 31.6 23.7 25.7 18.9 
Cocaine (including crack)  9.5 5.1 4.4* 2.3* 5.3 3.5 
Last year 
Any drug  13.7 7.4 11.5 8.1 8.1 6.2 
Cocaine (including crack) 3.4 1.6 1.5* 0.7* 1.5 1.2 
Last month  
Any drug  8.6 4.0 7.4 5.1 4.9 2.6 
Cocaine (including crack) 1.7 0.7 0.9* 0.3* 0.7 0.2 
Base   13,434 16,170 957 1,164 1,685 1,765 
* These figures for the Northern Ireland Crime Survey are for cocaine only (and do not include 
data for crack). 
Source: Standard Table prepared for United Kingdom Focal Point based on crime surveys 
 
Table 12.10: Percentage prevalence of use of any drug and cocaine (including crack) among 
16 to 24 and 16 to 34 year olds by gender in England and Wales 2005/06 and Scotland 2004  
 
BCS 2005/06 SCS 2004 
16-24 16-34 16-24 16-34 Drug 
Male  Female Male  Female Male  Female Male  Female 
Lifetime 
Any Drug 49.2 40.9 52.0 41.3 35.6 34.7 39.0 33.5 
Cocaine*  13.3 8.2 15.3 8.9 3.8 7.3 9.0 7.2 
Last year 
Any Drug 29.9 20.6 24.9 14.1 17.7 20.3 15.9 14.1 
Cocaine*  7.6 4.3 6.5 3.3 2.1 3.8 2.8 2.8 
Last month 
Any Drug 19.2 11.1 15.6 7.9 11.1 7.3 9.8 5.8 
Cocaine*  4.1 2.0 3.2 1.6 1.0 0.0 1.1 0.3 
*includes crack 
data for this age group is not available by gender in Northern Ireland 
Source: Standard Table prepared for United Kingdom Focal Point based on crime surveys 
Age of first use  
Analysis of age of first use in England and Wales in 2004/05 does not provide 
information by particular drugs.  The 2004 SCVS suggests a majority of both men 
and women start to use cocaine in their early twenties (Murray and Harkins 2006).  In 
Northern Ireland the average age of first use of cocaine powder was age 22; no 
regular female users of cocaine powder were identified in the survey (NACD and 
DAIRU 2006).  In both surveys base numbers are small and therefore, findings 
should be treated with caution. 
Regional differences  
Differences in cocaine use between England and Wales, Northern Ireland and 
Scotland have been referred to previously.  Within England and Wales, Ramsey and 
Partridge (1999) reporting on the 1998 BCS looked specifically at regional variations 
in use of cocaine and showed that it was more prevalent in London, the South and 
Merseyside than elsewhere in England and Wales.  Roe (2005), reporting on the 
2004/05 BCS found that London, the North West, (of which Merseyside is a part) and 
the South, (both South East and South West), continued to have a higher prevalence 
than the rest of England, all with recent prevalence of over two per cent, though 
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Wales also had a prevalence rate of 2 per cent.  In 2005/06 a rise in recent cocaine 
use was reported across all regions apart from Wales where it had fallen.  London 
continued to have the highest prevalence but use in the North East rose above other 
regions, having the second highest prevalence of recent cocaine use in England and 
Wales.  The Eastern region also saw a large rise in cocaine use, having the third 
highest prevalence along with the South West and North West, in the South East 
recent cocaine use remained stable at 2.2 per cent (Roe and Man 2006). 
 
Amongst 16 to 24 year olds in 2004/05, the South, (both South East and South West) 
had a higher prevalence than elsewhere in England and Wales, including London, 
although London and Wales had the next highest prevalence, with the North West in 
fifth place.  In 2005/06 the pattern was markedly different with the South, both East 
and West, and Wales reporting a fall in recent cocaine use.  The North East 
experienced a large rise and had the highest prevalence in the country, followed by 
the North West and London (Roe and Man 2006). 
12.1.3. Analysis of prevalence by education, employment, risk perception and 
urbanisation level  
England and Wales  
The report on the 1994 BCS noted that in the 1980s cocaine was referred to as the 
‘yuppie’ drug providing evidence of its use amongst more affluent urban young 
people (Ramsey and Percy 1996).  The 2003/04 BCS report undertook an in depth 
analysis of drug use by a number of social characteristics, these included education 
and employment (Chivite-Matthews et al. 2005). 
Education 
Figure 12.1 suggests that in the general population those without educational 
qualifications are less likely to have used drugs recently, including cocaine than 
those with the highest level of qualifications; a degree, diploma or A levels. 
 
Figure 12.1: Percentage prevalence of 16 to 59 year olds reporting having used any drug, 
cannabis and cocaine in the last year by respondent’s highest level of education in England 
and Wales, 2003/04 
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Source: Chivite-Matthews et al. 2005 
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Analysis from the 2005/06 BCS also shows that people with no qualifications are 
least likely to use cocaine (Chivite-Matthews et al. 2005). 
Employment 
Analysis suggests that the unemployed are considerably more likely to have used 
any drug, including crack and cocaine, than those who are employed, though the 
latter are more likely to have used cocaine (though not crack) than those reported as 
being economically inactive.  Crack use is more prevalent amongst the unemployed 
(Chivite-Matthews et al. 2005). Analysis from the 2005/06 BCS found similar results 
for cocaine use (Roe and Man 2006). 
Risk perception 
Risk perception in the use of cocaine and crack is not available for the 2004/05 BCS 
and the 2004 SCVS.  Analysis of the Northern Ireland Drug Prevalence Survey 
provides information on risk perception in the use of cocaine.  Those who had used 
cocaine were likely to perceive the risk to be lower than those who had not used  
(NACD and DAIRU 2006). 
Urbanisation level 
Analysis of the 2000 BCS (Ramsey et al. 2001) showed that affluent young urbanites 
were more likely to use cocaine than other groups.  The 2003/04 BCS analysis 
shows that that those living in inner city areas are more likely to use both cocaine 
and crack and those living in rural areas are the least likely (Chivite-Matthews et al. 
2005). 
Frequency of visits to pubs and wine bars  
Frequency of visits to pubs and wine bars in 2003/04 was analysed by different age 
groups (Table 12.11) and suggests that younger people (age 16 to 29) who made 
three or more evening visits to pubs or wine bars had the highest proportion of 
cocaine use (as well as ecstasy and hallucinogen use).  Similarly, amongst older 
respondents (aged 30 to 59) who visited pubs or wine bars three or more evenings 
per week in the last month levels of cocaine use were greater than those who made 
less frequent visits to pubs or wine bars respectively (Chivite–Matthews et al. 2005).  
Analysis from the 2005/06 BCS found similar results for cocaine (Roe and Man 
2006). 
 
Table 12.11: Percentage of 16 to 29, 30 to 59 and 16 to 59 year olds reporting having used drugs 
in the last year by frequency of visits to a pub or wine bar in the evening in the last month in 
England and Wales, 2003/04 
 
Age 
group 16-29 year olds 30-59 year olds 16- 59 year olds Total 
Visits to 
pubs or 
wine bars 
< 3 times 
a week 
> 3 times 
a week 
< 3 times 
a week 
> 3 times 
a week 
< 3 times 
a week 
> 3 times 
a week  
Cocaine 3.7 13.1 1.0 3.1 1.7 8.3 2.4 
Crack 0.4 0.6 0.1 0.1 0.2 0.4 0.2 
Any Drug 21.9 42.2 6.2 14.1 10.3 28.6 12.3 
Base 4,349 910 17,512 1,423 21,861 2,334 24,197 
Source: Chivite–Matthews et al. 2005 
Visits to discos and nightclubs  
In 2003/04, analysis was also undertaken of recent drug use by frequency of visits to 
nightclubs or discos in the last month showing that use of cocaine by club goers of all 
ages was much higher than those who do not visit such venues (Table 12.12). 
Analysis of the 2005/06 found similar results (Roe and Man 2006). 
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Table 12.12: Percentage of 16 to 29, 30 to 59 and 16 to 59 year olds reporting having used 
drugs in the last year by visits to discos and nightclubs in England and Wales, 2003/04 
 
Age group 16-29 years 30-59 years 16- 59 years  
Visits to night 
clubs or discos 
None Club 
goers 
None Club 
goers 
None Club 
goers 
Total 
Cocaine   3.3 8.0 0.8 4.5 1.3 6.9 2.4 
Crack  0.4 0.5 0.1 0.1 0.1 0.4 0.2 
Any Drug  18.5 34.0 5.8 16.5 8.2 28.4 12.3 
Base 2,898 2,362 17,125 1,811 20,023 4,173 24,197 
Source: Chivite-Matthews et al. 2005 
 
Other characteristics analysed were: ACORN category: whether lived in a council 
estate area; marital status; household structure; household income; accommodation 
type; social class; physical disorder and disability.  Differences were found in the 
following. 
Neighbourhood type 
Analysis of both the 2000 BCS (Ramsey et al. 2001) and 2004/05 BCS (Chivite-
Matthews et al. 2005) suggested that those living in ‘rising’ neighbourhoods were the 
most likely to use cocaine, while those in ‘thriving’ and ‘expanding’ neighbourhoods 
were the least likely to use.  ACORN stands for 'A Classification of Residential 
Neighbourhoods' and is a based on 40 census variables covering demographic 
structure, household composition, housing, socio-economic structure and residents' 
employment characteristics.  Analysis of the 2005/06 BCS is based upon revised 
ACORN types and therefore differs from that of the previous BCS.  However, it 
shows that cocaine use is highest amongst those neighbourhoods described as 
‘urban prosperity’ areas.  Analysis is confined to cocaine use and does not allow 
comparison with use of any drug but previous analysis has shown the two are linked. 
(Table 12.13). 
 
Table 12.13: Percentage of 16 to 59 year olds reporting having used cocaine in the last year 
by ACORN category in England and Wales, 2005/06 
 
ACORN Wealthy 
Achiever 
Urban 
Prosperity 
Comfortably 
Off 
Moderate 
Means 
Hard 
Pressed  
Total 
Cocaine 1.5 4.8 2.3 2.3 2.4 2.4 
Base 7,645 2,743 9,635 4,357 5,333 29,784 
Source: Roe and Man 2006  
Marital status  
Single people and cohabiting couples were considerably more likely to use any drug 
as well as cocaine than those who were married, divorced or separated (Table 
12.14). 
 
Table 12.14: Percentage of 16 to 59 year olds reporting having used drugs in the last year by 
marital status in England and Wales, 2003/04 
 
Drug  Marital Status   
 Married Cohabiting Single Widowed Divorced Separated Total 
Cocaine  0.7 4.0 5.4 - 1.0 0.9 2.4 
Cannabis 4.1 15.9 21 .8 4.0 8.7 7.5 10.8 
Any Drug 4.7 18.4 24.7 5.4 10.0 9.1 12.3 
Base 12,005 2,537 6,203 390 2,179 875 24,197 
 numbers for crack were too small for analysis 
Source: Chivite-Matthews et al. 2005 
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Household structure 
Analysis by household structure suggests that those without children are the most 
likely to use cocaine, though a single adult living with children was more likely to use 
than households with more than one adult, plus children (Chivite-Matthews et al. 
2005). 
Household income 
Analysis by household income shows that middle income families (those with an 
income of over £20,000, but less than £30,000) are less likely to use cocaine (and 
any drug) than either those on low incomes or the more affluent (Table 12.15). 
 
Table 12.15: Percentage of 16 to 59 year olds reporting having used drugs in the last year by 
household income in England and Wales, 2003/04 
 
Drug Household income  
 Less than 
£5,000 
£5,000 to 
less than 
£10,000 
£10,000 to 
less than 
£20,000 
£20,000 to 
less than 
£30,000 
£30,000 or 
more 
Total 
Cocaine 2.2 2.6 2.6 1.7 2.6 2.4 
Cannabis  13.1 13.7 10.6 8.7 10.2 10.8 
Any Drug  15.4 15.1 12.2 9.9 11.6 12.3 
Base  1,327 1,806 4,053 4,205 8,351 24,197 
numbers for crack were too small for analysis 
Source: Chivite-Matthews et al. 2005 
Tenure 
Analysis of the 2003/04 BCS by tenure confirms the analysis undertaken by Ramsey 
et al. (2001) of the 2000 BCS that those living in private rented accommodation are 
much more likely to use cocaine (and any drug) than those who either own a property 
or are social renters, the latter being more likely to use cocaine (and any drug) than 
the former (Table 12.16). 
 
Table 12.16: Percentage of 16 to 59 year olds reporting having used drugs in the last year by 
tenure in England and Wales, 2003/04 
 
Drug Tenure 
 Owner 
occupiers 
Social renters Private 
renters 
Total 
Cocaine 1.7 2.5 5.6 2.4 
Crack  0.1 0.3 0.3 0.2 
Cannabis 8.2 13.3 21.2 10.8 
Any Drug 9.4 15.5 23.9 12.3 
Base 17,244 4,036 2,874 24,197 
Source: Chivite-Matthews et al. 2005 
Accommodation type 
Those living in flats or maisonettes are more likely to use any drug, including cocaine 
and crack than those living in any other type of accommodation, again confirming 
analysis undertaken by Ramsey et al. (2001) of the 2000 BCS (Table 12.17).  
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Table 12.17: Percentage of 16 to 59 year olds reporting having used drugs in the last year by 
accommodation type in England and Wales, 2003/04 
 
Drug Accommodation type 
 All houses Detached Semi-
detached 
Terrace Flats/ 
maisonettes 
Total 
Cocaine  2.1 1.4 1.9 2.8 5.4 2.4 
Crack 0.2 0.1 0.1 0.2 0.3 0.2 
Cannabis  10.0 8.0 9.0 12.8 17.6 10.8 
Any Drug  11.5 9.0 10.6 14.4 20.1 12.3 
Base  20,679 5,656 7,970 7,053 2,457 24,197 
Source: Chivite-Matthews et al. 2005 
Social class 
Professional people and skilled non-manual were least likely to use, with semi-
skilled, skilled and managerial and technical people most likely to use cocaine (Table 
12. 18) 
 
Table 12.18: Percentage of 16 to 59 year olds reporting having used drugs in the last year by 
social class in England and Wales, 2003/04 
 
Drug Social Class  
 Professional Managerial 
& technical 
Skilled 
non-
manual 
Skilled 
manual 
Semi-
skilled 
Unskilled Total 
Cocaine 1.8 2.6 1.5 2.9 3.3 2.1 2.4 
Cannabis 7.7 10.0 9.5 12.3 11.4 11.3 10.8 
Any Drug 8.4 11.4 11.1 13.9 13.4 12.9 12.3 
Base 1,111 7,261 5,201 4,038 3,376 1,279 24,197 
numbers for crack were too small for analysis 
Source: Chivite-Matthews et al. 2005 
 
No difference was found in whether individuals lived in a council estate or non-
council estate area, or had a disability or physical disorder (Chivite-Matthews et al. 
2005).  
12.1.4 Analysis of use of cocaine and other substances (alcohol, amphetamine type 
stimulants, cannabis and opiates) within the same time frame (LTP, LYP) 
 
See Figure 2.1 in Chapter 2, which shows that recent use of cocaine continues to be 
much less prevalent than use of cannabis, but that over time it has replaced 
amphetamines as the second most used drug. 
12.1.5 Analysis of frequency of use (use in last 30 days)   
Even with the large numbers surveyed by the BCS, numbers using recently are too 
small to provide reliable evidence of frequency of use and therefore are not 
considered in this report.  However, analysis of frequency of use211 has been 
undertaken for those who report recent use rather than current use.  This suggests 
that amongst young people aged 16 to 24, less than half use frequently and that the 
number of those using any drug, including cannabis, more than once a month has 
declined since 2003/04.  The size of the sample using crack was too small for 
analysis to be undertaken.  In 2004/05 frequent cocaine use decreased but then rose 
sharply in 2005/06 well above 2003/04 levels (Figure 12.2). 
 
                                                 
211 Frequent use, in the BCS, is defined as taking a drug more than once a month. 
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Figure 12.2: Percentage of 16 to 24 year olds (last year drug users) using any drug, cannabis 
and cocaine more than once a month in the last year in England and Wales, 2003/04 to 
2005/06 
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Source: Chivite Matthews et al. 2005; Roe 2005; Roe and Man 2006 
12.1.6 Analysis on crack  
With numbers so small less analysis has been undertaken on crack use within the 
general population, nevertheless it is more widespread than use of heroin, though 
less widespread than use of cocaine.  Indications suggest that crack users, like 
cocaine users, are more likely to live in inner city areas, rent their accommodation 
(Table 12.16) and live in a flat/maisonette (Table 12.17) than non-crack users but 
unlike cocaine users are much more likely to be unemployed (see section 12.1.3). 
12.2 Cocaine use among school students  
Prevalence among 15/16 year olds and 17/18 year olds  
School children aged over 15 do not take part in school surveys in the United 
Kingdom, except in Northern Ireland.  At age 16, young people can leave school and 
therefore evidence amongst young people aged 16 to 18 is from general household 
surveys, when 17 and 18 year olds are not necessarily at school.  In Northern 
Ireland, school children aged 16 report much higher use of cocaine than those aged 
15; four per cent reporting ever having used, compared with 1.3 per cent of 15 year 
olds (SMR 2005). 
Prevalence in school children aged 15 and under  
School survey for England 2005 
Table 12.19 shows use of cocaine and crack increases with age as does use of most 
drugs, with the exception of volatile substances. 
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Table 12.19: Percentage of pupils who have taken individual drugs in lifetime, in the last year 
(including in the last month) and in the last month by age in England, 2005 
 
Age Drug 11 years 12 years 13 years 14 years 15 years 
Lifetime 
Any drug 14.2 15.5 22.4 35.5 44.7 
Cocaine 0.4 0.7 1.6 3.5 5.0 
Crack 0.5 0.9 1.3 2.1 1.9 
Last year 
Any drug 6.2 9.4 14.8 26.3 33.9 
Cocaine 0.4 0.4 1.0 2.8 4.3 
Crack 0.3 0.4 0.9 1.6 1.5 
Last month 
Any drug 3.3 4.2 7.8 16.1 20.3 
Cocaine 0.2 0.1 0.4 1.5 1.7 
Crack 0.2 0.2 0.4 0.6 0.8 
Base 1350 1700 1781 1810 1907 
Source: Standard Table prepared for United Kingdom Focal Point based on school survey. 
 
Table 12.20 shows that boys are slightly more likely to use than girls. 
Table 9.16 
Table 12.20: Percentage of pupils aged 11 to 15 who have taken individual drugs in lifetime, 
in the last year (including in the last month) and in the last month, by sex in England, 2005 
 
Drug Lifetime Last year Last month 
 Boys Girls Total Boys Girls Total Boys Girls Total 
Cocaine 2.6 2.1 2.4 2.1 1.7 1.9 0.9 0.7 0.8 
Crack 1.3 1.5 1.4 0.9 1.1 1.0 0.5 0.4 0.5 
Any 
drug 27.8 27.2 27.5 19.3 18.8 19.1 11.5 10.3 10.9 
Base 4,296 4,252 8,548 4,253 4,223 8,476 4,208 4,200 8,408 
Source: Standard Table prepared for United Kingdom Focal Point based on school survey 
School surveys for Northern Ireland 2003 
Data are from a Standard Table prepared for United Kingdom Focal Point and 
aggregated by three age groups, 11 to 12, 13 to 14 and 15 to 16.  These data 
suggest that the effect of age on cocaine and crack use is not as large as its effect on 
use of any drug (Table 12.21).  
 
Table 12.21: Percentage of pupils who have taken individual drugs in lifetime, in the last year 
(including in the last month) and in the last month, by age in Northern Ireland, 2003  
 
Age Drug 11 to 12 years 13 to 14 years 15 to 16 years 
Lifetime 
Any drug 9.6 16.9 34.0 
Cocaine 1.7 2.0 2.1 
Crack 1.0 1.8 1.6 
Last year 
Any drug 5.5 11.2 21.6 
Cocaine 1.2 1.5 1.6 
Crack 0.6 1.4 1.1 
Last month 
Any drug 2.9 5.8 9.8 
Cocaine 1.0 0.9 0.8 
Crack 0.4 0.5 0.5 
Source: Standard Table prepared for United Kingdom Focal Point based on school survey 
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School survey for Scotland 2004 
Data for Scotland, from the Schools Adolescent Lifestyle and Substance Use Survey 
(SALSUS) show an increase in cocaine use with age (Table 12.22) 
 
Table 12.22: Percentage of pupils who have taken individual drugs in lifetime, in the last year 
(including in the last month) and in the last month, by age in Scotland, 2004 
 
Age Drug 13 years 15 years 
Lifetime   
Any drug 13 35 
Cocaine 1 3 
Crack 1 1 
Last year   
Any drug 11 31 
Cocaine 1 2 
Crack 1 1 
Last month   
Any drug 7 20 
Cocaine 0 1 
Crack   
Source: Corbett et al. 2004 
Frequency of using cocaine  
Analysis of data for England and for Scotland does not look at frequency by particular 
drugs, by age.  In Northern Ireland, among those who had ever used cocaine, eight 
per cent indicated that they had used the drug on a daily basis, with nine per cent 
using the drug a few times a week.  The majority (60%) of users of cocaine reported 
that they either no longer used the drug (38%) or used it rarely (22%) (DAIRU 2005). 
Number of Times Used Cocaine 
Surveys in England do not report on how many times a drug has been used.  In 
Northern Ireland 43 per cent of users reported that they had used cocaine only once, 
with a further 17 per cent reported using the drug on only two occasions.  Amongst 
those pupils who said that they had ever used crack, 10 per cent reported daily use, 
but a majority (52%) reported that they either rarely used or do not use it any more 
(25%)  In this survey one in three crack users reported that they had used the drug 
only once, with a further 19 per cent reporting using it on only two occasions (SMR 
2005).  These data are for secondary school children up to and including age 16.  
Age of first use  
SALSUS does not analyse age of first use of individual drugs.  In England pupils 
reported having first tried cocaine and crack as young as 11 (NatCen/NFER 2005).   
 
In Northern Ireland among those who could remember what age they started using 
cocaine, one quarter were aged 13 with 30 per cent aged 14.  Among those who 
could remember what age they started using crack, 40 per cent said they were aged 
16 but 11 per cent said they were aged ten or younger (SMR 2005).  
Ease of obtaining cocaine and crack 
Analysis of data for England does not look at ease of obtaining particular drugs.  
Information on the perceived ease of obtaining crack, but not cocaine, is available for 
Northern Ireland.  The majority of survey respondents (73%) did not know how easy 
or difficult it would be to get crack if they wanted to, 13 per cent reported that it would 
be either ‘very easy’ or ‘easy’, with a similar proportion (14%) saying it would be 
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either ‘very difficult’ (7%) or ‘difficult’ (7%), younger people were least likely to know 
(SMR 2005). 
 
In Scotland younger people were also less likely to know about the ease of obtaining 
crack and cocaine.  Twenty-four per cent of 15 year olds believed it would be easy to 
obtain cocaine or crack compared to 12 per cent of 13 year olds. (Corbett et al. 
2005). 
Attitudes to cocaine use  
Information is available on attitudes to cocaine use.  In England very few pupils felt 
that it was acceptable to try, or use, cocaine, though acceptance increased with age 
(NatCen/NFER 2006). 
 
In Scotland, a majority of 15 year olds felt that cocaine was dangerous, even those 
who had used it, though the latter were slightly less likely to think this (Corbett et al. 
2005). 
Trends in cocaine use  
After a period of stability from a very low base there was a rise in prevalence of 
recent use in England in 2005 but it is not clear if this is the start of a trend or just an 
artefact of sampling.  Until 2003, around one per cent of pupils had used cocaine, in 
2004 1.4 per cent and in 2005 this figure rose to 1.9 per cent. 
12.3 Prevalence and patterns of use among specific populations  
12.3.1 Prevalence of problem cocaine and crack use: estimates of problem 
prevalence in the United Kingdom  
A national, and 149 local estimates, of crack use have been undertaken for England; 
however these were not available at the time of writing.  
Estimates of Problem Heroin Use and Cocaine Use in Northern Ireland. 
National and local estimates of problem drug use have recently been published for 
Northern Ireland; these are for opiate users and for opiate and/or problem cocaine 
users (Hay et al. 2006).  Results are shown in Table 12.23. 
 
Table 12.23: Estimated number of opiate users and opiate and/or problem cocaine users 
aged 15 to 64 years old and rate per thousand population, by HSSB area in Northern Ireland, 
2004  
 
HSSB Area Opiate users Opiate and/or problem cocaine 
users 
 Estimate Rate 95% CI Estimate Rate 95% CI 
Eastern 725 1.68 1.07 3.04 1,612 3.74 2.75 5.40 
Northern 360 1.29 1.04 1.70 663 2.38 1.85 3.09 
Southern 130 0.65 0.27 2.41 466 2.34 0.76 3.31 
Western 180 0.99 0.48 3.60 562 3.08 1.75 7.00 
Northern Ireland  1,395 1.28 1.21 1.75 3,303 3.03 2.84 3.95 
Source: Hay et al. 2006 
 
12.3.2 Surveys of different groups 
Opioid substitution clients 
See research by Sumnall et al. (2005) in section on injecting in 12.4.2. 
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50,000. Latest published data from this survey (2003) reports that almost 75 per cent 
of readers who completed a survey questionnaire, have ever used cocaine and 41 
per cent currently use, with the mean age of first use around 20.4 years 
(McCambridge et al. 2005).  While reported lifetime use of cocaine has remained 
fairly stable between 1999 and 2003, the percentage of those reporting current use 
increased (from 36 per cent in 1999). Although there are no published data from this 
survey after 2003, latest figures from Mixmag suggest that the percentage of people 
reporting current use of cocaine has increased considerably to 79 per cent 
(Mitcheson 2006).  Furthermore, use of any drug in a nightclub setting (including 
cocaine) is closely associated with alcohol use, with around 95 per cent of those 
taking drugs also consuming alcohol (Deehan and Saville 2003).  
Sex workers 
The Home Office suggests that sex and drug markets are seen as interconnected, so 
much so that when a police operation focusing on the crack market arrested 118 
prostitutes, many were referred to drug treatment services (Home Office 2004).  
Surveys of sex workers in the United Kingdom have reported high levels of illegal 
drug use, particularly among street sex workers.  One survey conducted in Leeds, 
Glasgow and Edinburgh found that 93 per cent of outdoor workers and 69 per cent of 
indoor workers had used an illegal drug in the past six months, including crack (32% 
outdoor, 4% indoor), and cocaine (17% outdoor, 15% indoor) (Church et al. 2001).  
Although heroin is often the most frequently used drug among sex workers, a number 
of reports have documented a rise in the level of reported crack use over the last 15 
years.  For instance in London, self reported use of crack among sex workers rose 
from 11 per cent in 1989/91 to 34 per cent in 1995/96 (Ward et al. 2000), while in 
Liverpool, self reported crack use among street sex workers increased from 17 per 
cent in 1996 to 75 per cent in 2004 (McCullagh et al. 1998; Bellis et al, in press). 
Ethnic minorities  
Analysis of ethnicity and drug use was undertaken for the 2001/02 British Crime 
Survey (Aust and Smith 2003).  This found higher levels of drug use among people 
from a mixed background compared to other ethnic groups.  These higher levels of 
use mainly concerned cocaine (as well as cannabis and ecstasy).   
 
Coulthard et al. (2002) in a survey of psychiatric morbidity among adults in England, 
Scotland and Wales, carried out in 2000 for the Department of Health, the Scottish 
Executive Health Department and the National Assembly for Wales,212 looked at drug 
use (and tobacco and alcohol use) and dependence213, and their relationship to 
psychiatric morbidity.  The survey found that Black and Asian groups were least likely 
to use crack and cocaine (Figure 12.3).  
 
                                                 
212 The survey was carried out between March and September 2000, of psychiatric morbidity 
among adults aged 16 to 74 living in private households in England, Scotland and Wales.  
The analysis covered in the report is based on 8,580 full or partial interviews.   
213 Degree of drug dependence was assessed by a set of five questions which had been used 
in previous studies; if someone answered ‘yes’ to at least one question they were defined as 
dependent. 
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Figure 12.3: Rate of illicit drug use in the past year by ethnicity (rate per thousand population) 
in England, Scotland and Wales, 2000 
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*Indian, Pakistani or Bangladeshi.  
Other groups are defined as not being any of the other categories and include Chinese 
Source: Coulthard et al. 2002 
Clients of consumption rooms 
There are no consumption rooms in the United Kingdom  
 
Drug Use amongst university students  
A survey of 500 students in Edinburgh reported that 23 per cent had used cocaine 
Friedman (2005).  
Cocaine and crack users reporting for treatment  
Neale and Robertson (2004) examined 585 new treatment clients in Scotland and 
found that those who had recently used cocaine and/or crack were more likely to:  
• have used non-prescribed benzodiazepines in the previous 90 days;  
• be seeking residential treatment;  
• have recently committed an acquisitive crime;  
• have been robbed, attacked or assaulted in the last six months;  
• have a spouse or partner; and  
• have a longer history of problematic drug use.  
Care leavers 
Research was conducted with 200 young people (with an average age of 18 years) in 
the process of leaving or having recently left care and with young people who had left 
home at a young age (‘runaways’) (Ward et al. 2003).  There were high levels of self 
reported drug use compared with general population surveys and 10 per cent had 
used cocaine within the last month.  Lifetime prevalence of crack was around 10 per 
cent.   
 
Analysis of the 2003 Offending Crime and Justice Survey considered the relationship 
between vulnerable groups and drugs use; these groups included those who had 
ever been in care, as well as truants, excludees and serious or frequent offenders 
(Becker and Roe 2005).  It was found that those in vulnerable groups displayed much 
higher levels of drug use, including use of cocaine and crack, than those not in 
vulnerable groups (Table 12.24).  
UNITED KINGDOM FOCAL POINT REPORT 2006 
 178
Table 12.24: Percentage of 10 to 24 year olds who have used drugs in the last year, by 
vulnerability in England and Wales, 2003 
 
Drug  
Not in a 
vulnerable 
group 
In any 
vulnerable 
group 
In only one 
vulnerable 
group 
In more than 
one vulnerable 
group 
Cocaine 2.9 9.8* 8.3* 14.3* 
Crack 0.0 1.9* 1.0* 3.0* 
Any drug  15.6 40.7*  34.1* 57.7* 
Base   2,894  1,140 774 304 
* p<0.05 using Pearson’s chi-squared test for significance on ‘any vulnerable group’ versus 
‘no vulnerable group’, ‘one vulnerable group’ versus ‘no vulnerable group’ and 'more than one 
vulnerable group’ versus ‘one vulnerable group’ . 
Source: Becker and Roe 2005 
 
Within vulnerable groups, those who had been in care (and those who had been 
homeless) had much lower levels of drug use than other vulnerable groups and did 
not report use of crack or cocaine (Table 12. 25). 
 
Table 12.25: Percentage of 10 to 24 year olds ever in care or homeless, truants, excludees 
and serious or frequent offenders who used drugs in the last year in England and Wales, 
2003 
 
Drug Ever in care or 
homeless 
Truants Excludees Serious or frequent 
offenders 
Cocaine - 10.3 7.9 9.7 
Crack - 0.9 0.8 1.4 
Any drug 22.7 43.1 31.6 35.7 
Base 64 111 241 359 
- indicates that there was no response in the category 
Source: Becker and Roe 2005 
Young offenders 
Analysis of the OCJS found that 9.7 per cent of serious or frequent offenders has had 
used cocaine and 1.4 per cent had used crack (see Table 12.25 above). 
Homeless young people 
A study into substance use amongst 160 homeless young people aged 25 years and 
under in England and Wales found that 95 per cent of them had used drugs (typically 
beginning experimentation aged 14 years).  A substantial minority had used crack 
cocaine (18%) in the last month (Wincup et al. 2003).  Also see findings from the 
OCJS in the previous section on care leavers.  
12.4 Problems related to cocaine and crack use 
12.4.1 Treatment demand for cocaine 
In England, recruitment of primary crack cocaine users into treatment services has 
been lower than anticipated by Government.  According to the National Drug 
Treatment Monitoring System (NDTMS) figures for 2004/05, only five per cent of drug 
users in contact with treatment services reported crack as their primary drug, with a 
further four per cent reporting cocaine as their main drug.  These are the same 
percentages as for 2003/04.  However, in 2004/05, of the 41 per cent of drug users in 
treatment who reported a secondary drug, 12 per cent reported crack as their 
secondary drug of use, which may be an indicator of the levels of polydrug use in the 
treatment population (3% reported cocaine as their secondary drug). 
 
Again, based on information for all those in treatment in England: 
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• for cocaine, use is slightly higher in younger age groups.  Over 5 per cent of 18 
year olds entering treatment reported cocaine as their main drug, compared to 
around 4 per cent aged between 19 and 44; 
• variations in the use of cocaine between ethnic groups is not as pronounced as 
with crack cocaine, with the reported highest use (around 6%) in mixed race 
people (mixed White and Black Caribbean and White and African), and the lowest 
at 3 per cent being amongst Pakistani drug users; and 
• there are some regional differences in cocaine use, but much smaller than for 
crack.  London and Eastern regions both reported almost 8 per cent of drug users 
in treatment have a primary cocaine problem, whereas East Midlands and 
Yorkshire and Humberside reported just over 1 per cent. 
 
For crack: 
• use is not higher in younger groups with 5 per cent of 19 to 24 year olds and 6 
per cent of 35 to 39 year olds entering treatment reporting crack as their main 
problem drug; 
• use is much higher in some ethnic minority treatment seeking groups, with 36 per 
cent of Black Caribbean treatment seekers, and 18 per cent of mixed race Black 
Caribbean and White treatment seekers reporting crack as their main drug, 
compared to only four per cent of White treatment seekers; and 
• there are large variations in rates of crack treatment seeking by region.  While 14 
per cent of drug users in treatment in London reported crack as their main drug, 
this was only the case for just over one per cent of the treatment population in 
both Yorkshire and Humberside and the North East. 
 
In a study to ascertain the size of the crack cocaine problem in a rural county of 
England, Vivancos et al. (2006)214 estimated that 31 per cent (95% C.I., 26% to 37%) 
of drug users in treatment services have moderate/severe dependence on crack.  In 
addition it was also found that factors associated with severe crack dependence are: 
severe dependence on benzodiazepines; the increasing number of drugs used, 
engaging in sex work and being of non-White ethnicity.  Those with severe 
dependence were found to have a higher prevalence of hepatitis B and C compared 
with those with moderate or no dependence.  The researchers suggest that users 
have ‘a frenzied drug life’ on entering treatment, requiring additional support to give 
structure to their lives so as to prevent relapse.  
12.4.2 Other problems related to cocaine and crack use 
Cocaine and crack-related deaths 
Data on drug related deaths in England and Wales shows that from 1999 to 2004 
deaths where cocaine is mentioned have increased substantially (Morgan et al. 
2006) (Table 12.26).  
 
                                                 
214 A questionnaire on drug dependence and risk behaviour was completed by 306 users of 
drug treatment services, and focus groups were conducted with 45 self-selected 
crack/cocaine users. 
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Table 12.26: Number of deaths related to any drug and cocaine, England and Wales, 1999 to 
2004 
 
 1999 2000 2001 2002 2003 2004 
All drug misuse 
Number  1,571 1,666 1,628 1,565 1,255 1,427 
Percentage 
change  
- 6 4 0 -20 -9 
Cocaine 
Number  88 80 96 139 113 147 
Percentage 
change  
- -9 9 58 28 67 
Source: Morgan and Griffith 2006 
Acute or chronic use 
No information available  
Cardiovascular problems 
Cocaine use and heart problems  
A study on cocaine use among patients complaining of chest pains, conducted at the 
Accident and Emergency unit of St Mary’s hospital in London during three years, 
shows that between seven and 10 per cent of the patients tested positive for cocaine.  
Figures are reported to be higher amongst people under the age of 40.  Amongst this 
group, during weekdays, a third were found to have traces of cocaine in their urine, 
and at weekends around a half had taken the drug.  Tests on a control group 
admitted without chest pains show results as low as three per cent.215. A full report of 
these findings is expected to be published in late 2006. 
Mental health disorders 
In the survey of psychiatric morbidity among adults in England, Scotland and Wales 
referred to earlier, Coulthard et al. (2002) looked at drug use (and tobacco and 
alcohol use) and dependence, and their relationship to psychiatric morbidity.  Lifetime 
prevalence for use of cocaine was four per cent, and crack, less than one per cent.  
Younger people are more likely to be dependent on cocaine and crack (Table 12.27). 
 
Table 12.27: Prevalence of drug dependence by age group (rate per thousand population) 
 
Drug Age 
 16–
19 
20–
24 
25–
29 
30–
34 
35–
39 
40–
44 
45–
49 
50–
54 
55–
59 
60–
64 
65–
69 
70–
74 
All 
Cocaine 6 8 4 1 3 4 - - - - - - 2 
Crack 5 2 - 2 2 - - - 2 - - - 1 
Any drug 
dependence 96 144 90 36 24 13 17 6 6 3 4 5 38 
Base 334 460 730 953 1006 842 723 822 703 739 668 600 8,580 
- indicates that there was no response in that category 
Source: Coulthard 2002 
Violence 
It is reported in the National Crack Plan (see below) that primary crack use 
sometimes leads to greater levels of violence and acquisitive crime and has been 
linked to the use of guns (Home Office 2003). 
 
                                                 
215 See: http://www.drugscope.org.uk/news_item.asp?intID=1252  
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In research based on the Drug Outcomes Research in Scotland (DORIS) longitudinal 
study, Neale et al. (2005) found that one in five (18%) drug users entering treatment 
had committed assault in the previous three months and a quarter had been 
assaulted in the previous six months216.  Amongst factors associated with committing 
an assault was having used crack in the last 90 days.  
Injecting 
Crack is regarded a major public health issue because of the sharing of injecting 
equipment.  In a retrospective study of crack injecting amongst treatment populations 
between 1 April 1999 to 31 March 2002 in Merseyside, Sumnall et al. (2005)217 found 
that crack injectors were more likely to report use of injected heroin (p<0.001), use of 
non-injected cocaine (p<0.01), and less likely to report use of non-injected heroin 
p<0.001).  It was also found that crack injection was significantly predicted by heroin 
injection (p<0.001).   
 
A community recruited cohort study of recently initiated injecting drug users in 
London undertaken by the Centre for Research on Drugs and Health Behaviour 
(CRDHB) in 2001/03 found evidence that the incidence of HIV was higher among 
those who reported injecting crack (around 6%) (Judd et al. 2005).  Results from the 
Unlinked Anonymous Prevalence Monitoring Programme  (UAPMP) enhancement 
pilot found a prevalence of 0.76 per cent among IDUs in England outside London, but 
those who reported injecting crack had a higher prevalence than those who did not 
(1.4% and 0.32% respectively) (HPA et al. 2006). 
Combinations with opioids 
See above  
12.5 Responses and interventions related to cocaine and crack use 
12.5.1 Treatment for cocaine and crack.  
A number of private and not-for-profit organisations offer programmes for the 
treatment of cocaine and crack use; some using nutrition and nutritional supplements 
as an important component as part of a social education model of drug 
rehabilitation218 and neuro-linguistic programming and hypnotherapy219. 
 
In England the main focus has been on the treatment of crack users. The National 
Treatment Outcome Research Study (NTORS) showed that 56 per cent of crack 
users who entered and completed treatment remained crack free after five years 
(Gossop et al. 2002).  On the basis of this research the NTA have suggested that 
crack users can do well in drug treatment (NTA 2002).  Pilot services for crack users 
were initiated in 2003 with a resource pack for treatment providers to help ensure 
consistent standards, setting out the competencies expected of staff and the training 
that may be required (NTA 2003).  Guidance is also provided by the Royal College of 
General Practitioners and Substance Misuse Management in General Practice 
(RCGP 2004; Ford 2005).  It is expected that treatment be provided in the context of 
a structured programme of drug treatment, which includes counselling, residential 
rehabilitation and day services.   
                                                 
216 Interviews were conducted with 560 drug users entering treatment. 
217 A sample size of 4,055. 
218 For example: http://www.drugrehab.co.uk/faq-cocaine.htm#top%20of%20page  
219 For example: 
http://www.justbewell.com/help_stop_taking_cocaine_addiction_hypnotherapy_nlp_london.ht
ml  
UNITED KINGDOM FOCAL POINT REPORT 2006 
 182
 
An impact evaluation of a pilot service specification and treatment delivery models 
has been completed but is not yet published. 
 
The Department of Health has commissioned research into effective approaches for 
treatment of cocaine and crack misuse in young people. 
Pharmacological approaches 
Cochrane review of the use of antidepressants in the treatment of cocaine use  
A Cochrane review of the use of antidepressants in the treatment of cocaine use, 
found that these drugs are not proven to reduce cocaine dependence.  However, it 
does suggest that this may be because people commonly stop using the 
antidepressants too soon (Lima et al. 2003). 
Counselling 
Counselling is the most widespread treatment offered for cocaine and crack use.  
The NTA suggest that early engagement with, and confidence in, treatment, and 
feelings that one's counsellor is understanding and helpful, promotes engagement 
with treatment programmes at a later date (NTA 2002). 
Behavioural treatment 
The NTA suggest that cognitive behavioural therapies can be effective (NTA 2002). 
Brief motivational interviewing among cocaine and ecstasy users 
Marsden et al. (2006) did not find brief motivational interventions to be any more 
effective at inducing behaviour change than the provision of information alone.  
Acupuncture 
Services do offer acupuncture for the treatment of dependence, though the number is 
unknown.  
Cochrane review of the use of auricular acupuncture for cocaine dependence 
In a Cochrane Review of the use of auricular acupuncture for cocaine dependence 
Gates et al. (2005) found that there is currently no evidence that it is effective for the 
treatment of cocaine dependence; any evidence that is available was said not to be 
of high quality.  
Responses to co-use of cocaine among opioid substitution clients 
Historically heroin use has been the main drug problem in England and therefore the 
main focus of drug treatment services.  This situation is now changing.  Although the 
proportion of primary crack and cocaine users in treatment remains relatively low, 
polydrug use is now the norm for the drug-using population evidence.  Increasingly 
drugs services in England are adopting flexible treatment packages which reflect 
both the range of drugs used and the complex needs of drug users (NTA 2002).   
 
Following their study of crack use in rural England, Vivancos et al. (2006) suggest 
that current service provision does not provide appropriate help to crack users and 
that given the lack of pharmacological treatment, programmes should offer a wide 
range of activities and interventions to provide structure to clients’ lives. 
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12.5.2 Harm reduction responses to cocaine and crack 
Availability of information materials 
There are a large number of websites which provide information about crack and 
cocaine, in addition to the national information and helplines.220  In addition 
information is available through most treatment centres and general practitioners.  
Distribution of drug consumption equipment 
Injecting equipment is available free of charge through syringe exchange schemes 
throughout the United Kingdom.  In addition, in 2003 an amendment was made to the 
Misuse of Drugs Act 1971 which allowed certain named items of paraphernalia 
(swabs, ampoules of water for injection, citric acid, utensils for the preparation of a 
controlled drug and filters) to be supplied by practitioners, pharmacists and persons 
engaged in the lawful provision of drug treatment.  
 
In 2005 regulation 6A of the Misuse of Drugs Regulations 2001 was amended to 
include ascorbic acid in the list of articles that may be supplied by practitioners, 
pharmacists and persons engaged in the lawful provision of drug treatment services 
for administering or preparing controlled drugs. This is because ascorbic acid is used 
as an acidifier in the preparation of crack for injection (Home Office 2005d).  
Policies at facilities for supervised drug consumption 
There are no consumption rooms in the United Kingdom.  
Provision and utilisation of quiet rooms, day hostels, 24-hour crisis intervention 
centres and other services 
Such areas cannot be used for consumption of drugs. 
12.5.3 Law enforcement activities in response to cocaine and crack use 
Supply reduction activities 
The police have the primary responsibility for seeing that drug markets are disrupted 
and those involved in selling drugs are arrested and brought to justice.  The Crime 
and Disorder Act 1998 places a requirement for the police and local authorities to 
work together to tackle local crime and disorder, including that related to drugs, in 
their area.  The Police Reform Act 2002 has added targets to cover the combating of 
drugs misuse as part of police activity.  
 
As part of the national Crack Plan (see below) tool kits have been developed to 
enable the disruption of crack markets, aimed at the police, Crime and Disorder 
Reduction Partnerships (CDRPs), D(A)ATs and other law enforcement agencies 
(Home Office 2003). The purpose of these toolkits is: 
• to offer practical suggestions to help the police and their partners disrupt crack 
markets; 
• to help the police and their partners understand how crack is sold and used, and 
how buying is financed; 
• to offer practical advice on mapping a crack market; 
• to offer advice on tactics that may help disrupt a crack market; 
• to offer advice on how to evaluate the success of police action; and 
• to stimulate more action against crack markets using a variety of methods. 
                                                 
220 For example: www.cocaine.org  
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Activities targeting crack houses 
The Anti-Social Behaviour Act 2003 was introduced to tackle the problem of 
properties used for the sale and use of crack and other Class A drugs, which are 
associated with serious nuisance.  The Act is part of both the national strategy on 
anti-social behaviour, which extends more widely than drug-related behaviour and 
the national crack strategy.  The Act makes an explicit link between penalties and 
powers to control drug-related behaviour with nuisance arising from them.  Previously 
the only punishable act was that of possessing or supplying (or producing or 
trafficking etc.) the drug itself.  The new Act criminalises subsequent nuisance 
associated with such offences and its powers are targeted against properties, not 
people, as it enables the closure of premises used in connection with the production, 
supply or use of Class A drugs which are associated with disorder or serious 
nuisance.  
 
An assessment of these powers found that closure under the new powers can be 
achieved swiftly, at its quickest, in less than 48 hours (Peters and Walker 2005). 
Operation Crackdown  
Operation Crackdown was launched in January 2005 and targeted local Class A drug 
markets (Home Office 2005e). Thirty-two police forces worked together to close drug 
dens, disrupt local drug markets, seize illegal firearms and convict drug suppliers. At 
the end of the three month campaign, the police forces had: 
• closed 170 crack houses; 
• seized over 100 kilograms of cocaine, 3 kilograms of crack, 100 kilograms of 
heroin and over 86,000 ecstasy tablets; 
• charged 1,471 people with supplying Class A drugs; 
• seized 483 firearms and 3,402 rounds of ammunition; and 
• seized €4.8 million (£3.2 million) in cash assets. 
12.5.4 Policies and strategies in response to cocaine and crack use 
Tackling crack: A national plan was launched in 2002 (Home Office 2002). The 
purpose was to build on best practice developed in those areas where positive action 
has already been taken to tackle the crack problem, and to prevent escalation in 
those communities most at risk.  In those areas most heavily affected, High Crack 
Areas (HCAs), it was expected that a much more comprehensive set of services 
would be delivered, including: action to stem trafficking; a programme of action by 
police in a number of key force areas to close local crack markets (see Operation 
Crackdown); improved capability of all drug services to meet the needs of users, 
backed by around 20 specialist programmes for crack users serving the HCAs (see 
Crack pilot programmes); new programmes to divert young people at risk from using 
crack and getting involved in related culture; media and communications campaigns 
to raise awareness of gun crime and crack risks; new criminal justice interventions 
and increased services for offenders in HCAs, making arrest referral services more 
able to track crack users into treatment and offer flexible, crack specific Drug Testing 
Treatment Orders (DTTO) programmes; new research into the effectiveness of 
treatment; and new programmes to meet the needs of special client groups most 
affected by crack, such as sex workers.  Since the report was published  a Drug 
Interventions Programme has been established which seeks to ensure drug users, 
including users of cocaine and crack, involved in the criminal justice system, are 
better able to access treatment (see Chapter 9). 
Crack strategy for London 
A crack strategy for London was launched in 2004 (GLADA 2004).  
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12.6 Cocaine and crack-related crime 
12.6.1 Property/acquisitive crime – crime committed under the influence of cocaine or 
crack 
There is no evidence that property/acquisitive crimes are committed under the 
influence of cocaine or crack.  However there is evidence that such crimes are 
committed to support use, mainly of crack.  
12.6.2 Prostitution 
Prostitution is not a crime in the United Kingdom.  For information about sex workers 
see 12.3.2. 
12.6.3 Crimes not directly linked to cocaine or crack 
No information  
12.7 Cocaine and crack markets 
12.7.1 Local markets and differences  
In research into local drug markets May et al. (2005) suggest that at street level, 
sellers of heroin and crack are often dependent users who sell drugs to fund their 
own use. Though they also suggest that some drug dealers move from retail sellers 
to middle-market distributors and vice versa, suggesting perhaps a fluidity in illicit 
markets.  
12.7.2 Products and modes of preparation 
Cocaine powder and crack are the primary products in the United Kingdom. 
12.7.3 Perceived availability 
See 12.2, section on ease of obtaining cocaine and crack. 
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13. Drugs and driving 
13.1 Policy 
13.1.1 National drug policy 
There is no explicit mention of driving under the influence of drugs in the Updated 
Drug Strategy (DSD 2002) or within other United Kingdom drug strategies 
(DHSSPSNI 2006a; Scottish Office 1999; National Assembly for Wales 2000).   
13.1.2 Road safety policy 
Tomorrow’s roads: safer for everyone (Department of Transport 2000), outlines the 
Government’s strategy for improving road safety between 2000 and 2010 in the 
United Kingdom.  Specific focus is placed upon driving under the influence of drugs 
and the strategy places emphasis upon the development of equipment and 
techniques for roadside identification of offences; and special training for police 
officers to recognise offences. 
 
The Road Safety Act introduced in July 2005 specifies a period of licence 
endorsement for individuals that fail to allow a biological specimen to be forensically 
tested for the presence of drugs or alcohol, and medical enquiries after 
disqualification for high risk offenders. 
 
The Road Safety Strategy for Wales aims for the overall reduction of real and 
perceived danger for road and footway users in Wales (Welsh Assembly 2003b).  It 
outlines specific actions in relation to drugs and driving: to undertake a research 
study into the prevalence of drug driving in Wales; to undertake a national publicity 
campaign to highlight driving under the influence of drugs; and to consider how to 
integrate drug driving into existing drug education and rehabilitation initiatives. 
13.1.3 The law 
It is an offence under section 3A and 4 of the Road Traffic Act 1988 for a person to 
be unfit to drive while impaired by drink or drugs.  The law does not make a 
distinction between illegal or misused licit drugs and over-the-counter or prescription 
drugs taken as directed by a medical practitioner.  
 
Convicted offenders face a minimum one year driving ban, a fine of up to €7,315 
(£5,000), and six months imprisonment.  The decision for conviction is based on 
demonstration that drug intoxication was the likely cause of driving impairment 
(Oliver et al. 2006; see section 13.3).  However, there is no legal definition of 
impairment in the Road Traffic Act, and no offence of driving in breach of a 
prescribed limit, as is the case for drink-driving.  This is because the presence of 
drugs alone is not evidence of impaired driving ability as some drugs such as 
cannabis can remain in the body for a period of time after its psychopharmacological 
effects have ceased.  Furthermore, the Misuse of Drugs Act 1971 does not class 
intoxication by drugs per se as an offence.  Conviction is therefore based on the 
requirement of demonstrating impairment through the testimony of lay witnesses, 
police officers, and forensic medical examiners.  During 2004, in England and Wales, 
all offences related to drugs or alcohol were dealt with by court proceedings 
(compared to offences such as obstruction waiting or parking offences which were 
predominantly dealt with by fixed penalties or penalty charge notices) (Fiti and 
Murray 2004). 
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It is a criminal offence (under the Road Traffic Act 1988 and the Motor Vehicles 
(Driving Licences) Regulations 1999 and punishable with a fine of up to €1,463 
(£1000)) to fail to notify the Drivers Medical Group of the Driver and Vehicle 
Licensing Agency (DVLA)221 of a medical condition that has developed or become 
worse since the issuing of a drivers licence.  The Drivers Medical Group establishes 
whether drivers who have medical conditions are able to satisfy the medical 
standards required for safe driving. This is based upon both the medical condition 
and the means of treatment. 
The implications of drug dependency upon driving license issue and renewal have 
been outlined by the DVLA.222 
i) Persistent use of, or dependency on, cannabis, amphetamines, ecstasy and 
hallucinogens, confirmed by medical enquiry, will lead to licence refusal or revocation 
for a minimum six month period, during which the individual must be drug free 
(independent medical assessment and urine screen arranged by DVLA, may be 
required).  
ii) Persistent use of, or dependency on, opioids, and cocaine, as confirmed by 
medical enquiry, will lead to licence refusal or revocation, for a minimum one year 
period during which the individual must be drug free (independent medical 
assessment and urine screen arranged by DVLA, may be required).  In addition, a 
favourable medical Consultant or Specialist report may be required on reapplication. 
Applicants or drivers complying fully with a medical Consultant supervised oral 
methadone maintenance programme may be licensed, subject to favourable 
assessment and, normally, annual medical review.  Applicants or drivers on an oral 
buprenorphine programme may be considered under the same criteria. 
iii) Persistent misuse of, or dependency on, benzodiazepines, confirmed by medical 
enquiry, leads to licence refusal or revocation until a minimum one year period free of 
such use has been attained.  An independent medical assessment and urine screen 
arranged by DVLA, may be required.  In addition a favourable medical Consultant or 
Specialist report may be required on reapplication. 
                                                 
221 The DVLA is an executive agency of the Department for Transport. 
222 See: http://www.dvla.gov.uk/media/pdf/medical/aagv1.pdf  
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13.1.4 Particular relevance to cannabis  
NO ADDITIONAL INFORMATION AVAILABLE  
13.1.5 Particular relevance to benzodiazepines 
NO ADDITIONAL INFORMATION AVAILABLE  
13.2 Prevalence and epidemiological methodology 
13.2.1 Prevalence estimates 
Ingram and colleagues (2001) conducted interviews with 1,008 Scottish drivers aged 
18 to 39 on behalf of the Scottish Executive.  Nine percent of respondents reported 
ever having driven under the influence of any illegal drugs, most commonly cannabis 
(29% ever, 12% in the previous year).  Drug-drivers were most likely to be young 
males aged between 20 and 24.  Many of the respondents in follow up interviews that 
reported smoking cannabis stated that they believed it had little or no impact upon 
driving skills or performance.  A similar number reported that they had accepted a lift 
in a car driven by someone they knew had been using drugs.  
 
In a follow up study (Myant et al. 2006), there was no significant change in 
prevalence since 2000, six per cent reported drug driving in their lifetime, and 3.5 
percent in the previous month.  Drug-drivers scored significantly higher on the Arnett 
Inventory of Sensation Seeking, a measure of risk taking.  Thirteen per cent reported 
ever having been a passenger of a drug-driver, the majority of whom had also used 
drugs at the time.  Respondents reported that driving after using drugs was more 
convenient than using other forms of transport. 
 
In a batch of 194 samples from drivers submitted by 22 United Kingdom police forces 
for forensic analysis (and therefore already suspected of containing drugs after 
unsatisfactory FIT performance), benzodiazepines were the most frequently reported 
drug, followed by opioids, and cannabinoids (Oliver et al. 2006).  Polydrug use was 
evident in 63 per cent of the samples analysed, most commonly benzodiazepines 
and opioids (59%). 
 
In their annual pre-Christmas campaign in 2005 addressing drink and drug driving, 
the Association for Chief Police Officers (ACPO) reported that 33 per cent (n =178) of 
the 540 drivers who were given a fit to drive test (see section 13.3.1) were arrested 
for drug offences (ACPO 2006).  
 
In Northern Ireland, 136 drug drivers were detected in 2004, an increase of 54 from 
the previous year (PSNI 2005).  
 
The Transport Research Laboratory investigated the presence of drugs in 1,184 road 
traffic fatalities between 1985 and 1987, and then again between 1996 and 1999 
(Tunbridge et al. 2001).  The results showed a six fold increase in the percentage of 
people testing positive for illegal drugs (with detection of cannabis increasing from 
2.6% to 11.9%).  Over the same period, the incidence of medicinal drugs (5.5%) and 
alcohol (35.0%) remained stable.  Drug taking, overall, increased by a factor of three, 
and the proportion of those testing positive for multiple drugs increased dramatically. 
 
In Scotland around 53 road fatalities were associated with ingestion of drugs in 2004 
(Scottish Executive 2006). 
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In an informal survey by the RAC Foundation, a motorists organisation, conducted 
with the readers of a United Kingdom motoring magazine it was reported that of the 
474 respondents, 20 per cent reported that they operated motor vehicles whilst 
intoxicated by drugs every day, and 44 per cent reported regularly driving with 
passengers in their car after taking drugs (RAC Foundation, 2006).  Sixty-seven per 
cent believed that drink driving was ‘worse’ than drug driving, and 49 per cent 
thought they were unlikely to get caught.  
Cannabis use 
There is currently no data specifically addressing the prevalence of cannabis related 
driving offences.  However, in the analysis of the 194 samples, referred to above, the 
cannabinoid, THC-COOH was detected in 33 per cent of cases (n = 64). Of those, 25 
per cent (n=17) were positive for cannabis alone. The active component THC was 
found in less than half (n=18) of the blood samples in which THC-COOH was 
detected (n=50) (Oliver et al. 2006).   
13.2.2 Mandatory drug testing of drivers 
The current laws do not permit random or mandatory enforcement testing of drivers 
in the United Kingdom, and there is currently no indication that such schemes of (i.e. 
random testing) will be introduced.  Current provision already allows police officers to 
stop a vehicle at random and form a suspicion of drug or alcohol impairment on the 
basis of the subsequent interview with the driver. 
13.2.3 Conclusions 
There is little data available on the prevalence of driving whilst intoxicated with drugs.  
Offences under the Road Traffic Act 1988 are not distinguished by substance and 
therefore it is not possible to conclude whether the number of incidents is increasing.  
Indirectly, survey data suggests that there are an appreciable number of individuals 
who engage in this type of behaviour. 
13.3 Detection, measurement and law enforcement 
13.3.1 Procedures for testing drivers 
There is currently no approved objective test available for detecting impairment of 
driving as a result of drug ingestion. 
 
New powers were introduced on roadside testing in September 2003 which amended 
section 6 of the Road Traffic Act 1988.  In its place, schedule 7 contained six new 
sections giving new powers for the police to administer three preliminary tests 
including an impairment test to indicate whether a person is unfit to drive due to 
drugs (field impairment test) and a test for the presence of drugs in a person's body 
(drug screening test). 
 
A new Code of Practice introduced in December 2004 detailed the tests to be 
undertaken, how they should be administered, the kind of observations that may be 
made and the inferences that may be drawn.  It also deals with the training of officers 
and their authorisation by Chief Constables.  The tests are a range of tasks including 
a pupilliary examination, the walk and turn test and the one-leg stand.  Other training 
helps officers to recognise the outward signs of drug impairment.  Refusal to 
participate is an offence in the same way as failure to provide a breath test for 
alcohol. 
 
The Department for Transport commissioned work to investigate the utility of the 
Field Impairment Test (FIT) by roadside officers from 22 United Kingdom police 
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forces (Oliver et al. 2006).  (See Figure 13.1 for these authors’ proposed outline of 
how FIT could be used within current driving enforcement procedures).  FIT is a five 
step procedure involving pupillary examination, the Romberg Test (estimation of the 
passing of 30 seconds), the walk and turn task, the one legged stand test, and the 
finger to nose task.  In general, the authors concluded that when administered by 
trained officers and verified by forensic analysis of biological samples, use of FIT 
lead to a sensitivity of 65 per cent (proportion of true positives that were correctly 
identified by FIT), a specificity of 77 per cent (the proportion of true negatives that 
were correctly identified by FIT), and an accuracy of 66 per cent (the proportion of 
cases correctly identified as being drug free or drug positive).  However, 71% of 
those who performed satisfactorily on FIT and voluntarily provided an anonymous 
oral fluid sample, tested positive for drugs. 
 
Researchers at the University of Surrey have developed a portable objective 
detection device proposed for screening of drug related impairments (Degia et al. 
2006).  This device records performance on tasks of tracking ability, sustained 
attention, divided attention, and reaction time. The Home Office Scientific 
Development Branch (HOSDB)223 is also investigating the feasibility of the 
development of a handheld impairment device and is working with the Forensic 
Science Service, to develop a drug screening device for use at the roadside.  This 
device is expected to be able to detect all drugs, including illicit drugs, prescription 
and over-the-counter medicines. 
13.3.2 Number of offences 
Between 2003 and 2004 there was a one per cent increase in the number of road 
offences related to driving after taking drugs or drinking alcohol in England and 
Wales (2003, 105,700; 2004, 107,200).  There were no separate data for drug only 
offences.  The average fine in 2004 for such offences was €318 (£217), and 27 per 
cent of guilty cases resulted in driving licence disqualification, and six per cent in 
immediate custodial sentence.  
13.3.3 Mandatory police training involved in traffic control 
Training is not mandatory but the Secretary of State for Transport has issued a 
preliminary Code of Practice for police officers undertaking such activities.224  Only 
those police officers authorised by chief officer of the force to which they belong are 
allowed to conduct roadside impairment tests (Section 6B(6) Road Traffic Act 1988).  
Before applying for approval a police officer must undergo training and assessment 
in the use of Field Impairment Tests in accordance with the standards set in BS EN 
ISO 9001: 2000225 and the Quality Manual held by the ACPO and the Association of 
Chief Police Officers Scotland (ACPOS).  In addition, officers must be trained in order 
to identify the signs and symptoms of drug influence.  
 
 
 
 
 
                                                 
223 See: http://scienceandresearch.homeoffice.gov.uk/hosdb/public-protection/road-safety-
cameras/  
224 See: http://police.homeoffice.gov.uk/news-and-publications/publication/operational-
policing/Code_of_practice_order.pdf?view=Binary  
225 See: http://www.bsi-global.com/Quality_management/Management/bseniso9001.xalter 
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Figure 13.1: Schematic representation of the procedure for investigating a driver suspected of 
being under the influence of drugs, with a proposed role for the Field Impairment Test (FIT) 
procedure  
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13.4 Prevention 
13.4.1 Training or guidelines for professionals 
The British Medical Association (BMA) published an internet resource226 outlining 
relevant issues about driving under the influence of drugs, both legal and illegal 
(2003).  Its target audience is both medical practitioners and the general public.  
 
The Royal Pharmaceutical Society published, Medicines That Can Impair Driving in 
2000227. 
 
The British National Formulary (BNF)228, which is published jointly by the BMA and 
Royal Pharmaceutical Society of Great Britain, provides information on the labelling 
of medicines that might impair driving and the duties of prescribers to inform patients 
of such effects. 
13.4.2 Publicity campaigns 
The Department for Transport website THINK!229 offers information on the effects of 
various drugs upon driving ability and is targeted at 17 to 35 year olds.  No evaluation 
has yet been published. 
 
Road Safety Scotland230 ran television, radio and ambient media campaigns 
highlighting drug driving in 2002 and in 2005.  The 2002 television campaign 
highlighted the use of FIT (see section 13.3.1) in response to research (Ingram et al. 
2001), which suggested that drivers thought that driving under the influence of drugs 
was unlikely to be detected by police.  Campaign evaluation indicated high 
awareness and understanding of the core message, particularly in 17 to 25 year olds.  
However, doubts still remained about police stopping drivers who had taken drugs 
but were not impaired in their driving.  The core message of the 2005 campaign was: 
'Drugs affect your judgement; drugs affect your driving; drugs can kill. If you're taking 
the car, don't take anything else.'  No evaluation has yet been published for the 2005 
campaign.  
 
Road Safety Scotland distributes Drivesafe campaign materials to Scottish 
pharmacists to display in shops and to put on prescription bags containing 
medication that might affect driving ability.  No evaluation of this campaign has been 
published. 
 
Transport for London launched Drug driving? you'd be off your head in March 
2006231. This campaign was targeted at drivers aged 17 to 25 and included radio 
advertsiements, beer mats, and posters in over 400 London pubs, bars, and clubs. 
No evaluation of this campaign has been published. 
Budgets 
NO INFORMATION IS AVAILABLE 
                                                 
226 See: http://www.bma.org.uk/ap.nsf/Content/Hubinternetresourcedrugsdriving  
227 See: http://www.rpsgb.org.uk  
228 See: http://www.bnf.org.uk  
229 See: http://www.drugdrive.com  
230 See: http://www.road-safety.org.uk/  
231 See: http://www.tfl.gov.uk/tfl/press-centre/press-releases/press-releases-
content.asp?prID=740  
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13.4.3 Enforcement outside nightclubs 
NO INFORMATION IS AVAILABLE 
13.4.4 Provision of alternative transport at nightclubs 
NO INFORMATION IS AVAILABLE 
13.4.5 Driving schools 
NO INFORMATION IS AVAILABLE 
13.4.6 Youth/peer or community approaches 
NO INFORMATION IS AVAILABLE 
13.4.7 Medicinal packaging 
In the United Kingdom, all medicines have an authorised Patient Information Leaflet 
explaining how the medicine acts, how it should be used and any side effects that 
might be experienced, including any influence on the ability to drive.  Prescribers 
should also advise patients if treatment is likely to affect their ability to drive. In 1999, 
the United Kingdom Medicines Control Agency (MCA) updated the driving warnings 
in the patient information provided with benzodiazepines.  Recommendations have 
also been made to update the standard warnings for pharmacists in the BNF.  
13.4.8 Classifying medicinal drugs  
NO INFORMATION IS AVAILABLE 
13.4.9 Media discussion 
National media regularly reports new research and campaign launches concerning 
drugs (both legal and illicit) and driving (e.g. Campaign to tackle drug driving. BBC 
News Online, 30th March, 2006).232 National television programmes produced by the 
BBC have also addressed this issue (e.g. Inside Out, Drugs and Driving broadcast 
Wednesday 21st April 2004).  The media is supportive of Government initiatives 
addressing such behaviour. 
 
                                                 
232 See: http://news.bbc.co.uk/1/hi/england/london/4859992.stm  
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DHI  Drug Harm Index 
DHSSPSNI  Department of Health, Social Services and Public Safety Northern Ireland 
DIP Drug Interventions Programme 
DIR Drug Interventions Record 
DMRI  Drug Misuse Research Imitative 
DOE Department of the Environment  
DORIS  Drug Outcome Research in Scotland  
DRD Drug Related Deaths 
DRR  Drug Rehabilitation Requirement 
DSD  Drug Strategy Directorate 
DT Department of Transport 
DTORS Drug Treatment Outcomes Research Study 
DTTO Drug Treatment and Testing Order 
DVLA Driver and Vehicle Licensing Agency 
DWP Department for Work and Pensions 
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ECM Every Child Matters 
EDDRA Exchange on Drug Demand Reduction Action 
EIU  Effective Interventions Unit 
EMCDDA  European Monitoring Centre for Drugs and Drug Addiction 
ESI  Education Sector Initiative 
ESPAD European School Survey Project on Alcohol and Other Drugs 
ESRC Economic and Social Research Council 
ETE  Education, Training and Employment 
EU European Union 
EYTC Edinburgh Youth Transitions Survey 
FIT Field Impairment Test 
FIUI Fatal injuries due to psychoactive drug intoxication 
FSS  Forensic Science Service 
FUP File Upload Portal 
GCSE General Certificate of Education 
GHB  Gamma hydroxybutyrate  
GLADA Greater London Alcohol and Drug Alliance 
GMR  General Mortality Register  
GO  Government Office 
GP  General Practitioner 
GRO  General Register Offices for England and Wales 
GRONI  General Register Office for Northern Ireland 
GROS  General Register Office for Scotland 
HAS  Health Advisory Service  
HBSC  Health Behaviour in School Aged Children 
HBV  Hepatitis B Virus 
HCAs High Crack Areas 
HCV  Hepatitis C Virus 
HDA Health Development Agency 
HIV  Human Immunodeficiency Virus  
HMPS Her Majesty’s Prison Service for England and Wales 
HMSO Her Majesty’s Stationary Office 
HOSDB Home Office Scientific Development Branch 
HPA  Health Protection Agency 
HPS Health Protection Scotland 
HSSB Health and Social Service Boards 
HSSD The Housing Strategy and Support Directorate 
ICD-10 International Statistical Classification of Diseases and Related Health 
Problems – tenth edition 
IDTS  Integrated Drug Treatment System 
IDUs Injecting Drug Users 
ISD ISD Information Services Division 
ITMDF Integrated Team Monitoring Data Form 
KPI Key Performance Indicator 
LAAs Local Area Agreements 
LCJBs   Local Criminal Justice Boards 
LDP Local Delivery Plan 
LDPF  London Drug Policy Forum 
LSCB Local Safeguarding Children Boards 
LSCB Local Safeguarding Children’s Boards 
LSD  Lysergic Dyethylamide acid  
LSPs Local Strategic Partnerships 
LST Life Skills Training 
MCA Medicines Control Agency 
MDA  Methylenedioxymethamphetamine  
MDMA  3,4-Methylenedioxy-n-methylamphetamine 
MDT  Mandatory Drug Tests  
MHRA  Medicines and Health Care Products Regulation Agency  
MMDU Merseyside Middle Market Drugs Unit 
MRC Medical Research Council  
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MRSA Methicillin resistant Staphylococcus aureus 
NACD National Advisory Committee on Drugs 
NatCen  National Centre for Social Research 
NCCDP National Collaborating Centre for Drug Prevention 
NCIS  National Criminal Intelligence Service 
NDEC  National Drug Evidence Centre 
NFER  National Foundation for Educational Research  
NHS  National Health Service 
NHSS National Healthy Schools Standard 
NICE  National Institute for Clinical and Health Excellence 
NICS Northern Ireland Court Services 
NICS  Northern Ireland Crime Survey 
NIDPS Northern Ireland Drug Prevalence Survey 
NIO Northern Ireland Office 
NOMS  National Offender Management Service 
np-SAD  National Programme on Substance Abuse Deaths 
NSDSG New Strategic Direction for Alcohol and Drugs Steering Group 
NTA  National Treatment Agency 
NTORS  National Treatment Outcome Research Study 
OCJS Offending Crime and Justice Survey 
OCJS Offending, Crime and Justice Survey 
ODPM Office of the Deputy Prime Minister 
Ofsted  Office for Standards in Education 
ONS  Office for National Statistics  
OPSI Office of Public Sector Information 
OR Odds ratio 
p2w  Progress2Work 
PCTs  Primary Care Trusts 
PDI Partnership Drugs Initiative 
PF Positive Futures 
PHSE Personal, Social and Health Education 
POCA  Proceeds of Crime Act 
PPO  Prolific and other Priority Offender 
PSA  Public Service Agreement  
PSHE Personal, Social and Health Education 
PSHE Personal, Social and Health Education 
PSNI Prison Service Northern Ireland 
RAC Royal Automobile Club 
RCGP  Royal College of General Practitioners 
RDS  Research Development and Statistics- 
REIA Race equality impact assessment 
RoB  Restriction on Bail 
RoB  Restriction on Bail 
SACDM Scottish Advisory Committee on Drugs Misuse 
SAD Scotland Against Drugs 
SALSUS  Scottish Schools Adolescent Lifestyle and Substance Use Survey 
SCDEA.  Scottish Crime and Drug Enforcement Agency 
SCHWL   Scottish Centre for Healthy Working Lives 
SCIEH  Scottish Centre for Infection and Environmental Health  
SCoPiC Social Contexts of Pathways into Crime 
SCS Scottish Crime Survey 
SCVS Scottish Crime and Victimisation Survey 
SDEA Scottish Drug Enforcement Agency 
SHAs Strategic Health Authorities 
SMATs Substance Misuse Action Teams 
SMMGP Substance Misuse Management in General Practice 
SMR  Special Mortality Register  
SMRT Substance Misuse Research Team 
SOCA Serious Organised Crime Agency 
SPS  Scottish Prison Service 
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SSLP Sure Start Local Programmes 
STI  Sexually Transmitted Infection 
TAS  Throughcare Addiction Service 
TC  Therapeutic community  
TDI Treatment Demand Indicator 
UAPMP  Unlinked Anonymous Prevalence Monitoring Programme 
UKADCU United Kingdom Anti Drugs Co ordination Unit 
VDT  Voluntary Drug Testing 
VSA  Volatile Substance Abuse 
WHO World Health Organisation 
YOT Youth Offending Team 
YPBAS Young Persons Behaviour and Attitudes Survey 
YPSMG  Young People Substance Misuse Partnership Grant 
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List of websites used in the text 
 
Aberlour 
www.aberlour.org.uk 
 
Bank of England 
www.bankofengland.co.uk 
 
British Broadcasting Corporation 
www.bbc.co.uk 
 
British Medical Association 
www.bma.org.uk 
 
British National Formulary 
www.bnf.org.uk 
 
Central Survey Unit, Northern Ireland 
Statistical Research Agency (NISRA) 
www.csu.nisra.gov.uk 
 
Centre for Drug Misuse Research, University 
of Glasgow 
www.gla.ac.uk/centres/drugmisuse 
 
Centre for Public Health, Liverpool John 
Moores University 
www.cph.org.uk 
 
Cocaine Organisation 
www.cocaine.org 
 
Communicable Disease Surveillance Centre, 
Northern Ireland 
www.cdscni.org.uk 
 
Commission for racial equality 
www.cre.gov.uk 
 
Criminal Justice System in England and 
Wales. 
www.cjsonline.gov.uk 
 
Department for Communities and Local 
Government 
www.communities.gov.uk 
 
Department for Education and Skills 
www.dfes.gov.uk 
 
Department for Transport 
www.dft.gov.uk 
 
Department for Transport, Local Government 
and the Regions 
www.dltr.gov.uk 
 
Department for Environment, Food and Rural 
Affairs 
http://www.defra.gov.uk 
 
Department of Health 
www.dh.gov.uk 
 
Department of Health, Social Services and 
Public Safety, Northern Ireland 
www.dhsspsni.gov.uk 
 
Driver and Vehicle Licensing Agency 
www.dvla.gov.uk 
 
Department of Transport Drug Drive 
www.drugdrive.com 
 
Drug Treatment Monitoring Unit (DTMU) 
www.dtmu.org.uk 
 
Northern Ireland drugs and alcohol website 
for professionals 
www.drugsalcohol 
 
Drug Information in Northern Ireland 
www.nics.gov.uk 
 
Drugs Misuse Information Scotland 
www.drugmisuse.isd.scotland.org 
 
National Collaborating Centre for Drug 
Prevention 
www.drugpreventionevidence 
 
Drug Rehab and Alcohol Treatment Centre 
www.drugrehab.co.uk 
 
Drugs Strategy Directorate, Home Office 
www.drugs.gov.uk 
 
DrugScope 
www.drugscope.org.uk 
 
Drug Treatment Outcomes Research Study 
http://www.dtors.org.uk 
 
Edinburgh Law School 
www.law.ed.ac.uk 
 
Every Child Matters 
www.everychildmatters.gov.uk 
 
FRANK 
www.talktofrank.com 
 
The Fostering Network 
www.fostering.net 
 
General Register Office 
www.gro.gov.uk 
 
Government News Network 
www.gnn.gov.uk 
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General Register Office for Scotland 
www.gro-scotland.gov 
 
General Register Office Northern Ireland 
www.groni.gov.uk 
 
Health Behaviour in School-aged Children 
www.hbsc.org 
 
Health Protection Agency 
www.hpa.org.uk 
 
Health Protection Scotland 
http://www.hps.scot.nhs.uk/ 
 
Healthcare Commission 
www.healthcarecommission.org.uk 
 
Her Majesty’s Prison Service for England and 
Wales 
www.hmprison.gov.uk 
 
Her Majesty’s Treasury 
www.hm-treasury.gov.uk 
 
Home Office 
www.homeoffice.gov.uk 
 
The Information Centre, National Health 
Service 
www.ic.nhs.uk 
 
Information Services Division, Scotland 
www.isdscotland.org 
 
Joseph Rowntree Foundation 
www.jrf.org.uk 
 
JustBeWell.com Hypnotherapy and NLP 
www.justbewell.com 
 
Keele University 
www.kcl.ac.uk 
 
King’s College, University of London 
www.kcl.ac.uk 
 
Know the Score 
www.knowthescore.info 
 
London government 
www.london.gov.uk 
 
Loughborough University 
www.lboro.ac.uk 
 
Matrix Research and Consultancy 
www.matrixcl.co.uk 
 
Medical Research Council 
www.mrc.ac.uk 
Mental Health Care 
www.mentalhealthcare.org 
 
National Collaborating Centre for Drug 
Prevention 
www.cph.org.uk/nccdp 
 
National Institute for Health and Clinical 
Excellence 
www.nice.org.uk 
 
National Treatment Agency for Substance 
Misuse 
www.nta.nhs.uk 
 
Northern Ireland Office 
www.nio.gov.uk 
 
Office of Public Sector Information 
www.opsi.gov.uk 
 
Office for National Statistics 
www.statistics.gov.uk 
 
Office for Standards in Education 
www.ofsted.gov.uk 
 
Police Service Northern Ireland 
www.psni.police.uk 
 
Politics.co.uk 
www.politics.co.uk 
 
Probation Board Northern Ireland 
www.pbni.org.uk 
 
Queen’s University, Belfast 
www.qub.ac.uk 
 
RAC Foundation 
www.racfoundation.org 
 
Race and Drugs Project 
www.raceanddrugsproject.co.uk 
 
Re-solv 
www.re-solv.org 
 
Royal College of General Practitioners 
www.rcgp.org.uk 
 
The Royal Pharmaceutical Society of Great 
Britain 
www.rpsgb.org.uk 
 
School of Law, University of Edinburgh 
www.law.ed.ac.uk 
 
Scottish Drug Enforcement Agency 
www.sdea.police.uk 
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Scottish Executive 
www.scotland.gov.uk 
 
Scottish Police Forces 
www.scottish.police.uk 
 
Scottish Prison Service 
www.sps.gov.uk 
 
Scottish Road Safety Campaign 
www.srsc.org.uk 
 
Serious Organised Crime Agency 
www.soca.gov.uk 
 
Skills for Justice 
www.skillsforjustice 
 
University of Sheffield 
www.shef.ac.uk 
 
Sure Start 
www.surestart.gov.uk 
 
Standards Site, Department for Education 
and Skills 
www.standards.dfes.gov.uk 
 
The Stationary Office 
www.official-documents 
 
Substance Misuse Management in General 
Practice 
www.smmgp.demon.co.uk 
 
Road Safety for Scotland 
http://www.road-safety.org.uk 
 
Teachernet 
www.teachernet.gov.uk 
 
Transport for London 
www.tfl.gov.uk 
 
Think 
www.drugdrive.co.uk 
 
Times 
www.timesonline.co.uk 
 
Turning Point 
www.turning-point.co.uk 
 
The United Kingdom Parliament 
www.parliament.uk 
 
United Kingdom Parliament 
www.parliament.uk 
 
VSA Reports 
www.vsareports.org. 
Welsh Assembly Government 
www.wales.gov.uk 
 
Welsh Local Government Association 
www.wlga.gov.uk  
 
Wired for Health 
www.wiredforhealth.gov.uk 
 
World Health Organisation Regional Office for 
Europe 
www.euro.who.int 
 
Youth Justice Board 
www.youth-justice-board.gov.uk 
